id	sid	tid	token	lemma	pos
chd-104	1	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-104	1	2	e1	e1	NOUN
chd-104	1	3	cancer	cancer	NOUN
chd-104	1	4	health	health	NOUN
chd-104	1	5	disparities	disparity	NOUN
chd-104	1	6	research	research	VERB
chd-104	1	7	notch	notch	ADJ
chd-104	1	8	signaling	signal	VERB
chd-104	1	9	pathway	pathway	NOUN
chd-104	1	10	:	:	PUNCT
chd-104	1	11	an	an	DET
chd-104	1	12	emerging	emerge	VERB
chd-104	1	13	therapeutic	therapeutic	ADJ
chd-104	1	14	target	target	NOUN
chd-104	1	15	for	for	ADP
chd-104	1	16	african	african	ADJ
chd-104	1	17	-	-	PUNCT
chd-104	1	18	american	american	ADJ
chd-104	1	19	triple	triple	ADJ
chd-104	1	20	negative	negative	ADJ
chd-104	1	21	breast	breast	NOUN
chd-104	1	22	cancer	cancer	NOUN
chd-104	1	23	patients	patient	NOUN
chd-104	1	24	nikita	nikita	VERB
chd-104	1	25	wright1	wright1	PROPN
chd-104	1	26	&	&	CCONJ
chd-104	1	27	,	,	PUNCT
chd-104	1	28	shristi	shristi	PROPN
chd-104	1	29	bhattarai1	bhattarai1	PROPN
chd-104	1	30	&	&	CCONJ
chd-104	1	31	,	,	PUNCT
chd-104	1	32	bikram	bikram	PROPN
chd-104	1	33	sahoo1	sahoo1	PROPN
chd-104	1	34	,	,	PUNCT
chd-104	1	35	mishal	mishal	PROPN
chd-104	1	36	imaan	imaan	PROPN
chd-104	1	37	syed1	syed1	PROPN
chd-104	1	38	,	,	PUNCT
chd-104	1	39	padmashree	padmashree	ADJ
chd-104	1	40	rida1	rida1	PROPN
chd-104	1	41	,	,	PUNCT
chd-104	1	42	ritu	ritu	PROPN
chd-104	1	43	aneja1,2	aneja1,2	PROPN
chd-104	1	44	*	*	PROPN
chd-104	1	45	1department	1department	NUM
chd-104	1	46	of	of	ADP
chd-104	1	47	biology	biology	NOUN
chd-104	1	48	,	,	PUNCT
chd-104	1	49	georgia	georgia	PROPN
chd-104	1	50	state	state	PROPN
chd-104	1	51	university	university	PROPN
chd-104	1	52	,	,	PUNCT
chd-104	1	53	atlanta	atlanta	PROPN
chd-104	1	54	,	,	PUNCT
chd-104	1	55	ga	ga	PROPN
chd-104	1	56	30303	30303	NUM
chd-104	1	57	2international	2international	ADJ
chd-104	1	58	consortium	consortium	NOUN
chd-104	1	59	for	for	ADP
chd-104	1	60	advancing	advance	VERB
chd-104	1	61	research	research	NOUN
chd-104	1	62	on	on	ADP
chd-104	1	63	triple	triple	ADJ
chd-104	1	64	negative	negative	ADJ
chd-104	1	65	breast	breast	NOUN
chd-104	1	66	cancer	cancer	NOUN
chd-104	1	67	,	,	PUNCT
chd-104	1	68	georgia	georgia	PROPN
chd-104	1	69	state	state	PROPN
chd-104	1	70	university	university	PROPN
chd-104	1	71	,	,	PUNCT
chd-104	1	72	atlanta	atlanta	PROPN
chd-104	1	73	,	,	PUNCT
chd-104	1	74	ga	ga	PROPN
chd-104	1	75	30303	30303	NUM
chd-104	1	76	&	&	CCONJ
chd-104	1	77	co	co	ADJ
chd-104	1	78	-	-	ADJ
chd-104	1	79	first	first	ADJ
chd-104	1	80	authors	author	NOUN
chd-104	1	81	*	*	PUNCT
chd-104	1	82	corresponding	correspond	VERB
chd-104	1	83	author	author	NOUN
chd-104	1	84	email	email	NOUN
chd-104	1	85	:	:	PUNCT
chd-104	1	86	raneja@gsu.edu	raneja@gsu.edu	NOUN
chd-104	1	87	abstract	abstract	ADJ
chd-104	1	88	the	the	DET
chd-104	1	89	most	most	ADV
chd-104	1	90	fatal	fatal	ADJ
chd-104	1	91	form	form	NOUN
chd-104	1	92	of	of	ADP
chd-104	1	93	breast	breast	NOUN
chd-104	1	94	cancer	cancer	NOUN
chd-104	1	95	,	,	PUNCT
chd-104	1	96	triple	triple	ADJ
chd-104	1	97	negative	negative	ADJ
chd-104	1	98	breast	breast	NOUN
chd-104	1	99	cancer	cancer	NOUN
chd-104	1	100	(	(	PUNCT
chd-104	1	101	tnbc	tnbc	ADV
chd-104	1	102	)	)	PUNCT
chd-104	1	103	,	,	PUNCT
chd-104	1	104	continues	continue	VERB
chd-104	1	105	to	to	PART
chd-104	1	106	challenge	challenge	VERB
chd-104	1	107	clinicians	clinician	NOUN
chd-104	1	108	worldwide	worldwide	ADV
chd-104	1	109	with	with	ADP
chd-104	1	110	its	its	PRON
chd-104	1	111	lack	lack	NOUN
chd-104	1	112	of	of	ADP
chd-104	1	113	reliable	reliable	ADJ
chd-104	1	114	prognostic	prognostic	ADJ
chd-104	1	115	biomarkers	biomarker	NOUN
chd-104	1	116	and	and	CCONJ
chd-104	1	117	pharmacologically	pharmacologically	ADV
chd-104	1	118	actionable	actionable	ADJ
chd-104	1	119	treatment	treatment	NOUN
chd-104	1	120	targets	target	NOUN
chd-104	1	121	.	.	PUNCT
chd-104	2	1	in	in	ADP
chd-104	2	2	the	the	DET
chd-104	2	3	us	us	PROPN
chd-104	2	4	,	,	PUNCT
chd-104	2	5	this	this	DET
chd-104	2	6	aggressive	aggressive	ADJ
chd-104	2	7	disease	disease	NOUN
chd-104	2	8	disproportionately	disproportionately	ADV
chd-104	2	9	afflicts	afflict	VERB
chd-104	2	10	african	african	ADJ
chd-104	2	11	-	-	PUNCT
chd-104	2	12	american	american	ADJ
chd-104	2	13	women	woman	NOUN
chd-104	2	14	at	at	ADP
chd-104	2	15	a	a	DET
chd-104	2	16	rate	rate	NOUN
chd-104	2	17	2	2	NUM
chd-104	2	18	-	-	SYM
chd-104	2	19	3	3	NUM
chd-104	2	20	times	time	NOUN
chd-104	2	21	higher	high	ADJ
chd-104	2	22	than	than	ADP
chd-104	2	23	european	european	ADJ
chd-104	2	24	-	-	PUNCT
chd-104	2	25	american	american	ADJ
chd-104	2	26	(	(	PUNCT
chd-104	2	27	ea	ea	NOUN
chd-104	2	28	)	)	PUNCT
chd-104	2	29	women	woman	NOUN
chd-104	2	30	,	,	PUNCT
chd-104	2	31	thereby	thereby	ADV
chd-104	2	32	contributing	contribute	VERB
chd-104	2	33	to	to	ADP
chd-104	2	34	the	the	DET
chd-104	2	35	observed	observe	VERB
chd-104	2	36	higher	high	ADJ
chd-104	2	37	mortality	mortality	NOUN
chd-104	2	38	rates	rate	NOUN
chd-104	2	39	of	of	ADP
chd-104	2	40	aa	aa	PROPN
chd-104	2	41	bc	bc	PROPN
chd-104	2	42	patients	patient	NOUN
chd-104	2	43	.	.	PUNCT
chd-104	3	1	in	in	ADP
chd-104	3	2	order	order	NOUN
chd-104	3	3	to	to	PART
chd-104	3	4	address	address	VERB
chd-104	3	5	the	the	DET
chd-104	3	6	unmet	unmet	NOUN
chd-104	3	7	clinical	clinical	ADJ
chd-104	3	8	need	need	NOUN
chd-104	3	9	for	for	ADP
chd-104	3	10	new	new	ADJ
chd-104	3	11	and	and	CCONJ
chd-104	3	12	effective	effective	ADJ
chd-104	3	13	treatments	treatment	NOUN
chd-104	3	14	for	for	ADP
chd-104	3	15	aa	aa	NOUN
chd-104	3	16	tnbcs	tnbc	NOUN
chd-104	3	17	,	,	PUNCT
chd-104	3	18	we	we	PRON
chd-104	3	19	describe	describe	VERB
chd-104	3	20	herein	herein	NOUN
chd-104	3	21	a	a	DET
chd-104	3	22	potentially	potentially	ADV
chd-104	3	23	actionable	actionable	ADJ
chd-104	3	24	pathway	pathway	NOUN
chd-104	3	25	that	that	PRON
chd-104	3	26	appears	appear	VERB
chd-104	3	27	to	to	PART
chd-104	3	28	be	be	AUX
chd-104	3	29	in	in	ADP
chd-104	3	30	overdrive	overdrive	NOUN
chd-104	3	31	in	in	ADP
chd-104	3	32	tnbcs	tnbc	NOUN
chd-104	3	33	of	of	ADP
chd-104	3	34	aa	aa	PROPN
chd-104	3	35	patients	patient	NOUN
chd-104	3	36	compared	compare	VERB
chd-104	3	37	to	to	ADP
chd-104	3	38	ea	ea	NOUN
chd-104	3	39	tnbcs	tnbc	NOUN
chd-104	3	40	:	:	PUNCT
chd-104	3	41	the	the	DET
chd-104	3	42	notch	notch	ADJ
chd-104	3	43	signaling	signal	VERB
chd-104	3	44	pathway	pathway	NOUN
chd-104	3	45	.	.	PUNCT
chd-104	4	1	notch	notch	ADJ
chd-104	4	2	signaling	signal	VERB
chd-104	4	3	is	be	AUX
chd-104	4	4	implicated	implicate	VERB
chd-104	4	5	in	in	ADP
chd-104	4	6	multiple	multiple	ADJ
chd-104	4	7	aspects	aspect	NOUN
chd-104	4	8	of	of	ADP
chd-104	4	9	carcinogenesis	carcinogenesis	NOUN
chd-104	4	10	and	and	CCONJ
chd-104	4	11	tumor	tumor	NOUN
chd-104	4	12	progression	progression	NOUN
chd-104	4	13	including	include	VERB
chd-104	4	14	the	the	DET
chd-104	4	15	regulation	regulation	NOUN
chd-104	4	16	of	of	ADP
chd-104	4	17	proliferation	proliferation	NOUN
chd-104	4	18	,	,	PUNCT
chd-104	4	19	apoptosis	apoptosis	NOUN
chd-104	4	20	,	,	PUNCT
chd-104	4	21	the	the	DET
chd-104	4	22	biology	biology	NOUN
chd-104	4	23	of	of	ADP
chd-104	4	24	cancer	cancer	NOUN
chd-104	4	25	stem	stem	NOUN
chd-104	4	26	cells	cell	NOUN
chd-104	4	27	,	,	PUNCT
chd-104	4	28	tumor	tumor	NOUN
chd-104	4	29	angiogenesis	angiogenesis	NOUN
chd-104	4	30	and	and	CCONJ
chd-104	4	31	epithelial	epithelial	ADJ
chd-104	4	32	-	-	PUNCT
chd-104	4	33	to	to	ADP
chd-104	4	34	-	-	PUNCT
chd-104	4	35	mesenchymal	mesenchymal	NOUN
chd-104	4	36	transition	transition	NOUN
chd-104	4	37	.	.	PUNCT
chd-104	5	1	our	our	PRON
chd-104	5	2	gene	gene	NOUN
chd-104	5	3	expression	expression	NOUN
chd-104	5	4	analyses	analysis	NOUN
chd-104	5	5	have	have	AUX
chd-104	5	6	uncovered	uncover	VERB
chd-104	5	7	significant	significant	ADJ
chd-104	5	8	upregulation	upregulation	NOUN
chd-104	5	9	of	of	ADP
chd-104	5	10	notch	notch	NOUN
chd-104	5	11	signaling	signal	VERB
chd-104	5	12	as	as	ADV
chd-104	5	13	well	well	ADV
chd-104	5	14	as	as	ADP
chd-104	5	15	gene	gene	NOUN
chd-104	5	16	ontologies	ontology	NOUN
chd-104	5	17	reflecting	reflect	VERB
chd-104	5	18	dysregulation	dysregulation	NOUN
chd-104	5	19	of	of	ADP
chd-104	5	20	key	key	ADJ
chd-104	5	21	processes	process	NOUN
chd-104	5	22	regulated	regulate	VERB
chd-104	5	23	by	by	ADP
chd-104	5	24	notch	notch	NOUN
chd-104	5	25	signaling	signal	VERB
chd-104	5	26	among	among	ADP
chd-104	5	27	aa	aa	NOUN
chd-104	5	28	compared	compare	VERB
chd-104	5	29	to	to	ADP
chd-104	5	30	ea	ea	NOUN
chd-104	5	31	tnbc	tnbc	VERB
chd-104	5	32	patients	patient	NOUN
chd-104	5	33	.	.	PUNCT
chd-104	6	1	furthermore	furthermore	ADV
chd-104	6	2	,	,	PUNCT
chd-104	6	3	we	we	PRON
chd-104	6	4	present	present	VERB
chd-104	6	5	evidence	evidence	NOUN
chd-104	6	6	suggesting	suggest	VERB
chd-104	6	7	that	that	SCONJ
chd-104	6	8	upregulated	upregulate	VERB
chd-104	6	9	notch	notch	NOUN
chd-104	6	10	signaling	signal	VERB
chd-104	6	11	may	may	AUX
chd-104	6	12	predict	predict	VERB
chd-104	6	13	poor	poor	ADJ
chd-104	6	14	prognosis	prognosis	NOUN
chd-104	6	15	in	in	ADP
chd-104	6	16	tnbc	tnbc	NOUN
chd-104	6	17	.	.	PUNCT
chd-104	7	1	our	our	PRON
chd-104	7	2	findings	finding	NOUN
chd-104	7	3	thus	thus	ADV
chd-104	7	4	suggest	suggest	VERB
chd-104	7	5	differences	difference	NOUN
chd-104	7	6	in	in	ADP
chd-104	7	7	notch	notch	NOUN
chd-104	7	8	signaling	signal	VERB
chd-104	7	9	among	among	ADP
chd-104	7	10	racially	racially	ADV
chd-104	7	11	-	-	PUNCT
chd-104	7	12	distinct	distinct	ADJ
chd-104	7	13	tnbc	tnbc	NOUN
chd-104	7	14	patients	patient	NOUN
chd-104	7	15	that	that	PRON
chd-104	7	16	may	may	AUX
chd-104	7	17	contribute	contribute	VERB
chd-104	7	18	to	to	ADP
chd-104	7	19	the	the	DET
chd-104	7	20	more	more	ADV
chd-104	7	21	aggressive	aggressive	ADJ
chd-104	7	22	clinical	clinical	ADJ
chd-104	7	23	behavior	behavior	NOUN
chd-104	7	24	of	of	ADP
chd-104	7	25	tnbc	tnbc	NOUN
chd-104	7	26	in	in	ADP
chd-104	7	27	aas	aas	PROPN
chd-104	7	28	.	.	PUNCT
chd-104	8	1	these	these	DET
chd-104	8	2	observations	observation	NOUN
chd-104	8	3	also	also	ADV
chd-104	8	4	suggest	suggest	VERB
chd-104	8	5	that	that	SCONJ
chd-104	8	6	notch	notch	NOUN
chd-104	8	7	signaling	signal	VERB
chd-104	8	8	may	may	AUX
chd-104	8	9	be	be	AUX
chd-104	8	10	an	an	DET
chd-104	8	11	attractive	attractive	ADJ
chd-104	8	12	therapeutic	therapeutic	ADJ
chd-104	8	13	target	target	NOUN
chd-104	8	14	for	for	ADP
chd-104	8	15	high	high	ADJ
chd-104	8	16	-	-	PUNCT
chd-104	8	17	risk	risk	NOUN
chd-104	8	18	aa	aa	NOUN
chd-104	8	19	tnbc	tnbc	PROPN
chd-104	8	20	patients	patient	NOUN
chd-104	8	21	.	.	PUNCT
chd-104	9	1	keywords	keyword	NOUN
chd-104	9	2	:	:	PUNCT
chd-104	9	3	triple	triple	ADJ
chd-104	9	4	negative	negative	ADJ
chd-104	9	5	breast	breast	NOUN
chd-104	9	6	cancer	cancer	NOUN
chd-104	9	7	,	,	PUNCT
chd-104	9	8	racial	racial	ADJ
chd-104	9	9	disparity	disparity	NOUN
chd-104	9	10	,	,	PUNCT
chd-104	9	11	notch	notch	ADJ
chd-104	9	12	signaling	signal	VERB
chd-104	9	13	pathway	pathway	NOUN
chd-104	9	14	,	,	PUNCT
chd-104	9	15	africanamerican	africanamerican	PROPN
chd-104	9	16	citation	citation	NOUN
chd-104	9	17	:	:	PUNCT
chd-104	10	1	wright	wright	PROPN
chd-104	10	2	n	n	PROPN
chd-104	10	3	et	et	NOUN
chd-104	10	4	al	al	PROPN
chd-104	10	5	(	(	PUNCT
chd-104	10	6	2019	2019	NUM
chd-104	10	7	)	)	PUNCT
chd-104	10	8	notch	notch	NOUN
chd-104	10	9	signaling	signal	VERB
chd-104	10	10	pathway	pathway	NOUN
chd-104	10	11	:	:	PUNCT
chd-104	10	12	an	an	DET
chd-104	10	13	emerging	emerge	VERB
chd-104	10	14	therapeutic	therapeutic	ADJ
chd-104	10	15	target	target	NOUN
chd-104	10	16	for	for	ADP
chd-104	10	17	africanamerican	africanamerican	ADJ
chd-104	10	18	triple	triple	ADJ
chd-104	10	19	negative	negative	ADJ
chd-104	10	20	breast	breast	NOUN
chd-104	10	21	cancer	cancer	NOUN
chd-104	10	22	patients	patient	NOUN
chd-104	10	23	.	.	PUNCT
chd-104	11	1	cancer	cancer	NOUN
chd-104	11	2	health	health	NOUN
chd-104	11	3	disparities	disparity	NOUN
chd-104	11	4	3	3	NUM
chd-104	11	5	:	:	PUNCT
chd-104	11	6	e1	e1	NOUN
chd-104	11	7	-	-	PUNCT
chd-104	11	8	e22	e22	NOUN
chd-104	11	9	.	.	PUNCT
chd-104	12	1	doi:10.9777	doi:10.9777	VERB
chd-104	12	2	/	/	SYM
chd-104	12	3	chd.2019.1013	chd.2019.1013	NUM
chd-104	12	4	.	.	PUNCT
chd-104	12	5	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-104	12	6	e2	e2	PROPN
chd-104	12	7	cancer	cancer	NOUN
chd-104	12	8	health	health	NOUN
chd-104	12	9	disparities	disparity	NOUN
chd-104	12	10	research	research	VERB
chd-104	12	11	the	the	DET
chd-104	12	12	tip	tip	NOUN
chd-104	12	13	of	of	ADP
chd-104	12	14	the	the	DET
chd-104	12	15	iceberg	iceberg	NOUN
chd-104	12	16	:	:	PUNCT
chd-104	12	17	racial	racial	ADJ
chd-104	12	18	disparities	disparity	NOUN
chd-104	12	19	in	in	ADP
chd-104	12	20	triple	triple	ADJ
chd-104	12	21	negative	negative	ADJ
chd-104	12	22	breast	breast	NOUN
chd-104	12	23	cancer	cancer	NOUN
chd-104	12	24	triple	triple	ADP
chd-104	12	25	negative	negative	ADJ
chd-104	12	26	breast	breast	NOUN
chd-104	12	27	cancer	cancer	NOUN
chd-104	12	28	(	(	PUNCT
chd-104	12	29	tnbc	tnbc	ADV
chd-104	12	30	)	)	PUNCT
chd-104	12	31	is	be	AUX
chd-104	12	32	a	a	DET
chd-104	12	33	significant	significant	ADJ
chd-104	12	34	public	public	ADJ
chd-104	12	35	health	health	NOUN
chd-104	12	36	concern	concern	NOUN
chd-104	12	37	in	in	ADP
chd-104	12	38	the	the	DET
chd-104	12	39	us	us	PROPN
chd-104	12	40	as	as	SCONJ
chd-104	12	41	it	it	PRON
chd-104	12	42	afflicts	afflict	VERB
chd-104	12	43	about	about	ADV
chd-104	12	44	one	one	NUM
chd-104	12	45	-	-	PUNCT
chd-104	12	46	fifth	fifth	NOUN
chd-104	12	47	of	of	ADP
chd-104	12	48	the	the	DET
chd-104	12	49	~2.8	~2.8	NOUN
chd-104	12	50	million	million	NUM
chd-104	12	51	women	woman	NOUN
chd-104	12	52	in	in	ADP
chd-104	12	53	the	the	DET
chd-104	12	54	country	country	NOUN
chd-104	12	55	with	with	ADP
chd-104	12	56	breast	breast	NOUN
chd-104	12	57	cancer	cancer	NOUN
chd-104	12	58	(	(	PUNCT
chd-104	12	59	bc	bc	PROPN
chd-104	12	60	)	)	PUNCT
chd-104	12	61	(	(	PUNCT
chd-104	12	62	criscitiello	criscitiello	PROPN
chd-104	12	63	et	et	PROPN
chd-104	12	64	al	al	PROPN
chd-104	12	65	.	.	PROPN
chd-104	12	66	,	,	PUNCT
chd-104	12	67	2012	2012	NUM
chd-104	12	68	;	;	PUNCT
chd-104	12	69	howlader	howlader	NOUN
chd-104	12	70	n	n	CCONJ
chd-104	12	71	,	,	PUNCT
chd-104	12	72	2014	2014	NUM
chd-104	12	73	)	)	PUNCT
chd-104	12	74	.	.	PUNCT
chd-104	13	1	worldwide	worldwide	ADV
chd-104	13	2	,	,	PUNCT
chd-104	13	3	the	the	DET
chd-104	13	4	disease	disease	NOUN
chd-104	13	5	accounts	account	VERB
chd-104	13	6	for	for	ADP
chd-104	13	7	approximately	approximately	ADV
chd-104	13	8	20	20	NUM
chd-104	13	9	%	%	NOUN
chd-104	13	10	of	of	ADP
chd-104	13	11	bc	bc	PROPN
chd-104	13	12	cases	case	NOUN
chd-104	13	13	.	.	PUNCT
chd-104	14	1	tnbc	tnbc	PROPN
chd-104	14	2	is	be	AUX
chd-104	14	3	the	the	DET
chd-104	14	4	most	most	ADV
chd-104	14	5	clinically	clinically	ADV
chd-104	14	6	challenging	challenging	ADJ
chd-104	14	7	subtype	subtype	NOUN
chd-104	14	8	of	of	ADP
chd-104	14	9	bc	bc	PROPN
chd-104	14	10	as	as	SCONJ
chd-104	14	11	it	it	PRON
chd-104	14	12	lacks	lack	VERB
chd-104	14	13	expression	expression	NOUN
chd-104	14	14	of	of	ADP
chd-104	14	15	the	the	DET
chd-104	14	16	pharmacologically	pharmacologically	ADV
chd-104	14	17	-	-	PUNCT
chd-104	14	18	targetable	targetable	ADJ
chd-104	14	19	estrogen	estrogen	NOUN
chd-104	14	20	receptor	receptor	NOUN
chd-104	14	21	(	(	PUNCT
chd-104	14	22	er	er	INTJ
chd-104	14	23	)	)	PUNCT
chd-104	14	24	,	,	PUNCT
chd-104	14	25	progesterone	progesterone	NOUN
chd-104	14	26	receptor	receptor	NOUN
chd-104	14	27	(	(	PUNCT
chd-104	14	28	pr	pr	NOUN
chd-104	14	29	)	)	PUNCT
chd-104	14	30	and	and	CCONJ
chd-104	14	31	human	human	ADJ
chd-104	14	32	epidermal	epidermal	ADJ
chd-104	14	33	growth	growth	NOUN
chd-104	14	34	factor	factor	NOUN
chd-104	14	35	receptor	receptor	NOUN
chd-104	14	36	2	2	NUM
chd-104	14	37	(	(	PUNCT
chd-104	14	38	her2	her2	PROPN
chd-104	14	39	)	)	PUNCT
chd-104	14	40	(	(	PUNCT
chd-104	14	41	bianchini	bianchini	PROPN
chd-104	14	42	et	et	PROPN
chd-104	14	43	al	al	PROPN
chd-104	14	44	.	.	PROPN
chd-104	14	45	,	,	PUNCT
chd-104	14	46	2016b	2016b	NUM
chd-104	14	47	;	;	PUNCT
chd-104	14	48	lehmann	lehmann	PROPN
chd-104	14	49	et	et	PROPN
chd-104	14	50	al	al	PROPN
chd-104	14	51	.	.	PROPN
chd-104	14	52	,	,	PUNCT
chd-104	14	53	2011	2011	NUM
chd-104	14	54	;	;	PUNCT
chd-104	14	55	shah	shah	PROPN
chd-104	14	56	et	et	PROPN
chd-104	14	57	al	al	PROPN
chd-104	14	58	.	.	PROPN
chd-104	14	59	,	,	PUNCT
chd-104	14	60	2012	2012	NUM
chd-104	14	61	)	)	PUNCT
chd-104	14	62	.	.	PUNCT
chd-104	15	1	furthermore	furthermore	ADV
chd-104	15	2	,	,	PUNCT
chd-104	15	3	the	the	DET
chd-104	15	4	disease	disease	NOUN
chd-104	15	5	is	be	AUX
chd-104	15	6	characterized	characterize	VERB
chd-104	15	7	by	by	ADP
chd-104	15	8	high	high	ADJ
chd-104	15	9	rates	rate	NOUN
chd-104	15	10	of	of	ADP
chd-104	15	11	recurrence	recurrence	NOUN
chd-104	15	12	and	and	CCONJ
chd-104	15	13	metastases	metastasis	NOUN
chd-104	15	14	,	,	PUNCT
chd-104	15	15	especially	especially	ADV
chd-104	15	16	within	within	ADP
chd-104	15	17	the	the	DET
chd-104	15	18	first	first	ADJ
chd-104	15	19	five	five	NUM
chd-104	15	20	years	year	NOUN
chd-104	15	21	post	post	NOUN
chd-104	15	22	diagnosis	diagnosis	NOUN
chd-104	15	23	(	(	PUNCT
chd-104	15	24	bianchini	bianchini	PROPN
chd-104	15	25	et	et	PROPN
chd-104	15	26	al	al	PROPN
chd-104	15	27	.	.	PROPN
chd-104	15	28	,	,	PUNCT
chd-104	15	29	2016a	2016a	NUM
chd-104	15	30	;	;	PUNCT
chd-104	15	31	kassam	kassam	PROPN
chd-104	15	32	et	et	PROPN
chd-104	15	33	al	al	PROPN
chd-104	15	34	.	.	PROPN
chd-104	15	35	,	,	PUNCT
chd-104	15	36	2009	2009	NUM
chd-104	15	37	;	;	PUNCT
chd-104	15	38	lehmann	lehmann	PROPN
chd-104	15	39	et	et	PROPN
chd-104	15	40	al	al	PROPN
chd-104	15	41	.	.	PROPN
chd-104	15	42	,	,	PUNCT
chd-104	15	43	2011	2011	NUM
chd-104	15	44	;	;	PUNCT
chd-104	15	45	shah	shah	PROPN
chd-104	15	46	et	et	PROPN
chd-104	15	47	al	al	PROPN
chd-104	15	48	.	.	PROPN
chd-104	15	49	,	,	PUNCT
chd-104	15	50	2012	2012	NUM
chd-104	15	51	)	)	PUNCT
chd-104	15	52	.	.	PUNCT
chd-104	16	1	tnbcs	tnbc	NOUN
chd-104	16	2	exhibit	exhibit	VERB
chd-104	16	3	high	high	ADJ
chd-104	16	4	interpatient	interpatient	NOUN
chd-104	16	5	heterogeneity	heterogeneity	NOUN
chd-104	16	6	and	and	CCONJ
chd-104	16	7	many	many	ADJ
chd-104	16	8	classification	classification	NOUN
chd-104	16	9	schemes	scheme	NOUN
chd-104	16	10	have	have	AUX
chd-104	16	11	emerged	emerge	VERB
chd-104	16	12	that	that	PRON
chd-104	16	13	categorize	categorize	VERB
chd-104	16	14	tnbcs	tnbc	NOUN
chd-104	16	15	into	into	ADP
chd-104	16	16	transcriptomically	transcriptomically	ADV
chd-104	16	17	-	-	PUNCT
chd-104	16	18	distinct	distinct	ADJ
chd-104	16	19	molecular	molecular	ADJ
chd-104	16	20	subtypes	subtype	NOUN
chd-104	16	21	and	and	CCONJ
chd-104	16	22	with	with	ADP
chd-104	16	23	unique	unique	ADJ
chd-104	16	24	dna	dna	PROPN
chd-104	16	25	copy	copy	VERB
chd-104	16	26	number	number	NOUN
chd-104	16	27	variations	variation	NOUN
chd-104	16	28	(	(	PUNCT
chd-104	16	29	burstein	burstein	VERB
chd-104	16	30	et	et	PROPN
chd-104	16	31	al	al	PROPN
chd-104	16	32	.	.	PROPN
chd-104	16	33	,	,	PUNCT
chd-104	16	34	2015	2015	NUM
chd-104	16	35	;	;	PUNCT
chd-104	16	36	lehmann	lehmann	PROPN
chd-104	16	37	et	et	PROPN
chd-104	16	38	al	al	PROPN
chd-104	16	39	.	.	PROPN
chd-104	16	40	,	,	PUNCT
chd-104	16	41	2016	2016	NUM
chd-104	16	42	)	)	PUNCT
chd-104	16	43	.	.	PUNCT
chd-104	17	1	tnbcs	tnbc	NOUN
chd-104	17	2	also	also	ADV
chd-104	17	3	exhibit	exhibit	VERB
chd-104	17	4	intratumoral	intratumoral	ADJ
chd-104	17	5	heterogeneity	heterogeneity	NOUN
chd-104	17	6	which	which	PRON
chd-104	17	7	,	,	PUNCT
chd-104	17	8	together	together	ADV
chd-104	17	9	with	with	ADP
chd-104	17	10	the	the	DET
chd-104	17	11	lack	lack	NOUN
chd-104	17	12	of	of	ADP
chd-104	17	13	clinically	clinically	ADV
chd-104	17	14	facile	facile	ADJ
chd-104	17	15	methods	method	NOUN
chd-104	17	16	of	of	ADP
chd-104	17	17	determining	determine	VERB
chd-104	17	18	molecular	molecular	ADJ
chd-104	17	19	subtypes	subtype	NOUN
chd-104	17	20	,	,	PUNCT
chd-104	17	21	thwarts	thwart	VERB
chd-104	17	22	the	the	DET
chd-104	17	23	development	development	NOUN
chd-104	17	24	of	of	ADP
chd-104	17	25	novel	novel	ADJ
chd-104	17	26	targeted	target	VERB
chd-104	17	27	treatments	treatment	NOUN
chd-104	17	28	.	.	PUNCT
chd-104	18	1	thus	thus	ADV
chd-104	18	2	,	,	PUNCT
chd-104	18	3	despite	despite	SCONJ
chd-104	18	4	advances	advance	NOUN
chd-104	18	5	in	in	ADP
chd-104	18	6	treatments	treatment	NOUN
chd-104	18	7	for	for	ADP
chd-104	18	8	other	other	ADJ
chd-104	18	9	bc	bc	PROPN
chd-104	18	10	subtypes	subtype	NOUN
chd-104	18	11	,	,	PUNCT
chd-104	18	12	chemotherapy	chemotherapy	NOUN
chd-104	18	13	remains	remain	VERB
chd-104	18	14	the	the	DET
chd-104	18	15	cornerstone	cornerstone	NOUN
chd-104	18	16	of	of	ADP
chd-104	18	17	treatment	treatment	NOUN
chd-104	18	18	for	for	ADP
chd-104	18	19	tnbc	tnbc	NOUN
chd-104	18	20	.	.	PUNCT
chd-104	19	1	tnbc	tnbc	VERB
chd-104	19	2	disproportionately	disproportionately	ADV
chd-104	19	3	afflicts	afflict	VERB
chd-104	19	4	african	african	ADJ
chd-104	19	5	-	-	PUNCT
chd-104	19	6	american	american	ADJ
chd-104	19	7	(	(	PUNCT
chd-104	19	8	raab	raab	PROPN
chd-104	19	9	et	et	PROPN
chd-104	19	10	al	al	PROPN
chd-104	19	11	.	.	PROPN
chd-104	19	12	)	)	PUNCT
chd-104	20	1	women	woman	NOUN
chd-104	20	2	,	,	PUNCT
chd-104	20	3	especially	especially	ADV
chd-104	20	4	younger	young	ADJ
chd-104	20	5	premenopausal	premenopausal	NOUN
chd-104	20	6	aas	aas	NOUN
chd-104	20	7	(	(	PUNCT
chd-104	20	8	brewster	brewster	NOUN
chd-104	20	9	et	et	PROPN
chd-104	20	10	al	al	PROPN
chd-104	20	11	.	.	PROPN
chd-104	20	12	,	,	PUNCT
chd-104	20	13	2014	2014	NUM
chd-104	20	14	;	;	PUNCT
chd-104	20	15	danforth	danforth	NOUN
chd-104	20	16	,	,	PUNCT
chd-104	20	17	2013	2013	NUM
chd-104	20	18	;	;	PUNCT
chd-104	20	19	jiagge	jiagge	PROPN
chd-104	20	20	et	et	PROPN
chd-104	20	21	al	al	PROPN
chd-104	20	22	.	.	PROPN
chd-104	20	23	,	,	PUNCT
chd-104	20	24	2018	2018	NUM
chd-104	20	25	;	;	PUNCT
chd-104	20	26	keenan	keenan	PROPN
chd-104	20	27	et	et	PROPN
chd-104	20	28	al	al	PROPN
chd-104	20	29	.	.	PROPN
chd-104	20	30	,	,	PUNCT
chd-104	20	31	2015	2015	NUM
chd-104	20	32	;	;	PUNCT
chd-104	20	33	newman	newman	PROPN
chd-104	20	34	and	and	CCONJ
chd-104	20	35	kaljee	kaljee	NOUN
chd-104	20	36	,	,	PUNCT
chd-104	20	37	2017	2017	NUM
chd-104	20	38	;	;	PUNCT
chd-104	20	39	wu	wu	PROPN
chd-104	20	40	et	et	PROPN
chd-104	20	41	al	al	PROPN
chd-104	20	42	.	.	PROPN
chd-104	20	43	,	,	PUNCT
chd-104	20	44	2017	2017	NUM
chd-104	20	45	)	)	PUNCT
chd-104	20	46	.	.	PUNCT
chd-104	21	1	after	after	ADP
chd-104	21	2	adjusting	adjust	VERB
chd-104	21	3	for	for	ADP
chd-104	21	4	potentially	potentially	ADV
chd-104	21	5	confounding	confound	VERB
chd-104	21	6	factors	factor	NOUN
chd-104	21	7	,	,	PUNCT
chd-104	21	8	including	include	VERB
chd-104	21	9	tumor	tumor	NOUN
chd-104	21	10	stage	stage	NOUN
chd-104	21	11	and	and	CCONJ
chd-104	21	12	grade	grade	NOUN
chd-104	21	13	(	(	PUNCT
chd-104	21	14	which	which	PRON
chd-104	21	15	tend	tend	VERB
chd-104	21	16	to	to	PART
chd-104	21	17	be	be	AUX
chd-104	21	18	higher	high	ADJ
chd-104	21	19	in	in	ADP
chd-104	21	20	aa	aa	ADJ
chd-104	21	21	women	woman	NOUN
chd-104	21	22	)	)	PUNCT
chd-104	21	23	and	and	CCONJ
chd-104	21	24	age	age	NOUN
chd-104	21	25	at	at	ADP
chd-104	21	26	diagnosis	diagnosis	NOUN
chd-104	21	27	and	and	CCONJ
chd-104	21	28	socioeconomic	socioeconomic	ADJ
chd-104	21	29	status	status	NOUN
chd-104	21	30	(	(	PUNCT
chd-104	21	31	which	which	PRON
chd-104	21	32	tend	tend	VERB
chd-104	21	33	to	to	PART
chd-104	21	34	be	be	AUX
chd-104	21	35	lower	low	ADJ
chd-104	21	36	in	in	ADP
chd-104	21	37	aa	aa	ADJ
chd-104	21	38	women	woman	NOUN
chd-104	21	39	)	)	PUNCT
chd-104	21	40	,	,	PUNCT
chd-104	21	41	aa	aa	PROPN
chd-104	21	42	women	woman	NOUN
chd-104	21	43	exhibit	exhibit	VERB
chd-104	21	44	~2	~2	NOUN
chd-104	21	45	times	time	NOUN
chd-104	21	46	the	the	DET
chd-104	21	47	likelihood	likelihood	NOUN
chd-104	21	48	of	of	ADP
chd-104	21	49	presenting	present	VERB
chd-104	21	50	with	with	ADP
chd-104	21	51	tnbc	tnbc	PROPN
chd-104	21	52	(	(	PUNCT
chd-104	21	53	dietze	dietze	PROPN
chd-104	21	54	et	et	PROPN
chd-104	21	55	al	al	PROPN
chd-104	21	56	.	.	PROPN
chd-104	21	57	,	,	PUNCT
chd-104	21	58	2015	2015	NUM
chd-104	21	59	)	)	PUNCT
chd-104	21	60	,	,	PUNCT
chd-104	21	61	which	which	PRON
chd-104	21	62	partially	partially	ADV
chd-104	21	63	explains	explain	VERB
chd-104	21	64	their	their	PRON
chd-104	21	65	worse	bad	ADJ
chd-104	21	66	outcomes	outcome	NOUN
chd-104	21	67	relative	relative	ADJ
chd-104	21	68	to	to	ADP
chd-104	21	69	ea	ea	NOUN
chd-104	21	70	patients	patient	NOUN
chd-104	21	71	.	.	PUNCT
chd-104	22	1	the	the	DET
chd-104	22	2	predisposition	predisposition	NOUN
chd-104	22	3	towards	towards	ADP
chd-104	22	4	developing	develop	VERB
chd-104	22	5	tnbc	tnbc	NOUN
chd-104	22	6	appears	appear	VERB
chd-104	22	7	to	to	PART
chd-104	22	8	be	be	AUX
chd-104	22	9	deeply	deeply	ADV
chd-104	22	10	rooted	root	VERB
chd-104	22	11	in	in	ADP
chd-104	22	12	biogeographic	biogeographic	ADJ
chd-104	22	13	ancestry	ancestry	NOUN
chd-104	22	14	.	.	PUNCT
chd-104	23	1	for	for	ADP
chd-104	23	2	example	example	NOUN
chd-104	23	3	,	,	PUNCT
chd-104	23	4	~50	~50	ADP
chd-104	23	5	%	%	NOUN
chd-104	23	6	of	of	ADP
chd-104	23	7	nigerian	nigerian	PROPN
chd-104	23	8	(	(	PUNCT
chd-104	23	9	agboola	agboola	PROPN
chd-104	23	10	et	et	PROPN
chd-104	23	11	al	al	PROPN
chd-104	23	12	.	.	PROPN
chd-104	23	13	,	,	PUNCT
chd-104	23	14	2012	2012	NUM
chd-104	23	15	)	)	PUNCT
chd-104	23	16	and	and	CCONJ
chd-104	23	17	malian	malian	NOUN
chd-104	23	18	(	(	PUNCT
chd-104	23	19	ly	ly	X
chd-104	23	20	et	et	PROPN
chd-104	23	21	al	al	PROPN
chd-104	23	22	.	.	PROPN
chd-104	23	23	,	,	PUNCT
chd-104	23	24	2012	2012	NUM
chd-104	23	25	)	)	PUNCT
chd-104	23	26	and	and	CCONJ
chd-104	23	27	~80	~80	X
chd-104	23	28	%	%	NOUN
chd-104	23	29	of	of	ADP
chd-104	23	30	ghanaian	ghanaian	ADJ
chd-104	23	31	(	(	PUNCT
chd-104	23	32	stark	stark	PROPN
chd-104	23	33	et	et	PROPN
chd-104	23	34	al	al	PROPN
chd-104	23	35	.	.	PROPN
chd-104	23	36	,	,	PUNCT
chd-104	23	37	2010a	2010a	NUM
chd-104	23	38	;	;	PUNCT
chd-104	23	39	stark	stark	PROPN
chd-104	23	40	et	et	PROPN
chd-104	23	41	al	al	PROPN
chd-104	23	42	.	.	PROPN
chd-104	23	43	,	,	PUNCT
chd-104	23	44	2010b	2010b	NUM
chd-104	23	45	)	)	PUNCT
chd-104	23	46	women	woman	NOUN
chd-104	23	47	with	with	ADP
chd-104	23	48	bc	bc	PROPN
chd-104	23	49	have	have	VERB
chd-104	23	50	triple	triple	ADJ
chd-104	23	51	-	-	PUNCT
chd-104	23	52	negative	negative	ADJ
chd-104	23	53	breast	breast	NOUN
chd-104	23	54	tumors	tumor	NOUN
chd-104	23	55	,	,	PUNCT
chd-104	23	56	in	in	ADP
chd-104	23	57	contrast	contrast	NOUN
chd-104	23	58	with	with	ADP
chd-104	23	59	~15	~15	X
chd-104	23	60	%	%	NOUN
chd-104	23	61	of	of	ADP
chd-104	23	62	ea	ea	PROPN
chd-104	23	63	(	(	PUNCT
chd-104	23	64	carey	carey	PROPN
chd-104	23	65	et	et	PROPN
chd-104	23	66	al	al	PROPN
chd-104	23	67	.	.	PROPN
chd-104	23	68	,	,	PUNCT
chd-104	23	69	2006	2006	NUM
chd-104	23	70	;	;	PUNCT
chd-104	23	71	stark	stark	PROPN
chd-104	23	72	et	et	PROPN
chd-104	23	73	al	al	PROPN
chd-104	23	74	.	.	PROPN
chd-104	23	75	,	,	PUNCT
chd-104	23	76	2010a	2010a	NUM
chd-104	23	77	)	)	PUNCT
chd-104	23	78	or	or	CCONJ
chd-104	23	79	white	white	ADJ
chd-104	23	80	british	british	ADJ
chd-104	23	81	women	woman	NOUN
chd-104	23	82	(	(	PUNCT
chd-104	23	83	agboola	agboola	PROPN
chd-104	23	84	et	et	PROPN
chd-104	23	85	al	al	PROPN
chd-104	23	86	.	.	PROPN
chd-104	23	87	,	,	PUNCT
chd-104	23	88	2012	2012	NUM
chd-104	23	89	;	;	PUNCT
chd-104	23	90	bowen	bowen	PROPN
chd-104	23	91	et	et	PROPN
chd-104	23	92	al	al	PROPN
chd-104	23	93	.	.	PROPN
chd-104	23	94	,	,	PUNCT
chd-104	23	95	2008	2008	NUM
chd-104	23	96	)	)	PUNCT
chd-104	23	97	.	.	PUNCT
chd-104	24	1	stark	stark	PROPN
chd-104	24	2	et	et	PROPN
chd-104	24	3	al	al	PROPN
chd-104	24	4	.	.	PROPN
chd-104	24	5	found	find	VERB
chd-104	24	6	that	that	SCONJ
chd-104	24	7	83	83	NUM
chd-104	24	8	%	%	NOUN
chd-104	24	9	of	of	ADP
chd-104	24	10	african	african	ADJ
chd-104	24	11	women	woman	NOUN
chd-104	24	12	presented	present	VERB
chd-104	24	13	with	with	ADP
chd-104	24	14	tnbc	tnbc	NOUN
chd-104	24	15	compared	compare	VERB
chd-104	24	16	to	to	ADP
chd-104	24	17	only	only	ADV
chd-104	24	18	41.9	41.9	NUM
chd-104	24	19	%	%	NOUN
chd-104	24	20	of	of	ADP
chd-104	24	21	aas	aas	NOUN
chd-104	24	22	and	and	CCONJ
chd-104	24	23	15.4	15.4	NUM
chd-104	24	24	%	%	NOUN
chd-104	24	25	of	of	ADP
chd-104	24	26	eas	ea	NOUN
chd-104	24	27	(	(	PUNCT
chd-104	24	28	stark	stark	PROPN
chd-104	24	29	et	et	PROPN
chd-104	24	30	al	al	PROPN
chd-104	24	31	.	.	PROPN
chd-104	24	32	,	,	PUNCT
chd-104	24	33	2010b	2010b	NUM
chd-104	24	34	)	)	PUNCT
chd-104	24	35	.	.	PUNCT
chd-104	25	1	although	although	SCONJ
chd-104	25	2	controversial	controversial	ADJ
chd-104	25	3	,	,	PUNCT
chd-104	25	4	racial	racial	ADJ
chd-104	25	5	disparities	disparity	NOUN
chd-104	25	6	in	in	ADP
chd-104	25	7	disease	disease	NOUN
chd-104	25	8	course	course	NOUN
chd-104	25	9	and	and	CCONJ
chd-104	25	10	outcomes	outcome	NOUN
chd-104	25	11	have	have	AUX
chd-104	25	12	been	be	AUX
chd-104	25	13	reported	report	VERB
chd-104	25	14	within	within	ADP
chd-104	25	15	the	the	DET
chd-104	25	16	tnbc	tnbc	ADJ
chd-104	25	17	subtype	subtype	NOUN
chd-104	25	18	.	.	PUNCT
chd-104	26	1	accumulating	accumulate	VERB
chd-104	26	2	evidence	evidence	NOUN
chd-104	26	3	suggest	suggest	VERB
chd-104	26	4	that	that	SCONJ
chd-104	26	5	aas	aas	PROPN
chd-104	26	6	present	present	NOUN
chd-104	26	7	with	with	ADP
chd-104	26	8	more	more	ADV
chd-104	26	9	unfavorable	unfavorable	ADJ
chd-104	26	10	clinicopathological	clinicopathological	ADJ
chd-104	26	11	characteristics	characteristic	NOUN
chd-104	26	12	such	such	ADJ
chd-104	26	13	as	as	ADP
chd-104	26	14	larger	large	ADJ
chd-104	26	15	tumor	tumor	NOUN
chd-104	26	16	size	size	NOUN
chd-104	26	17	,	,	PUNCT
chd-104	26	18	higher	high	ADJ
chd-104	26	19	proliferation	proliferation	NOUN
chd-104	26	20	,	,	PUNCT
chd-104	26	21	more	more	ADV
chd-104	26	22	extensive	extensive	ADJ
chd-104	26	23	lymph	lymph	NOUN
chd-104	26	24	node	node	NOUN
chd-104	26	25	involvement	involvement	NOUN
chd-104	26	26	,	,	PUNCT
chd-104	26	27	as	as	ADV
chd-104	26	28	well	well	ADV
chd-104	26	29	as	as	ADP
chd-104	26	30	present	present	ADJ
chd-104	26	31	at	at	ADP
chd-104	26	32	a	a	DET
chd-104	26	33	younger	young	ADJ
chd-104	26	34	age	age	NOUN
chd-104	26	35	than	than	ADP
chd-104	26	36	eas	ea	NOUN
chd-104	26	37	among	among	ADP
chd-104	26	38	tnbc	tnbc	ADJ
chd-104	26	39	patients	patient	NOUN
chd-104	26	40	(	(	PUNCT
chd-104	26	41	dietze	dietze	PROPN
chd-104	26	42	et	et	PROPN
chd-104	26	43	al	al	PROPN
chd-104	26	44	.	.	PROPN
chd-104	26	45	,	,	PUNCT
chd-104	26	46	2015	2015	NUM
chd-104	26	47	;	;	PUNCT
chd-104	26	48	lund	lund	PROPN
chd-104	26	49	et	et	PROPN
chd-104	26	50	al	al	PROPN
chd-104	26	51	.	.	PROPN
chd-104	26	52	,	,	PUNCT
chd-104	26	53	2009	2009	NUM
chd-104	26	54	;	;	PUNCT
chd-104	26	55	sullivan	sullivan	PROPN
chd-104	26	56	et	et	PROPN
chd-104	26	57	al	al	PROPN
chd-104	26	58	.	.	PROPN
chd-104	26	59	,	,	PUNCT
chd-104	26	60	2014	2014	NUM
chd-104	26	61	)	)	PUNCT
chd-104	26	62	.	.	PUNCT
chd-104	27	1	furthermore	furthermore	ADV
chd-104	27	2	,	,	PUNCT
chd-104	27	3	aas	aas	PROPN
chd-104	27	4	have	have	AUX
chd-104	27	5	been	be	AUX
chd-104	27	6	reported	report	VERB
chd-104	27	7	to	to	PART
chd-104	27	8	harbor	harbor	VERB
chd-104	27	9	more	more	ADV
chd-104	27	10	aggressive	aggressive	ADJ
chd-104	27	11	tnbc	tnbc	ADJ
chd-104	27	12	subtypes	subtype	NOUN
chd-104	27	13	such	such	ADJ
chd-104	27	14	as	as	ADP
chd-104	27	15	basal	basal	NOUN
chd-104	27	16	-	-	PUNCT
chd-104	27	17	like	like	ADJ
chd-104	27	18	1	1	NUM
chd-104	27	19	and	and	CCONJ
chd-104	27	20	mesenchymal	mesenchymal	NOUN
chd-104	27	21	stem	stem	NOUN
chd-104	27	22	-	-	PUNCT
chd-104	27	23	like	like	ADJ
chd-104	27	24	as	as	ADV
chd-104	27	25	well	well	ADV
chd-104	27	26	as	as	ADP
chd-104	27	27	greater	great	ADJ
chd-104	27	28	intratumoral	intratumoral	ADJ
chd-104	27	29	heterogeneity	heterogeneity	NOUN
chd-104	27	30	than	than	ADP
chd-104	27	31	eas	eas	PROPN
chd-104	27	32	(	(	PUNCT
chd-104	27	33	keenan	keenan	PROPN
chd-104	27	34	et	et	PROPN
chd-104	27	35	al	al	PROPN
chd-104	27	36	.	.	PROPN
chd-104	27	37	,	,	PUNCT
chd-104	27	38	2015	2015	NUM
chd-104	27	39	;	;	PUNCT
chd-104	27	40	lindner	lindner	PROPN
chd-104	27	41	et	et	PROPN
chd-104	27	42	al	al	PROPN
chd-104	27	43	.	.	PROPN
chd-104	27	44	,	,	PUNCT
chd-104	27	45	2013	2013	NUM
chd-104	27	46	)	)	PUNCT
chd-104	27	47	.	.	PUNCT
chd-104	28	1	as	as	ADP
chd-104	28	2	a	a	DET
chd-104	28	3	result	result	NOUN
chd-104	28	4	,	,	PUNCT
chd-104	28	5	aas	aas	PROPN
chd-104	28	6	have	have	AUX
chd-104	28	7	been	be	AUX
chd-104	28	8	reported	report	VERB
chd-104	28	9	to	to	PART
chd-104	28	10	experience	experience	VERB
chd-104	28	11	shorter	short	ADJ
chd-104	28	12	overall	overall	ADJ
chd-104	28	13	survival	survival	NOUN
chd-104	28	14	(	(	PUNCT
chd-104	28	15	os	os	NOUN
chd-104	28	16	)	)	PUNCT
chd-104	28	17	and	and	CCONJ
chd-104	28	18	progression	progression	NOUN
chd-104	28	19	-	-	PUNCT
chd-104	28	20	free	free	ADJ
chd-104	28	21	survival	survival	NOUN
chd-104	28	22	(	(	PUNCT
chd-104	28	23	pfs	pfs	PROPN
chd-104	28	24	)	)	PUNCT
chd-104	28	25	than	than	ADP
chd-104	28	26	eas	ea	NOUN
chd-104	28	27	among	among	ADP
chd-104	28	28	tnbc	tnbc	ADJ
chd-104	28	29	patients	patient	NOUN
chd-104	28	30	(	(	PUNCT
chd-104	28	31	dietze	dietze	PROPN
chd-104	28	32	et	et	PROPN
chd-104	28	33	al	al	PROPN
chd-104	28	34	.	.	PROPN
chd-104	28	35	,	,	PUNCT
chd-104	28	36	2015	2015	NUM
chd-104	28	37	;	;	PUNCT
chd-104	28	38	lund	lund	PROPN
chd-104	28	39	et	et	PROPN
chd-104	28	40	al	al	PROPN
chd-104	28	41	.	.	PROPN
chd-104	28	42	,	,	PUNCT
chd-104	28	43	2009	2009	NUM
chd-104	28	44	;	;	PUNCT
chd-104	28	45	sullivan	sullivan	PROPN
chd-104	28	46	et	et	PROPN
chd-104	28	47	al	al	PROPN
chd-104	28	48	.	.	PROPN
chd-104	28	49	,	,	PUNCT
chd-104	28	50	2014	2014	NUM
chd-104	28	51	)	)	PUNCT
chd-104	28	52	.	.	PUNCT
chd-104	29	1	newman	newman	PROPN
chd-104	29	2	and	and	CCONJ
chd-104	29	3	colleagues	colleague	NOUN
chd-104	29	4	observed	observe	VERB
chd-104	29	5	30	30	NUM
chd-104	29	6	%	%	NOUN
chd-104	29	7	higher	high	ADJ
chd-104	29	8	mortality	mortality	NOUN
chd-104	29	9	rate	rate	NOUN
chd-104	29	10	among	among	ADP
chd-104	29	11	aa	aa	NOUN
chd-104	29	12	compared	compare	VERB
chd-104	29	13	to	to	ADP
chd-104	29	14	ea	ea	NOUN
chd-104	29	15	tnbc	tnbc	VERB
chd-104	29	16	patients	patient	NOUN
chd-104	29	17	(	(	PUNCT
chd-104	29	18	newman	newman	PROPN
chd-104	29	19	et	et	PROPN
chd-104	29	20	al	al	PROPN
chd-104	29	21	.	.	PROPN
chd-104	29	22	,	,	PUNCT
chd-104	29	23	2006	2006	NUM
chd-104	29	24	)	)	PUNCT
chd-104	29	25	.	.	PUNCT
chd-104	30	1	these	these	DET
chd-104	30	2	recent	recent	ADJ
chd-104	30	3	findings	finding	NOUN
chd-104	30	4	have	have	AUX
chd-104	30	5	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-104	30	6	e3	e3	NOUN
chd-104	30	7	cancer	cancer	NOUN
chd-104	30	8	health	health	NOUN
chd-104	30	9	disparities	disparity	NOUN
chd-104	30	10	research	research	NOUN
chd-104	30	11	sparked	spark	VERB
chd-104	30	12	investigations	investigation	NOUN
chd-104	30	13	into	into	ADP
chd-104	30	14	distinctions	distinction	NOUN
chd-104	30	15	in	in	ADP
chd-104	30	16	inherent	inherent	ADJ
chd-104	30	17	tumor	tumor	NOUN
chd-104	30	18	biology	biology	NOUN
chd-104	30	19	between	between	ADP
chd-104	30	20	aa	aa	NOUN
chd-104	30	21	and	and	CCONJ
chd-104	30	22	ea	ea	NOUN
chd-104	30	23	tnbcs	tnbc	NOUN
chd-104	30	24	to	to	PART
chd-104	30	25	elucidate	elucidate	VERB
chd-104	30	26	the	the	DET
chd-104	30	27	molecular	molecular	ADJ
chd-104	30	28	underpinnings	underpinning	NOUN
chd-104	30	29	driving	drive	VERB
chd-104	30	30	the	the	DET
chd-104	30	31	racially	racially	ADV
chd-104	30	32	disparate	disparate	ADJ
chd-104	30	33	burden	burden	NOUN
chd-104	30	34	in	in	ADP
chd-104	30	35	tnbc	tnbc	NOUN
chd-104	30	36	.	.	PUNCT
chd-104	31	1	currently	currently	ADV
chd-104	31	2	,	,	PUNCT
chd-104	31	3	there	there	PRON
chd-104	31	4	are	be	VERB
chd-104	31	5	no	no	DET
chd-104	31	6	reliable	reliable	ADJ
chd-104	31	7	methods	method	NOUN
chd-104	31	8	to	to	PART
chd-104	31	9	identify	identify	VERB
chd-104	31	10	aa	aa	NOUN
chd-104	31	11	tnbc	tnbc	ADJ
chd-104	31	12	patients	patient	NOUN
chd-104	31	13	at	at	ADP
chd-104	31	14	high	high	ADJ
chd-104	31	15	risk	risk	NOUN
chd-104	31	16	of	of	ADP
chd-104	31	17	poor	poor	ADJ
chd-104	31	18	outcomes	outcome	NOUN
chd-104	31	19	,	,	PUNCT
chd-104	31	20	which	which	PRON
chd-104	31	21	would	would	AUX
chd-104	31	22	indicate	indicate	VERB
chd-104	31	23	the	the	DET
chd-104	31	24	need	need	NOUN
chd-104	31	25	to	to	PART
chd-104	31	26	offer	offer	VERB
chd-104	31	27	more	more	ADV
chd-104	31	28	aggressive	aggressive	ADJ
chd-104	31	29	treatment	treatment	NOUN
chd-104	31	30	.	.	PUNCT
chd-104	32	1	identification	identification	NOUN
chd-104	32	2	of	of	ADP
chd-104	32	3	biomarkers	biomarker	NOUN
chd-104	32	4	that	that	PRON
chd-104	32	5	can	can	AUX
chd-104	32	6	risk	risk	VERB
chd-104	32	7	-	-	PUNCT
chd-104	32	8	stratify	stratify	VERB
chd-104	32	9	aa	aa	NOUN
chd-104	32	10	tnbc	tnbc	PROPN
chd-104	32	11	patients	patient	NOUN
chd-104	32	12	and	and	CCONJ
chd-104	32	13	predict	predict	VERB
chd-104	32	14	responsiveness	responsiveness	NOUN
chd-104	32	15	to	to	ADP
chd-104	32	16	targeted	target	VERB
chd-104	32	17	and	and	CCONJ
chd-104	32	18	cytotoxic	cytotoxic	ADJ
chd-104	32	19	agents	agent	NOUN
chd-104	32	20	could	could	AUX
chd-104	32	21	improve	improve	VERB
chd-104	32	22	prognosis	prognosis	NOUN
chd-104	32	23	of	of	ADP
chd-104	32	24	this	this	DET
chd-104	32	25	high	high	ADJ
chd-104	32	26	-	-	PUNCT
chd-104	32	27	risk	risk	NOUN
chd-104	32	28	patient	patient	NOUN
chd-104	32	29	population	population	NOUN
chd-104	32	30	.	.	PUNCT
chd-104	33	1	top	top	ADJ
chd-104	33	2	notch	notch	ADJ
chd-104	33	3	distinctions	distinction	NOUN
chd-104	33	4	:	:	PUNCT
chd-104	33	5	shedding	shed	VERB
chd-104	33	6	light	light	NOUN
chd-104	33	7	on	on	ADP
chd-104	33	8	the	the	DET
chd-104	33	9	notch	notch	NOUN
chd-104	33	10	signaling	signal	VERB
chd-104	33	11	pathway	pathway	NOUN
chd-104	33	12	in	in	ADP
chd-104	33	13	triple	triple	ADJ
chd-104	33	14	negative	negative	ADJ
chd-104	33	15	breast	breast	NOUN
chd-104	33	16	cancer	cancer	NOUN
chd-104	33	17	the	the	DET
chd-104	33	18	notch	notch	ADJ
chd-104	33	19	signaling	signal	VERB
chd-104	33	20	pathway	pathway	NOUN
chd-104	33	21	has	have	AUX
chd-104	33	22	recently	recently	ADV
chd-104	33	23	emerged	emerge	VERB
chd-104	33	24	as	as	ADP
chd-104	33	25	a	a	DET
chd-104	33	26	novel	novel	ADJ
chd-104	33	27	therapeutic	therapeutic	ADJ
chd-104	33	28	target	target	NOUN
chd-104	33	29	of	of	ADP
chd-104	33	30	interest	interest	NOUN
chd-104	33	31	in	in	ADP
chd-104	33	32	tnbc	tnbc	NOUN
chd-104	33	33	.	.	PUNCT
chd-104	34	1	the	the	DET
chd-104	34	2	pathway	pathway	NOUN
chd-104	34	3	is	be	AUX
chd-104	34	4	present	present	ADJ
chd-104	34	5	in	in	ADP
chd-104	34	6	most	most	ADJ
chd-104	34	7	multicellular	multicellular	ADJ
chd-104	34	8	organisms	organism	NOUN
chd-104	34	9	and	and	CCONJ
chd-104	34	10	is	be	AUX
chd-104	34	11	highly	highly	ADV
chd-104	34	12	conserved	conserve	VERB
chd-104	34	13	.	.	PUNCT
chd-104	35	1	it	it	PRON
chd-104	35	2	is	be	AUX
chd-104	35	3	essential	essential	ADJ
chd-104	35	4	for	for	ADP
chd-104	35	5	cell	cell	NOUN
chd-104	35	6	proliferation	proliferation	NOUN
chd-104	35	7	,	,	PUNCT
chd-104	35	8	differentiation	differentiation	NOUN
chd-104	35	9	and	and	CCONJ
chd-104	35	10	development	development	NOUN
chd-104	35	11	and	and	CCONJ
chd-104	35	12	plays	play	VERB
chd-104	35	13	keys	key	NOUN
chd-104	35	14	roles	role	NOUN
chd-104	35	15	in	in	ADP
chd-104	35	16	cell	cell	NOUN
chd-104	35	17	fate	fate	NOUN
chd-104	35	18	determination	determination	NOUN
chd-104	35	19	(	(	PUNCT
chd-104	35	20	ranganathan	ranganathan	PROPN
chd-104	35	21	et	et	PROPN
chd-104	35	22	al	al	PROPN
chd-104	35	23	.	.	PROPN
chd-104	35	24	,	,	PUNCT
chd-104	35	25	2011	2011	NUM
chd-104	35	26	)	)	PUNCT
chd-104	35	27	.	.	PUNCT
chd-104	36	1	there	there	PRON
chd-104	36	2	are	be	VERB
chd-104	36	3	four	four	NUM
chd-104	36	4	different	different	ADJ
chd-104	36	5	notch	notch	NOUN
chd-104	36	6	receptors	receptor	NOUN
chd-104	36	7	(	(	PUNCT
chd-104	36	8	notch1	notch1	NOUN
chd-104	36	9	,	,	PUNCT
chd-104	36	10	notch2	notch2	PROPN
chd-104	36	11	,	,	PUNCT
chd-104	36	12	notch3	notch3	PROPN
chd-104	36	13	and	and	CCONJ
chd-104	36	14	notch4	notch4	NOUN
chd-104	36	15	)	)	PUNCT
chd-104	36	16	expressed	express	VERB
chd-104	36	17	in	in	ADP
chd-104	36	18	mammals	mammal	NOUN
chd-104	36	19	(	(	PUNCT
chd-104	36	20	dontu	dontu	VERB
chd-104	36	21	et	et	PROPN
chd-104	36	22	al	al	PROPN
chd-104	36	23	.	.	PROPN
chd-104	36	24	,	,	PUNCT
chd-104	36	25	2004	2004	NUM
chd-104	36	26	)	)	PUNCT
chd-104	36	27	.	.	PUNCT
chd-104	37	1	the	the	DET
chd-104	37	2	notch	notch	ADJ
chd-104	37	3	receptor	receptor	NOUN
chd-104	37	4	is	be	AUX
chd-104	37	5	a	a	DET
chd-104	37	6	hetero	hetero	NOUN
chd-104	37	7	-	-	PUNCT
chd-104	37	8	oligomer	oligomer	ADJ
chd-104	37	9	transmembrane	transmembrane	NOUN
chd-104	37	10	receptor	receptor	NOUN
chd-104	37	11	protein	protein	NOUN
chd-104	37	12	composed	compose	VERB
chd-104	37	13	of	of	ADP
chd-104	37	14	an	an	DET
chd-104	37	15	extracellular	extracellular	ADJ
chd-104	37	16	protein	protein	NOUN
chd-104	37	17	domain	domain	NOUN
chd-104	37	18	,	,	PUNCT
chd-104	37	19	a	a	DET
chd-104	37	20	single	single	ADJ
chd-104	37	21	transmembrane	transmembrane	NOUN
chd-104	37	22	pass	pass	NOUN
chd-104	37	23	and	and	CCONJ
chd-104	37	24	a	a	DET
chd-104	37	25	small	small	ADJ
chd-104	37	26	intracellular	intracellular	ADJ
chd-104	37	27	region	region	NOUN
chd-104	37	28	.	.	PUNCT
chd-104	38	1	notch	notch	ADJ
chd-104	38	2	receptors	receptor	NOUN
chd-104	38	3	on	on	ADP
chd-104	38	4	the	the	DET
chd-104	38	5	cell	cell	NOUN
chd-104	38	6	surface	surface	NOUN
chd-104	38	7	engage	engage	VERB
chd-104	38	8	with	with	ADP
chd-104	38	9	notch	notch	ADJ
chd-104	38	10	ligandsdelta	ligandsdelta	NOUN
chd-104	38	11	-	-	PUNCT
chd-104	38	12	like	like	ADJ
chd-104	38	13	(	(	PUNCT
chd-104	38	14	dll1	dll1	PROPN
chd-104	38	15	,	,	PUNCT
chd-104	38	16	dll3	dll3	PROPN
chd-104	38	17	,	,	PUNCT
chd-104	38	18	dll4	dll4	PROPN
chd-104	38	19	)	)	PUNCT
chd-104	38	20	and	and	CCONJ
chd-104	38	21	jagged	jagged	ADJ
chd-104	38	22	(	(	PUNCT
chd-104	38	23	jag1	jag1	NOUN
chd-104	38	24	,	,	PUNCT
chd-104	38	25	jag2	jag2	PROPN
chd-104	38	26	)	)	PUNCT
chd-104	38	27	to	to	PART
chd-104	38	28	initiate	initiate	VERB
chd-104	38	29	the	the	DET
chd-104	38	30	signaling	signal	VERB
chd-104	38	31	cascade	cascade	NOUN
chd-104	38	32	(	(	PUNCT
chd-104	38	33	bray	bray	PROPN
chd-104	38	34	et	et	PROPN
chd-104	38	35	al	al	PROPN
chd-104	38	36	.	.	PROPN
chd-104	38	37	,	,	PUNCT
chd-104	38	38	2008	2008	NUM
chd-104	38	39	;	;	PUNCT
chd-104	38	40	brou	brou	PROPN
chd-104	38	41	et	et	PROPN
chd-104	38	42	al	al	PROPN
chd-104	38	43	.	.	PROPN
chd-104	38	44	,	,	PUNCT
chd-104	38	45	2000	2000	NUM
chd-104	38	46	;	;	PUNCT
chd-104	38	47	fiuza	fiuza	NOUN
chd-104	38	48	and	and	CCONJ
chd-104	38	49	arias	aria	NOUN
chd-104	38	50	,	,	PUNCT
chd-104	38	51	2007	2007	NUM
chd-104	38	52	)	)	PUNCT
chd-104	38	53	.	.	PUNCT
chd-104	39	1	after	after	ADP
chd-104	39	2	the	the	DET
chd-104	39	3	interaction	interaction	NOUN
chd-104	39	4	of	of	ADP
chd-104	39	5	a	a	DET
chd-104	39	6	notch	notch	ADJ
chd-104	39	7	ligand	ligand	NOUN
chd-104	39	8	with	with	ADP
chd-104	39	9	its	its	PRON
chd-104	39	10	receptor	receptor	NOUN
chd-104	39	11	,	,	PUNCT
chd-104	39	12	a	a	DET
chd-104	39	13	metalloprotease	metalloprotease	NOUN
chd-104	39	14	protein	protein	NOUN
chd-104	39	15	from	from	ADP
chd-104	39	16	the	the	DET
chd-104	39	17	adam	adam	NOUN
chd-104	39	18	-	-	PUNCT
chd-104	39	19	family	family	NOUN
chd-104	39	20	(	(	PUNCT
chd-104	39	21	adam10	adam10	X
chd-104	39	22	)	)	PUNCT
chd-104	39	23	cleaves	cleave	VERB
chd-104	39	24	the	the	DET
chd-104	39	25	notch	notch	ADJ
chd-104	39	26	receptor	receptor	NOUN
chd-104	39	27	outside	outside	ADP
chd-104	39	28	the	the	DET
chd-104	39	29	membrane	membrane	NOUN
chd-104	39	30	(	(	PUNCT
chd-104	39	31	van	van	PROPN
chd-104	39	32	tetering	tetering	NOUN
chd-104	39	33	et	et	PROPN
chd-104	39	34	al	al	PROPN
chd-104	39	35	.	.	PROPN
chd-104	39	36	,	,	PUNCT
chd-104	39	37	2009	2009	NUM
chd-104	39	38	)	)	PUNCT
chd-104	39	39	;	;	PUNCT
chd-104	39	40	the	the	DET
chd-104	39	41	extracellular	extracellular	ADJ
chd-104	39	42	portion	portion	NOUN
chd-104	39	43	of	of	ADP
chd-104	39	44	the	the	DET
chd-104	39	45	notch	notch	ADJ
chd-104	39	46	receptor	receptor	NOUN
chd-104	39	47	attached	attach	VERB
chd-104	39	48	to	to	ADP
chd-104	39	49	its	its	PRON
chd-104	39	50	ligand	ligand	NOUN
chd-104	39	51	is	be	AUX
chd-104	39	52	thus	thus	ADV
chd-104	39	53	released	release	VERB
chd-104	39	54	and	and	CCONJ
chd-104	39	55	gets	get	AUX
chd-104	39	56	endocytosed	endocytose	VERB
chd-104	39	57	by	by	ADP
chd-104	39	58	ligand	ligand	NOUN
chd-104	39	59	-	-	PUNCT
chd-104	39	60	expressing	express	VERB
chd-104	39	61	cells	cell	NOUN
chd-104	39	62	.	.	PUNCT
chd-104	40	1	the	the	DET
chd-104	40	2	remaining	remain	VERB
chd-104	40	3	part	part	NOUN
chd-104	40	4	of	of	ADP
chd-104	40	5	the	the	DET
chd-104	40	6	notch	notch	ADJ
chd-104	40	7	receptor	receptor	NOUN
chd-104	40	8	inside	inside	ADP
chd-104	40	9	the	the	DET
chd-104	40	10	inner	inner	ADJ
chd-104	40	11	leaflet	leaflet	NOUN
chd-104	40	12	of	of	ADP
chd-104	40	13	the	the	DET
chd-104	40	14	cell	cell	NOUN
chd-104	40	15	membrane	membrane	NOUN
chd-104	40	16	undergoes	undergo	VERB
chd-104	40	17	a	a	DET
chd-104	40	18	cleavage	cleavage	NOUN
chd-104	40	19	by	by	ADP
chd-104	40	20	an	an	DET
chd-104	40	21	enzyme	enzyme	NOUN
chd-104	40	22	called	call	VERB
chd-104	40	23	gamma	gamma	NOUN
chd-104	40	24	-	-	PUNCT
chd-104	40	25	secretase	secretase	NOUN
chd-104	40	26	,	,	PUNCT
chd-104	40	27	releasing	release	VERB
chd-104	40	28	the	the	DET
chd-104	40	29	intracellular	intracellular	ADJ
chd-104	40	30	domain	domain	NOUN
chd-104	40	31	of	of	ADP
chd-104	40	32	the	the	DET
chd-104	40	33	notch	notch	ADJ
chd-104	40	34	protein	protein	NOUN
chd-104	40	35	(	(	PUNCT
chd-104	40	36	borggrefe	borggrefe	ADJ
chd-104	40	37	and	and	CCONJ
chd-104	40	38	liefke	liefke	NOUN
chd-104	40	39	,	,	PUNCT
chd-104	40	40	2012	2012	NUM
chd-104	40	41	)	)	PUNCT
chd-104	40	42	.	.	PUNCT
chd-104	41	1	the	the	DET
chd-104	41	2	notch	notch	ADJ
chd-104	41	3	intracellular	intracellular	ADJ
chd-104	41	4	domain	domain	NOUN
chd-104	41	5	then	then	ADV
chd-104	41	6	forms	form	VERB
chd-104	41	7	a	a	DET
chd-104	41	8	trimeric	trimeric	ADJ
chd-104	41	9	core	core	NOUN
chd-104	41	10	transactivation	transactivation	NOUN
chd-104	41	11	complex	complex	NOUN
chd-104	41	12	with	with	ADP
chd-104	41	13	the	the	DET
chd-104	41	14	sequence	sequence	NOUN
chd-104	41	15	-	-	PUNCT
chd-104	41	16	specific	specific	ADJ
chd-104	41	17	dna	dna	NOUN
chd-104	41	18	binding	bind	VERB
chd-104	41	19	protein	protein	NOUN
chd-104	41	20	,	,	PUNCT
chd-104	41	21	csl	csl	NOUN
chd-104	41	22	(	(	PUNCT
chd-104	41	23	cbf-1	cbf-1	NOUN
chd-104	41	24	/	/	SYM
chd-104	41	25	su(h)/lag-1	su(h)/lag-1	NOUN
chd-104	41	26	)	)	PUNCT
chd-104	41	27	,	,	PUNCT
chd-104	41	28	and	and	CCONJ
chd-104	41	29	the	the	DET
chd-104	41	30	transcriptional	transcriptional	ADJ
chd-104	41	31	co	co	NOUN
chd-104	41	32	-	-	NOUN
chd-104	41	33	activator	activator	NOUN
chd-104	41	34	,	,	PUNCT
chd-104	41	35	mastermind	mastermind	NOUN
chd-104	41	36	,	,	PUNCT
chd-104	41	37	to	to	PART
chd-104	41	38	activate	activate	VERB
chd-104	41	39	transcription	transcription	NOUN
chd-104	41	40	of	of	ADP
chd-104	41	41	target	target	NOUN
chd-104	41	42	genes	gene	NOUN
chd-104	41	43	(	(	PUNCT
chd-104	41	44	nam	nam	NOUN
chd-104	41	45	et	et	PROPN
chd-104	41	46	al	al	PROPN
chd-104	41	47	.	.	PROPN
chd-104	41	48	,	,	PUNCT
chd-104	41	49	2006	2006	NUM
chd-104	41	50	;	;	PUNCT
chd-104	41	51	wilson	wilson	PROPN
chd-104	41	52	and	and	CCONJ
chd-104	41	53	kovall	kovall	PROPN
chd-104	41	54	,	,	PUNCT
chd-104	41	55	2006	2006	NUM
chd-104	41	56	)	)	PUNCT
chd-104	41	57	.	.	PUNCT
chd-104	42	1	transcriptional	transcriptional	ADJ
chd-104	42	2	targets	target	NOUN
chd-104	42	3	include	include	VERB
chd-104	42	4	transcription	transcription	NOUN
chd-104	42	5	factors	factor	NOUN
chd-104	42	6	(	(	PUNCT
chd-104	42	7	nf‐κb2	nf‐κb2	NOUN
chd-104	42	8	and	and	CCONJ
chd-104	42	9	c‐	c‐	NOUN
chd-104	42	10	myc	myc	PROPN
chd-104	42	11	)	)	PUNCT
chd-104	42	12	,	,	PUNCT
chd-104	42	13	cell‐cycle	cell‐cycle	NOUN
chd-104	42	14	regulators	regulator	NOUN
chd-104	42	15	(	(	PUNCT
chd-104	42	16	cyclin	cyclin	NOUN
chd-104	42	17	d1	d1	PROPN
chd-104	42	18	and	and	CCONJ
chd-104	42	19	p21	p21	NOUN
chd-104	42	20	)	)	PUNCT
chd-104	42	21	,	,	PUNCT
chd-104	42	22	growth	growth	NOUN
chd-104	42	23	factor	factor	NOUN
chd-104	42	24	receptors	receptor	NOUN
chd-104	42	25	and	and	CCONJ
chd-104	42	26	regulators	regulator	NOUN
chd-104	42	27	of	of	ADP
chd-104	42	28	angiogenesis	angiogenesis	NOUN
chd-104	42	29	and	and	CCONJ
chd-104	42	30	apoptosis	apoptosis	NOUN
chd-104	42	31	.	.	PUNCT
chd-104	43	1	dysregulated	dysregulated	ADJ
chd-104	43	2	notch	notch	NOUN
chd-104	43	3	signaling	signal	VERB
chd-104	43	4	is	be	AUX
chd-104	43	5	associated	associate	VERB
chd-104	43	6	with	with	ADP
chd-104	43	7	various	various	ADJ
chd-104	43	8	malignancies	malignancy	NOUN
chd-104	43	9	.	.	PUNCT
chd-104	44	1	expression	expression	NOUN
chd-104	44	2	of	of	ADP
chd-104	44	3	notch	notch	ADJ
chd-104	44	4	receptors	receptor	NOUN
chd-104	44	5	and	and	CCONJ
chd-104	44	6	ligand	ligand	NOUN
chd-104	44	7	protein	protein	NOUN
chd-104	44	8	have	have	AUX
chd-104	44	9	been	be	AUX
chd-104	44	10	reported	report	VERB
chd-104	44	11	to	to	PART
chd-104	44	12	be	be	AUX
chd-104	44	13	upregulated	upregulate	VERB
chd-104	44	14	in	in	ADP
chd-104	44	15	breast	breast	NOUN
chd-104	44	16	tumors	tumor	NOUN
chd-104	44	17	compared	compare	VERB
chd-104	44	18	to	to	ADP
chd-104	44	19	normal	normal	ADJ
chd-104	44	20	breast	breast	NOUN
chd-104	44	21	tissues	tissue	NOUN
chd-104	44	22	(	(	PUNCT
chd-104	44	23	mittal	mittal	PROPN
chd-104	44	24	et	et	PROPN
chd-104	44	25	al	al	PROPN
chd-104	44	26	.	.	PROPN
chd-104	44	27	,	,	PUNCT
chd-104	44	28	2009	2009	NUM
chd-104	44	29	;	;	PUNCT
chd-104	44	30	rizzo	rizzo	PROPN
chd-104	44	31	et	et	PROPN
chd-104	44	32	al	al	PROPN
chd-104	44	33	.	.	PROPN
chd-104	44	34	,	,	PUNCT
chd-104	44	35	2008	2008	NUM
chd-104	44	36	;	;	PUNCT
chd-104	44	37	zardawi	zardawi	PROPN
chd-104	44	38	et	et	PROPN
chd-104	44	39	al	al	PROPN
chd-104	44	40	.	.	PROPN
chd-104	44	41	,	,	PUNCT
chd-104	44	42	2010	2010	NUM
chd-104	44	43	)	)	PUNCT
chd-104	44	44	.	.	PUNCT
chd-104	45	1	parr	parr	PROPN
chd-104	45	2	et	et	PROPN
chd-104	45	3	al	al	PROPN
chd-104	45	4	.	.	PROPN
chd-104	45	5	observed	observe	VERB
chd-104	45	6	an	an	DET
chd-104	45	7	aberrant	aberrant	ADJ
chd-104	45	8	level	level	NOUN
chd-104	45	9	of	of	ADP
chd-104	45	10	notch-1	notch-1	NUM
chd-104	45	11	and	and	CCONJ
chd-104	45	12	notch-2	notch-2	NUM
chd-104	45	13	expression	expression	NOUN
chd-104	45	14	in	in	ADP
chd-104	45	15	breast	breast	NOUN
chd-104	45	16	tumor	tumor	NOUN
chd-104	45	17	tissue	tissue	NOUN
chd-104	45	18	via	via	ADP
chd-104	45	19	immunohistochemistry	immunohistochemistry	NOUN
chd-104	45	20	and	and	CCONJ
chd-104	45	21	quantitative	quantitative	ADJ
chd-104	45	22	rt	rt	NOUN
chd-104	45	23	-	-	PUNCT
chd-104	45	24	pcr	pcr	NOUN
chd-104	45	25	.	.	PUNCT
chd-104	46	1	the	the	DET
chd-104	46	2	study	study	NOUN
chd-104	46	3	demonstrated	demonstrate	VERB
chd-104	46	4	that	that	SCONJ
chd-104	46	5	high	high	ADJ
chd-104	46	6	expression	expression	NOUN
chd-104	46	7	level	level	NOUN
chd-104	46	8	of	of	ADP
chd-104	46	9	notch	notch	ADJ
chd-104	46	10	ligands	ligand	NOUN
chd-104	46	11	and/or	and/or	CCONJ
chd-104	46	12	receptors	receptor	NOUN
chd-104	46	13	correlated	correlate	VERB
chd-104	46	14	significantly	significantly	ADV
chd-104	46	15	with	with	ADP
chd-104	46	16	poor	poor	ADJ
chd-104	46	17	clinical	clinical	ADJ
chd-104	46	18	outcomes	outcome	NOUN
chd-104	46	19	(	(	PUNCT
chd-104	46	20	parr	parr	X
chd-104	46	21	et	et	PROPN
chd-104	46	22	al	al	PROPN
chd-104	46	23	.	.	PROPN
chd-104	46	24	,	,	PUNCT
chd-104	46	25	2004	2004	NUM
chd-104	46	26	)	)	PUNCT
chd-104	46	27	.	.	PUNCT
chd-104	47	1	moreover	moreover	ADV
chd-104	47	2	,	,	PUNCT
chd-104	47	3	several	several	ADJ
chd-104	47	4	studies	study	NOUN
chd-104	47	5	suggest	suggest	VERB
chd-104	47	6	that	that	SCONJ
chd-104	47	7	increased	increase	VERB
chd-104	47	8	expression	expression	NOUN
chd-104	47	9	of	of	ADP
chd-104	47	10	notch	notch	NOUN
chd-104	47	11	is	be	AUX
chd-104	47	12	associated	associate	VERB
chd-104	47	13	with	with	ADP
chd-104	47	14	oncogene	oncogene	NOUN
chd-104	47	15	expression	expression	NOUN
chd-104	47	16	,	,	PUNCT
chd-104	47	17	maintaining	maintain	VERB
chd-104	47	18	stemness	stemness	NOUN
chd-104	47	19	of	of	ADP
chd-104	47	20	bc	bc	PROPN
chd-104	47	21	stem	stem	NOUN
chd-104	47	22	cells	cell	NOUN
chd-104	47	23	and	and	CCONJ
chd-104	47	24	deregulated	deregulated	ADJ
chd-104	47	25	cell	cell	NOUN
chd-104	47	26	cycle	cycle	NOUN
chd-104	47	27	progression	progression	NOUN
chd-104	47	28	(	(	PUNCT
chd-104	47	29	harrison	harrison	NOUN
chd-104	47	30	et	et	PROPN
chd-104	47	31	al	al	PROPN
chd-104	47	32	.	.	PROPN
chd-104	47	33	,	,	PUNCT
chd-104	47	34	2010	2010	NUM
chd-104	47	35	;	;	PUNCT
chd-104	47	36	ronchini	ronchini	NOUN
chd-104	47	37	and	and	CCONJ
chd-104	47	38	capobianco	capobianco	NOUN
chd-104	47	39	,	,	PUNCT
chd-104	47	40	2001	2001	NUM
chd-104	47	41	;	;	PUNCT
chd-104	47	42	sharma	sharma	PROPN
chd-104	47	43	et	et	PROPN
chd-104	47	44	al	al	PROPN
chd-104	47	45	.	.	PROPN
chd-104	47	46	,	,	PUNCT
chd-104	47	47	2006	2006	NUM
chd-104	47	48	;	;	PUNCT
chd-104	47	49	weng	weng	PROPN
chd-104	47	50	et	et	PROPN
chd-104	47	51	al	al	PROPN
chd-104	47	52	.	.	PROPN
chd-104	47	53	,	,	PUNCT
chd-104	47	54	2006	2006	NUM
chd-104	47	55	)	)	PUNCT
chd-104	47	56	.	.	PUNCT
chd-104	48	1	notch	notch	NOUN
chd-104	48	2	signaling	signal	VERB
chd-104	48	3	plays	play	VERB
chd-104	48	4	a	a	DET
chd-104	48	5	critical	critical	ADJ
chd-104	48	6	role	role	NOUN
chd-104	48	7	in	in	ADP
chd-104	48	8	tnbc	tnbc	NOUN
chd-104	48	9	.	.	PUNCT
chd-104	49	1	dickson	dickson	PROPN
chd-104	49	2	et	et	PROPN
chd-104	49	3	al	al	PROPN
chd-104	49	4	.	.	PROPN
chd-104	49	5	were	be	AUX
chd-104	49	6	the	the	DET
chd-104	49	7	first	first	ADJ
chd-104	49	8	to	to	PART
chd-104	49	9	uncover	uncover	VERB
chd-104	49	10	an	an	DET
chd-104	49	11	association	association	NOUN
chd-104	49	12	of	of	ADP
chd-104	49	13	notch	notch	ADJ
chd-104	49	14	expression	expression	NOUN
chd-104	49	15	with	with	ADP
chd-104	49	16	tnbc	tnbc	NOUN
chd-104	49	17	.	.	PUNCT
chd-104	50	1	the	the	DET
chd-104	50	2	study	study	NOUN
chd-104	50	3	revealed	reveal	VERB
chd-104	50	4	a	a	DET
chd-104	50	5	significant	significant	ADJ
chd-104	50	6	correlation	correlation	NOUN
chd-104	50	7	of	of	ADP
chd-104	50	8	overexpression	overexpression	NOUN
chd-104	50	9	of	of	ADP
chd-104	50	10	jag-1	jag-1	PUNCT
chd-104	50	11	and	and	CCONJ
chd-104	50	12	notch-1	notch-1	NUM
chd-104	50	13	with	with	ADP
chd-104	50	14	poor	poor	ADJ
chd-104	50	15	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-104	50	16	e4	e4	PROPN
chd-104	50	17	cancer	cancer	NOUN
chd-104	50	18	health	health	NOUN
chd-104	50	19	disparities	disparity	NOUN
chd-104	50	20	research	research	NOUN
chd-104	50	21	prognosis	prognosis	NOUN
chd-104	50	22	among	among	ADP
chd-104	50	23	tnbc	tnbc	ADJ
chd-104	50	24	patients	patient	NOUN
chd-104	50	25	(	(	PUNCT
chd-104	50	26	dickson	dickson	PROPN
chd-104	50	27	et	et	PROPN
chd-104	50	28	al	al	PROPN
chd-104	50	29	.	.	PROPN
chd-104	50	30	,	,	PUNCT
chd-104	50	31	2007	2007	NUM
chd-104	50	32	)	)	PUNCT
chd-104	50	33	.	.	PUNCT
chd-104	51	1	furthermore	furthermore	ADV
chd-104	51	2	,	,	PUNCT
chd-104	51	3	notch-1	notch-1	PROPN
chd-104	51	4	and	and	CCONJ
chd-104	51	5	notch-4	notch-4	NUM
chd-104	51	6	receptors	receptor	NOUN
chd-104	51	7	have	have	AUX
chd-104	51	8	been	be	AUX
chd-104	51	9	discovered	discover	VERB
chd-104	51	10	to	to	PART
chd-104	51	11	be	be	AUX
chd-104	51	12	overexpressed	overexpresse	VERB
chd-104	51	13	in	in	ADP
chd-104	51	14	tnbc	tnbc	ADJ
chd-104	51	15	vascular	vascular	ADJ
chd-104	51	16	endothelial	endothelial	NOUN
chd-104	51	17	cells	cell	NOUN
chd-104	51	18	(	(	PUNCT
chd-104	51	19	speiser	speiser	NOUN
chd-104	51	20	et	et	PROPN
chd-104	51	21	al	al	PROPN
chd-104	51	22	.	.	PROPN
chd-104	51	23	,	,	PUNCT
chd-104	51	24	2012	2012	NUM
chd-104	51	25	)	)	PUNCT
chd-104	51	26	.	.	PUNCT
chd-104	52	1	recent	recent	ADJ
chd-104	52	2	studies	study	NOUN
chd-104	52	3	also	also	ADV
chd-104	52	4	uncovered	uncover	VERB
chd-104	52	5	a	a	DET
chd-104	52	6	jagged1	jagged1	PROPN
chd-104	52	7	-	-	PUNCT
chd-104	52	8	notch1	notch1	NOUN
chd-104	52	9	-	-	PUNCT
chd-104	52	10	cyclind1	cyclind1	NOUN
chd-104	52	11	axis	axis	NOUN
chd-104	52	12	playing	play	VERB
chd-104	52	13	a	a	DET
chd-104	52	14	key	key	ADJ
chd-104	52	15	role	role	NOUN
chd-104	52	16	in	in	ADP
chd-104	52	17	maintaining	maintain	VERB
chd-104	52	18	proliferation	proliferation	NOUN
chd-104	52	19	of	of	ADP
chd-104	52	20	tnbc	tnbc	NOUN
chd-104	52	21	,	,	PUNCT
chd-104	52	22	as	as	SCONJ
chd-104	52	23	opposed	oppose	VERB
chd-104	52	24	to	to	ADP
chd-104	52	25	other	other	ADJ
chd-104	52	26	types	type	NOUN
chd-104	52	27	of	of	ADP
chd-104	52	28	bc	bc	PROPN
chd-104	52	29	(	(	PUNCT
chd-104	52	30	cohen	cohen	PROPN
chd-104	52	31	et	et	PROPN
chd-104	52	32	al	al	PROPN
chd-104	52	33	.	.	PROPN
chd-104	52	34	,	,	PUNCT
chd-104	52	35	2010	2010	NUM
chd-104	52	36	)	)	PUNCT
chd-104	52	37	.	.	PUNCT
chd-104	53	1	notch3	notch3	ADJ
chd-104	53	2	signaling	signal	VERB
chd-104	53	3	controls	control	NOUN
chd-104	53	4	survival	survival	NOUN
chd-104	53	5	of	of	ADP
chd-104	53	6	hypoxic	hypoxic	ADJ
chd-104	53	7	tnbc	tnbc	ADJ
chd-104	53	8	cells	cell	NOUN
chd-104	53	9	and	and	CCONJ
chd-104	53	10	notch4	notch4	NOUN
chd-104	53	11	is	be	AUX
chd-104	53	12	involved	involve	VERB
chd-104	53	13	in	in	ADP
chd-104	53	14	self	self	NOUN
chd-104	53	15	-	-	PUNCT
chd-104	53	16	renewal	renewal	NOUN
chd-104	53	17	of	of	ADP
chd-104	53	18	bc	bc	PROPN
chd-104	53	19	stem	stem	NOUN
chd-104	53	20	cells	cell	NOUN
chd-104	53	21	.	.	PUNCT
chd-104	54	1	(	(	PUNCT
chd-104	54	2	harrison	harrison	NOUN
chd-104	54	3	et	et	PROPN
chd-104	54	4	al	al	PROPN
chd-104	54	5	.	.	PROPN
chd-104	54	6	,	,	PUNCT
chd-104	54	7	2010	2010	NUM
chd-104	54	8	;	;	PUNCT
chd-104	54	9	sansone	sansone	PROPN
chd-104	54	10	et	et	PROPN
chd-104	54	11	al	al	PROPN
chd-104	54	12	.	.	PROPN
chd-104	54	13	,	,	PUNCT
chd-104	54	14	2007	2007	NUM
chd-104	54	15	)	)	PUNCT
chd-104	54	16	evidence	evidence	NOUN
chd-104	54	17	reinforcing	reinforce	VERB
chd-104	54	18	the	the	DET
chd-104	54	19	notion	notion	NOUN
chd-104	54	20	that	that	SCONJ
chd-104	54	21	dysregulation	dysregulation	NOUN
chd-104	54	22	of	of	ADP
chd-104	54	23	notch	notch	NOUN
chd-104	54	24	signaling	signal	VERB
chd-104	54	25	is	be	AUX
chd-104	54	26	pathogenetically	pathogenetically	ADV
chd-104	54	27	relevant	relevant	ADJ
chd-104	54	28	in	in	ADP
chd-104	54	29	tnbc	tnbc	PROPN
chd-104	54	30	came	come	VERB
chd-104	54	31	from	from	ADP
chd-104	54	32	a	a	DET
chd-104	54	33	study	study	NOUN
chd-104	54	34	wherein	wherein	SCONJ
chd-104	54	35	chromosomal	chromosomal	ADJ
chd-104	54	36	rearrangements	rearrangement	NOUN
chd-104	54	37	producing	produce	VERB
chd-104	54	38	constitutively	constitutively	ADV
chd-104	54	39	active	active	ADJ
chd-104	54	40	versions	version	NOUN
chd-104	54	41	of	of	ADP
chd-104	54	42	notch1	notch1	NOUN
chd-104	54	43	or	or	CCONJ
chd-104	54	44	notch2	notch2	NOUN
chd-104	54	45	were	be	AUX
chd-104	54	46	detected	detect	VERB
chd-104	54	47	almost	almost	ADV
chd-104	54	48	exclusively	exclusively	ADV
chd-104	54	49	in	in	ADP
chd-104	54	50	tnbc	tnbc	ADJ
chd-104	54	51	cell	cell	NOUN
chd-104	54	52	lines	line	NOUN
chd-104	54	53	and	and	CCONJ
chd-104	54	54	tumors	tumor	NOUN
chd-104	55	1	(	(	PUNCT
chd-104	55	2	robinson	robinson	PROPN
chd-104	55	3	et	et	PROPN
chd-104	55	4	al	al	PROPN
chd-104	55	5	.	.	PROPN
chd-104	55	6	,	,	PUNCT
chd-104	55	7	2011	2011	NUM
chd-104	55	8	)	)	PUNCT
chd-104	55	9	.	.	PUNCT
chd-104	56	1	when	when	SCONJ
chd-104	56	2	the	the	DET
chd-104	56	3	notch	notch	NOUN
chd-104	56	4	signaling	signal	VERB
chd-104	56	5	pathway	pathway	NOUN
chd-104	56	6	gets	get	AUX
chd-104	56	7	activated	activate	VERB
chd-104	56	8	,	,	PUNCT
chd-104	56	9	the	the	DET
chd-104	56	10	notch	notch	ADJ
chd-104	56	11	intracellular	intracellular	ADJ
chd-104	56	12	domain	domain	NOUN
chd-104	56	13	(	(	PUNCT
chd-104	56	14	icd	icd	PROPN
chd-104	56	15	)	)	PUNCT
chd-104	56	16	,	,	PUNCT
chd-104	56	17	generated	generate	VERB
chd-104	56	18	by	by	ADP
chd-104	56	19	the	the	DET
chd-104	56	20	enzyme	enzyme	NOUN
chd-104	56	21	gamma	gamma	NOUN
chd-104	56	22	-	-	PUNCT
chd-104	56	23	secretase	secretase	NOUN
chd-104	56	24	,	,	PUNCT
chd-104	56	25	translocates	translocate	NOUN
chd-104	56	26	from	from	ADP
chd-104	56	27	the	the	DET
chd-104	56	28	cytoplasm	cytoplasm	NOUN
chd-104	56	29	to	to	ADP
chd-104	56	30	the	the	DET
chd-104	56	31	nucleus	nucleus	NOUN
chd-104	56	32	where	where	SCONJ
chd-104	56	33	it	it	PRON
chd-104	56	34	binds	bind	VERB
chd-104	56	35	to	to	ADP
chd-104	56	36	the	the	DET
chd-104	56	37	csl	csl	PROPN
chd-104	56	38	complex	complex	NOUN
chd-104	56	39	to	to	PART
chd-104	56	40	initiate	initiate	VERB
chd-104	56	41	the	the	DET
chd-104	56	42	transcription	transcription	NOUN
chd-104	56	43	of	of	ADP
chd-104	56	44	downstream	downstream	ADJ
chd-104	56	45	targets	target	NOUN
chd-104	56	46	(	(	PUNCT
chd-104	56	47	shih	shih	NOUN
chd-104	56	48	ie	ie	X
chd-104	56	49	and	and	CCONJ
chd-104	56	50	wang	wang	PROPN
chd-104	56	51	,	,	PUNCT
chd-104	56	52	2007	2007	NUM
chd-104	56	53	)	)	PUNCT
chd-104	56	54	.	.	PUNCT
chd-104	57	1	the	the	DET
chd-104	57	2	nuclear	nuclear	ADJ
chd-104	57	3	localization	localization	NOUN
chd-104	57	4	of	of	ADP
chd-104	57	5	notch	notch	NOUN
chd-104	57	6	has	have	AUX
chd-104	57	7	been	be	AUX
chd-104	57	8	reported	report	VERB
chd-104	57	9	to	to	PART
chd-104	57	10	occur	occur	VERB
chd-104	57	11	more	more	ADV
chd-104	57	12	frequently	frequently	ADV
chd-104	57	13	in	in	ADP
chd-104	57	14	tnbc	tnbc	NOUN
chd-104	57	15	compared	compare	VERB
chd-104	57	16	to	to	ADP
chd-104	57	17	hormone	hormone	NOUN
chd-104	57	18	receptor	receptor	NOUN
chd-104	57	19	-	-	PUNCT
chd-104	57	20	positive	positive	ADJ
chd-104	57	21	tumors	tumor	NOUN
chd-104	57	22	(	(	PUNCT
chd-104	57	23	touplikioti	touplikioti	NOUN
chd-104	57	24	,	,	PUNCT
chd-104	57	25	2012	2012	NUM
chd-104	57	26	)	)	PUNCT
chd-104	57	27	.	.	PUNCT
chd-104	58	1	moreover	moreover	ADV
chd-104	58	2	,	,	PUNCT
chd-104	58	3	speiser	speiser	NOUN
chd-104	58	4	et	et	PROPN
chd-104	58	5	al	al	PROPN
chd-104	58	6	.	.	PROPN
chd-104	58	7	discovered	discover	VERB
chd-104	58	8	more	more	ADV
chd-104	58	9	positive	positive	ADJ
chd-104	58	10	nuclear	nuclear	ADJ
chd-104	58	11	and	and	CCONJ
chd-104	58	12	cytoplasmic	cytoplasmic	ADJ
chd-104	58	13	staining	staining	NOUN
chd-104	58	14	of	of	ADP
chd-104	58	15	notch-1	notch-1	NUM
chd-104	58	16	and	and	CCONJ
chd-104	58	17	notch-4	notch-4	NUM
chd-104	58	18	in	in	ADP
chd-104	58	19	tnbc	tnbc	ADJ
chd-104	58	20	samples	sample	NOUN
chd-104	58	21	and	and	CCONJ
chd-104	58	22	more	more	ADV
chd-104	58	23	positive	positive	ADJ
chd-104	58	24	membrane	membrane	NOUN
chd-104	58	25	staining	staining	NOUN
chd-104	58	26	of	of	ADP
chd-104	58	27	these	these	DET
chd-104	58	28	proteins	protein	NOUN
chd-104	58	29	in	in	ADP
chd-104	58	30	hormone	hormone	NOUN
chd-104	58	31	receptor	receptor	NOUN
chd-104	58	32	-	-	PUNCT
chd-104	58	33	positive	positive	ADJ
chd-104	58	34	breast	breast	NOUN
chd-104	58	35	tumor	tumor	NOUN
chd-104	58	36	specimens	specimen	NOUN
chd-104	58	37	(	(	PUNCT
chd-104	58	38	speiser	speiser	NOUN
chd-104	58	39	et	et	PROPN
chd-104	58	40	al	al	PROPN
chd-104	58	41	.	.	PROPN
chd-104	58	42	,	,	PUNCT
chd-104	58	43	2012	2012	NUM
chd-104	58	44	)	)	PUNCT
chd-104	58	45	.	.	PUNCT
chd-104	59	1	many	many	ADJ
chd-104	59	2	studies	study	NOUN
chd-104	59	3	on	on	ADP
chd-104	59	4	notch	notch	ADJ
chd-104	59	5	signaling	signal	VERB
chd-104	59	6	have	have	AUX
chd-104	59	7	postulated	postulate	VERB
chd-104	59	8	that	that	SCONJ
chd-104	59	9	its	its	PRON
chd-104	59	10	cellular	cellular	ADJ
chd-104	59	11	localization	localization	NOUN
chd-104	59	12	can	can	AUX
chd-104	59	13	be	be	AUX
chd-104	59	14	a	a	DET
chd-104	59	15	morphological	morphological	ADJ
chd-104	59	16	illustration	illustration	NOUN
chd-104	59	17	of	of	ADP
chd-104	59	18	its	its	PRON
chd-104	59	19	function	function	NOUN
chd-104	59	20	(	(	PUNCT
chd-104	59	21	bray	bray	PROPN
chd-104	59	22	et	et	PROPN
chd-104	59	23	al	al	PROPN
chd-104	59	24	.	.	PROPN
chd-104	59	25	,	,	PUNCT
chd-104	59	26	2008	2008	NUM
chd-104	59	27	)	)	PUNCT
chd-104	59	28	.	.	PUNCT
chd-104	60	1	as	as	SCONJ
chd-104	60	2	previously	previously	ADV
chd-104	60	3	described	describe	VERB
chd-104	60	4	,	,	PUNCT
chd-104	60	5	upon	upon	SCONJ
chd-104	60	6	interaction	interaction	NOUN
chd-104	60	7	of	of	ADP
chd-104	60	8	the	the	DET
chd-104	60	9	transmembrane	transmembrane	NOUN
chd-104	61	1	notch	notch	NOUN
chd-104	61	2	receptor	receptor	NOUN
chd-104	61	3	with	with	ADP
chd-104	61	4	its	its	PRON
chd-104	61	5	ligand	ligand	NOUN
chd-104	62	1	,	,	PUNCT
chd-104	62	2	the	the	DET
chd-104	62	3	receptor	receptor	NOUN
chd-104	62	4	is	be	AUX
chd-104	62	5	proteolytically	proteolytically	ADV
chd-104	62	6	cleaved	cleaved	ADJ
chd-104	62	7	and	and	CCONJ
chd-104	62	8	the	the	DET
chd-104	62	9	nicd	nicd	NOUN
chd-104	62	10	is	be	AUX
chd-104	62	11	released	release	VERB
chd-104	62	12	into	into	ADP
chd-104	62	13	the	the	DET
chd-104	62	14	nucleus	nucleus	NOUN
chd-104	62	15	.	.	PUNCT
chd-104	63	1	inside	inside	ADP
chd-104	63	2	the	the	DET
chd-104	63	3	nucleus	nucleus	NOUN
chd-104	63	4	,	,	PUNCT
chd-104	63	5	nicd	nicd	NOUN
chd-104	63	6	modulates	modulate	VERB
chd-104	63	7	transcription	transcription	NOUN
chd-104	63	8	of	of	ADP
chd-104	63	9	target	target	NOUN
chd-104	63	10	genes	gene	NOUN
chd-104	63	11	via	via	ADP
chd-104	63	12	interaction	interaction	NOUN
chd-104	63	13	with	with	ADP
chd-104	63	14	csl	csl	PROPN
chd-104	63	15	(	(	PUNCT
chd-104	63	16	schroeter	schroeter	NOUN
chd-104	63	17	et	et	PROPN
chd-104	63	18	al	al	PROPN
chd-104	63	19	.	.	PROPN
chd-104	63	20	,	,	PUNCT
chd-104	63	21	1998	1998	NUM
chd-104	63	22	;	;	PUNCT
chd-104	63	23	weijzen	weijzen	PROPN
chd-104	63	24	et	et	PROPN
chd-104	63	25	al	al	PROPN
chd-104	63	26	.	.	PROPN
chd-104	63	27	,	,	PUNCT
chd-104	63	28	2002	2002	NUM
chd-104	63	29	)	)	PUNCT
chd-104	63	30	.	.	PUNCT
chd-104	64	1	thus	thus	ADV
chd-104	64	2	,	,	PUNCT
chd-104	64	3	the	the	DET
chd-104	64	4	subcellular	subcellular	ADJ
chd-104	64	5	localization	localization	NOUN
chd-104	64	6	of	of	ADP
chd-104	64	7	the	the	DET
chd-104	64	8	notch	notch	ADJ
chd-104	64	9	protein	protein	NOUN
chd-104	64	10	reflects	reflect	VERB
chd-104	64	11	the	the	DET
chd-104	64	12	functional	functional	ADJ
chd-104	64	13	activity	activity	NOUN
chd-104	64	14	of	of	ADP
chd-104	64	15	the	the	DET
chd-104	64	16	receptor	receptor	NOUN
chd-104	64	17	.	.	PUNCT
chd-104	65	1	membrane	membrane	NOUN
chd-104	65	2	localization	localization	NOUN
chd-104	65	3	of	of	ADP
chd-104	65	4	the	the	DET
chd-104	65	5	notch	notch	ADJ
chd-104	65	6	protein	protein	NOUN
chd-104	65	7	represents	represent	VERB
chd-104	65	8	a	a	DET
chd-104	65	9	mature	mature	ADJ
chd-104	65	10	receptor	receptor	NOUN
chd-104	65	11	that	that	PRON
chd-104	65	12	has	have	AUX
chd-104	65	13	not	not	PART
chd-104	65	14	yet	yet	ADV
chd-104	65	15	been	be	AUX
chd-104	65	16	activated	activate	VERB
chd-104	65	17	;	;	PUNCT
chd-104	65	18	cytoplasmic	cytoplasmic	ADJ
chd-104	65	19	localization	localization	NOUN
chd-104	65	20	of	of	ADP
chd-104	65	21	the	the	DET
chd-104	65	22	protein	protein	NOUN
chd-104	65	23	represents	represent	VERB
chd-104	65	24	a	a	DET
chd-104	65	25	newly	newly	ADV
chd-104	65	26	synthesized	synthesize	VERB
chd-104	65	27	receptor	receptor	NOUN
chd-104	65	28	which	which	PRON
chd-104	65	29	is	be	AUX
chd-104	65	30	on	on	ADP
chd-104	65	31	its	its	PRON
chd-104	65	32	way	way	NOUN
chd-104	65	33	to	to	AUX
chd-104	65	34	plasma	plasma	VERB
chd-104	65	35	membrane	membrane	NOUN
chd-104	65	36	;	;	PUNCT
chd-104	65	37	and	and	CCONJ
chd-104	65	38	nuclear	nuclear	ADJ
chd-104	65	39	localization	localization	NOUN
chd-104	65	40	of	of	ADP
chd-104	65	41	notch	notch	ADJ
chd-104	65	42	protein	protein	NOUN
chd-104	65	43	reflects	reflect	VERB
chd-104	65	44	the	the	DET
chd-104	65	45	activated	activated	ADJ
chd-104	65	46	state	state	NOUN
chd-104	65	47	of	of	ADP
chd-104	65	48	the	the	DET
chd-104	65	49	receptor	receptor	NOUN
chd-104	65	50	(	(	PUNCT
chd-104	65	51	speiser	speiser	NOUN
chd-104	65	52	et	et	PROPN
chd-104	65	53	al	al	PROPN
chd-104	65	54	.	.	PROPN
chd-104	65	55	,	,	PUNCT
chd-104	65	56	2012	2012	NUM
chd-104	65	57	)	)	PUNCT
chd-104	65	58	.	.	PUNCT
chd-104	66	1	however	however	ADV
chd-104	66	2	,	,	PUNCT
chd-104	66	3	the	the	DET
chd-104	66	4	correlation	correlation	NOUN
chd-104	66	5	between	between	ADP
chd-104	66	6	the	the	DET
chd-104	66	7	amount	amount	NOUN
chd-104	66	8	of	of	ADP
chd-104	66	9	notch	notch	NOUN
chd-104	66	10	staining	stain	VERB
chd-104	66	11	and	and	CCONJ
chd-104	66	12	notch	notch	ADJ
chd-104	66	13	pathway	pathway	NOUN
chd-104	66	14	activity	activity	NOUN
chd-104	66	15	,	,	PUNCT
chd-104	66	16	especially	especially	ADV
chd-104	66	17	if	if	SCONJ
chd-104	66	18	the	the	DET
chd-104	66	19	staining	stain	VERB
chd-104	66	20	is	be	AUX
chd-104	66	21	distributed	distribute	VERB
chd-104	66	22	to	to	ADP
chd-104	66	23	the	the	DET
chd-104	66	24	nucleus	nucleus	NOUN
chd-104	66	25	or	or	CCONJ
chd-104	66	26	cytoplasm	cytoplasm	NOUN
chd-104	66	27	,	,	PUNCT
chd-104	66	28	remains	remain	VERB
chd-104	66	29	unknown	unknown	ADJ
chd-104	66	30	.	.	PUNCT
chd-104	67	1	furthermore	furthermore	ADV
chd-104	67	2	,	,	PUNCT
chd-104	67	3	in	in	ADP
chd-104	67	4	a	a	DET
chd-104	67	5	study	study	NOUN
chd-104	67	6	by	by	ADP
chd-104	67	7	yao	yao	PROPN
chd-104	67	8	et	et	PROPN
chd-104	67	9	al	al	PROPN
chd-104	67	10	.	.	PROPN
chd-104	67	11	,	,	PUNCT
chd-104	67	12	there	there	PRON
chd-104	67	13	was	be	VERB
chd-104	67	14	significantly	significantly	ADV
chd-104	67	15	more	more	ADV
chd-104	67	16	membranous	membranous	ADJ
chd-104	67	17	staining	stain	VERB
chd-104	67	18	in	in	ADP
chd-104	67	19	the	the	DET
chd-104	67	20	er	er	INTJ
chd-104	67	21	-	-	PUNCT
chd-104	67	22	positive	positive	ADJ
chd-104	67	23	compared	compare	VERB
chd-104	67	24	to	to	ADP
chd-104	67	25	the	the	DET
chd-104	67	26	ernegative	ernegative	ADJ
chd-104	67	27	bc	bc	PROPN
chd-104	67	28	cases	case	NOUN
chd-104	67	29	(	(	PUNCT
chd-104	67	30	yao	yao	NOUN
chd-104	67	31	et	et	PROPN
chd-104	67	32	al	al	PROPN
chd-104	67	33	.	.	PROPN
chd-104	67	34	,	,	PUNCT
chd-104	67	35	2011	2011	NUM
chd-104	67	36	)	)	PUNCT
chd-104	67	37	.	.	PUNCT
chd-104	68	1	this	this	DET
chd-104	68	2	finding	finding	NOUN
chd-104	68	3	suggests	suggest	VERB
chd-104	68	4	that	that	SCONJ
chd-104	68	5	estrogen	estrogen	NOUN
chd-104	68	6	increases	increase	VERB
chd-104	68	7	notch-1	notch-1	NUM
chd-104	68	8	protein	protein	NOUN
chd-104	68	9	levels	level	NOUN
chd-104	68	10	and	and	CCONJ
chd-104	68	11	causes	cause	VERB
chd-104	68	12	it	it	PRON
chd-104	68	13	to	to	PART
chd-104	68	14	accumulate	accumulate	VERB
chd-104	68	15	at	at	ADP
chd-104	68	16	the	the	DET
chd-104	68	17	cell	cell	NOUN
chd-104	68	18	membrane	membrane	NOUN
chd-104	68	19	[	[	PUNCT
chd-104	68	20	which	which	PRON
chd-104	68	21	represents	represent	VERB
chd-104	68	22	a	a	DET
chd-104	68	23	mature	mature	ADJ
chd-104	68	24	but	but	CCONJ
chd-104	68	25	nonactivated	nonactivated	ADJ
chd-104	68	26	form	form	NOUN
chd-104	68	27	of	of	ADP
chd-104	68	28	notch-1	notch-1	PROPN
chd-104	68	29	]	]	PUNCT
chd-104	68	30	,	,	PUNCT
chd-104	68	31	but	but	CCONJ
chd-104	68	32	not	not	PART
chd-104	68	33	in	in	ADP
chd-104	68	34	the	the	DET
chd-104	68	35	nucleus	nucleus	NOUN
chd-104	68	36	(	(	PUNCT
chd-104	68	37	rizzo	rizzo	PROPN
chd-104	68	38	et	et	PROPN
chd-104	68	39	al	al	PROPN
chd-104	68	40	.	.	PROPN
chd-104	68	41	,	,	PUNCT
chd-104	68	42	2008	2008	NUM
chd-104	68	43	)	)	PUNCT
chd-104	68	44	.	.	PUNCT
chd-104	69	1	thus	thus	ADV
chd-104	69	2	,	,	PUNCT
chd-104	69	3	nuclear	nuclear	ADJ
chd-104	69	4	localized	localize	VERB
chd-104	69	5	notch-1	notch-1	PROPN
chd-104	69	6	and	and	CCONJ
chd-104	69	7	notch-4	notch-4	PRON
chd-104	69	8	may	may	AUX
chd-104	69	9	serve	serve	VERB
chd-104	69	10	as	as	ADP
chd-104	69	11	potential	potential	ADJ
chd-104	69	12	therapeutic	therapeutic	ADJ
chd-104	69	13	targets	target	NOUN
chd-104	69	14	for	for	ADP
chd-104	69	15	tnbc	tnbc	ADJ
chd-104	69	16	patients	patient	NOUN
chd-104	69	17	.	.	PUNCT
chd-104	70	1	moreover	moreover	ADV
chd-104	70	2	,	,	PUNCT
chd-104	70	3	rizzo	rizzo	PROPN
chd-104	70	4	et	et	PROPN
chd-104	70	5	al	al	PROPN
chd-104	70	6	.	.	PROPN
chd-104	70	7	observed	observe	VERB
chd-104	70	8	sensitivity	sensitivity	NOUN
chd-104	70	9	of	of	ADP
chd-104	70	10	tnbc	tnbc	ADJ
chd-104	70	11	cells	cell	NOUN
chd-104	70	12	to	to	PART
chd-104	70	13	notch	notch	VERB
chd-104	70	14	inhibitors	inhibitor	NOUN
chd-104	70	15	.	.	PUNCT
chd-104	71	1	the	the	DET
chd-104	71	2	authors	author	NOUN
chd-104	71	3	demonstrated	demonstrate	VERB
chd-104	71	4	arrest	arrest	NOUN
chd-104	71	5	of	of	ADP
chd-104	71	6	tnbc	tnbc	ADJ
chd-104	71	7	cells	cell	NOUN
chd-104	71	8	in	in	ADP
chd-104	71	9	g2	g2	PROPN
chd-104	71	10	phase	phase	NOUN
chd-104	71	11	of	of	ADP
chd-104	71	12	cell	cell	NOUN
chd-104	71	13	cycle	cycle	NOUN
chd-104	71	14	upon	upon	SCONJ
chd-104	71	15	knockdown	knockdown	NOUN
chd-104	71	16	of	of	ADP
chd-104	71	17	notch-1	notch-1	NUM
chd-104	71	18	and	and	CCONJ
chd-104	71	19	notch-4	notch-4	NUM
chd-104	71	20	with	with	ADP
chd-104	71	21	sirna	sirna	PROPN
chd-104	71	22	or	or	CCONJ
chd-104	71	23	pharmacological	pharmacological	ADJ
chd-104	71	24	inhibition	inhibition	NOUN
chd-104	71	25	of	of	ADP
chd-104	71	26	gamma	gamma	NOUN
chd-104	71	27	-	-	PUNCT
chd-104	71	28	secretase	secretase	NOUN
chd-104	71	29	(	(	PUNCT
chd-104	71	30	gsi	gsi	PROPN
chd-104	71	31	)	)	PUNCT
chd-104	71	32	(	(	PUNCT
chd-104	71	33	rizzo	rizzo	PROPN
chd-104	71	34	et	et	PROPN
chd-104	71	35	al	al	PROPN
chd-104	71	36	.	.	PROPN
chd-104	71	37	,	,	PUNCT
chd-104	71	38	2008	2008	NUM
chd-104	71	39	)	)	PUNCT
chd-104	71	40	.	.	PUNCT
chd-104	72	1	gsi	gsi	PROPN
chd-104	72	2	inhibitors	inhibitor	NOUN
chd-104	72	3	are	be	AUX
chd-104	72	4	currently	currently	ADV
chd-104	72	5	in	in	ADP
chd-104	72	6	clinical	clinical	ADJ
chd-104	72	7	trials	trial	NOUN
chd-104	72	8	to	to	PART
chd-104	72	9	reduce	reduce	VERB
chd-104	72	10	notch	notch	NOUN
chd-104	72	11	signaling	signal	VERB
chd-104	72	12	in	in	ADP
chd-104	72	13	patients	patient	NOUN
chd-104	72	14	with	with	ADP
chd-104	72	15	recurrent	recurrent	ADJ
chd-104	72	16	tnbc	tnbc	NOUN
chd-104	72	17	(	(	PUNCT
chd-104	72	18	olsauskas	olsauskas	NOUN
chd-104	72	19	-	-	PUNCT
chd-104	72	20	kuprys	kuprys	NOUN
chd-104	72	21	et	et	PROPN
chd-104	72	22	al	al	PROPN
chd-104	72	23	.	.	PROPN
chd-104	72	24	,	,	PUNCT
chd-104	72	25	2013	2013	NUM
chd-104	72	26	)	)	PUNCT
chd-104	72	27	.	.	PUNCT
chd-104	73	1	a	a	DET
chd-104	73	2	recent	recent	ADJ
chd-104	73	3	clinical	clinical	ADJ
chd-104	73	4	trial	trial	NOUN
chd-104	73	5	demonstrated	demonstrate	VERB
chd-104	73	6	that	that	SCONJ
chd-104	73	7	the	the	DET
chd-104	73	8	administration	administration	NOUN
chd-104	73	9	of	of	ADP
chd-104	73	10	a	a	DET
chd-104	73	11	gsi	gsi	PROPN
chd-104	73	12	inhibitor	inhibitor	NOUN
chd-104	73	13	in	in	ADP
chd-104	73	14	combination	combination	NOUN
chd-104	73	15	with	with	ADP
chd-104	73	16	docetaxel	docetaxel	NOUN
chd-104	73	17	elicited	elicit	VERB
chd-104	73	18	anti	anti	ADJ
chd-104	73	19	-	-	ADJ
chd-104	73	20	tumor	tumor	ADJ
chd-104	73	21	activity	activity	NOUN
chd-104	73	22	in	in	ADP
chd-104	73	23	patients	patient	NOUN
chd-104	73	24	with	with	ADP
chd-104	73	25	locally	locally	ADV
chd-104	73	26	advanced	advanced	ADJ
chd-104	73	27	/	/	SYM
chd-104	73	28	metastatic	metastatic	ADJ
chd-104	73	29	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-104	73	30	e5	e5	PROPN
chd-104	73	31	cancer	cancer	NOUN
chd-104	73	32	health	health	NOUN
chd-104	73	33	disparities	disparity	NOUN
chd-104	73	34	research	research	NOUN
chd-104	73	35	tnbc	tnbc	PROPN
chd-104	73	36	(	(	PUNCT
chd-104	73	37	locatelli	locatelli	NOUN
chd-104	73	38	and	and	CCONJ
chd-104	73	39	curigliano	curigliano	NOUN
chd-104	73	40	,	,	PUNCT
chd-104	73	41	2017	2017	NUM
chd-104	73	42	)	)	PUNCT
chd-104	73	43	.	.	PUNCT
chd-104	74	1	thus	thus	ADV
chd-104	74	2	,	,	PUNCT
chd-104	74	3	notch	notch	ADJ
chd-104	74	4	signaling	signal	VERB
chd-104	74	5	,	,	PUNCT
chd-104	74	6	which	which	PRON
chd-104	74	7	is	be	AUX
chd-104	74	8	highly	highly	ADV
chd-104	74	9	upregulated	upregulated	ADJ
chd-104	74	10	in	in	ADP
chd-104	74	11	tnbc	tnbc	NOUN
chd-104	74	12	,	,	PUNCT
chd-104	74	13	may	may	AUX
chd-104	74	14	be	be	AUX
chd-104	74	15	a	a	DET
chd-104	74	16	potential	potential	ADJ
chd-104	74	17	therapeutic	therapeutic	ADJ
chd-104	74	18	target	target	NOUN
chd-104	74	19	for	for	ADP
chd-104	74	20	tnbc	tnbc	ADJ
chd-104	74	21	patients	patient	NOUN
chd-104	74	22	,	,	PUNCT
chd-104	74	23	who	who	PRON
chd-104	74	24	lack	lack	VERB
chd-104	74	25	good	good	ADJ
chd-104	74	26	targeted	target	VERB
chd-104	74	27	therapy	therapy	NOUN
chd-104	74	28	options	option	NOUN
chd-104	74	29	.	.	PUNCT
chd-104	75	1	uncharted	uncharted	ADJ
chd-104	75	2	territory	territory	NOUN
chd-104	75	3	:	:	PUNCT
chd-104	75	4	investigating	investigate	VERB
chd-104	75	5	disparities	disparity	NOUN
chd-104	75	6	in	in	ADP
chd-104	75	7	the	the	DET
chd-104	75	8	notch	notch	NOUN
chd-104	75	9	signaling	signal	VERB
chd-104	75	10	pathway	pathway	NOUN
chd-104	75	11	among	among	ADP
chd-104	75	12	racially	racially	ADV
chd-104	75	13	-	-	PUNCT
chd-104	75	14	distinct	distinct	ADJ
chd-104	75	15	triple	triple	ADJ
chd-104	75	16	negative	negative	ADJ
chd-104	75	17	breast	breast	NOUN
chd-104	75	18	cancer	cancer	NOUN
chd-104	75	19	patients	patient	NOUN
chd-104	75	20	the	the	DET
chd-104	75	21	emergence	emergence	NOUN
chd-104	75	22	of	of	ADP
chd-104	75	23	notch	notch	NOUN
chd-104	75	24	signaling	signal	VERB
chd-104	75	25	as	as	ADP
chd-104	75	26	a	a	DET
chd-104	75	27	therapeutic	therapeutic	ADJ
chd-104	75	28	target	target	NOUN
chd-104	75	29	of	of	ADP
chd-104	75	30	interest	interest	NOUN
chd-104	75	31	in	in	ADP
chd-104	75	32	tnbc	tnbc	NOUN
chd-104	75	33	has	have	AUX
chd-104	75	34	spurred	spur	VERB
chd-104	75	35	interest	interest	NOUN
chd-104	75	36	in	in	ADP
chd-104	75	37	this	this	DET
chd-104	75	38	pathway	pathway	NOUN
chd-104	75	39	as	as	ADP
chd-104	75	40	a	a	DET
chd-104	75	41	potential	potential	ADJ
chd-104	75	42	suspect	suspect	NOUN
chd-104	75	43	in	in	ADP
chd-104	75	44	the	the	DET
chd-104	75	45	racially	racially	ADV
chd-104	75	46	disparate	disparate	ADJ
chd-104	75	47	burden	burden	NOUN
chd-104	75	48	in	in	ADP
chd-104	75	49	tnbc	tnbc	NOUN
chd-104	75	50	.	.	PUNCT
chd-104	76	1	however	however	ADV
chd-104	76	2	,	,	PUNCT
chd-104	76	3	literature	literature	NOUN
chd-104	76	4	evidence	evidence	NOUN
chd-104	76	5	supporting	support	VERB
chd-104	76	6	this	this	DET
chd-104	76	7	speculation	speculation	NOUN
chd-104	76	8	remains	remain	VERB
chd-104	76	9	sparse	sparse	ADJ
chd-104	76	10	.	.	PUNCT
chd-104	77	1	a	a	DET
chd-104	77	2	genome	genome	NOUN
chd-104	77	3	-	-	PUNCT
chd-104	77	4	wide	wide	ADJ
chd-104	77	5	association	association	NOUN
chd-104	77	6	study	study	NOUN
chd-104	77	7	conducted	conduct	VERB
chd-104	77	8	by	by	ADP
chd-104	77	9	adriano	adriano	PROPN
chd-104	77	10	and	and	CCONJ
chd-104	77	11	colleagues	colleague	NOUN
chd-104	77	12	revealed	reveal	VERB
chd-104	77	13	that	that	SCONJ
chd-104	77	14	a	a	DET
chd-104	77	15	snp	snp	NOUN
chd-104	77	16	in	in	ADP
chd-104	77	17	the	the	DET
chd-104	77	18	notch4	notch4	NOUN
chd-104	77	19	locus	locus	NOUN
chd-104	77	20	was	be	AUX
chd-104	77	21	significantly	significantly	ADV
chd-104	77	22	associated	associate	VERB
chd-104	77	23	with	with	ADP
chd-104	77	24	aa	aa	NOUN
chd-104	77	25	but	but	CCONJ
chd-104	77	26	not	not	PART
chd-104	77	27	ea	ea	NOUN
chd-104	77	28	sarcoidosis	sarcoidosis	NOUN
chd-104	77	29	patients	patient	NOUN
chd-104	77	30	and	and	CCONJ
chd-104	77	31	this	this	DET
chd-104	77	32	finding	finding	NOUN
chd-104	77	33	remained	remain	VERB
chd-104	77	34	consistent	consistent	ADJ
chd-104	77	35	in	in	ADP
chd-104	77	36	multivariate	multivariate	NOUN
chd-104	77	37	models	model	NOUN
chd-104	77	38	(	(	PUNCT
chd-104	77	39	adrianto	adrianto	NOUN
chd-104	77	40	et	et	PROPN
chd-104	77	41	al	al	PROPN
chd-104	77	42	.	.	PROPN
chd-104	77	43	,	,	PUNCT
chd-104	77	44	2012	2012	NUM
chd-104	77	45	)	)	PUNCT
chd-104	77	46	.	.	PUNCT
chd-104	78	1	sarcoidosis	sarcoidosis	NOUN
chd-104	78	2	disproportionately	disproportionately	ADV
chd-104	78	3	afflicts	afflict	VERB
chd-104	78	4	aas	aas	NOUN
chd-104	78	5	suggesting	suggest	VERB
chd-104	78	6	that	that	SCONJ
chd-104	78	7	this	this	DET
chd-104	78	8	genetic	genetic	ADJ
chd-104	78	9	variant	variant	NOUN
chd-104	78	10	may	may	AUX
chd-104	78	11	play	play	VERB
chd-104	78	12	a	a	DET
chd-104	78	13	role	role	NOUN
chd-104	78	14	in	in	ADP
chd-104	78	15	the	the	DET
chd-104	78	16	disease	disease	NOUN
chd-104	78	17	’s	’s	PART
chd-104	78	18	disparate	disparate	ADJ
chd-104	78	19	burden	burden	NOUN
chd-104	78	20	(	(	PUNCT
chd-104	78	21	cozier	cozy	ADJ
chd-104	78	22	et	et	PROPN
chd-104	78	23	al	al	PROPN
chd-104	78	24	.	.	PROPN
chd-104	78	25	,	,	PUNCT
chd-104	78	26	2011	2011	NUM
chd-104	78	27	;	;	PUNCT
chd-104	78	28	james	james	PROPN
chd-104	78	29	and	and	CCONJ
chd-104	78	30	sherlock	sherlock	PROPN
chd-104	78	31	,	,	PUNCT
chd-104	78	32	1994	1994	NUM
chd-104	78	33	)	)	PUNCT
chd-104	78	34	.	.	PUNCT
chd-104	79	1	furthermore	furthermore	ADV
chd-104	79	2	,	,	PUNCT
chd-104	79	3	stewart	stewart	PROPN
chd-104	79	4	et	et	PROPN
chd-104	79	5	al	al	PROPN
chd-104	79	6	.	.	PROPN
chd-104	79	7	discovered	discover	VERB
chd-104	79	8	that	that	SCONJ
chd-104	79	9	the	the	DET
chd-104	79	10	notch	notch	ADJ
chd-104	79	11	2	2	NUM
chd-104	79	12	n	n	CCONJ
chd-104	79	13	-	-	PUNCT
chd-104	79	14	terminal	terminal	NOUN
chd-104	79	15	-	-	PUNCT
chd-104	79	16	like	like	ADJ
chd-104	79	17	(	(	PUNCT
chd-104	79	18	notch2nl	notch2nl	ADJ
chd-104	79	19	)	)	PUNCT
chd-104	79	20	gene	gene	NOUN
chd-104	79	21	was	be	AUX
chd-104	79	22	significantly	significantly	ADV
chd-104	79	23	upregulated	upregulate	VERB
chd-104	79	24	among	among	ADP
chd-104	79	25	aa	aa	NOUN
chd-104	79	26	compared	compare	VERB
chd-104	79	27	to	to	ADP
chd-104	79	28	ea	ea	PROPN
chd-104	79	29	bc	bc	PROPN
chd-104	79	30	patients	patient	NOUN
chd-104	79	31	in	in	ADP
chd-104	79	32	the	the	DET
chd-104	79	33	tcga	tcga	ADJ
chd-104	79	34	dataset	dataset	NOUN
chd-104	79	35	(	(	PUNCT
chd-104	79	36	stewart	stewart	PROPN
chd-104	79	37	et	et	PROPN
chd-104	79	38	al	al	PROPN
chd-104	79	39	.	.	PROPN
chd-104	79	40	,	,	PUNCT
chd-104	79	41	2013	2013	NUM
chd-104	79	42	)	)	PUNCT
chd-104	79	43	.	.	PUNCT
chd-104	80	1	however	however	ADV
chd-104	80	2	,	,	PUNCT
chd-104	80	3	ethnic	ethnic	ADJ
chd-104	80	4	differences	difference	NOUN
chd-104	80	5	in	in	ADP
chd-104	80	6	notch	notch	NOUN
chd-104	80	7	signaling	signal	VERB
chd-104	80	8	and	and	CCONJ
chd-104	80	9	its	its	PRON
chd-104	80	10	role	role	NOUN
chd-104	80	11	in	in	ADP
chd-104	80	12	the	the	DET
chd-104	80	13	higher	high	ADJ
chd-104	80	14	incidence	incidence	NOUN
chd-104	80	15	of	of	ADP
chd-104	80	16	and	and	CCONJ
chd-104	80	17	poorer	poor	ADJ
chd-104	80	18	outcomes	outcome	NOUN
chd-104	80	19	from	from	ADP
chd-104	80	20	tnbc	tnbc	NOUN
chd-104	80	21	remain	remain	VERB
chd-104	80	22	understudied	understudied	ADJ
chd-104	80	23	.	.	PUNCT
chd-104	81	1	we	we	PRON
chd-104	81	2	recently	recently	ADV
chd-104	81	3	queried	query	VERB
chd-104	81	4	tcga	tcga	NOUN
chd-104	81	5	breast	breast	NOUN
chd-104	81	6	dataset	dataset	NOUN
chd-104	81	7	for	for	ADP
chd-104	81	8	aa	aa	NOUN
chd-104	81	9	and	and	CCONJ
chd-104	81	10	ea	ea	NOUN
chd-104	81	11	tnbc	tnbc	VERB
chd-104	81	12	patients	patient	NOUN
chd-104	81	13	and	and	CCONJ
chd-104	81	14	exploited	exploit	VERB
chd-104	81	15	bioinformatics	bioinformatics	NOUN
chd-104	81	16	tools	tool	NOUN
chd-104	81	17	to	to	PART
chd-104	81	18	determine	determine	VERB
chd-104	81	19	differentiallyexpressed	differentiallyexpresse	VERB
chd-104	81	20	genes	gene	NOUN
chd-104	81	21	,	,	PUNCT
chd-104	81	22	biological	biological	ADJ
chd-104	81	23	pathways	pathway	NOUN
chd-104	81	24	,	,	PUNCT
chd-104	81	25	and	and	CCONJ
chd-104	81	26	gene	gene	NOUN
chd-104	81	27	ontologies	ontology	NOUN
chd-104	81	28	between	between	ADP
chd-104	81	29	the	the	DET
chd-104	81	30	racially	racially	ADV
chd-104	81	31	-	-	PUNCT
chd-104	81	32	distinct	distinct	ADJ
chd-104	81	33	tnbc	tnbc	NOUN
chd-104	81	34	patients	patient	NOUN
chd-104	81	35	.	.	PUNCT
chd-104	82	1	according	accord	VERB
chd-104	82	2	to	to	ADP
chd-104	82	3	our	our	PRON
chd-104	82	4	deseq2	deseq2	PROPN
chd-104	82	5	or	or	CCONJ
chd-104	82	6	differential	differential	ADJ
chd-104	82	7	gene	gene	NOUN
chd-104	82	8	expression	expression	NOUN
chd-104	82	9	analyses	analysis	NOUN
chd-104	82	10	,	,	PUNCT
chd-104	82	11	we	we	PRON
chd-104	82	12	observed	observe	VERB
chd-104	82	13	significant	significant	ADJ
chd-104	82	14	upregulation	upregulation	NOUN
chd-104	82	15	of	of	ADP
chd-104	82	16	genes	gene	NOUN
chd-104	82	17	encoding	encode	VERB
chd-104	82	18	key	key	ADJ
chd-104	82	19	components	component	NOUN
chd-104	82	20	of	of	ADP
chd-104	82	21	the	the	DET
chd-104	82	22	notch	notch	NOUN
chd-104	82	23	signaling	signal	VERB
chd-104	82	24	network	network	NOUN
chd-104	82	25	such	such	ADJ
chd-104	82	26	as	as	ADP
chd-104	82	27	notchregulated	notchregulated	ADJ
chd-104	82	28	ankyrin	ankyrin	ADJ
chd-104	82	29	repeat	repeat	NOUN
chd-104	82	30	protein	protein	NOUN
chd-104	82	31	(	(	PUNCT
chd-104	82	32	nrarp	nrarp	ADJ
chd-104	82	33	)	)	PUNCT
chd-104	82	34	,	,	PUNCT
chd-104	82	35	notch2nl	notch2nl	PROPN
chd-104	82	36	,	,	PUNCT
chd-104	82	37	delta	delta	NOUN
chd-104	82	38	/	/	SYM
chd-104	82	39	notch	notch	NOUN
chd-104	82	40	-	-	PUNCT
chd-104	82	41	like	like	ADJ
chd-104	82	42	egfr	egfr	NOUN
chd-104	82	43	repeat	repeat	NOUN
chd-104	82	44	containing	contain	VERB
chd-104	82	45	(	(	PUNCT
chd-104	82	46	dner	dner	NOUN
chd-104	82	47	)	)	PUNCT
chd-104	82	48	,	,	PUNCT
chd-104	82	49	jagged	jag	VERB
chd-104	82	50	1	1	NUM
chd-104	82	51	(	(	PUNCT
chd-104	82	52	jag1	jag1	PROPN
chd-104	82	53	)	)	PUNCT
chd-104	82	54	,	,	PUNCT
chd-104	82	55	jagged	jag	VERB
chd-104	82	56	2	2	NUM
chd-104	82	57	(	(	PUNCT
chd-104	82	58	jag2	jag2	PROPN
chd-104	82	59	)	)	PUNCT
chd-104	82	60	,	,	PUNCT
chd-104	82	61	hess	hess	PROPN
chd-104	82	62	family	family	NOUN
chd-104	82	63	belch	belch	NOUN
chd-104	82	64	transcription	transcription	NOUN
chd-104	82	65	factor	factor	NOUN
chd-104	82	66	4	4	NUM
chd-104	82	67	(	(	PUNCT
chd-104	82	68	hes4	hes4	NOUN
chd-104	82	69	)	)	PUNCT
chd-104	82	70	,	,	PUNCT
chd-104	82	71	and	and	CCONJ
chd-104	82	72	matrix	matrix	NOUN
chd-104	82	73	metalloproteinase-9	metalloproteinase-9	NUM
chd-104	82	74	(	(	PUNCT
chd-104	82	75	mmp9	mmp9	PROPN
chd-104	82	76	)	)	PUNCT
chd-104	82	77	among	among	ADP
chd-104	82	78	aa	aa	NOUN
chd-104	82	79	compared	compare	VERB
chd-104	82	80	to	to	ADP
chd-104	82	81	ea	ea	NOUN
chd-104	82	82	tnbc	tnbc	VERB
chd-104	82	83	samples	sample	NOUN
chd-104	82	84	(	(	PUNCT
chd-104	82	85	p<0.05	p<0.05	NOUN
chd-104	82	86	)	)	PUNCT
chd-104	82	87	(	(	PUNCT
chd-104	82	88	table	table	NOUN
chd-104	82	89	1	1	NUM
chd-104	82	90	)	)	PUNCT
chd-104	82	91	.	.	PUNCT
chd-104	83	1	we	we	PRON
chd-104	83	2	employed	employ	VERB
chd-104	83	3	the	the	DET
chd-104	83	4	gage	gage	NOUN
chd-104	83	5	and	and	CCONJ
chd-104	83	6	pathview	pathview	NOUN
chd-104	83	7	packages	package	NOUN
chd-104	83	8	to	to	PART
chd-104	83	9	identify	identify	VERB
chd-104	83	10	differentiallyexpressed	differentiallyexpresse	VERB
chd-104	83	11	biological	biological	ADJ
chd-104	83	12	pathways	pathway	NOUN
chd-104	83	13	or	or	CCONJ
chd-104	83	14	experimentallyderived	experimentallyderive	VERB
chd-104	83	15	differential	differential	NOUN
chd-104	83	16	expression	expression	NOUN
chd-104	83	17	sets	set	NOUN
chd-104	83	18	(	(	PUNCT
chd-104	83	19	table	table	NOUN
chd-104	83	20	2	2	NUM
chd-104	83	21	)	)	PUNCT
chd-104	83	22	and	and	CCONJ
chd-104	83	23	gene	gene	NOUN
chd-104	83	24	ontologies	ontology	NOUN
chd-104	83	25	(	(	PUNCT
chd-104	83	26	table	table	NOUN
chd-104	83	27	3	3	NUM
chd-104	83	28	)	)	PUNCT
chd-104	83	29	between	between	ADP
chd-104	83	30	rna	rna	NOUN
chd-104	83	31	sequenced	sequence	VERB
chd-104	83	32	aa	aa	NOUN
chd-104	83	33	and	and	CCONJ
chd-104	83	34	ea	ea	NOUN
chd-104	83	35	tnbc	tnbc	VERB
chd-104	83	36	samples	sample	NOUN
chd-104	83	37	.	.	PUNCT
chd-104	84	1	interestingly	interestingly	ADV
chd-104	84	2	,	,	PUNCT
chd-104	84	3	we	we	PRON
chd-104	84	4	discovered	discover	VERB
chd-104	84	5	that	that	SCONJ
chd-104	84	6	the	the	DET
chd-104	84	7	notch	notch	NOUN
chd-104	84	8	signaling	signal	VERB
chd-104	84	9	pathway	pathway	NOUN
chd-104	84	10	expression	expression	NOUN
chd-104	84	11	set	set	NOUN
chd-104	84	12	was	be	AUX
chd-104	84	13	more	more	ADV
chd-104	84	14	upregulated	upregulated	ADJ
chd-104	84	15	in	in	ADP
chd-104	84	16	aa	aa	NOUN
chd-104	84	17	compared	compare	VERB
chd-104	84	18	to	to	ADP
chd-104	84	19	ea	ea	NOUN
chd-104	84	20	tnbc	tnbc	VERB
chd-104	84	21	samples	sample	NOUN
chd-104	84	22	(	(	PUNCT
chd-104	84	23	p=0.054	p=0.054	NOUN
chd-104	84	24	)	)	PUNCT
chd-104	84	25	.	.	PUNCT
chd-104	85	1	we	we	PRON
chd-104	85	2	also	also	ADV
chd-104	85	3	observed	observe	VERB
chd-104	85	4	significant	significant	ADJ
chd-104	85	5	downregulation	downregulation	NOUN
chd-104	85	6	of	of	ADP
chd-104	85	7	key	key	ADJ
chd-104	85	8	processes	process	NOUN
chd-104	85	9	that	that	PRON
chd-104	85	10	are	be	AUX
chd-104	85	11	normally	normally	ADV
chd-104	85	12	repressed	repress	VERB
chd-104	85	13	by	by	ADP
chd-104	85	14	notch	notch	NOUN
chd-104	85	15	signaling	signal	VERB
chd-104	85	16	such	such	ADJ
chd-104	85	17	as	as	ADP
chd-104	85	18	focal	focal	ADJ
chd-104	85	19	adhesion	adhesion	NOUN
chd-104	85	20	,	,	PUNCT
chd-104	85	21	extracellular	extracellular	ADJ
chd-104	85	22	matrix	matrix	NOUN
chd-104	85	23	(	(	PUNCT
chd-104	85	24	ecm)-receptor	ecm)-receptor	NOUN
chd-104	85	25	interaction	interaction	NOUN
chd-104	85	26	,	,	PUNCT
chd-104	85	27	and	and	CCONJ
chd-104	85	28	adherents	adherent	NOUN
chd-104	85	29	junction	junction	NOUN
chd-104	85	30	expression	expression	NOUN
chd-104	85	31	sets	set	VERB
chd-104	85	32	as	as	ADV
chd-104	85	33	well	well	ADV
chd-104	85	34	as	as	ADP
chd-104	85	35	cell	cell	NOUN
chd-104	85	36	junction	junction	NOUN
chd-104	85	37	assembly	assembly	NOUN
chd-104	85	38	,	,	PUNCT
chd-104	85	39	cell	cell	NOUN
chd-104	85	40	-	-	PUNCT
chd-104	85	41	cell	cell	NOUN
chd-104	85	42	junction	junction	NOUN
chd-104	85	43	organization	organization	NOUN
chd-104	85	44	,	,	PUNCT
chd-104	85	45	cell	cell	NOUN
chd-104	85	46	-	-	PUNCT
chd-104	85	47	cell	cell	NOUN
chd-104	85	48	adhesion	adhesion	NOUN
chd-104	85	49	,	,	PUNCT
chd-104	85	50	epithelial	epithelial	ADJ
chd-104	85	51	cell	cell	NOUN
chd-104	85	52	development	development	NOUN
chd-104	85	53	,	,	PUNCT
chd-104	85	54	negative	negative	ADJ
chd-104	85	55	regulation	regulation	NOUN
chd-104	85	56	of	of	ADP
chd-104	85	57	endothelial	endothelial	ADJ
chd-104	85	58	cell	cell	NOUN
chd-104	85	59	proliferation	proliferation	NOUN
chd-104	85	60	,	,	PUNCT
chd-104	85	61	double	double	ADJ
chd-104	85	62	-	-	PUNCT
chd-104	85	63	strand	strand	NOUN
chd-104	85	64	break	break	NOUN
chd-104	85	65	repair	repair	NOUN
chd-104	85	66	,	,	PUNCT
chd-104	85	67	and	and	CCONJ
chd-104	85	68	regulation	regulation	NOUN
chd-104	85	69	of	of	ADP
chd-104	85	70	dna	dna	PROPN
chd-104	85	71	repair	repair	NOUN
chd-104	85	72	gene	gene	NOUN
chd-104	85	73	ontologies	ontology	NOUN
chd-104	85	74	(	(	PUNCT
chd-104	85	75	p<0.05	p<0.05	NOUN
chd-104	85	76	)	)	PUNCT
chd-104	85	77	.	.	PUNCT
chd-104	86	1	furthermore	furthermore	ADV
chd-104	86	2	,	,	PUNCT
chd-104	86	3	we	we	PRON
chd-104	86	4	observed	observe	VERB
chd-104	86	5	significant	significant	ADJ
chd-104	86	6	upregulation	upregulation	NOUN
chd-104	86	7	of	of	ADP
chd-104	86	8	gene	gene	NOUN
chd-104	86	9	ontologies	ontology	NOUN
chd-104	86	10	reflecting	reflect	VERB
chd-104	86	11	t	t	NOUN
chd-104	86	12	cell	cell	NOUN
chd-104	86	13	antitumoral	antitumoral	ADJ
chd-104	86	14	immunity	immunity	NOUN
chd-104	86	15	(	(	PUNCT
chd-104	86	16	which	which	PRON
chd-104	86	17	is	be	AUX
chd-104	86	18	enhanced	enhance	VERB
chd-104	86	19	by	by	ADP
chd-104	86	20	notch	notch	ADJ
chd-104	86	21	signaling	signal	VERB
chd-104	86	22	)	)	PUNCT
chd-104	86	23	such	such	ADJ
chd-104	86	24	as	as	ADP
chd-104	86	25	t	t	PROPN
chd-104	86	26	cell	cell	NOUN
chd-104	86	27	differentiation	differentiation	NOUN
chd-104	86	28	,	,	PUNCT
chd-104	86	29	t	t	NOUN
chd-104	86	30	cell	cell	NOUN
chd-104	86	31	activation	activation	NOUN
chd-104	86	32	,	,	PUNCT
chd-104	86	33	adaptive	adaptive	ADJ
chd-104	86	34	immune	immune	ADJ
chd-104	86	35	response	response	NOUN
chd-104	86	36	,	,	PUNCT
chd-104	86	37	and	and	CCONJ
chd-104	86	38	interferon	interferon	ADJ
chd-104	86	39	-	-	PUNCT
chd-104	86	40	gamma	gamma	NOUN
chd-104	86	41	production	production	NOUN
chd-104	86	42	(	(	PUNCT
chd-104	86	43	p<0.05	p<0.05	NOUN
chd-104	86	44	)	)	PUNCT
chd-104	86	45	.	.	PUNCT
chd-104	87	1	moreover	moreover	ADV
chd-104	87	2	,	,	PUNCT
chd-104	87	3	kaplan	kaplan	PROPN
chd-104	87	4	-	-	PUNCT
chd-104	87	5	meier	meier	PROPN
chd-104	87	6	survival	survival	NOUN
chd-104	87	7	analyses	analysis	NOUN
chd-104	87	8	revealed	reveal	VERB
chd-104	87	9	that	that	SCONJ
chd-104	87	10	overexpression	overexpression	NOUN
chd-104	87	11	of	of	ADP
chd-104	87	12	dner	dner	NOUN
chd-104	87	13	predicted	predict	VERB
chd-104	87	14	significantly	significantly	ADV
chd-104	87	15	poorer	poor	ADJ
chd-104	87	16	relapse	relapse	NOUN
chd-104	87	17	-	-	PUNCT
chd-104	87	18	free	free	ADJ
chd-104	87	19	survival	survival	NOUN
chd-104	87	20	(	(	PUNCT
chd-104	87	21	rfs	rfs	PROPN
chd-104	87	22	)	)	PUNCT
chd-104	87	23	in	in	ADP
chd-104	87	24	tnbcs	tnbc	NOUN
chd-104	87	25	(	(	PUNCT
chd-104	87	26	hr=2.4	hr=2.4	NUM
chd-104	87	27	;	;	PUNCT
chd-104	87	28	p=0.0012	p=0.0012	PROPN
chd-104	87	29	)	)	PUNCT
chd-104	87	30	;	;	PUNCT
chd-104	87	31	jag2	jag2	NOUN
chd-104	87	32	expression	expression	NOUN
chd-104	87	33	also	also	ADV
chd-104	87	34	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-104	87	35	e6	e6	NOUN
chd-104	87	36	cancer	cancer	NOUN
chd-104	87	37	health	health	NOUN
chd-104	87	38	disparities	disparity	NOUN
chd-104	87	39	research	research	NOUN
chd-104	87	40	table	table	NOUN
chd-104	87	41	1	1	NUM
chd-104	87	42	.	.	PUNCT
chd-104	88	1	genes	gene	NOUN
chd-104	88	2	significantly	significantly	ADV
chd-104	88	3	upregulated	upregulate	VERB
chd-104	88	4	among	among	ADP
chd-104	88	5	aa	aa	NOUN
chd-104	88	6	compared	compare	VERB
chd-104	88	7	to	to	ADP
chd-104	88	8	ea	ea	NOUN
chd-104	88	9	tnbc	tnbc	VERB
chd-104	88	10	patients	patient	NOUN
chd-104	88	11	in	in	ADP
chd-104	88	12	the	the	DET
chd-104	88	13	tcga	tcga	PROPN
chd-104	88	14	dataset	dataset	NOUN
chd-104	88	15	.	.	PUNCT
chd-104	89	1	gene	gene	NOUN
chd-104	89	2	symbol	symbol	PROPN
chd-104	89	3	entrez	entrez	PROPN
chd-104	89	4	name	name	PROPN
chd-104	89	5	base	base	NOUN
chd-104	89	6	mean	mean	PROPN
chd-104	89	7	log2foldchange	log2foldchange	PROPN
chd-104	89	8	p	p	NOUN
chd-104	89	9	value	value	NOUN
chd-104	89	10	ensg00000198435	ensg00000198435	PROPN
chd-104	89	11	nrarp	nrarp	ADJ
chd-104	89	12	441478	441478	NUM
chd-104	89	13	notch	notch	ADV
chd-104	89	14	-	-	PUNCT
chd-104	89	15	regulated	regulate	VERB
chd-104	89	16	ankyrin	ankyrin	ADJ
chd-104	89	17	repeat	repeat	NOUN
chd-104	89	18	protein	protein	NOUN
chd-104	89	19	516.3894051	516.3894051	NUM
chd-104	89	20	5.051550368	5.051550368	NUM
chd-104	89	21	4.38e-07	4.38e-07	NUM
chd-104	89	22	ensg00000167244	ensg00000167244	PROPN
chd-104	89	23	igf2	igf2	PROPN
chd-104	89	24	3481	3481	NUM
chd-104	89	25	insulin	insulin	NOUN
chd-104	89	26	like	like	ADP
chd-104	89	27	growth	growth	NOUN
chd-104	89	28	factor	factor	NOUN
chd-104	89	29	2	2	NUM
chd-104	89	30	2619.306453	2619.306453	NUM
chd-104	89	31	-1.233367377	-1.233367377	NOUN
chd-104	89	32	1.02e-05	1.02e-05	NUM
chd-104	89	33	ensg00000157764	ensg00000157764	PROPN
chd-104	89	34	braf	braf	NOUN
chd-104	89	35	673	673	NUM
chd-104	89	36	b	b	X
chd-104	89	37	-	-	PUNCT
chd-104	89	38	raf	raf	NOUN
chd-104	89	39	proto	proto	NOUN
chd-104	89	40	-	-	PUNCT
chd-104	89	41	oncogene	oncogene	ADJ
chd-104	89	42	,	,	PUNCT
chd-104	89	43	serine	serine	NOUN
chd-104	89	44	/	/	SYM
chd-104	89	45	threonine	threonine	ADJ
chd-104	89	46	kinase	kinase	NOUN
chd-104	89	47	214.9862772	214.9862772	NUM
chd-104	89	48	-0.502496583	-0.502496583	NOUN
chd-104	89	49	2.33e-05	2.33e-05	NUM
chd-104	89	50	ensg00000165105	ensg00000165105	PROPN
chd-104	89	51	rasef	rasef	NOUN
chd-104	89	52	158158	158158	NUM
chd-104	89	53	ras	ras	X
chd-104	89	54	and	and	CCONJ
chd-104	89	55	ef	ef	ADJ
chd-104	89	56	-	-	ADJ
chd-104	89	57	hand	hand	NOUN
chd-104	89	58	domain	domain	NOUN
chd-104	89	59	containing	contain	VERB
chd-104	89	60	162.6660192	162.6660192	NUM
chd-104	89	61	-0.958748689	-0.958748689	NOUN
chd-104	89	62	7.76e-05	7.76e-05	NUM
chd-104	89	63	ensg00000184916	ensg00000184916	PROPN
chd-104	89	64	jag2	jag2	NOUN
chd-104	89	65	3714	3714	NUM
chd-104	89	66	jagged	jag	VERB
chd-104	89	67	2	2	NUM
chd-104	89	68	836.7242091	836.7242091	NUM
chd-104	89	69	3.853121028	3.853121028	NUM
chd-104	89	70	0.0001166	0.0001166	NUM
chd-104	89	71	ensg00000188290	ensg00000188290	PROPN
chd-104	89	72	hes4	hes4	NOUN
chd-104	89	73	57801	57801	NUM
chd-104	89	74	he	he	PRON
chd-104	89	75	s	s	VERB
chd-104	89	76	family	family	NOUN
chd-104	89	77	bhlh	bhlh	NOUN
chd-104	89	78	transcription	transcription	NOUN
chd-104	89	79	factor	factor	NOUN
chd-104	89	80	4	4	NUM
chd-104	89	81	137.2454011	137.2454011	NUM
chd-104	90	1	3.84511881	3.84511881	NUM
chd-104	90	2	0.0001205	0.0001205	NUM
chd-104	90	3	ensg00000171408	ensg00000171408	PROPN
chd-104	90	4	pde7b	pde7b	PROPN
chd-104	90	5	27115	27115	NUM
chd-104	90	6	phosphodiesterase	phosphodiesterase	NOUN
chd-104	90	7	7b	7b	NOUN
chd-104	90	8	70.86301288	70.86301288	NUM
chd-104	90	9	-0.806853305	-0.806853305	NOUN
chd-104	90	10	0.0001551	0.0001551	NUM
chd-104	90	11	ensg00000073921	ensg00000073921	ADP
chd-104	90	12	picalm	picalm	NOUN
chd-104	90	13	8301	8301	NUM
chd-104	90	14	phosphatidylinositol	phosphatidylinositol	NOUN
chd-104	90	15	binding	bind	VERB
chd-104	90	16	clathrin	clathrin	NOUN
chd-104	90	17	assembly	assembly	NOUN
chd-104	90	18	protein	protein	NOUN
chd-104	90	19	4146.086807	4146.086807	CCONJ
chd-104	90	20	-0.328030427	-0.328030427	NOUN
chd-104	90	21	0.0001577	0.0001577	NUM
chd-104	90	22	ensg00000264343	ensg00000264343	PROPN
chd-104	90	23	notch2nl	notch2nl	PROPN
chd-104	90	24	388677	388677	NUM
chd-104	90	25	notch	notch	VERB
chd-104	90	26	2	2	NUM
chd-104	90	27	n	n	CCONJ
chd-104	90	28	-	-	PUNCT
chd-104	90	29	terminal	terminal	ADJ
chd-104	90	30	like	like	ADP
chd-104	90	31	1130.083257	1130.083257	NUM
chd-104	90	32	3.692675235	3.692675235	NUM
chd-104	90	33	0.0002219	0.0002219	NUM
chd-104	90	34	ensg00000185737	ensg00000185737	PROPN
chd-104	90	35	nrg3	nrg3	NOUN
chd-104	90	36	10718	10718	NUM
chd-104	90	37	neuregulin	neuregulin	PROPN
chd-104	90	38	3	3	NUM
chd-104	90	39	18.2400562	18.2400562	NUM
chd-104	90	40	-1.093851375	-1.093851375	NOUN
chd-104	90	41	0.0002292	0.0002292	NUM
chd-104	90	42	ensg00000046889	ensg00000046889	PROPN
chd-104	90	43	prex2	prex2	NOUN
chd-104	90	44	80243	80243	NUM
chd-104	90	45	phosphatidylinositol-3,4,5	phosphatidylinositol-3,4,5	NOUN
chd-104	90	46	-	-	PUNCT
chd-104	90	47	trisphosphate	trisphosphate	ADJ
chd-104	90	48	dependent	dependent	ADJ
chd-104	90	49	rac	rac	PROPN
chd-104	90	50	exchange	exchange	NOUN
chd-104	90	51	factor	factor	NOUN
chd-104	90	52	2	2	NUM
chd-104	90	53	35.37360263	35.37360263	NUM
chd-104	90	54	-0.965093716	-0.965093716	NOUN
chd-104	90	55	0.0003995	0.0003995	NUM
chd-104	91	1	ensg00000151689	ensg00000151689	NOUN
chd-104	91	2	inpp1	inpp1	NOUN
chd-104	91	3	3628	3628	NUM
chd-104	91	4	inositol	inositol	PROPN
chd-104	91	5	polyphosphate-1	polyphosphate-1	PROPN
chd-104	91	6	-	-	NOUN
chd-104	91	7	phosphatase	phosphatase	NOUN
chd-104	91	8	257.8331804	257.8331804	NUM
chd-104	91	9	-0.464334443	-0.464334443	NOUN
chd-104	91	10	0.0007263	0.0007263	NUM
chd-104	91	11	ensg00000151151	ensg00000151151	PROPN
chd-104	91	12	ipmk	ipmk	NOUN
chd-104	91	13	253430	253430	NUM
chd-104	91	14	inositol	inositol	NOUN
chd-104	91	15	polyphosphate	polyphosphate	NOUN
chd-104	91	16	multikinase	multikinase	VERB
chd-104	91	17	66.09782388	66.09782388	NUM
chd-104	91	18	-0.677173589	-0.677173589	NOUN
chd-104	91	19	0.0007599	0.0007599	NUM
chd-104	91	20	ensg00000101384	ensg00000101384	PROPN
chd-104	91	21	jag1	jag1	VERB
chd-104	91	22	182	182	NUM
chd-104	91	23	jagged	jagged	ADJ
chd-104	91	24	1	1	NUM
chd-104	91	25	2029.134072	2029.134072	NUM
chd-104	91	26	3.352573762	3.352573762	NUM
chd-104	91	27	0.0008006	0.0008006	NUM
chd-104	91	28	ensg00000169435	ensg00000169435	PROPN
chd-104	91	29	rassf6	rassf6	PROPN
chd-104	91	30	166824	166824	NUM
chd-104	91	31	ras	ras	PROPN
chd-104	91	32	association	association	PROPN
chd-104	91	33	domain	domain	NOUN
chd-104	91	34	family	family	NOUN
chd-104	91	35	member	member	NOUN
chd-104	91	36	6	6	NUM
chd-104	91	37	87.45601131	87.45601131	NUM
chd-104	91	38	-0.732054428	-0.732054428	NOUN
chd-104	91	39	0.0010291	0.0010291	NUM
chd-104	91	40	ensg00000041353	ensg00000041353	PROPN
chd-104	91	41	rab27b	rab27b	PRON
chd-104	91	42	5874	5874	NUM
chd-104	91	43	rab27b	rab27b	NOUN
chd-104	91	44	,	,	PUNCT
chd-104	91	45	member	member	NOUN
chd-104	91	46	ras	ras	PROPN
chd-104	91	47	oncogene	oncogene	PROPN
chd-104	91	48	family	family	NOUN
chd-104	91	49	67.49077359	67.49077359	NUM
chd-104	91	50	-0.735088474	-0.735088474	NOUN
chd-104	91	51	0.0011336	0.0011336	NUM
chd-104	91	52	ensg00000175985	ensg00000175985	PROPN
chd-104	91	53	plekhd1	plekhd1	NOUN
chd-104	91	54	400224	400224	NUM
chd-104	91	55	pleckstrin	pleckstrin	PROPN
chd-104	91	56	homology	homology	NOUN
chd-104	91	57	and	and	CCONJ
chd-104	91	58	coiled	coil	VERB
chd-104	91	59	-	-	PUNCT
chd-104	91	60	coil	coil	NOUN
chd-104	91	61	domain	domain	NOUN
chd-104	91	62	containing	contain	VERB
chd-104	91	63	d1	d1	PROPN
chd-104	91	64	3.551807893	3.551807893	NUM
chd-104	91	65	-0.997599044	-0.997599044	NOUN
chd-104	91	66	0.0012151	0.0012151	NUM
chd-104	91	67	ensg00000169220	ensg00000169220	ADJ
chd-104	91	68	rgs14	rgs14	NOUN
chd-104	91	69	10636	10636	NUM
chd-104	91	70	regulator	regulator	NOUN
chd-104	91	71	of	of	ADP
chd-104	91	72	g	g	NOUN
chd-104	91	73	-	-	PUNCT
chd-104	91	74	protein	protein	NOUN
chd-104	91	75	signaling	signal	VERB
chd-104	91	76	14	14	NUM
chd-104	91	77	356.4357972	356.4357972	NUM
chd-104	91	78	0.493690701	0.493690701	NUM
chd-104	91	79	0.0013154	0.0013154	NUM
chd-104	91	80	ensg00000154678	ensg00000154678	PROPN
chd-104	91	81	pde1c	pde1c	PROPN
chd-104	91	82	5137	5137	NUM
chd-104	91	83	phosphodiesterase	phosphodiesterase	NOUN
chd-104	91	84	1c	1c	NOUN
chd-104	91	85	63.21150224	63.21150224	NUM
chd-104	91	86	-0.857678049	-0.857678049	NOUN
chd-104	91	87	0.0014838	0.0014838	NUM
chd-104	91	88	ensg00000151491	ensg00000151491	PROPN
chd-104	91	89	eps8	eps8	NOUN
chd-104	91	90	2059	2059	NUM
chd-104	91	91	epidermal	epidermal	ADJ
chd-104	91	92	growth	growth	NOUN
chd-104	91	93	factor	factor	NOUN
chd-104	91	94	receptor	receptor	NOUN
chd-104	91	95	pathway	pathway	NOUN
chd-104	91	96	substrate	substrate	NOUN
chd-104	91	97	8	8	NUM
chd-104	91	98	895.8248723	895.8248723	NUM
chd-104	91	99	-0.525349111	-0.525349111	NOUN
chd-104	91	100	0.0016848	0.0016848	NUM
chd-104	91	101	ensg00000064932	ensg00000064932	PROPN
chd-104	91	102	sbno2	sbno2	NOUN
chd-104	91	103	22904	22904	NUM
chd-104	91	104	strawberry	strawberry	NOUN
chd-104	91	105	notch	notch	NOUN
chd-104	91	106	homolog	homolog	PROPN
chd-104	91	107	2	2	NUM
chd-104	91	108	1823.609706	1823.609706	NUM
chd-104	91	109	3.135072772	3.135072772	NUM
chd-104	91	110	0.0017181	0.0017181	NUM
chd-104	91	111	ensg00000011405	ensg00000011405	NOUN
chd-104	91	112	pik3c2a	pik3c2a	ADJ
chd-104	91	113	5286	5286	NUM
chd-104	91	114	phosphatidylinositol-4	phosphatidylinositol-4	NOUN
chd-104	91	115	-	-	ADJ
chd-104	91	116	phosphate	phosphate	ADJ
chd-104	91	117	3	3	NUM
chd-104	91	118	-	-	PUNCT
chd-104	91	119	kinase	kinase	NOUN
chd-104	91	120	catalytic	catalytic	ADJ
chd-104	91	121	subunit	subunit	NOUN
chd-104	91	122	type	type	NOUN
chd-104	91	123	2	2	NUM
chd-104	91	124	alpha	alpha	NOUN
chd-104	91	125	1239.790208	1239.790208	NUM
chd-104	91	126	-0.396160165	-0.396160165	NOUN
chd-104	91	127	0.0017905	0.0017905	VERB
chd-104	91	128	ensg00000109452	ensg00000109452	NOUN
chd-104	91	129	inpp4b	inpp4b	VERB
chd-104	91	130	8821	8821	NUM
chd-104	91	131	inositol	inositol	ADJ
chd-104	91	132	polyphosphate-4	polyphosphate-4	NOUN
chd-104	91	133	-	-	PUNCT
chd-104	91	134	phosphatase	phosphatase	NOUN
chd-104	91	135	type	type	NOUN
chd-104	91	136	ii	ii	PROPN
chd-104	91	137	b	b	PROPN
chd-104	91	138	152.8627179	152.8627179	NUM
chd-104	91	139	-0.735904178	-0.735904178	NOUN
chd-104	91	140	0.0018282	0.0018282	NUM
chd-104	91	141	ensg00000178568	ensg00000178568	NOUN
chd-104	91	142	erbb4	erbb4	VERB
chd-104	91	143	2066	2066	NUM
chd-104	91	144	erb	erb	ADJ
chd-104	91	145	-	-	PUNCT
chd-104	91	146	b2	b2	NOUN
chd-104	91	147	receptor	receptor	NOUN
chd-104	91	148	tyrosine	tyrosine	NOUN
chd-104	91	149	kinase	kinase	VERB
chd-104	91	150	4	4	NUM
chd-104	91	151	74.66419079	74.66419079	NUM
chd-104	91	152	-0.896585238	-0.896585238	NOUN
chd-104	91	153	0.0024244	0.0024244	NUM
chd-104	91	154	ensg00000187957	ensg00000187957	PROPN
chd-104	91	155	dner	dner	NOUN
chd-104	91	156	92737	92737	NUM
chd-104	91	157	delta	delta	NOUN
chd-104	91	158	/	/	SYM
chd-104	91	159	notch	notch	NOUN
chd-104	91	160	like	like	ADP
chd-104	91	161	egf	egf	PROPN
chd-104	91	162	repeat	repeat	NOUN
chd-104	91	163	containing	contain	VERB
chd-104	91	164	173.0818588	173.0818588	NUM
chd-104	91	165	2.870907184	2.870907184	NUM
chd-104	91	166	0.004093	0.004093	NUM
chd-104	91	167	ensg00000078142	ensg00000078142	PROPN
chd-104	91	168	pik3c3	pik3c3	NOUN
chd-104	91	169	5289	5289	NUM
chd-104	91	170	phosphatidylinositol	phosphatidylinositol	NOUN
chd-104	91	171	3	3	NUM
chd-104	91	172	-	-	PUNCT
chd-104	91	173	kinase	kinase	NOUN
chd-104	91	174	catalytic	catalytic	ADJ
chd-104	91	175	subunit	subunit	NOUN
chd-104	91	176	type	type	VERB
chd-104	91	177	3	3	NUM
chd-104	91	178	551.5572258	551.5572258	NUM
chd-104	91	179	-0.281487717	-0.281487717	NOUN
chd-104	92	1	0.0055186	0.0055186	NUM
chd-104	92	2	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-104	92	3	e7	e7	PROPN
chd-104	92	4	cancer	cancer	NOUN
chd-104	92	5	health	health	NOUN
chd-104	92	6	disparities	disparity	NOUN
chd-104	92	7	research	research	VERB
chd-104	92	8	ensg00000085832	ensg00000085832	PROPN
chd-104	92	9	eps15	eps15	PROPN
chd-104	92	10	2060	2060	NUM
chd-104	92	11	epidermal	epidermal	ADJ
chd-104	92	12	growth	growth	NOUN
chd-104	92	13	factor	factor	NOUN
chd-104	92	14	receptor	receptor	NOUN
chd-104	92	15	pathway	pathway	NOUN
chd-104	92	16	substrate	substrate	NOUN
chd-104	92	17	15	15	NUM
chd-104	92	18	1725.645419	1725.645419	NUM
chd-104	92	19	-0.21533493	-0.21533493	VERB
chd-104	92	20	0.0055454	0.0055454	NUM
chd-104	92	21	ensg00000137825	ensg00000137825	PROPN
chd-104	92	22	itpka	itpka	VERB
chd-104	92	23	3706	3706	NUM
chd-104	92	24	inositol	inositol	NOUN
chd-104	92	25	-	-	PUNCT
chd-104	92	26	trisphosphate	trisphosphate	NOUN
chd-104	92	27	3	3	NUM
chd-104	92	28	-	-	PUNCT
chd-104	92	29	kinase	kinase	NOUN
chd-104	92	30	a	a	DET
chd-104	92	31	11.85034496	11.85034496	NUM
chd-104	92	32	-0.688848495	-0.688848495	NOUN
chd-104	92	33	0.0061921	0.0061921	NUM
chd-104	92	34	ensg00000137142	ensg00000137142	PROPN
chd-104	92	35	igfbpl1	igfbpl1	PROPN
chd-104	92	36	347252	347252	NUM
chd-104	92	37	insulin	insulin	NOUN
chd-104	92	38	like	like	ADP
chd-104	92	39	growth	growth	NOUN
chd-104	92	40	factor	factor	NOUN
chd-104	92	41	binding	bind	VERB
chd-104	92	42	protein	protein	NOUN
chd-104	92	43	like	like	ADP
chd-104	92	44	1	1	NUM
chd-104	92	45	12.11877278	12.11877278	NUM
chd-104	92	46	-0.790048534	-0.790048534	NOUN
chd-104	92	47	0.0062746	0.0062746	NUM
chd-104	92	48	ensg00000073536	ensg00000073536	PROPN
chd-104	92	49	nle1	nle1	PROPN
chd-104	92	50	54475	54475	NUM
chd-104	92	51	notchless	notchless	ADJ
chd-104	92	52	homolog	homolog	NOUN
chd-104	92	53	1	1	NUM
chd-104	92	54	347.5008396	347.5008396	NUM
chd-104	92	55	2.711514433	2.711514433	NUM
chd-104	92	56	0.0066977	0.0066977	NUM
chd-104	92	57	ensg00000163964	ensg00000163964	PROPN
chd-104	92	58	pigx	pigx	NOUN
chd-104	92	59	54965	54965	NUM
chd-104	92	60	phosphatidylinositol	phosphatidylinositol	NOUN
chd-104	92	61	glycan	glycan	NOUN
chd-104	92	62	anchor	anchor	NOUN
chd-104	92	63	biosynthesis	biosynthesis	VERB
chd-104	92	64	class	class	NOUN
chd-104	92	65	x	x	NOUN
chd-104	92	66	740.0513792	740.0513792	NUM
chd-104	92	67	-0.330509569	-0.330509569	NOUN
chd-104	92	68	0.0084688	0.0084688	NUM
chd-104	92	69	ensg00000097033	ensg00000097033	PROPN
chd-104	92	70	sh3glb1	sh3glb1	PROPN
chd-104	92	71	51100	51100	NUM
chd-104	92	72	sh3	sh3	NOUN
chd-104	92	73	domain	domain	NOUN
chd-104	92	74	containing	contain	VERB
chd-104	92	75	grb2	grb2	PROPN
chd-104	92	76	like	like	ADP
chd-104	92	77	endophilin	endophilin	PROPN
chd-104	92	78	b1	b1	PROPN
chd-104	92	79	2960.384131	2960.384131	PROPN
chd-104	92	80	-0.219544393	-0.219544393	VERB
chd-104	92	81	0.0084951	0.0084951	NUM
chd-104	92	82	ensg00000169752	ensg00000169752	PROPN
chd-104	92	83	nrg4	nrg4	VERB
chd-104	92	84	145957	145957	NUM
chd-104	92	85	neuregulin	neuregulin	NOUN
chd-104	92	86	4	4	NUM
chd-104	92	87	7.692847298	7.692847298	NUM
chd-104	92	88	-0.718554497	-0.718554497	NOUN
chd-104	93	1	0.0086447	0.0086447	NUM
chd-104	93	2	ensg00000161896	ensg00000161896	NOUN
chd-104	93	3	ip6k3	ip6k3	NOUN
chd-104	93	4	117283	117283	NUM
chd-104	93	5	inositol	inositol	NOUN
chd-104	93	6	hexakisphosphate	hexakisphosphate	NOUN
chd-104	93	7	kinase	kinase	PROPN
chd-104	93	8	3	3	NUM
chd-104	93	9	11.780405	11.780405	NUM
chd-104	93	10	-0.794971219	-0.794971219	NOUN
chd-104	93	11	0.0092705	0.0092705	NUM
chd-104	93	12	ensg00000162434	ensg00000162434	PROPN
chd-104	93	13	jak1	jak1	PROPN
chd-104	93	14	3716	3716	NUM
chd-104	93	15	janus	janus	PROPN
chd-104	93	16	kinase	kinase	PROPN
chd-104	93	17	1	1	NUM
chd-104	94	1	3697.004587	3697.004587	NUM
chd-104	94	2	-0.265820839	-0.265820839	NOUN
chd-104	94	3	0.0099595	0.0099595	NUM
chd-104	94	4	ensg00000197563	ensg00000197563	PROPN
chd-104	94	5	pign	pign	NOUN
chd-104	94	6	23556	23556	NUM
chd-104	94	7	phosphatidylinositol	phosphatidylinositol	NOUN
chd-104	94	8	glycan	glycan	NOUN
chd-104	94	9	anchor	anchor	NOUN
chd-104	94	10	biosynthesis	biosynthesis	VERB
chd-104	94	11	class	class	NOUN
chd-104	94	12	n	n	CCONJ
chd-104	94	13	628.3454755	628.3454755	NUM
chd-104	94	14	-0.361073745	-0.361073745	NOUN
chd-104	94	15	0.0100388	0.0100388	NUM
chd-104	94	16	ensg00000146648	ensg00000146648	PROPN
chd-104	94	17	erbb1	erbb1	NOUN
chd-104	94	18	1956	1956	NUM
chd-104	94	19	epidermal	epidermal	ADJ
chd-104	94	20	growth	growth	NOUN
chd-104	94	21	factor	factor	NOUN
chd-104	94	22	receptor	receptor	NOUN
chd-104	94	23	788.1655218	788.1655218	NUM
chd-104	94	24	-0.514822969	-0.514822969	NOUN
chd-104	94	25	0.0106547	0.0106547	NUM
chd-104	94	26	ensg00000186479	ensg00000186479	PROPN
chd-104	94	27	rgs7bp	rgs7bp	NOUN
chd-104	94	28	401190	401190	NUM
chd-104	94	29	regulator	regulator	NOUN
chd-104	94	30	of	of	ADP
chd-104	94	31	g	g	NOUN
chd-104	94	32	-	-	PUNCT
chd-104	94	33	protein	protein	NOUN
chd-104	94	34	signaling	signal	VERB
chd-104	94	35	7	7	NUM
chd-104	94	36	binding	bind	VERB
chd-104	94	37	protein	protein	NOUN
chd-104	94	38	9.793117489	9.793117489	NUM
chd-104	94	39	-0.738439155	-0.738439155	NOUN
chd-104	94	40	0.0107012	0.0107012	NUM
chd-104	94	41	ensg00000197081	ensg00000197081	PROPN
chd-104	94	42	igf2r	igf2r	PROPN
chd-104	94	43	3482	3482	NUM
chd-104	94	44	insulin	insulin	NOUN
chd-104	94	45	like	like	ADP
chd-104	94	46	growth	growth	NOUN
chd-104	94	47	factor	factor	NOUN
chd-104	94	48	2	2	NUM
chd-104	94	49	receptor	receptor	NOUN
chd-104	94	50	3893.882883	3893.882883	NUM
chd-104	94	51	-0.353086769	-0.353086769	NOUN
chd-104	94	52	0.0109115	0.0109115	NUM
chd-104	94	53	ensg00000100985	ensg00000100985	NOUN
chd-104	94	54	mmp9	mmp9	PROPN
chd-104	94	55	4318	4318	NUM
chd-104	94	56	matrix	matrix	NOUN
chd-104	94	57	metallopeptidase	metallopeptidase	NOUN
chd-104	94	58	9	9	NUM
chd-104	94	59	2820.554471	2820.554471	PROPN
chd-104	94	60	0.550370107	0.550370107	NUM
chd-104	94	61	0.0117042	0.0117042	NUM
chd-104	94	62	ensg00000106780	ensg00000106780	PROPN
chd-104	94	63	megf9	megf9	NOUN
chd-104	94	64	1955	1955	NUM
chd-104	94	65	multiple	multiple	ADJ
chd-104	94	66	egf	egf	PROPN
chd-104	94	67	like	like	ADP
chd-104	94	68	domains	domain	NOUN
chd-104	94	69	9	9	NUM
chd-104	94	70	788.1489691	788.1489691	NUM
chd-104	94	71	-0.382312117	-0.382312117	NOUN
chd-104	94	72	0.0121799	0.0121799	NUM
chd-104	94	73	ensg00000182836	ensg00000182836	ADJ
chd-104	94	74	plcxd3	plcxd3	NOUN
chd-104	94	75	345557	345557	NUM
chd-104	94	76	phosphatidylinositol	phosphatidylinositol	NOUN
chd-104	94	77	specific	specific	ADJ
chd-104	94	78	phospholipase	phospholipase	NOUN
chd-104	94	79	c	c	NOUN
chd-104	95	1	x	x	PROPN
chd-104	95	2	domain	domain	NOUN
chd-104	95	3	containing	contain	VERB
chd-104	95	4	3	3	NUM
chd-104	95	5	16.82951336	16.82951336	NUM
chd-104	95	6	-0.73024397	-0.73024397	NOUN
chd-104	95	7	0.0140536	0.0140536	NUM
chd-104	95	8	ensg00000122126	ensg00000122126	NOUN
chd-104	95	9	ocrl	ocrl	VERB
chd-104	95	10	4952	4952	NUM
chd-104	95	11	ocrl	ocrl	NOUN
chd-104	95	12	,	,	PUNCT
chd-104	95	13	inositol	inositol	NOUN
chd-104	95	14	polyphosphate-5	polyphosphate-5	NOUN
chd-104	95	15	-	-	PUNCT
chd-104	95	16	phosphatase	phosphatase	NOUN
chd-104	95	17	1231.48057	1231.48057	NUM
chd-104	95	18	-0.285100271	-0.285100271	NOUN
chd-104	95	19	0.0151527	0.0151527	NUM
chd-104	95	20	ensg00000184588	ensg00000184588	PROPN
chd-104	95	21	pde4b	pde4b	PROPN
chd-104	95	22	5142	5142	NUM
chd-104	95	23	phosphodiesterase	phosphodiesterase	NOUN
chd-104	95	24	4b	4b	PROPN
chd-104	95	25	1333.079513	1333.079513	NUM
chd-104	95	26	-0.509410864	-0.509410864	PROPN
chd-104	96	1	0.0163107	0.0163107	NUM
chd-104	96	2	ensg00000114302	ensg00000114302	PROPN
chd-104	96	3	prkar2a	prkar2a	NOUN
chd-104	96	4	5576	5576	NUM
chd-104	96	5	protein	protein	NOUN
chd-104	96	6	kinase	kinase	NOUN
chd-104	96	7	camp	camp	NOUN
chd-104	96	8	-	-	PUNCT
chd-104	96	9	dependent	dependent	ADJ
chd-104	96	10	type	type	NOUN
chd-104	96	11	ii	ii	NOUN
chd-104	96	12	regulatory	regulatory	ADJ
chd-104	96	13	subunit	subunit	NOUN
chd-104	96	14	alpha	alpha	NOUN
chd-104	96	15	311.0446898	311.0446898	NUM
chd-104	96	16	-0.458155081	-0.458155081	NUM
chd-104	96	17	0.0166052	0.0166052	NUM
chd-104	96	18	ensg00000116711	ensg00000116711	NOUN
chd-104	96	19	pla2g4a	pla2g4a	PROPN
chd-104	96	20	5321	5321	NUM
chd-104	96	21	phospholipase	phospholipase	NOUN
chd-104	96	22	a2	a2	PROPN
chd-104	96	23	group	group	NOUN
chd-104	96	24	iva	iva	NOUN
chd-104	96	25	336.2022255	336.2022255	NUM
chd-104	96	26	-0.582605068	-0.582605068	ADJ
chd-104	96	27	0.0171755	0.0171755	NUM
chd-104	96	28	ensg00000171105	ensg00000171105	NOUN
chd-104	96	29	insr	insr	VERB
chd-104	96	30	3643	3643	NUM
chd-104	96	31	insulin	insulin	NOUN
chd-104	96	32	receptor	receptor	NOUN
chd-104	96	33	1909.416792	1909.416792	NUM
chd-104	96	34	-0.295867756	-0.295867756	VERB
chd-104	96	35	0.0173053	0.0173053	NUM
chd-104	96	36	ensg00000164318	ensg00000164318	PROPN
chd-104	96	37	egflam	egflam	PROPN
chd-104	96	38	133584	133584	NUM
chd-104	96	39	egf	egf	NOUN
chd-104	96	40	like	like	ADP
chd-104	96	41	,	,	PUNCT
chd-104	96	42	fibronectin	fibronectin	NOUN
chd-104	96	43	type	type	NOUN
chd-104	96	44	iii	iii	NOUN
chd-104	96	45	and	and	CCONJ
chd-104	96	46	laminin	laminin	NOUN
chd-104	96	47	g	g	NOUN
chd-104	96	48	domains	domain	NOUN
chd-104	96	49	229.0134131	229.0134131	NUM
chd-104	96	50	-0.469580197	-0.469580197	NOUN
chd-104	96	51	0.0176762	0.0176762	NUM
chd-104	96	52	ensg00000132554	ensg00000132554	PROPN
chd-104	96	53	rgs22	rgs22	VERB
chd-104	96	54	26166	26166	NUM
chd-104	96	55	regulator	regulator	NOUN
chd-104	96	56	of	of	ADP
chd-104	96	57	g	g	NOUN
chd-104	96	58	-	-	PUNCT
chd-104	96	59	protein	protein	NOUN
chd-104	96	60	signaling	signal	VERB
chd-104	96	61	22	22	NUM
chd-104	96	62	4.574242623	4.574242623	NUM
chd-104	96	63	-0.636004928	-0.636004928	NOUN
chd-104	97	1	0.0192316	0.0192316	NUM
chd-104	97	2	ensg00000184613	ensg00000184613	PROPN
chd-104	97	3	nell2	nell2	NOUN
chd-104	97	4	4753	4753	NUM
chd-104	97	5	neural	neural	ADJ
chd-104	97	6	egfl	egfl	PROPN
chd-104	97	7	like	like	ADP
chd-104	97	8	2	2	NUM
chd-104	97	9	196.5001129	196.5001129	NUM
chd-104	97	10	-0.572676436	-0.572676436	NOUN
chd-104	97	11	0.0232947	0.0232947	NUM
chd-104	97	12	ensg00000142892	ensg00000142892	PROPN
chd-104	97	13	pigk	pigk	PROPN
chd-104	97	14	10026	10026	NUM
chd-104	97	15	phosphatidylinositol	phosphatidylinositol	NOUN
chd-104	97	16	glycan	glycan	NOUN
chd-104	97	17	anchor	anchor	NOUN
chd-104	97	18	biosynthesis	biosynthesis	VERB
chd-104	97	19	class	class	NOUN
chd-104	97	20	k	k	NOUN
chd-104	97	21	781.7799581	781.7799581	NUM
chd-104	97	22	-0.208806421	-0.208806421	NOUN
chd-104	97	23	0.0234037	0.0234037	NUM
chd-104	97	24	ensg00000141639	ensg00000141639	PROPN
chd-104	97	25	mapk4	mapk4	PROPN
chd-104	97	26	5596	5596	NUM
chd-104	97	27	mitogen	mitogen	NOUN
chd-104	97	28	-	-	PUNCT
chd-104	97	29	activated	activate	VERB
chd-104	97	30	protein	protein	NOUN
chd-104	97	31	kinase	kinase	NOUN
chd-104	97	32	4	4	NUM
chd-104	97	33	208.7727368	208.7727368	NUM
chd-104	97	34	-0.569541107	-0.569541107	NOUN
chd-104	97	35	0.0325864	0.0325864	NUM
chd-104	97	36	ensg00000107643	ensg00000107643	PROPN
chd-104	97	37	mapk8	mapk8	PROPN
chd-104	97	38	5599	5599	NUM
chd-104	97	39	mitogen	mitogen	NOUN
chd-104	97	40	-	-	PUNCT
chd-104	97	41	activated	activate	VERB
chd-104	97	42	protein	protein	NOUN
chd-104	97	43	kinase	kinase	NOUN
chd-104	97	44	8	8	NUM
chd-104	97	45	324.7787941	324.7787941	NUM
chd-104	97	46	-0.300393202	-0.300393202	NOUN
chd-104	97	47	0.033222	0.033222	NUM
chd-104	97	48	ensg00000100078	ensg00000100078	PROPN
chd-104	97	49	pla2g3	pla2g3	PROPN
chd-104	97	50	50487	50487	NUM
chd-104	97	51	phospholipase	phospholipase	NOUN
chd-104	97	52	a2	a2	PROPN
chd-104	97	53	group	group	PROPN
chd-104	97	54	iii	iii	PROPN
chd-104	97	55	6.341731975	6.341731975	NUM
chd-104	97	56	-0.631494614	-0.631494614	NOUN
chd-104	98	1	0.0378273	0.0378273	NUM
chd-104	98	2	ensg00000198759	ensg00000198759	PROPN
chd-104	98	3	egfl6	egfl6	PROPN
chd-104	99	1	25975	25975	NUM
chd-104	99	2	egf	egf	NOUN
chd-104	99	3	like	like	ADP
chd-104	99	4	domain	domain	NOUN
chd-104	99	5	multiple	multiple	NOUN
chd-104	99	6	6	6	NUM
chd-104	99	7	182.8515839	182.8515839	NUM
chd-104	99	8	-0.479870257	-0.479870257	NOUN
chd-104	99	9	0.0381221	0.0381221	NUM
chd-104	99	10	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-104	99	11	e8	e8	PROPN
chd-104	99	12	cancer	cancer	NOUN
chd-104	99	13	health	health	NOUN
chd-104	99	14	disparities	disparity	NOUN
chd-104	99	15	research	research	NOUN
chd-104	99	16	ensg00000107175	ensg00000107175	PROPN
chd-104	99	17	creb3	creb3	NOUN
chd-104	99	18	10488	10488	NUM
chd-104	99	19	camp	camp	NOUN
chd-104	99	20	responsive	responsive	ADJ
chd-104	99	21	element	element	NOUN
chd-104	99	22	binding	bind	VERB
chd-104	99	23	protein	protein	NOUN
chd-104	99	24	3	3	NUM
chd-104	99	25	1217.85437	1217.85437	NUM
chd-104	99	26	-0.203621813	-0.203621813	NOUN
chd-104	99	27	0.0407954	0.0407954	NUM
chd-104	99	28	ensg00000145725	ensg00000145725	PROPN
chd-104	99	29	ppip5k2	ppip5k2	PRON
chd-104	99	30	23262	23262	NUM
chd-104	99	31	diphosphoinositol	diphosphoinositol	NOUN
chd-104	99	32	pentakisphosphate	pentakisphosphate	NOUN
chd-104	99	33	kinase	kinase	PROPN
chd-104	99	34	2	2	NUM
chd-104	99	35	756.5355326	756.5355326	NUM
chd-104	99	36	-0.222844677	-0.222844677	NOUN
chd-104	99	37	0.0425919	0.0425919	NUM
chd-104	99	38	ensg00000154217	ensg00000154217	PROPN
chd-104	99	39	pitpnc1	pitpnc1	NOUN
chd-104	99	40	26207	26207	NUM
chd-104	99	41	phosphatidylinositol	phosphatidylinositol	NOUN
chd-104	99	42	transfer	transfer	NOUN
chd-104	99	43	protein	protein	NOUN
chd-104	99	44	,	,	PUNCT
chd-104	99	45	cytoplasmic	cytoplasmic	ADJ
chd-104	99	46	1	1	NUM
chd-104	99	47	348.007567	348.007567	NUM
chd-104	99	48	-0.291090967	-0.291090967	NOUN
chd-104	99	49	0.0466811	0.0466811	NUM
chd-104	99	50	ensg00000158786	ensg00000158786	ADP
chd-104	99	51	pla2g2f	pla2g2f	ADJ
chd-104	99	52	64600	64600	NUM
chd-104	99	53	phospholipase	phospholipase	NOUN
chd-104	99	54	a2	a2	PROPN
chd-104	99	55	group	group	NOUN
chd-104	99	56	iif	iif	PROPN
chd-104	99	57	1.839617956	1.839617956	NUM
chd-104	99	58	-0.585514584	-0.585514584	NOUN
chd-104	99	59	0.0480319	0.0480319	PROPN
chd-104	99	60	ensg00000166997	ensg00000166997	PROPN
chd-104	99	61	cnpy4	cnpy4	PROPN
chd-104	99	62	245812	245812	NUM
chd-104	99	63	canopy	canopy	NOUN
chd-104	99	64	fgf	fgf	PROPN
chd-104	99	65	signaling	signal	VERB
chd-104	99	66	regulator	regulator	NOUN
chd-104	99	67	4	4	NUM
chd-104	99	68	378.1533882	378.1533882	NUM
chd-104	99	69	-0.251460656	-0.251460656	NOUN
chd-104	99	70	0.0527973	0.0527973	NUM
chd-104	99	71	ensg00000109339	ensg00000109339	NOUN
chd-104	99	72	mapk10	mapk10	NOUN
chd-104	99	73	5602	5602	NUM
chd-104	99	74	mitogen	mitogen	NOUN
chd-104	99	75	-	-	PUNCT
chd-104	99	76	activated	activate	VERB
chd-104	99	77	protein	protein	NOUN
chd-104	99	78	kinase	kinase	NOUN
chd-104	100	1	10	10	NUM
chd-104	100	2	137.1476556	137.1476556	NUM
chd-104	100	3	-0.515298729	-0.515298729	ADJ
chd-104	100	4	0.0555319	0.0555319	NUM
chd-104	100	5	ensg00000138698	ensg00000138698	PROPN
chd-104	100	6	rap1gds1	rap1gds1	VERB
chd-104	100	7	5910	5910	NUM
chd-104	100	8	rap1	rap1	PROPN
chd-104	100	9	gtpase	gtpase	NOUN
chd-104	100	10	-	-	PUNCT
chd-104	100	11	gdp	gdp	NOUN
chd-104	100	12	dissociation	dissociation	NOUN
chd-104	100	13	stimulator	stimulator	NOUN
chd-104	100	14	1	1	NUM
chd-104	100	15	1021.906809	1021.906809	NUM
chd-104	100	16	-0.195978894	-0.195978894	NOUN
chd-104	100	17	0.0566303	0.0566303	NUM
chd-104	100	18	ensg00000138798	ensg00000138798	PROPN
chd-104	100	19	egf	egf	NOUN
chd-104	100	20	1950	1950	NUM
chd-104	100	21	epidermal	epidermal	ADJ
chd-104	100	22	growth	growth	NOUN
chd-104	100	23	factor	factor	NOUN
chd-104	100	24	142.104671	142.104671	NUM
chd-104	100	25	-0.531883076	-0.531883076	NOUN
chd-104	100	26	0.0619204	0.0619204	NUM
chd-104	100	27	ensg00000070193	ensg00000070193	NOUN
chd-104	100	28	fgf10	fgf10	ADJ
chd-104	100	29	2255	2255	NUM
chd-104	100	30	fibroblast	fibroblast	ADJ
chd-104	100	31	growth	growth	NOUN
chd-104	100	32	factor	factor	NOUN
chd-104	100	33	10	10	NUM
chd-104	100	34	3.462625673	3.462625673	NUM
chd-104	100	35	-0.562797728	-0.562797728	NOUN
chd-104	101	1	0.0638813	0.0638813	NUM
chd-104	101	2	ensg00000113070	ensg00000113070	PROPN
chd-104	101	3	hbegf	hbegf	PROPN
chd-104	101	4	1839	1839	NUM
chd-104	101	5	heparin	heparin	ADJ
chd-104	101	6	binding	bind	VERB
chd-104	101	7	egf	egf	NOUN
chd-104	101	8	like	like	ADP
chd-104	101	9	growth	growth	NOUN
chd-104	101	10	factor	factor	NOUN
chd-104	101	11	277.4721214	277.4721214	NUM
chd-104	101	12	-0.313566424	-0.313566424	VERB
chd-104	101	13	0.0768535	0.0768535	NUM
chd-104	101	14	ensg00000065361	ensg00000065361	PROPN
chd-104	101	15	erbb3	erbb3	PROPN
chd-104	102	1	2065	2065	NUM
chd-104	102	2	erb	erb	NOUN
chd-104	102	3	-	-	PUNCT
chd-104	102	4	b2	b2	NOUN
chd-104	102	5	receptor	receptor	NOUN
chd-104	102	6	tyrosine	tyrosine	NOUN
chd-104	102	7	kinase	kinase	NOUN
chd-104	102	8	3	3	NUM
chd-104	103	1	3949.329412	3949.329412	NUM
chd-104	103	2	-0.056599349	-0.056599349	NOUN
chd-104	103	3	0.7418933	0.7418933	NUM
chd-104	103	4	table	table	NOUN
chd-104	103	5	2	2	NUM
chd-104	103	6	.	.	PUNCT
chd-104	103	7	biological	biological	ADJ
chd-104	103	8	pathways	pathway	NOUN
chd-104	103	9	significantly	significantly	ADV
chd-104	103	10	upregulated	upregulate	VERB
chd-104	103	11	and	and	CCONJ
chd-104	103	12	downregulated	downregulate	VERB
chd-104	103	13	among	among	ADP
chd-104	103	14	aa	aa	NOUN
chd-104	103	15	compared	compare	VERB
chd-104	103	16	to	to	ADP
chd-104	103	17	ea	ea	NOUN
chd-104	103	18	tnbc	tnbc	VERB
chd-104	103	19	patients	patient	NOUN
chd-104	103	20	in	in	ADP
chd-104	103	21	tcga	tcga	PROPN
chd-104	103	22	dataset	dataset	PROPN
chd-104	103	23	.	.	PUNCT
chd-104	104	1	upregulated	upregulate	VERB
chd-104	104	2	kegg	kegg	NOUN
chd-104	104	3	pathways	pathway	NOUN
chd-104	104	4	p	p	ADJ
chd-104	104	5	-	-	PUNCT
chd-104	104	6	value	value	NOUN
chd-104	104	7	hsa03010	hsa03010	NOUN
chd-104	104	8	ribosome	ribosome	PROPN
chd-104	104	9	0.005533158	0.005533158	NUM
chd-104	104	10	hsa04672	hsa04672	NOUN
chd-104	104	11	intestinal	intestinal	ADJ
chd-104	104	12	immune	immune	ADJ
chd-104	104	13	network	network	NOUN
chd-104	104	14	for	for	ADP
chd-104	104	15	iga	iga	PROPN
chd-104	104	16	production	production	NOUN
chd-104	104	17	0.006164042	0.006164042	NUM
chd-104	104	18	hsa04640	hsa04640	VERB
chd-104	104	19	hematopoietic	hematopoietic	ADJ
chd-104	104	20	cell	cell	NOUN
chd-104	104	21	lineage	lineage	NOUN
chd-104	104	22	0.028001619	0.028001619	NUM
chd-104	104	23	hsa04330	hsa04330	NOUN
chd-104	104	24	notch	notch	NOUN
chd-104	104	25	signaling	signal	VERB
chd-104	104	26	pathway	pathway	NOUN
chd-104	104	27	0.053768917	0.053768917	NUM
chd-104	104	28	downregulated	downregulate	VERB
chd-104	104	29	kegg	kegg	NOUN
chd-104	104	30	pathways	pathway	NOUN
chd-104	104	31	hsa00600	hsa00600	VERB
chd-104	104	32	sphingolipid	sphingolipid	VERB
chd-104	104	33	metabolism	metabolism	NOUN
chd-104	104	34	0.01816452	0.01816452	NUM
chd-104	104	35	hsa00512	hsa00512	ADJ
chd-104	104	36	mucin	mucin	NOUN
chd-104	104	37	type	type	NOUN
chd-104	104	38	o	o	NOUN
chd-104	104	39	-	-	ADJ
chd-104	104	40	glycan	glycan	NOUN
chd-104	104	41	biosynthesis	biosynthesis	VERB
chd-104	104	42	0.02316771	0.02316771	NUM
chd-104	104	43	hsa04510	hsa04510	ADJ
chd-104	104	44	focal	focal	ADJ
chd-104	104	45	adhesion	adhesion	NOUN
chd-104	104	46	0.02628723	0.02628723	NUM
chd-104	104	47	hsa00982	hsa00982	NOUN
chd-104	104	48	drug	drug	NOUN
chd-104	104	49	metabolism	metabolism	NOUN
chd-104	104	50	cytochrome	cytochrome	NOUN
chd-104	104	51	p450	p450	PROPN
chd-104	104	52	0.02880007	0.02880007	NUM
chd-104	104	53	hsa04520	hsa04520	NOUN
chd-104	104	54	adherens	adheren	NOUN
chd-104	104	55	junction	junction	NOUN
chd-104	104	56	0.03365944	0.03365944	NUM
chd-104	104	57	hsa00500	hsa00500	NOUN
chd-104	104	58	starch	starch	NOUN
chd-104	104	59	and	and	CCONJ
chd-104	104	60	sucrose	sucrose	VERB
chd-104	104	61	metabolism	metabolism	NOUN
chd-104	104	62	0.03901639	0.03901639	NUM
chd-104	104	63	hsa00983	hsa00983	ADJ
chd-104	104	64	drug	drug	NOUN
chd-104	104	65	metabolism	metabolism	NOUN
chd-104	104	66	other	other	ADJ
chd-104	104	67	enzymes	enzyme	NOUN
chd-104	104	68	0.04328416	0.04328416	NUM
chd-104	104	69	hsa04512	hsa04512	ADJ
chd-104	104	70	ecm	ecm	NOUN
chd-104	104	71	-	-	PUNCT
chd-104	104	72	receptor	receptor	NOUN
chd-104	104	73	interaction	interaction	NOUN
chd-104	104	74	0.04359347	0.04359347	ADJ
chd-104	104	75	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-104	104	76	e9	e9	PROPN
chd-104	104	77	cancer	cancer	NOUN
chd-104	104	78	health	health	NOUN
chd-104	104	79	disparities	disparity	NOUN
chd-104	104	80	research	research	NOUN
chd-104	104	81	table	table	NOUN
chd-104	104	82	3	3	NUM
chd-104	104	83	.	.	PUNCT
chd-104	105	1	gene	gene	NOUN
chd-104	105	2	ontologies	ontology	NOUN
chd-104	105	3	significantly	significantly	ADV
chd-104	105	4	upregulated	upregulate	VERB
chd-104	105	5	and	and	CCONJ
chd-104	105	6	downregulated	downregulate	VERB
chd-104	105	7	among	among	ADP
chd-104	105	8	aa	aa	NOUN
chd-104	105	9	compared	compare	VERB
chd-104	105	10	to	to	ADP
chd-104	105	11	ea	ea	NOUN
chd-104	105	12	tnbc	tnbc	VERB
chd-104	105	13	patients	patient	NOUN
chd-104	105	14	in	in	ADP
chd-104	105	15	tcga	tcga	PROPN
chd-104	105	16	dataset	dataset	PROPN
chd-104	105	17	.	.	PUNCT
chd-104	106	1	upregulated	upregulate	VERB
chd-104	106	2	p	p	NOUN
chd-104	106	3	value	value	NOUN
chd-104	106	4	go:0048534	go:0048534	NOUN
chd-104	106	5	hematopoietic	hematopoietic	ADJ
chd-104	106	6	or	or	CCONJ
chd-104	106	7	lymphoid	lymphoid	ADJ
chd-104	106	8	organ	organ	NOUN
chd-104	106	9	development	development	NOUN
chd-104	106	10	0.000429373	0.000429373	NUM
chd-104	106	11	go:0002521	go:0002521	NOUN
chd-104	106	12	leukocyte	leukocyte	NOUN
chd-104	106	13	differentiation	differentiation	NOUN
chd-104	106	14	0.000467453	0.000467453	NUM
chd-104	106	15	go:0030097	go:0030097	NUM
chd-104	106	16	hemopoiesis	hemopoiesis	NOUN
chd-104	106	17	0.000595111	0.000595111	NUM
chd-104	106	18	go:0002252	go:0002252	VERB
chd-104	106	19	immune	immune	ADJ
chd-104	106	20	effector	effector	NOUN
chd-104	106	21	process	process	NOUN
chd-104	106	22	0.000606896	0.000606896	NUM
chd-104	106	23	go:0030098	go:0030098	DET
chd-104	106	24	lymphocyte	lymphocyte	ADJ
chd-104	106	25	differentiation	differentiation	NOUN
chd-104	106	26	0.000668007	0.000668007	NUM
chd-104	106	27	go:0002520	go:0002520	ADJ
chd-104	106	28	immune	immune	ADJ
chd-104	106	29	system	system	NOUN
chd-104	106	30	development	development	NOUN
chd-104	106	31	0.000752091	0.000752091	NUM
chd-104	106	32	go:0001816	go:0001816	PROPN
chd-104	106	33	cytokine	cytokine	NOUN
chd-104	106	34	production	production	NOUN
chd-104	106	35	0.001262715	0.001262715	NUM
chd-104	106	36	go:0001817	go:0001817	NOUN
chd-104	106	37	regulation	regulation	NOUN
chd-104	106	38	of	of	ADP
chd-104	106	39	cytokine	cytokine	ADJ
chd-104	106	40	production	production	NOUN
chd-104	106	41	0.001304632	0.001304632	NUM
chd-104	106	42	go:0019080	go:0019080	NUM
chd-104	106	43	viral	viral	ADJ
chd-104	106	44	genome	genome	NOUN
chd-104	106	45	expression	expression	NOUN
chd-104	106	46	0.002009214	0.002009214	NUM
chd-104	106	47	go:0019083	go:0019083	NOUN
chd-104	106	48	viral	viral	ADJ
chd-104	106	49	transcription	transcription	NOUN
chd-104	106	50	0.002009214	0.002009214	NUM
chd-104	106	51	go:0060337	go:0060337	NOUN
chd-104	106	52	type	type	NOUN
chd-104	106	53	i	i	PRON
chd-104	106	54	interferon	interferon	ADJ
chd-104	106	55	-	-	PUNCT
chd-104	106	56	mediated	mediate	VERB
chd-104	106	57	signaling	signal	VERB
chd-104	106	58	pathway	pathway	NOUN
chd-104	106	59	0.002260808	0.002260808	NUM
chd-104	106	60	go:0071357	go:0071357	ADJ
chd-104	106	61	cellular	cellular	ADJ
chd-104	106	62	response	response	NOUN
chd-104	106	63	to	to	PART
chd-104	106	64	type	type	VERB
chd-104	106	65	i	i	PRON
chd-104	106	66	interferon	interferon	VERB
chd-104	106	67	0.002260808	0.002260808	NUM
chd-104	106	68	go:0001818	go:0001818	ADP
chd-104	106	69	negative	negative	ADJ
chd-104	106	70	regulation	regulation	NOUN
chd-104	106	71	of	of	ADP
chd-104	106	72	cytokine	cytokine	ADJ
chd-104	106	73	production	production	NOUN
chd-104	106	74	0.002341488	0.002341488	NUM
chd-104	106	75	go:0034340	go:0034340	NOUN
chd-104	106	76	response	response	NOUN
chd-104	106	77	to	to	PART
chd-104	106	78	type	type	VERB
chd-104	106	79	i	i	PRON
chd-104	106	80	interferon	interferon	ADJ
chd-104	106	81	0.002360857	0.002360857	NUM
chd-104	106	82	go:0045087	go:0045087	NOUN
chd-104	106	83	innate	innate	ADJ
chd-104	106	84	immune	immune	ADJ
chd-104	106	85	response	response	NOUN
chd-104	106	86	0.002660009	0.002660009	NUM
chd-104	106	87	go:0050776	go:0050776	NOUN
chd-104	106	88	regulation	regulation	NOUN
chd-104	106	89	of	of	ADP
chd-104	106	90	immune	immune	ADJ
chd-104	106	91	response	response	NOUN
chd-104	106	92	0.003381564	0.003381564	NUM
chd-104	106	93	go:0006415	go:0006415	PRON
chd-104	106	94	translational	translational	ADJ
chd-104	106	95	termination	termination	NOUN
chd-104	106	96	0.003994976	0.003994976	NUM
chd-104	106	97	go:0019058	go:0019058	PART
chd-104	106	98	viral	viral	ADJ
chd-104	106	99	infectious	infectious	ADJ
chd-104	106	100	cycle	cycle	NOUN
chd-104	106	101	0.004289754	0.004289754	NUM
chd-104	106	102	go:0045321	go:0045321	ADJ
chd-104	106	103	leukocyte	leukocyte	NOUN
chd-104	106	104	activation	activation	NOUN
chd-104	106	105	0.005368308	0.005368308	NUM
chd-104	106	106	go:0046649	go:0046649	NOUN
chd-104	106	107	lymphocyte	lymphocyte	ADJ
chd-104	106	108	activation	activation	NOUN
chd-104	106	109	0.006021313	0.006021313	NUM
chd-104	106	110	go:0002443	go:0002443	NOUN
chd-104	106	111	leukocyte	leukocyte	NOUN
chd-104	106	112	mediated	mediate	VERB
chd-104	106	113	immunity	immunity	NOUN
chd-104	106	114	0.006737807	0.006737807	NUM
chd-104	106	115	go:0043241	go:0043241	NOUN
chd-104	106	116	protein	protein	NOUN
chd-104	106	117	complex	complex	ADJ
chd-104	106	118	disassembly	disassembly	NOUN
chd-104	106	119	0.006915896	0.006915896	NUM
chd-104	106	120	go:0045619	go:0045619	ADP
chd-104	106	121	regulation	regulation	NOUN
chd-104	106	122	of	of	ADP
chd-104	106	123	lymphocyte	lymphocyte	ADJ
chd-104	106	124	differentiation	differentiation	NOUN
chd-104	106	125	0.00711599	0.00711599	NUM
chd-104	106	126	go:0043624	go:0043624	NOUN
chd-104	106	127	cellular	cellular	ADJ
chd-104	106	128	protein	protein	NOUN
chd-104	106	129	complex	complex	ADJ
chd-104	106	130	disassembly	disassembly	NOUN
chd-104	106	131	0.009113965	0.009113965	NUM
chd-104	106	132	go:0032609	go:0032609	PROPN
chd-104	106	133	interferon	interferon	ADJ
chd-104	106	134	-	-	PUNCT
chd-104	106	135	gamma	gamma	NOUN
chd-104	106	136	production	production	NOUN
chd-104	106	137	0.009394054	0.009394054	NUM
chd-104	106	138	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	VERB
chd-104	106	139	e10	e10	NUM
chd-104	106	140	cancer	cancer	NOUN
chd-104	106	141	health	health	NOUN
chd-104	106	142	disparities	disparity	NOUN
chd-104	106	143	research	research	VERB
chd-104	106	144	go:0030217	go:0030217	PROPN
chd-104	106	145	t	t	NOUN
chd-104	106	146	cell	cell	NOUN
chd-104	106	147	differentiation	differentiation	NOUN
chd-104	106	148	0.009403061	0.009403061	NUM
chd-104	107	1	go:0071356	go:0071356	NOUN
chd-104	108	1	cellular	cellular	ADJ
chd-104	108	2	response	response	NOUN
chd-104	108	3	to	to	ADP
chd-104	108	4	tumor	tumor	NOUN
chd-104	108	5	necrosis	necrosis	NOUN
chd-104	108	6	factor	factor	NOUN
chd-104	108	7	0.009678773	0.009678773	NUM
chd-104	108	8	go:0009615	go:0009615	NOUN
chd-104	108	9	response	response	NOUN
chd-104	108	10	to	to	ADP
chd-104	108	11	virus	virus	VERB
chd-104	108	12	0.009744867	0.009744867	PRON
chd-104	108	13	go:0051250	go:0051250	PROPN
chd-104	108	14	negative	negative	ADJ
chd-104	108	15	regulation	regulation	NOUN
chd-104	108	16	of	of	ADP
chd-104	108	17	lymphocyte	lymphocyte	ADJ
chd-104	108	18	activation	activation	NOUN
chd-104	108	19	0.009818976	0.009818976	NUM
chd-104	108	20	go:0050778	go:0050778	VERB
chd-104	108	21	positive	positive	ADJ
chd-104	108	22	regulation	regulation	NOUN
chd-104	108	23	of	of	ADP
chd-104	108	24	immune	immune	ADJ
chd-104	108	25	response	response	NOUN
chd-104	108	26	0.009903295	0.009903295	NUM
chd-104	108	27	go:2000106	go:2000106	NOUN
chd-104	108	28	regulation	regulation	NOUN
chd-104	108	29	of	of	ADP
chd-104	108	30	leukocyte	leukocyte	ADJ
chd-104	108	31	apoptotic	apoptotic	ADJ
chd-104	108	32	process	process	NOUN
chd-104	108	33	0.010825095	0.010825095	NUM
chd-104	108	34	go:0071887	go:0071887	ADJ
chd-104	108	35	leukocyte	leukocyte	ADJ
chd-104	108	36	apoptotic	apoptotic	ADJ
chd-104	108	37	process	process	NOUN
chd-104	108	38	0.011246013	0.011246013	NUM
chd-104	108	39	go:0042089	go:0042089	NOUN
chd-104	108	40	cytokine	cytokine	ADJ
chd-104	108	41	biosynthetic	biosynthetic	ADJ
chd-104	108	42	process	process	NOUN
chd-104	108	43	0.011366604	0.011366604	NUM
chd-104	108	44	go:0002695	go:0002695	NOUN
chd-104	108	45	negative	negative	ADJ
chd-104	108	46	regulation	regulation	NOUN
chd-104	108	47	of	of	ADP
chd-104	108	48	leukocyte	leukocyte	ADJ
chd-104	108	49	activation	activation	NOUN
chd-104	108	50	0.011891576	0.011891576	NUM
chd-104	108	51	go:0002684	go:0002684	INTJ
chd-104	108	52	positive	positive	ADJ
chd-104	108	53	regulation	regulation	NOUN
chd-104	108	54	of	of	ADP
chd-104	108	55	immune	immune	ADJ
chd-104	108	56	system	system	NOUN
chd-104	108	57	process	process	NOUN
chd-104	108	58	0.012690724	0.012690724	NUM
chd-104	108	59	go:0050866	go:0050866	ADJ
chd-104	108	60	negative	negative	ADJ
chd-104	108	61	regulation	regulation	NOUN
chd-104	108	62	of	of	ADP
chd-104	108	63	cell	cell	NOUN
chd-104	108	64	activation	activation	NOUN
chd-104	108	65	0.012821361	0.012821361	NUM
chd-104	109	1	go:0034113	go:0034113	DET
chd-104	109	2	heterotypic	heterotypic	NOUN
chd-104	109	3	cell	cell	NOUN
chd-104	109	4	-	-	PUNCT
chd-104	109	5	cell	cell	NOUN
chd-104	109	6	adhesion	adhesion	NOUN
chd-104	109	7	0.012850245	0.012850245	NUM
chd-104	109	8	go:0006414	go:0006414	NOUN
chd-104	109	9	translational	translational	ADJ
chd-104	109	10	elongation	elongation	NOUN
chd-104	109	11	0.013939004	0.013939004	NUM
chd-104	109	12	go:0002253	go:0002253	PROPN
chd-104	109	13	activation	activation	NOUN
chd-104	109	14	of	of	ADP
chd-104	109	15	immune	immune	ADJ
chd-104	109	16	response	response	NOUN
chd-104	109	17	0.014337616	0.014337616	NUM
chd-104	109	18	go:0051607	go:0051607	ADJ
chd-104	109	19	defense	defense	NOUN
chd-104	109	20	response	response	NOUN
chd-104	109	21	to	to	AUX
chd-104	109	22	virus	virus	VERB
chd-104	109	23	0.01448594	0.01448594	NUM
chd-104	110	1	go:0034341	go:0034341	NOUN
chd-104	110	2	response	response	NOUN
chd-104	110	3	to	to	ADP
chd-104	110	4	interferon	interferon	ADJ
chd-104	110	5	-	-	PUNCT
chd-104	110	6	gamma	gamma	NOUN
chd-104	110	7	0.014747388	0.014747388	NUM
chd-104	110	8	go:0032984	go:0032984	PROPN
chd-104	110	9	macromolecular	macromolecular	PROPN
chd-104	110	10	complex	complex	ADJ
chd-104	110	11	disassembly	disassembly	NOUN
chd-104	110	12	0.01485217	0.01485217	NUM
chd-104	110	13	go:0032649	go:0032649	NOUN
chd-104	110	14	regulation	regulation	NOUN
chd-104	110	15	of	of	ADP
chd-104	110	16	interferon	interferon	ADJ
chd-104	110	17	-	-	PUNCT
chd-104	110	18	gamma	gamma	NOUN
chd-104	110	19	production	production	NOUN
chd-104	110	20	0.015069142	0.015069142	NUM
chd-104	110	21	go:0051707	go:0051707	PROPN
chd-104	110	22	response	response	NOUN
chd-104	110	23	to	to	ADP
chd-104	110	24	other	other	ADJ
chd-104	110	25	organism	organism	NOUN
chd-104	110	26	0.017081494	0.017081494	NUM
chd-104	110	27	go:0002263	go:0002263	NOUN
chd-104	110	28	cell	cell	NOUN
chd-104	110	29	activation	activation	NOUN
chd-104	110	30	involved	involve	VERB
chd-104	110	31	in	in	ADP
chd-104	110	32	immune	immune	ADJ
chd-104	110	33	response	response	NOUN
chd-104	110	34	0.017140132	0.017140132	NUM
chd-104	110	35	go:0002366	go:0002366	VERB
chd-104	110	36	leukocyte	leukocyte	NOUN
chd-104	110	37	activation	activation	NOUN
chd-104	110	38	involved	involve	VERB
chd-104	110	39	in	in	ADP
chd-104	110	40	immune	immune	ADJ
chd-104	110	41	response	response	NOUN
chd-104	110	42	0.017140132	0.017140132	NUM
chd-104	110	43	go:0045580	go:0045580	NOUN
chd-104	110	44	regulation	regulation	NOUN
chd-104	110	45	of	of	ADP
chd-104	110	46	t	t	PROPN
chd-104	110	47	cell	cell	NOUN
chd-104	110	48	differentiation	differentiation	NOUN
chd-104	110	49	0.017360252	0.017360252	NUM
chd-104	110	50	go:0000184	go:0000184	NOUN
chd-104	110	51	nuclear	nuclear	NOUN
chd-104	110	52	-	-	PUNCT
chd-104	110	53	transcribed	transcribe	VERB
chd-104	110	54	mrna	mrna	PROPN
chd-104	110	55	catabolic	catabolic	ADJ
chd-104	110	56	process	process	NOUN
chd-104	110	57	,	,	PUNCT
chd-104	110	58	nonsense	nonsense	NOUN
chd-104	110	59	-	-	PUNCT
chd-104	110	60	mediated	mediate	VERB
chd-104	110	61	decay	decay	NOUN
chd-104	110	62	0.017466425	0.017466425	NUM
chd-104	110	63	go:0071346	go:0071346	VERB
chd-104	110	64	cellular	cellular	ADJ
chd-104	110	65	response	response	NOUN
chd-104	110	66	to	to	ADP
chd-104	110	67	interferon	interferon	ADJ
chd-104	110	68	-	-	PUNCT
chd-104	110	69	gamma	gamma	NOUN
chd-104	110	70	0.017582795	0.017582795	NUM
chd-104	110	71	go:0021903	go:0021903	PROPN
chd-104	110	72	rostrocaudal	rostrocaudal	ADJ
chd-104	110	73	neural	neural	ADJ
chd-104	110	74	tube	tube	NOUN
chd-104	110	75	patterning	pattern	VERB
chd-104	110	76	0.01828075	0.01828075	NUM
chd-104	110	77	go:0071706	go:0071706	PROPN
chd-104	110	78	tumor	tumor	NOUN
chd-104	110	79	necrosis	necrosis	NOUN
chd-104	110	80	factor	factor	NOUN
chd-104	110	81	superfamily	superfamily	ADV
chd-104	110	82	cytokine	cytokine	VERB
chd-104	110	83	production	production	NOUN
chd-104	110	84	0.018894657	0.018894657	NUM
chd-104	110	85	go:0008544	go:0008544	PROPN
chd-104	110	86	epidermis	epidermis	NOUN
chd-104	110	87	development	development	NOUN
chd-104	110	88	0.019826968	0.019826968	NUM
chd-104	110	89	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-104	110	90	e11	e11	NOUN
chd-104	110	91	cancer	cancer	NOUN
chd-104	110	92	health	health	NOUN
chd-104	110	93	disparities	disparity	NOUN
chd-104	110	94	research	research	VERB
chd-104	110	95	go:0050701	go:0050701	VERB
chd-104	110	96	interleukin-1	interleukin-1	NUM
chd-104	110	97	secretion	secretion	NOUN
chd-104	110	98	0.01990773	0.01990773	NUM
chd-104	110	99	go:0032088	go:0032088	VERB
chd-104	110	100	negative	negative	ADJ
chd-104	110	101	regulation	regulation	NOUN
chd-104	110	102	of	of	ADP
chd-104	110	103	nf	nf	ADJ
chd-104	110	104	-	-	PUNCT
chd-104	110	105	kappab	kappab	NOUN
chd-104	110	106	transcription	transcription	NOUN
chd-104	110	107	factor	factor	NOUN
chd-104	110	108	activity	activity	NOUN
chd-104	110	109	0.020009424	0.020009424	NUM
chd-104	110	110	go:0032640	go:0032640	ADJ
chd-104	110	111	tumor	tumor	NOUN
chd-104	110	112	necrosis	necrosis	NOUN
chd-104	110	113	factor	factor	NOUN
chd-104	110	114	production	production	NOUN
chd-104	110	115	0.02003891	0.02003891	NUM
chd-104	110	116	go:0032680	go:0032680	NOUN
chd-104	110	117	regulation	regulation	NOUN
chd-104	110	118	of	of	ADP
chd-104	110	119	tumor	tumor	NOUN
chd-104	110	120	necrosis	necrosis	NOUN
chd-104	110	121	factor	factor	NOUN
chd-104	110	122	production	production	NOUN
chd-104	110	123	0.02003891	0.02003891	NUM
chd-104	110	124	go:0002460	go:0002460	VERB
chd-104	110	125	adaptive	adaptive	ADJ
chd-104	110	126	immune	immune	ADJ
chd-104	110	127	response	response	NOUN
chd-104	110	128	based	base	VERB
chd-104	110	129	on	on	ADP
chd-104	110	130	somatic	somatic	ADJ
chd-104	110	131	recombination	recombination	NOUN
chd-104	110	132	of	of	ADP
chd-104	110	133	immune	immune	ADJ
chd-104	110	134	receptors	receptor	NOUN
chd-104	110	135	built	build	VERB
chd-104	110	136	from	from	ADP
chd-104	110	137	immunoglobulin	immunoglobulin	NOUN
chd-104	110	138	superfamily	superfamily	NOUN
chd-104	110	139	domains	domain	NOUN
chd-104	110	140	0.020144927	0.020144927	NUM
chd-104	110	141	go:0042113	go:0042113	PROPN
chd-104	110	142	b	b	PROPN
chd-104	110	143	cell	cell	NOUN
chd-104	110	144	activation	activation	NOUN
chd-104	110	145	0.020274634	0.020274634	NUM
chd-104	110	146	go:0035587	go:0035587	ADJ
chd-104	110	147	purinergic	purinergic	NOUN
chd-104	110	148	receptor	receptor	NOUN
chd-104	110	149	signaling	signal	VERB
chd-104	110	150	pathway	pathway	NOUN
chd-104	110	151	0.021137639	0.021137639	NUM
chd-104	110	152	go:0042035	go:0042035	NUM
chd-104	110	153	regulation	regulation	NOUN
chd-104	110	154	of	of	ADP
chd-104	110	155	cytokine	cytokine	ADJ
chd-104	110	156	biosynthetic	biosynthetic	ADJ
chd-104	110	157	process	process	NOUN
chd-104	110	158	0.021288775	0.021288775	NUM
chd-104	110	159	go:0034470	go:0034470	NOUN
chd-104	110	160	ncrna	ncrna	NOUN
chd-104	110	161	processing	process	VERB
chd-104	110	162	0.021369145	0.021369145	NUM
chd-104	110	163	go:0002444	go:0002444	NOUN
chd-104	110	164	myeloid	myeloid	ADJ
chd-104	110	165	leukocyte	leukocyte	NOUN
chd-104	110	166	mediated	mediate	VERB
chd-104	110	167	immunity	immunity	NOUN
chd-104	110	168	0.021915664	0.021915664	NUM
chd-104	110	169	go:0009607	go:0009607	VERB
chd-104	110	170	response	response	NOUN
chd-104	110	171	to	to	ADP
chd-104	110	172	biotic	biotic	ADJ
chd-104	110	173	stimulus	stimulus	NOUN
chd-104	110	174	0.02334661	0.02334661	NUM
chd-104	110	175	go:0051249	go:0051249	NOUN
chd-104	110	176	regulation	regulation	NOUN
chd-104	110	177	of	of	ADP
chd-104	110	178	lymphocyte	lymphocyte	ADJ
chd-104	110	179	activation	activation	NOUN
chd-104	110	180	0.02428066	0.02428066	NUM
chd-104	110	181	go:0042107	go:0042107	ADP
chd-104	110	182	cytokine	cytokine	ADJ
chd-104	110	183	metabolic	metabolic	NOUN
chd-104	110	184	process	process	NOUN
chd-104	110	185	0.025345542	0.025345542	NUM
chd-104	110	186	go:0030917	go:0030917	NOUN
chd-104	110	187	midbrain	midbrain	NOUN
chd-104	110	188	-	-	PUNCT
chd-104	110	189	hindbrain	hindbrain	NOUN
chd-104	110	190	boundary	boundary	ADJ
chd-104	110	191	development	development	NOUN
chd-104	110	192	0.025352336	0.025352336	PROPN
chd-104	110	193	go:0060333	go:0060333	VERB
chd-104	110	194	interferon	interferon	ADJ
chd-104	110	195	-	-	PUNCT
chd-104	110	196	gamma	gamma	NOUN
chd-104	110	197	-	-	PUNCT
chd-104	110	198	mediated	mediate	VERB
chd-104	110	199	signaling	signal	VERB
chd-104	110	200	pathway	pathway	NOUN
chd-104	110	201	0.025576575	0.025576575	NUM
chd-104	110	202	go:0006941	go:0006941	ADP
chd-104	110	203	striated	striated	ADJ
chd-104	110	204	muscle	muscle	NOUN
chd-104	110	205	contraction	contraction	NOUN
chd-104	110	206	0.026309493	0.026309493	NUM
chd-104	110	207	go:0003009	go:0003009	NOUN
chd-104	110	208	skeletal	skeletal	ADJ
chd-104	110	209	muscle	muscle	NOUN
chd-104	110	210	contraction	contraction	NOUN
chd-104	110	211	0.026410898	0.026410898	NUM
chd-104	110	212	go:0006959	go:0006959	ADP
chd-104	110	213	humoral	humoral	ADJ
chd-104	110	214	immune	immune	ADJ
chd-104	110	215	response	response	NOUN
chd-104	110	216	0.027278157	0.027278157	NUM
chd-104	110	217	go:0071345	go:0071345	PRON
chd-104	110	218	cellular	cellular	ADJ
chd-104	110	219	response	response	NOUN
chd-104	110	220	to	to	PART
chd-104	110	221	cytokine	cytokine	VERB
chd-104	110	222	stimulus	stimulus	ADJ
chd-104	110	223	0.027348302	0.027348302	NUM
chd-104	110	224	go:0032715	go:0032715	NOUN
chd-104	110	225	negative	negative	ADJ
chd-104	110	226	regulation	regulation	NOUN
chd-104	110	227	of	of	ADP
chd-104	110	228	interleukin-6	interleukin-6	NUM
chd-104	110	229	production	production	NOUN
chd-104	110	230	0.028648897	0.028648897	NUM
chd-104	111	1	go:0031348	go:0031348	PROPN
chd-104	111	2	negative	negative	ADJ
chd-104	111	3	regulation	regulation	NOUN
chd-104	111	4	of	of	ADP
chd-104	111	5	defense	defense	NOUN
chd-104	111	6	response	response	NOUN
chd-104	111	7	0.028778621	0.028778621	NUM
chd-104	111	8	go:0002703	go:0002703	NUM
chd-104	111	9	regulation	regulation	NOUN
chd-104	111	10	of	of	ADP
chd-104	111	11	leukocyte	leukocyte	NOUN
chd-104	111	12	mediated	mediate	VERB
chd-104	111	13	immunity	immunity	NOUN
chd-104	111	14	0.028922763	0.028922763	NUM
chd-104	111	15	go:0043299	go:0043299	NOUN
chd-104	111	16	leukocyte	leukocyte	NOUN
chd-104	111	17	degranulation	degranulation	NOUN
chd-104	111	18	0.029801087	0.029801087	NUM
chd-104	111	19	go:0043173	go:0043173	PROPN
chd-104	111	20	nucleotide	nucleotide	PROPN
chd-104	111	21	salvage	salvage	NOUN
chd-104	111	22	0.029893126	0.029893126	NUM
chd-104	111	23	go:0006613	go:0006613	ADJ
chd-104	111	24	cotranslational	cotranslational	ADJ
chd-104	111	25	protein	protein	NOUN
chd-104	111	26	targeting	target	VERB
chd-104	111	27	to	to	ADP
chd-104	111	28	membrane	membrane	VERB
chd-104	112	1	0.030068796	0.030068796	NUM
chd-104	112	2	go:0006614	go:0006614	NUM
chd-104	112	3	srp	srp	PROPN
chd-104	112	4	-	-	PUNCT
chd-104	112	5	dependent	dependent	ADJ
chd-104	112	6	cotranslational	cotranslational	ADJ
chd-104	112	7	protein	protein	NOUN
chd-104	112	8	targeting	target	VERB
chd-104	112	9	to	to	PART
chd-104	112	10	membrane	membrane	VERB
chd-104	112	11	0.030068796	0.030068796	NUM
chd-104	112	12	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-104	112	13	e12	e12	NOUN
chd-104	112	14	cancer	cancer	NOUN
chd-104	112	15	health	health	NOUN
chd-104	112	16	disparities	disparity	NOUN
chd-104	112	17	research	research	VERB
chd-104	112	18	go:0071219	go:0071219	CCONJ
chd-104	112	19	cellular	cellular	ADJ
chd-104	112	20	response	response	NOUN
chd-104	112	21	to	to	ADP
chd-104	112	22	molecule	molecule	NOUN
chd-104	112	23	of	of	ADP
chd-104	112	24	bacterial	bacterial	ADJ
chd-104	112	25	origin	origin	NOUN
chd-104	112	26	0.030789397	0.030789397	NUM
chd-104	112	27	go:0002250	go:0002250	ADJ
chd-104	112	28	adaptive	adaptive	ADJ
chd-104	112	29	immune	immune	ADJ
chd-104	112	30	response	response	NOUN
chd-104	112	31	0.030841904	0.030841904	NUM
chd-104	112	32	go:0097028	go:0097028	ADJ
chd-104	112	33	dendritic	dendritic	ADJ
chd-104	112	34	cell	cell	NOUN
chd-104	112	35	differentiation	differentiation	NOUN
chd-104	112	36	0.031317678	0.031317678	NUM
chd-104	112	37	go:0002697	go:0002697	VERB
chd-104	112	38	regulation	regulation	NOUN
chd-104	112	39	of	of	ADP
chd-104	112	40	immune	immune	ADJ
chd-104	112	41	effector	effector	NOUN
chd-104	112	42	process	process	NOUN
chd-104	112	43	0.031523821	0.031523821	NUM
chd-104	112	44	go:0071222	go:0071222	ADJ
chd-104	112	45	cellular	cellular	ADJ
chd-104	112	46	response	response	NOUN
chd-104	112	47	to	to	AUX
chd-104	112	48	lipopolysaccharide	lipopolysaccharide	VERB
chd-104	112	49	0.031667044	0.031667044	NUM
chd-104	112	50	go:0007606	go:0007606	NOUN
chd-104	112	51	sensory	sensory	ADJ
chd-104	112	52	perception	perception	NOUN
chd-104	112	53	of	of	ADP
chd-104	112	54	chemical	chemical	NOUN
chd-104	112	55	stimulus	stimulus	NOUN
chd-104	112	56	0.032245552	0.032245552	NUM
chd-104	112	57	go:0050865	go:0050865	ADJ
chd-104	112	58	regulation	regulation	NOUN
chd-104	112	59	of	of	ADP
chd-104	112	60	cell	cell	NOUN
chd-104	112	61	activation	activation	NOUN
chd-104	112	62	0.032311054	0.032311054	NUM
chd-104	113	1	go:0051930	go:0051930	INTJ
chd-104	113	2	regulation	regulation	NOUN
chd-104	113	3	of	of	ADP
chd-104	113	4	sensory	sensory	ADJ
chd-104	113	5	perception	perception	NOUN
chd-104	113	6	of	of	ADP
chd-104	113	7	pain	pain	NOUN
chd-104	113	8	0.034463637	0.034463637	PROPN
chd-104	114	1	go:0051931	go:0051931	PRON
chd-104	114	2	regulation	regulation	NOUN
chd-104	114	3	of	of	ADP
chd-104	114	4	sensory	sensory	ADJ
chd-104	114	5	perception	perception	NOUN
chd-104	114	6	0.034463637	0.034463637	NUM
chd-104	114	7	go:0045047	go:0045047	NUM
chd-104	114	8	protein	protein	NOUN
chd-104	114	9	targeting	target	VERB
chd-104	114	10	to	to	ADP
chd-104	114	11	er	er	INTJ
chd-104	114	12	0.034644877	0.034644877	NUM
chd-104	114	13	go:0072599	go:0072599	NOUN
chd-104	114	14	establishment	establishment	NOUN
chd-104	114	15	of	of	ADP
chd-104	114	16	protein	protein	NOUN
chd-104	114	17	localization	localization	NOUN
chd-104	114	18	to	to	ADP
chd-104	114	19	endoplasmic	endoplasmic	ADJ
chd-104	114	20	reticulum	reticulum	NOUN
chd-104	114	21	0.034644877	0.034644877	NUM
chd-104	114	22	go:0043433	go:0043433	NUM
chd-104	114	23	negative	negative	ADJ
chd-104	114	24	regulation	regulation	NOUN
chd-104	114	25	of	of	ADP
chd-104	114	26	sequence	sequence	NOUN
chd-104	114	27	-	-	PUNCT
chd-104	114	28	specific	specific	ADJ
chd-104	114	29	dna	dna	NOUN
chd-104	114	30	binding	bind	VERB
chd-104	114	31	transcription	transcription	NOUN
chd-104	114	32	factor	factor	NOUN
chd-104	114	33	activity	activity	NOUN
chd-104	114	34	0.034934546	0.034934546	NUM
chd-104	114	35	go:0002764	go:0002764	NOUN
chd-104	114	36	immune	immune	ADJ
chd-104	114	37	response	response	NOUN
chd-104	114	38	-	-	PUNCT
chd-104	114	39	regulating	regulate	VERB
chd-104	114	40	signaling	signal	VERB
chd-104	114	41	pathway	pathway	NOUN
chd-104	114	42	0.035070643	0.035070643	NUM
chd-104	114	43	go:0050848	go:0050848	PROPN
chd-104	114	44	regulation	regulation	NOUN
chd-104	114	45	of	of	ADP
chd-104	114	46	calcium	calcium	NOUN
chd-104	114	47	-	-	PUNCT
chd-104	114	48	mediated	mediate	VERB
chd-104	114	49	signaling	signal	VERB
chd-104	114	50	0.035464555	0.035464555	NUM
chd-104	114	51	go:0051216	go:0051216	NOUN
chd-104	114	52	cartilage	cartilage	NOUN
chd-104	114	53	development	development	NOUN
chd-104	114	54	0.035996334	0.035996334	NUM
chd-104	114	55	go:0070586	go:0070586	ADJ
chd-104	114	56	cell	cell	NOUN
chd-104	114	57	-	-	PUNCT
chd-104	114	58	cell	cell	NOUN
chd-104	114	59	adhesion	adhesion	NOUN
chd-104	114	60	involved	involve	VERB
chd-104	114	61	in	in	ADP
chd-104	114	62	gastrulation	gastrulation	NOUN
chd-104	114	63	0.036025281	0.036025281	NUM
chd-104	114	64	go:0010470	go:0010470	PROPN
chd-104	114	65	regulation	regulation	NOUN
chd-104	114	66	of	of	ADP
chd-104	114	67	gastrulation	gastrulation	NOUN
chd-104	114	68	0.03613861	0.03613861	NUM
chd-104	114	69	go:0006402	go:0006402	PROPN
chd-104	114	70	mrna	mrna	PROPN
chd-104	114	71	catabolic	catabolic	ADJ
chd-104	114	72	process	process	NOUN
chd-104	114	73	0.036140008	0.036140008	NUM
chd-104	114	74	go:0042074	go:0042074	PROPN
chd-104	114	75	cell	cell	NOUN
chd-104	114	76	migration	migration	NOUN
chd-104	114	77	involved	involve	VERB
chd-104	114	78	in	in	ADP
chd-104	114	79	gastrulation	gastrulation	NOUN
chd-104	114	80	0.036712677	0.036712677	NUM
chd-104	114	81	go:0002757	go:0002757	NOUN
chd-104	114	82	immune	immune	ADJ
chd-104	114	83	response	response	NOUN
chd-104	114	84	-	-	PUNCT
chd-104	114	85	activating	activate	VERB
chd-104	114	86	signal	signal	NOUN
chd-104	114	87	transduction	transduction	NOUN
chd-104	114	88	0.036719431	0.036719431	NUM
chd-104	114	89	go:0050704	go:0050704	NOUN
chd-104	114	90	regulation	regulation	NOUN
chd-104	114	91	of	of	ADP
chd-104	114	92	interleukin-1	interleukin-1	NOUN
chd-104	114	93	secretion	secretion	NOUN
chd-104	114	94	0.037451445	0.037451445	NUM
chd-104	114	95	go:0070972	go:0070972	PROPN
chd-104	114	96	protein	protein	NOUN
chd-104	114	97	localization	localization	NOUN
chd-104	114	98	to	to	ADP
chd-104	114	99	endoplasmic	endoplasmic	ADJ
chd-104	114	100	reticulum	reticulum	NOUN
chd-104	114	101	0.037618557	0.037618557	NUM
chd-104	114	102	go:0000956	go:0000956	PROPN
chd-104	114	103	nuclear	nuclear	NOUN
chd-104	114	104	-	-	PUNCT
chd-104	114	105	transcribed	transcribe	VERB
chd-104	114	106	mrna	mrna	PROPN
chd-104	114	107	catabolic	catabolic	ADJ
chd-104	114	108	process	process	NOUN
chd-104	114	109	0.037782421	0.037782421	NUM
chd-104	114	110	go:0002694	go:0002694	NOUN
chd-104	114	111	regulation	regulation	NOUN
chd-104	114	112	of	of	ADP
chd-104	114	113	leukocyte	leukocyte	ADJ
chd-104	114	114	activation	activation	NOUN
chd-104	114	115	0.03779717	0.03779717	NUM
chd-104	114	116	go:0061383	go:0061383	NOUN
chd-104	114	117	trabecula	trabecula	NOUN
chd-104	114	118	morphogenesis	morphogenesis	NOUN
chd-104	114	119	0.038343425	0.038343425	NUM
chd-104	114	120	go:0032612	go:0032612	NOUN
chd-104	114	121	interleukin-1	interleukin-1	NOUN
chd-104	114	122	production	production	NOUN
chd-104	114	123	0.038674489	0.038674489	NUM
chd-104	114	124	go:0035809	go:0035809	NOUN
chd-104	114	125	regulation	regulation	NOUN
chd-104	114	126	of	of	ADP
chd-104	114	127	urine	urine	NOUN
chd-104	114	128	volume	volume	NOUN
chd-104	114	129	0.038920075	0.038920075	NUM
chd-104	114	130	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-104	114	131	e13	e13	NOUN
chd-104	114	132	cancer	cancer	NOUN
chd-104	114	133	health	health	NOUN
chd-104	114	134	disparities	disparity	NOUN
chd-104	114	135	research	research	VERB
chd-104	114	136	go:0002449	go:0002449	PRON
chd-104	114	137	lymphocyte	lymphocyte	NOUN
chd-104	114	138	mediated	mediate	VERB
chd-104	114	139	immunity	immunity	NOUN
chd-104	114	140	0.039034069	0.039034069	NUM
chd-104	114	141	go:0002683	go:0002683	VERB
chd-104	114	142	negative	negative	ADJ
chd-104	114	143	regulation	regulation	NOUN
chd-104	114	144	of	of	ADP
chd-104	114	145	immune	immune	ADJ
chd-104	114	146	system	system	NOUN
chd-104	114	147	process	process	NOUN
chd-104	114	148	0.039201076	0.039201076	NUM
chd-104	114	149	go:0030183	go:0030183	NUM
chd-104	114	150	b	b	NOUN
chd-104	114	151	cell	cell	NOUN
chd-104	114	152	differentiation	differentiation	NOUN
chd-104	114	153	0.039462908	0.039462908	NUM
chd-104	114	154	go:0001783	go:0001783	NOUN
chd-104	114	155	b	b	NOUN
chd-104	114	156	cell	cell	NOUN
chd-104	114	157	apoptotic	apoptotic	ADJ
chd-104	114	158	process	process	NOUN
chd-104	114	159	0.040421151	0.040421151	NUM
chd-104	114	160	go:0042249	go:0042249	NOUN
chd-104	114	161	establishment	establishment	NOUN
chd-104	114	162	of	of	ADP
chd-104	114	163	planar	planar	ADJ
chd-104	114	164	polarity	polarity	NOUN
chd-104	114	165	of	of	ADP
chd-104	114	166	embryonic	embryonic	ADJ
chd-104	114	167	epithelium	epithelium	NOUN
chd-104	114	168	0.040903568	0.040903568	NUM
chd-104	114	169	go:0006400	go:0006400	NOUN
chd-104	114	170	trna	trna	PROPN
chd-104	114	171	modification	modification	NOUN
chd-104	114	172	0.040910207	0.040910207	NUM
chd-104	114	173	go:0070228	go:0070228	PROPN
chd-104	114	174	regulation	regulation	NOUN
chd-104	114	175	of	of	ADP
chd-104	114	176	lymphocyte	lymphocyte	ADJ
chd-104	114	177	apoptotic	apoptotic	ADJ
chd-104	114	178	process	process	NOUN
chd-104	114	179	0.04166174	0.04166174	NUM
chd-104	114	180	go:0006399	go:0006399	PROPN
chd-104	114	181	trna	trna	PROPN
chd-104	114	182	metabolic	metabolic	NOUN
chd-104	114	183	process	process	NOUN
chd-104	114	184	0.041688021	0.041688021	NUM
chd-104	115	1	go:0032729	go:0032729	PROPN
chd-104	115	2	positive	positive	ADJ
chd-104	115	3	regulation	regulation	NOUN
chd-104	115	4	of	of	ADP
chd-104	115	5	interferon	interferon	ADJ
chd-104	115	6	-	-	PUNCT
chd-104	115	7	gamma	gamma	NOUN
chd-104	115	8	production	production	NOUN
chd-104	115	9	0.041968537	0.041968537	NUM
chd-104	115	10	go:0050909	go:0050909	ADJ
chd-104	115	11	sensory	sensory	ADJ
chd-104	115	12	perception	perception	NOUN
chd-104	115	13	of	of	ADP
chd-104	115	14	taste	taste	NOUN
chd-104	115	15	0.042391791	0.042391791	NUM
chd-104	115	16	go:0033209	go:0033209	ADJ
chd-104	115	17	tumor	tumor	NOUN
chd-104	115	18	necrosis	necrosis	NOUN
chd-104	115	19	factor	factor	NOUN
chd-104	115	20	-	-	PUNCT
chd-104	115	21	mediated	mediate	VERB
chd-104	115	22	signaling	signal	VERB
chd-104	115	23	pathway	pathway	NOUN
chd-104	115	24	0.043478576	0.043478576	NUM
chd-104	116	1	go:0031334	go:0031334	NUM
chd-104	116	2	positive	positive	ADJ
chd-104	116	3	regulation	regulation	NOUN
chd-104	116	4	of	of	ADP
chd-104	116	5	protein	protein	NOUN
chd-104	116	6	complex	complex	ADJ
chd-104	116	7	assembly	assembly	NOUN
chd-104	116	8	0.044230876	0.044230876	NUM
chd-104	116	9	go:0050868	go:0050868	VERB
chd-104	116	10	negative	negative	ADJ
chd-104	116	11	regulation	regulation	NOUN
chd-104	116	12	of	of	ADP
chd-104	116	13	t	t	NOUN
chd-104	116	14	cell	cell	NOUN
chd-104	116	15	activation	activation	NOUN
chd-104	116	16	0.044579293	0.044579293	NUM
chd-104	116	17	go:0042110	go:0042110	PROPN
chd-104	116	18	t	t	PROPN
chd-104	116	19	cell	cell	NOUN
chd-104	116	20	activation	activation	NOUN
chd-104	116	21	0.045651071	0.045651071	NUM
chd-104	116	22	go:0071347	go:0071347	ADJ
chd-104	116	23	cellular	cellular	ADJ
chd-104	116	24	response	response	NOUN
chd-104	116	25	to	to	ADP
chd-104	116	26	interleukin-1	interleukin-1	NUM
chd-104	116	27	0.045684339	0.045684339	NUM
chd-104	116	28	go:0003416	go:0003416	CCONJ
chd-104	116	29	endochondral	endochondral	ADJ
chd-104	116	30	bone	bone	NOUN
chd-104	116	31	growth	growth	NOUN
chd-104	116	32	0.046119963	0.046119963	NUM
chd-104	116	33	go:0060026	go:0060026	VERB
chd-104	116	34	convergent	convergent	NOUN
chd-104	116	35	extension	extension	NOUN
chd-104	116	36	0.046776142	0.046776142	NUM
chd-104	116	37	go:0023021	go:0023021	NOUN
chd-104	116	38	termination	termination	NOUN
chd-104	116	39	of	of	ADP
chd-104	116	40	signal	signal	ADJ
chd-104	116	41	transduction	transduction	NOUN
chd-104	116	42	0.046852554	0.046852554	NUM
chd-104	116	43	go:0038032	go:0038032	ADP
chd-104	116	44	termination	termination	NOUN
chd-104	116	45	of	of	ADP
chd-104	116	46	g	g	NOUN
chd-104	116	47	-	-	PUNCT
chd-104	116	48	protein	protein	NOUN
chd-104	116	49	coupled	couple	VERB
chd-104	116	50	receptor	receptor	NOUN
chd-104	116	51	signaling	signal	VERB
chd-104	116	52	pathway	pathway	NOUN
chd-104	116	53	0.047117236	0.047117236	NUM
chd-104	116	54	go:0010657	go:0010657	PROPN
chd-104	116	55	muscle	muscle	NOUN
chd-104	116	56	cell	cell	NOUN
chd-104	116	57	apoptotic	apoptotic	ADJ
chd-104	116	58	process	process	NOUN
chd-104	117	1	0.047468866	0.047468866	NUM
chd-104	117	2	go:0006401	go:0006401	NOUN
chd-104	117	3	rna	rna	NOUN
chd-104	117	4	catabolic	catabolic	ADJ
chd-104	117	5	process	process	NOUN
chd-104	117	6	0.047552326	0.047552326	NUM
chd-104	117	7	go:0042254	go:0042254	NOUN
chd-104	117	8	ribosome	ribosome	NOUN
chd-104	117	9	biogenesis	biogenesis	NOUN
chd-104	117	10	0.047629412	0.047629412	NUM
chd-104	117	11	go:0022904	go:0022904	NOUN
chd-104	117	12	respiratory	respiratory	ADJ
chd-104	117	13	electron	electron	NOUN
chd-104	117	14	transport	transport	NOUN
chd-104	117	15	chain	chain	VERB
chd-104	117	16	0.048240328	0.048240328	NUM
chd-104	117	17	go:0043094	go:0043094	PART
chd-104	117	18	cellular	cellular	ADJ
chd-104	117	19	metabolic	metabolic	NOUN
chd-104	117	20	compound	compound	NOUN
chd-104	117	21	salvage	salvage	NOUN
chd-104	117	22	0.048452721	0.048452721	NUM
chd-104	118	1	go:0006612	go:0006612	NOUN
chd-104	118	2	protein	protein	NOUN
chd-104	118	3	targeting	target	VERB
chd-104	118	4	to	to	PART
chd-104	118	5	membrane	membrane	VERB
chd-104	118	6	0.048517893	0.048517893	NUM
chd-104	118	7	go:0042401	go:0042401	PROPN
chd-104	118	8	cellular	cellular	ADJ
chd-104	118	9	biogenic	biogenic	ADJ
chd-104	118	10	amine	amine	ADJ
chd-104	118	11	biosynthetic	biosynthetic	ADJ
chd-104	118	12	process	process	NOUN
chd-104	118	13	0.048738698	0.048738698	NUM
chd-104	118	14	go:0051495	go:0051495	PROPN
chd-104	118	15	positive	positive	ADJ
chd-104	118	16	regulation	regulation	NOUN
chd-104	118	17	of	of	ADP
chd-104	118	18	cytoskeleton	cytoskeleton	PROPN
chd-104	118	19	organization	organization	NOUN
chd-104	118	20	0.048955127	0.048955127	NUM
chd-104	118	21	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-104	118	22	e14	e14	NOUN
chd-104	118	23	cancer	cancer	NOUN
chd-104	118	24	health	health	NOUN
chd-104	118	25	disparities	disparity	NOUN
chd-104	118	26	research	research	NOUN
chd-104	118	27	go:0002285	go:0002285	PROPN
chd-104	118	28	lymphocyte	lymphocyte	ADJ
chd-104	118	29	activation	activation	NOUN
chd-104	118	30	involved	involve	VERB
chd-104	118	31	in	in	ADP
chd-104	118	32	immune	immune	ADJ
chd-104	118	33	response	response	NOUN
chd-104	118	34	0.049073929	0.049073929	NUM
chd-104	118	35	go:0050864	go:0050864	PROPN
chd-104	118	36	regulation	regulation	NOUN
chd-104	118	37	of	of	ADP
chd-104	118	38	b	b	NOUN
chd-104	118	39	cell	cell	NOUN
chd-104	118	40	activation	activation	NOUN
chd-104	118	41	0.049545191	0.049545191	NUM
chd-104	118	42	downregulated	downregulate	VERB
chd-104	118	43	go:0043687	go:0043687	PROPN
chd-104	118	44	post	post	ADJ
chd-104	118	45	-	-	ADJ
chd-104	118	46	translational	translational	ADJ
chd-104	118	47	protein	protein	NOUN
chd-104	118	48	modification	modification	NOUN
chd-104	118	49	0.000493768	0.000493768	NUM
chd-104	118	50	go:0007156	go:0007156	NOUN
chd-104	118	51	homophilic	homophilic	ADJ
chd-104	118	52	cell	cell	NOUN
chd-104	118	53	adhesion	adhesion	NOUN
chd-104	118	54	0.000891909	0.000891909	NUM
chd-104	118	55	go:0070085	go:0070085	NOUN
chd-104	118	56	glycosylation	glycosylation	NOUN
chd-104	118	57	0.001919505	0.001919505	NUM
chd-104	118	58	go:0006486	go:0006486	PROPN
chd-104	118	59	protein	protein	NOUN
chd-104	118	60	glycosylation	glycosylation	NOUN
chd-104	118	61	0.002075176	0.002075176	NUM
chd-104	118	62	go:0043413	go:0043413	PROPN
chd-104	118	63	macromolecule	macromolecule	NOUN
chd-104	118	64	glycosylation	glycosylation	NOUN
chd-104	118	65	0.002075176	0.002075176	PROPN
chd-104	118	66	go:0006665	go:0006665	NOUN
chd-104	118	67	sphingolipid	sphingolipid	NOUN
chd-104	118	68	metabolic	metabolic	NOUN
chd-104	118	69	process	process	NOUN
chd-104	119	1	0.002745447	0.002745447	NUM
chd-104	119	2	go:0007270	go:0007270	NOUN
chd-104	119	3	neuron	neuron	NOUN
chd-104	119	4	-	-	PUNCT
chd-104	119	5	neuron	neuron	NOUN
chd-104	119	6	synaptic	synaptic	ADJ
chd-104	119	7	transmission	transmission	NOUN
chd-104	119	8	0.002807343	0.002807343	NUM
chd-104	119	9	go:0051966	go:0051966	NOUN
chd-104	119	10	regulation	regulation	NOUN
chd-104	119	11	of	of	ADP
chd-104	119	12	synaptic	synaptic	ADJ
chd-104	119	13	transmission	transmission	NOUN
chd-104	119	14	,	,	PUNCT
chd-104	119	15	glutamatergic	glutamatergic	ADJ
chd-104	119	16	0.003328871	0.003328871	NUM
chd-104	119	17	go:0006687	go:0006687	PROPN
chd-104	119	18	glycosphingolipid	glycosphingolipid	ADJ
chd-104	119	19	metabolic	metabolic	NOUN
chd-104	119	20	process	process	NOUN
chd-104	119	21	0.003952335	0.003952335	NUM
chd-104	119	22	go:0009101	go:0009101	NOUN
chd-104	119	23	glycoprotein	glycoprotein	NOUN
chd-104	119	24	biosynthetic	biosynthetic	ADJ
chd-104	119	25	process	process	NOUN
chd-104	119	26	0.004520639	0.004520639	NUM
chd-104	119	27	go:0035249	go:0035249	NOUN
chd-104	119	28	synaptic	synaptic	ADJ
chd-104	119	29	transmission	transmission	NOUN
chd-104	119	30	,	,	PUNCT
chd-104	119	31	glutamatergic	glutamatergic	ADJ
chd-104	119	32	0.004653915	0.004653915	NUM
chd-104	119	33	go:0007158	go:0007158	PROPN
chd-104	119	34	neuron	neuron	NOUN
chd-104	119	35	cell	cell	NOUN
chd-104	119	36	-	-	PUNCT
chd-104	119	37	cell	cell	NOUN
chd-104	119	38	adhesion	adhesion	NOUN
chd-104	119	39	0.004656323	0.004656323	NUM
chd-104	119	40	go:0006643	go:0006643	PROPN
chd-104	119	41	membrane	membrane	NOUN
chd-104	119	42	lipid	lipid	NOUN
chd-104	119	43	metabolic	metabolic	NOUN
chd-104	119	44	process	process	NOUN
chd-104	119	45	0.005041899	0.005041899	NUM
chd-104	119	46	go:0018196	go:0018196	NOUN
chd-104	119	47	peptidyl	peptidyl	NOUN
chd-104	119	48	-	-	PUNCT
chd-104	119	49	asparagine	asparagine	NOUN
chd-104	119	50	modification	modification	NOUN
chd-104	119	51	0.005612873	0.005612873	NUM
chd-104	119	52	go:0018279	go:0018279	PROPN
chd-104	119	53	protein	protein	NOUN
chd-104	119	54	n	n	CCONJ
chd-104	119	55	-	-	PUNCT
chd-104	119	56	linked	link	VERB
chd-104	119	57	glycosylation	glycosylation	NOUN
chd-104	119	58	via	via	ADP
chd-104	119	59	asparagine	asparagine	NOUN
chd-104	119	60	0.005612873	0.005612873	NUM
chd-104	119	61	go:0006487	go:0006487	PROPN
chd-104	119	62	protein	protein	NOUN
chd-104	119	63	n	n	CCONJ
chd-104	119	64	-	-	PUNCT
chd-104	119	65	linked	link	VERB
chd-104	119	66	glycosylation	glycosylation	NOUN
chd-104	119	67	0.005970635	0.005970635	NUM
chd-104	119	68	go:0031645	go:0031645	ADJ
chd-104	119	69	negative	negative	ADJ
chd-104	119	70	regulation	regulation	NOUN
chd-104	119	71	of	of	ADP
chd-104	119	72	neurological	neurological	ADJ
chd-104	119	73	system	system	NOUN
chd-104	119	74	process	process	NOUN
chd-104	119	75	0.006532083	0.006532083	NUM
chd-104	119	76	go:0051968	go:0051968	NUM
chd-104	119	77	positive	positive	ADJ
chd-104	119	78	regulation	regulation	NOUN
chd-104	119	79	of	of	ADP
chd-104	119	80	synaptic	synaptic	ADJ
chd-104	119	81	transmission	transmission	NOUN
chd-104	119	82	,	,	PUNCT
chd-104	119	83	glutamatergic	glutamatergic	ADJ
chd-104	119	84	0.006542085	0.006542085	NUM
chd-104	119	85	go:0009100	go:0009100	NUM
chd-104	119	86	glycoprotein	glycoprotein	NOUN
chd-104	119	87	metabolic	metabolic	NOUN
chd-104	119	88	process	process	NOUN
chd-104	119	89	0.007071823	0.007071823	NUM
chd-104	119	90	go:0016266	go:0016266	PROPN
chd-104	119	91	o	o	ADJ
chd-104	119	92	-	-	ADJ
chd-104	119	93	glycan	glycan	NOUN
chd-104	119	94	processing	processing	NOUN
chd-104	119	95	0.00822715	0.00822715	NUM
chd-104	119	96	go:0007595	go:0007595	PROPN
chd-104	119	97	lactation	lactation	NOUN
chd-104	119	98	0.008438853	0.008438853	NUM
chd-104	119	99	go:0007610	go:0007610	NUM
chd-104	119	100	behavior	behavior	NOUN
chd-104	119	101	0.009407186	0.009407186	NUM
chd-104	119	102	go:0007420	go:0007420	ADJ
chd-104	119	103	brain	brain	NOUN
chd-104	119	104	development	development	NOUN
chd-104	119	105	0.009694387	0.009694387	NUM
chd-104	119	106	go:0050808	go:0050808	NOUN
chd-104	119	107	synapse	synapse	NOUN
chd-104	119	108	organization	organization	NOUN
chd-104	119	109	0.010243263	0.010243263	NUM
chd-104	119	110	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-104	119	111	e15	e15	PROPN
chd-104	119	112	cancer	cancer	NOUN
chd-104	119	113	health	health	NOUN
chd-104	119	114	disparities	disparity	NOUN
chd-104	119	115	research	research	VERB
chd-104	119	116	go:0036148	go:0036148	PROPN
chd-104	119	117	phosphatidylglycerol	phosphatidylglycerol	VERB
chd-104	119	118	acyl	acyl	NOUN
chd-104	119	119	-	-	PUNCT
chd-104	119	120	chain	chain	NOUN
chd-104	119	121	remodeling	remodeling	NOUN
chd-104	119	122	0.010257756	0.010257756	NUM
chd-104	119	123	go:0042391	go:0042391	NOUN
chd-104	119	124	regulation	regulation	NOUN
chd-104	119	125	of	of	ADP
chd-104	119	126	membrane	membrane	NOUN
chd-104	119	127	potential	potential	ADJ
chd-104	119	128	0.010342608	0.010342608	NUM
chd-104	119	129	go:0006805	go:0006805	PROPN
chd-104	119	130	xenobiotic	xenobiotic	ADJ
chd-104	119	131	metabolic	metabolic	NOUN
chd-104	119	132	process	process	NOUN
chd-104	119	133	0.010598743	0.010598743	NUM
chd-104	119	134	go:0071466	go:0071466	NUM
chd-104	119	135	cellular	cellular	ADJ
chd-104	119	136	response	response	NOUN
chd-104	119	137	to	to	ADP
chd-104	119	138	xenobiotic	xenobiotic	ADJ
chd-104	119	139	stimulus	stimulus	NOUN
chd-104	119	140	0.011270151	0.011270151	NUM
chd-104	119	141	go:0030879	go:0030879	NUM
chd-104	119	142	mammary	mammary	ADJ
chd-104	119	143	gland	gland	NOUN
chd-104	119	144	development	development	NOUN
chd-104	119	145	0.011361444	0.011361444	NUM
chd-104	119	146	go:0001508	go:0001508	NOUN
chd-104	119	147	regulation	regulation	NOUN
chd-104	119	148	of	of	ADP
chd-104	119	149	action	action	NOUN
chd-104	119	150	potential	potential	NOUN
chd-104	119	151	0.011440865	0.011440865	NUM
chd-104	119	152	go:0051970	go:0051970	ADJ
chd-104	119	153	negative	negative	ADJ
chd-104	119	154	regulation	regulation	NOUN
chd-104	119	155	of	of	ADP
chd-104	119	156	transmission	transmission	NOUN
chd-104	119	157	of	of	ADP
chd-104	119	158	nerve	nerve	NOUN
chd-104	119	159	impulse	impulse	ADJ
chd-104	119	160	0.011501433	0.011501433	NUM
chd-104	119	161	go:0048667	go:0048667	NOUN
chd-104	119	162	cell	cell	NOUN
chd-104	119	163	morphogenesis	morphogenesis	NOUN
chd-104	119	164	involved	involve	VERB
chd-104	119	165	in	in	ADP
chd-104	119	166	neuron	neuron	NOUN
chd-104	119	167	differentiation	differentiation	NOUN
chd-104	119	168	0.012566558	0.012566558	NUM
chd-104	119	169	go:0051932	go:0051932	VERB
chd-104	119	170	synaptic	synaptic	ADJ
chd-104	119	171	transmission	transmission	NOUN
chd-104	119	172	,	,	PUNCT
chd-104	119	173	gabaergic	gabaergic	NOUN
chd-104	119	174	0.012763237	0.012763237	NUM
chd-104	119	175	go:0044723	go:0044723	NOUN
chd-104	119	176	single	single	ADJ
chd-104	119	177	-	-	PUNCT
chd-104	119	178	organism	organism	NOUN
chd-104	119	179	carbohydrate	carbohydrate	NOUN
chd-104	119	180	metabolic	metabolic	NOUN
chd-104	119	181	process	process	NOUN
chd-104	119	182	0.012821492	0.012821492	NUM
chd-104	119	183	go:0006664	go:0006664	NUM
chd-104	119	184	glycolipid	glycolipid	ADJ
chd-104	119	185	metabolic	metabolic	NOUN
chd-104	119	186	process	process	NOUN
chd-104	119	187	0.01400463	0.01400463	NUM
chd-104	119	188	go:0050805	go:0050805	VERB
chd-104	119	189	negative	negative	ADJ
chd-104	119	190	regulation	regulation	NOUN
chd-104	119	191	of	of	ADP
chd-104	119	192	synaptic	synaptic	ADJ
chd-104	119	193	transmission	transmission	NOUN
chd-104	119	194	0.015334527	0.015334527	NUM
chd-104	119	195	go:0007626	go:0007626	NOUN
chd-104	119	196	locomotory	locomotory	ADJ
chd-104	119	197	behavior	behavior	NOUN
chd-104	119	198	0.015430043	0.015430043	PRON
chd-104	119	199	go:0009410	go:0009410	ADJ
chd-104	119	200	response	response	NOUN
chd-104	119	201	to	to	ADP
chd-104	119	202	xenobiotic	xenobiotic	ADJ
chd-104	119	203	stimulus	stimulus	NOUN
chd-104	119	204	0.015493698	0.015493698	NUM
chd-104	119	205	go:0048193	go:0048193	NUM
chd-104	119	206	golgi	golgi	PROPN
chd-104	119	207	vesicle	vesicle	PROPN
chd-104	119	208	transport	transport	VERB
chd-104	119	209	0.015772984	0.015772984	NUM
chd-104	119	210	go:0048609	go:0048609	NOUN
chd-104	119	211	multicellular	multicellular	ADJ
chd-104	119	212	organismal	organismal	ADJ
chd-104	119	213	reproductive	reproductive	ADJ
chd-104	119	214	process	process	NOUN
chd-104	119	215	0.015789414	0.015789414	NUM
chd-104	119	216	go:0031047	go:0031047	NOUN
chd-104	119	217	gene	gene	NOUN
chd-104	119	218	silencing	silence	VERB
chd-104	119	219	by	by	ADP
chd-104	119	220	rna	rna	NOUN
chd-104	119	221	0.016586363	0.016586363	NUM
chd-104	119	222	go:0048812	go:0048812	PROPN
chd-104	119	223	neuron	neuron	PROPN
chd-104	119	224	projection	projection	NOUN
chd-104	119	225	morphogenesis	morphogenesis	NOUN
chd-104	119	226	0.016607133	0.016607133	NUM
chd-104	119	227	go:0044708	go:0044708	NUM
chd-104	119	228	single	single	ADJ
chd-104	119	229	-	-	PUNCT
chd-104	119	230	organism	organism	NOUN
chd-104	119	231	behavior	behavior	NOUN
chd-104	119	232	0.018681325	0.018681325	NUM
chd-104	119	233	go:0030900	go:0030900	PROPN
chd-104	119	234	forebrain	forebrain	NOUN
chd-104	119	235	development	development	NOUN
chd-104	119	236	0.020384121	0.020384121	NUM
chd-104	119	237	go:0060271	go:0060271	PROPN
chd-104	119	238	cilium	cilium	NOUN
chd-104	119	239	morphogenesis	morphogenesis	VERB
chd-104	119	240	0.020950746	0.020950746	NUM
chd-104	119	241	go:0007173	go:0007173	NOUN
chd-104	119	242	epidermal	epidermal	ADJ
chd-104	119	243	growth	growth	NOUN
chd-104	119	244	factor	factor	NOUN
chd-104	119	245	receptor	receptor	NOUN
chd-104	119	246	signaling	signal	VERB
chd-104	119	247	pathway	pathway	NOUN
chd-104	119	248	0.021617695	0.021617695	NUM
chd-104	119	249	go:0038127	go:0038127	NOUN
chd-104	119	250	erbb	erbb	PROPN
chd-104	119	251	signaling	signal	VERB
chd-104	119	252	pathway	pathway	NOUN
chd-104	119	253	0.021617695	0.021617695	NUM
chd-104	119	254	go:0008610	go:0008610	PRON
chd-104	119	255	lipid	lipid	NOUN
chd-104	119	256	biosynthetic	biosynthetic	ADJ
chd-104	119	257	process	process	NOUN
chd-104	119	258	0.022799925	0.022799925	NUM
chd-104	119	259	go:0034329	go:0034329	PROPN
chd-104	119	260	cell	cell	NOUN
chd-104	119	261	junction	junction	NOUN
chd-104	119	262	assembly	assembly	NOUN
chd-104	119	263	0.022808921	0.022808921	NUM
chd-104	119	264	go:0006470	go:0006470	NOUN
chd-104	119	265	protein	protein	NOUN
chd-104	119	266	dephosphorylation	dephosphorylation	NOUN
chd-104	119	267	0.023740415	0.023740415	NUM
chd-104	119	268	go:0044262	go:0044262	DET
chd-104	119	269	cellular	cellular	ADJ
chd-104	119	270	carbohydrate	carbohydrate	NOUN
chd-104	119	271	metabolic	metabolic	NOUN
chd-104	119	272	process	process	NOUN
chd-104	119	273	0.023838856	0.023838856	NUM
chd-104	119	274	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-104	119	275	e16	e16	NOUN
chd-104	119	276	cancer	cancer	NOUN
chd-104	119	277	health	health	NOUN
chd-104	119	278	disparities	disparity	NOUN
chd-104	120	1	research	research	NOUN
chd-104	120	2	go:0006654	go:0006654	PROPN
chd-104	120	3	phosphatidic	phosphatidic	ADJ
chd-104	120	4	acid	acid	NOUN
chd-104	120	5	biosynthetic	biosynthetic	ADJ
chd-104	120	6	process	process	NOUN
chd-104	120	7	0.024003206	0.024003206	NUM
chd-104	120	8	go:0046473	go:0046473	NOUN
chd-104	120	9	phosphatidic	phosphatidic	ADJ
chd-104	120	10	acid	acid	NOUN
chd-104	120	11	metabolic	metabolic	NOUN
chd-104	120	12	process	process	NOUN
chd-104	120	13	0.024003206	0.024003206	NUM
chd-104	120	14	go:0007631	go:0007631	SYM
chd-104	120	15	feeding	feed	VERB
chd-104	120	16	behavior	behavior	NOUN
chd-104	120	17	0.024218683	0.024218683	NUM
chd-104	120	18	go:0007215	go:0007215	NUM
chd-104	120	19	glutamate	glutamate	ADJ
chd-104	120	20	receptor	receptor	NOUN
chd-104	120	21	signaling	signal	VERB
chd-104	120	22	pathway	pathway	NOUN
chd-104	120	23	0.025341571	0.025341571	NUM
chd-104	120	24	go:0007169	go:0007169	PROPN
chd-104	120	25	transmembrane	transmembrane	ADJ
chd-104	120	26	receptor	receptor	NOUN
chd-104	120	27	protein	protein	NOUN
chd-104	120	28	tyrosine	tyrosine	PROPN
chd-104	120	29	kinase	kinase	PROPN
chd-104	120	30	signaling	signal	VERB
chd-104	120	31	pathway	pathway	NOUN
chd-104	120	32	0.025778202	0.025778202	NUM
chd-104	120	33	go:0048732	go:0048732	DET
chd-104	120	34	gland	gland	NOUN
chd-104	120	35	development	development	NOUN
chd-104	120	36	0.026371412	0.026371412	NUM
chd-104	120	37	go:0007409	go:0007409	PART
chd-104	120	38	axonogenesis	axonogenesis	NOUN
chd-104	120	39	0.028034327	0.028034327	NUM
chd-104	120	40	go:0030902	go:0030902	PROPN
chd-104	120	41	hindbrain	hindbrain	NOUN
chd-104	120	42	development	development	NOUN
chd-104	120	43	0.028207007	0.028207007	NUM
chd-104	120	44	go:0050905	go:0050905	VERB
chd-104	120	45	neuromuscular	neuromuscular	ADJ
chd-104	120	46	process	process	NOUN
chd-104	120	47	0.028868056	0.028868056	NUM
chd-104	120	48	go:0035265	go:0035265	NOUN
chd-104	120	49	organ	organ	NOUN
chd-104	120	50	growth	growth	NOUN
chd-104	120	51	0.029870897	0.029870897	NUM
chd-104	120	52	go:0032228	go:0032228	PROPN
chd-104	120	53	regulation	regulation	NOUN
chd-104	120	54	of	of	ADP
chd-104	120	55	synaptic	synaptic	ADJ
chd-104	120	56	transmission	transmission	NOUN
chd-104	120	57	,	,	PUNCT
chd-104	120	58	gabaergic	gabaergic	ADJ
chd-104	120	59	0.030572469	0.030572469	NUM
chd-104	120	60	go:0021533	go:0021533	PROPN
chd-104	120	61	cell	cell	NOUN
chd-104	120	62	differentiation	differentiation	NOUN
chd-104	120	63	in	in	ADP
chd-104	120	64	hindbrain	hindbrain	NOUN
chd-104	120	65	0.030591893	0.030591893	NUM
chd-104	120	66	go:0006112	go:0006112	NOUN
chd-104	120	67	energy	energy	NOUN
chd-104	120	68	reserve	reserve	NOUN
chd-104	120	69	metabolic	metabolic	NOUN
chd-104	120	70	process	process	NOUN
chd-104	120	71	0.030725257	0.030725257	NUM
chd-104	120	72	go:0010165	go:0010165	NOUN
chd-104	120	73	response	response	NOUN
chd-104	120	74	to	to	ADP
chd-104	120	75	x	x	NOUN
chd-104	120	76	-	-	NOUN
chd-104	120	77	ray	ray	VERB
chd-104	120	78	0.031143637	0.031143637	NUM
chd-104	120	79	go:0043044	go:0043044	NOUN
chd-104	120	80	atp	atp	NOUN
chd-104	120	81	-	-	PUNCT
chd-104	120	82	dependent	dependent	ADJ
chd-104	120	83	chromatin	chromatin	NOUN
chd-104	120	84	remodeling	remodel	VERB
chd-104	120	85	0.031721256	0.031721256	NUM
chd-104	120	86	go:0021549	go:0021549	PROPN
chd-104	120	87	cerebellum	cerebellum	ADJ
chd-104	120	88	development	development	NOUN
chd-104	120	89	0.031913742	0.031913742	NUM
chd-104	120	90	go:0032787	go:0032787	NOUN
chd-104	120	91	monocarboxylic	monocarboxylic	PROPN
chd-104	120	92	acid	acid	PROPN
chd-104	120	93	metabolic	metabolic	NOUN
chd-104	120	94	process	process	NOUN
chd-104	120	95	0.032020432	0.032020432	NUM
chd-104	121	1	go:0006892	go:0006892	VERB
chd-104	121	2	post	post	ADJ
chd-104	121	3	-	-	ADJ
chd-104	121	4	golgi	golgi	ADJ
chd-104	121	5	vesicle	vesicle	NOUN
chd-104	121	6	-	-	PUNCT
chd-104	121	7	mediated	mediate	VERB
chd-104	121	8	transport	transport	NOUN
chd-104	121	9	0.032510822	0.032510822	NUM
chd-104	121	10	go:0052646	go:0052646	PROPN
chd-104	121	11	alditol	alditol	ADJ
chd-104	121	12	phosphate	phosphate	NOUN
chd-104	121	13	metabolic	metabolic	NOUN
chd-104	121	14	process	process	NOUN
chd-104	121	15	0.03300986	0.03300986	NUM
chd-104	121	16	go:0007157	go:0007157	NOUN
chd-104	121	17	heterophilic	heterophilic	ADJ
chd-104	121	18	cell	cell	NOUN
chd-104	121	19	-	-	PUNCT
chd-104	121	20	cell	cell	NOUN
chd-104	121	21	adhesion	adhesion	NOUN
chd-104	121	22	0.033442154	0.033442154	NUM
chd-104	121	23	go:0014812	go:0014812	NOUN
chd-104	121	24	muscle	muscle	NOUN
chd-104	121	25	cell	cell	NOUN
chd-104	121	26	migration	migration	NOUN
chd-104	121	27	0.033592578	0.033592578	NUM
chd-104	121	28	go:0006302	go:0006302	NOUN
chd-104	121	29	double	double	ADJ
chd-104	121	30	-	-	PUNCT
chd-104	121	31	strand	strand	NOUN
chd-104	121	32	break	break	NOUN
chd-104	121	33	repair	repair	NOUN
chd-104	121	34	0.03376071	0.03376071	NUM
chd-104	121	35	go:0045216	go:0045216	NOUN
chd-104	121	36	cell	cell	NOUN
chd-104	121	37	-	-	PUNCT
chd-104	121	38	cell	cell	NOUN
chd-104	121	39	junction	junction	NOUN
chd-104	121	40	organization	organization	NOUN
chd-104	121	41	0.034066295	0.034066295	NUM
chd-104	121	42	go:0006457	go:0006457	PROPN
chd-104	121	43	protein	protein	NOUN
chd-104	121	44	folding	fold	VERB
chd-104	121	45	0.034232181	0.034232181	NUM
chd-104	122	1	go:0006282	go:0006282	ADJ
chd-104	122	2	regulation	regulation	NOUN
chd-104	122	3	of	of	ADP
chd-104	122	4	dna	dna	PROPN
chd-104	122	5	repair	repair	VERB
chd-104	122	6	0.03433869	0.03433869	NUM
chd-104	122	7	go:0001570	go:0001570	NOUN
chd-104	122	8	vasculogenesis	vasculogenesis	NOUN
chd-104	122	9	0.034798997	0.034798997	NUM
chd-104	122	10	go:0046620	go:0046620	NOUN
chd-104	122	11	regulation	regulation	NOUN
chd-104	122	12	of	of	ADP
chd-104	122	13	organ	organ	NOUN
chd-104	122	14	growth	growth	NOUN
chd-104	122	15	0.035079657	0.035079657	NUM
chd-104	122	16	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PART
chd-104	122	17	e17	e17	NOUN
chd-104	122	18	cancer	cancer	NOUN
chd-104	122	19	health	health	NOUN
chd-104	122	20	disparities	disparity	NOUN
chd-104	122	21	research	research	NOUN
chd-104	122	22	go:0016337	go:0016337	ADP
chd-104	122	23	cell	cell	NOUN
chd-104	122	24	-	-	PUNCT
chd-104	122	25	cell	cell	NOUN
chd-104	122	26	adhesion	adhesion	NOUN
chd-104	122	27	0.035209378	0.035209378	NUM
chd-104	122	28	go:0060479	go:0060479	NOUN
chd-104	122	29	lung	lung	NOUN
chd-104	122	30	cell	cell	NOUN
chd-104	122	31	differentiation	differentiation	NOUN
chd-104	122	32	0.035239581	0.035239581	NUM
chd-104	122	33	go:0032941	go:0032941	ADP
chd-104	122	34	secretion	secretion	NOUN
chd-104	122	35	by	by	ADP
chd-104	122	36	tissue	tissue	NOUN
chd-104	122	37	0.036128621	0.036128621	NUM
chd-104	122	38	go:0000271	go:0000271	PROPN
chd-104	122	39	polysaccharide	polysaccharide	NOUN
chd-104	122	40	biosynthetic	biosynthetic	ADJ
chd-104	122	41	process	process	NOUN
chd-104	122	42	0.036630136	0.036630136	NUM
chd-104	122	43	go:0022037	go:0022037	PROPN
chd-104	122	44	metencephalon	metencephalon	NOUN
chd-104	122	45	development	development	NOUN
chd-104	122	46	0.036660654	0.036660654	NUM
chd-104	122	47	go:0032870	go:0032870	NOUN
chd-104	122	48	cellular	cellular	ADJ
chd-104	122	49	response	response	NOUN
chd-104	122	50	to	to	ADP
chd-104	122	51	hormone	hormone	NOUN
chd-104	122	52	stimulus	stimulus	NOUN
chd-104	122	53	0.036922137	0.036922137	NUM
chd-104	122	54	go:0002064	go:0002064	NOUN
chd-104	122	55	epithelial	epithelial	ADJ
chd-104	122	56	cell	cell	NOUN
chd-104	122	57	development	development	NOUN
chd-104	122	58	0.03723918	0.03723918	NUM
chd-104	122	59	go:0030728	go:0030728	NOUN
chd-104	122	60	ovulation	ovulation	NOUN
chd-104	122	61	0.038142428	0.038142428	NUM
chd-104	122	62	go:0007411	go:0007411	VERB
chd-104	122	63	axon	axon	NOUN
chd-104	122	64	guidance	guidance	VERB
chd-104	123	1	0.038665746	0.038665746	NUM
chd-104	123	2	go:0036151	go:0036151	NOUN
chd-104	123	3	phosphatidylcholine	phosphatidylcholine	NOUN
chd-104	123	4	acyl	acyl	NOUN
chd-104	123	5	-	-	PUNCT
chd-104	123	6	chain	chain	NOUN
chd-104	123	7	remodeling	remodeling	NOUN
chd-104	123	8	0.03867378	0.03867378	NUM
chd-104	123	9	go:0060487	go:0060487	NOUN
chd-104	123	10	lung	lung	NOUN
chd-104	123	11	epithelial	epithelial	ADJ
chd-104	123	12	cell	cell	NOUN
chd-104	123	13	differentiation	differentiation	NOUN
chd-104	123	14	0.039970158	0.039970158	NUM
chd-104	123	15	go:0034330	go:0034330	DET
chd-104	123	16	cell	cell	NOUN
chd-104	123	17	junction	junction	NOUN
chd-104	123	18	organization	organization	NOUN
chd-104	123	19	0.040342663	0.040342663	NUM
chd-104	123	20	go:1901888	go:1901888	NUM
chd-104	123	21	regulation	regulation	NOUN
chd-104	123	22	of	of	ADP
chd-104	123	23	cell	cell	NOUN
chd-104	123	24	junction	junction	NOUN
chd-104	123	25	assembly	assembly	NOUN
chd-104	123	26	0.041298928	0.041298928	PRON
chd-104	123	27	go:0036149	go:0036149	AUX
chd-104	123	28	phosphatidylinositol	phosphatidylinositol	NOUN
chd-104	123	29	acyl	acyl	NOUN
chd-104	123	30	-	-	PUNCT
chd-104	123	31	chain	chain	NOUN
chd-104	123	32	remodeling	remodeling	NOUN
chd-104	123	33	0.041658096	0.041658096	NUM
chd-104	123	34	go:0030949	go:0030949	NOUN
chd-104	123	35	positive	positive	ADJ
chd-104	123	36	regulation	regulation	NOUN
chd-104	123	37	of	of	ADP
chd-104	123	38	vascular	vascular	ADJ
chd-104	123	39	endothelial	endothelial	ADJ
chd-104	123	40	growth	growth	NOUN
chd-104	123	41	factor	factor	NOUN
chd-104	123	42	receptor	receptor	NOUN
chd-104	123	43	signaling	signal	VERB
chd-104	123	44	pathway	pathway	NOUN
chd-104	123	45	0.041896616	0.041896616	NUM
chd-104	123	46	go:0007274	go:0007274	NOUN
chd-104	123	47	neuromuscular	neuromuscular	ADJ
chd-104	123	48	synaptic	synaptic	ADJ
chd-104	123	49	transmission	transmission	NOUN
chd-104	123	50	0.042046032	0.042046032	NUM
chd-104	123	51	go:0071599	go:0071599	PRON
chd-104	123	52	otic	otic	ADJ
chd-104	123	53	vesicle	vesicle	NOUN
chd-104	123	54	development	development	NOUN
chd-104	123	55	0.042937278	0.042937278	NUM
chd-104	123	56	go:0006493	go:0006493	PROPN
chd-104	123	57	protein	protein	NOUN
chd-104	123	58	o	o	NOUN
chd-104	123	59	-	-	ADJ
chd-104	123	60	linked	link	VERB
chd-104	123	61	glycosylation	glycosylation	NOUN
chd-104	123	62	0.043137696	0.043137696	NUM
chd-104	123	63	go:0001937	go:0001937	PRON
chd-104	123	64	negative	negative	ADJ
chd-104	123	65	regulation	regulation	NOUN
chd-104	123	66	of	of	ADP
chd-104	123	67	endothelial	endothelial	ADJ
chd-104	123	68	cell	cell	NOUN
chd-104	123	69	proliferation	proliferation	NOUN
chd-104	123	70	0.043387826	0.043387826	NUM
chd-104	123	71	go:0048545	go:0048545	PROPN
chd-104	123	72	response	response	NOUN
chd-104	123	73	to	to	ADP
chd-104	123	74	steroid	steroid	NOUN
chd-104	123	75	hormone	hormone	NOUN
chd-104	123	76	stimulus	stimulus	NOUN
chd-104	123	77	0.043541689	0.043541689	NUM
chd-104	123	78	go:0005977	go:0005977	PROPN
chd-104	123	79	glycogen	glycogen	NOUN
chd-104	123	80	metabolic	metabolic	NOUN
chd-104	123	81	process	process	NOUN
chd-104	123	82	0.046227756	0.046227756	NUM
chd-104	123	83	go:0034508	go:0034508	NOUN
chd-104	123	84	centromere	centromere	NOUN
chd-104	123	85	complex	complex	ADJ
chd-104	123	86	assembly	assembly	NOUN
chd-104	123	87	0.047156367	0.047156367	NUM
chd-104	123	88	go:0061418	go:0061418	PRON
chd-104	123	89	regulation	regulation	NOUN
chd-104	123	90	of	of	ADP
chd-104	123	91	transcription	transcription	NOUN
chd-104	123	92	from	from	ADP
chd-104	123	93	rna	rna	NOUN
chd-104	123	94	polymerase	polymerase	NOUN
chd-104	123	95	ii	ii	NOUN
chd-104	123	96	promoter	promoter	NOUN
chd-104	123	97	in	in	ADP
chd-104	123	98	response	response	NOUN
chd-104	123	99	to	to	PART
chd-104	123	100	hypoxia	hypoxia	VERB
chd-104	123	101	0.04743104	0.04743104	NUM
chd-104	123	102	go:0044257	go:0044257	NOUN
chd-104	123	103	cellular	cellular	ADJ
chd-104	123	104	protein	protein	NOUN
chd-104	123	105	catabolic	catabolic	ADJ
chd-104	123	106	process	process	NOUN
chd-104	123	107	0.047832199	0.047832199	NUM
chd-104	123	108	go:0051963	go:0051963	NUM
chd-104	123	109	regulation	regulation	NOUN
chd-104	123	110	of	of	ADP
chd-104	123	111	synapse	synapse	NOUN
chd-104	123	112	assembly	assembly	NOUN
chd-104	123	113	0.048565239	0.048565239	NUM
chd-104	123	114	go:0060740	go:0060740	NOUN
chd-104	123	115	prostate	prostate	NOUN
chd-104	123	116	gland	gland	NOUN
chd-104	123	117	epithelium	epithelium	NOUN
chd-104	123	118	morphogenesis	morphogenesis	NOUN
chd-104	123	119	0.048742367	0.048742367	NUM
chd-104	123	120	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PART
chd-104	123	121	e18	e18	PROPN
chd-104	123	122	cancer	cancer	NOUN
chd-104	123	123	health	health	NOUN
chd-104	123	124	disparities	disparity	NOUN
chd-104	123	125	research	research	NOUN
chd-104	123	126	predicted	predict	VERB
chd-104	123	127	significantly	significantly	ADV
chd-104	123	128	worse	bad	ADJ
chd-104	123	129	rfs	rfs	X
chd-104	123	130	in	in	ADP
chd-104	123	131	tnbcs	tnbc	NOUN
chd-104	123	132	(	(	PUNCT
chd-104	123	133	hr=1.75	hr=1.75	NOUN
chd-104	123	134	;	;	PUNCT
chd-104	123	135	p=0.027	p=0.027	X
chd-104	123	136	)	)	PUNCT
chd-104	123	137	;	;	PUNCT
chd-104	123	138	nrarp	nrarp	ADJ
chd-104	123	139	expression	expression	NOUN
chd-104	123	140	was	be	AUX
chd-104	123	141	associated	associate	VERB
chd-104	123	142	with	with	ADP
chd-104	123	143	a	a	DET
chd-104	123	144	trend	trend	NOUN
chd-104	123	145	towards	towards	ADP
chd-104	123	146	poorer	poor	ADJ
chd-104	123	147	rfs	rfs	NOUN
chd-104	123	148	in	in	ADP
chd-104	123	149	tnbcs	tnbc	NOUN
chd-104	123	150	(	(	PUNCT
chd-104	123	151	hr=1.53	hr=1.53	NOUN
chd-104	123	152	;	;	PUNCT
chd-104	123	153	p=0.17	p=0.17	PROPN
chd-104	123	154	)	)	PUNCT
chd-104	123	155	;	;	PUNCT
chd-104	123	156	and	and	CCONJ
chd-104	123	157	notch2nl	notch2nl	ADJ
chd-104	123	158	expression	expression	NOUN
chd-104	123	159	was	be	AUX
chd-104	123	160	associated	associate	VERB
chd-104	123	161	with	with	ADP
chd-104	123	162	poorer	poor	ADJ
chd-104	123	163	rfs	rfs	NOUN
chd-104	123	164	in	in	ADP
chd-104	123	165	tnbc	tnbc	PROPN
chd-104	123	166	(	(	PUNCT
chd-104	123	167	hr=1.001	hr=1.001	NOUN
chd-104	123	168	;	;	PUNCT
chd-104	123	169	p=0.01	p=0.01	NUM
chd-104	123	170	)	)	PUNCT
chd-104	123	171	.	.	PUNCT
chd-104	124	1	the	the	DET
chd-104	124	2	prognostic	prognostic	ADJ
chd-104	124	3	value	value	NOUN
chd-104	124	4	of	of	ADP
chd-104	124	5	notch2nl	notch2nl	ADJ
chd-104	124	6	expression	expression	NOUN
chd-104	124	7	level	level	NOUN
chd-104	124	8	was	be	AUX
chd-104	124	9	upheld	uphold	VERB
chd-104	124	10	after	after	ADP
chd-104	124	11	adjusting	adjust	VERB
chd-104	124	12	for	for	ADP
chd-104	124	13	age	age	NOUN
chd-104	124	14	,	,	PUNCT
chd-104	124	15	stage	stage	NOUN
chd-104	124	16	and	and	CCONJ
chd-104	124	17	race	race	NOUN
chd-104	124	18	(	(	PUNCT
chd-104	124	19	aa	aa	NOUN
chd-104	124	20	vs.	vs.	ADP
chd-104	124	21	ea	ea	NUM
chd-104	124	22	)	)	PUNCT
chd-104	124	23	;	;	PUNCT
chd-104	124	24	in	in	ADP
chd-104	124	25	fact	fact	NOUN
chd-104	124	26	,	,	PUNCT
chd-104	124	27	the	the	DET
chd-104	124	28	expression	expression	NOUN
chd-104	124	29	of	of	ADP
chd-104	124	30	notch2nl	notch2nl	PROPN
chd-104	124	31	was	be	AUX
chd-104	124	32	the	the	DET
chd-104	124	33	only	only	ADJ
chd-104	124	34	significant	significant	ADJ
chd-104	124	35	predictor	predictor	NOUN
chd-104	124	36	of	of	ADP
chd-104	124	37	rfs	rfs	PROPN
chd-104	124	38	in	in	ADP
chd-104	124	39	multivariable	multivariable	ADJ
chd-104	124	40	analyses	analysis	NOUN
chd-104	124	41	(	(	PUNCT
chd-104	124	42	p=0.003	p=0.003	NOUN
chd-104	124	43	)	)	PUNCT
chd-104	124	44	.	.	PUNCT
chd-104	125	1	interestingly	interestingly	ADV
chd-104	125	2	,	,	PUNCT
chd-104	125	3	dner	dner	NOUN
chd-104	125	4	ranked	rank	VERB
chd-104	125	5	in	in	ADP
chd-104	125	6	the	the	DET
chd-104	125	7	top	top	ADJ
chd-104	125	8	1	1	NUM
chd-104	125	9	%	%	NOUN
chd-104	125	10	of	of	ADP
chd-104	125	11	genes	gene	NOUN
chd-104	125	12	most	most	ADV
chd-104	125	13	highly	highly	ADV
chd-104	125	14	dysregulated	dysregulated	ADJ
chd-104	125	15	in	in	ADP
chd-104	125	16	the	the	DET
chd-104	125	17	basal	basal	NOUN
chd-104	125	18	-	-	PUNCT
chd-104	125	19	like	like	ADJ
chd-104	125	20	immuno	immuno	NOUN
chd-104	125	21	-	-	PUNCT
chd-104	125	22	suppressed	suppress	VERB
chd-104	125	23	(	(	PUNCT
chd-104	125	24	blis	bli	NOUN
chd-104	125	25	)	)	PUNCT
chd-104	125	26	tnbc	tnbc	VERB
chd-104	125	27	molecular	molecular	ADJ
chd-104	125	28	subtype	subtype	NOUN
chd-104	125	29	.	.	PUNCT
chd-104	126	1	aas	aas	PROPN
chd-104	126	2	tend	tend	VERB
chd-104	126	3	to	to	PART
chd-104	126	4	harbor	harbor	VERB
chd-104	126	5	basal	basal	NOUN
chd-104	126	6	-	-	PUNCT
chd-104	126	7	like	like	ADJ
chd-104	126	8	subtypes	subtype	NOUN
chd-104	126	9	of	of	ADP
chd-104	126	10	tnbc	tnbc	NOUN
chd-104	126	11	and	and	CCONJ
chd-104	126	12	the	the	DET
chd-104	126	13	blis	blis	PROPN
chd-104	126	14	molecular	molecular	ADJ
chd-104	126	15	subtype	subtype	NOUN
chd-104	126	16	is	be	AUX
chd-104	126	17	1	1	NUM
chd-104	126	18	of	of	ADP
chd-104	126	19	2	2	NUM
chd-104	126	20	basal	basal	NOUN
chd-104	126	21	-	-	PUNCT
chd-104	126	22	like	like	ADJ
chd-104	126	23	tnbc	tnbc	NOUN
chd-104	126	24	molecular	molecular	ADJ
chd-104	126	25	subtypes	subtype	NOUN
chd-104	126	26	recently	recently	ADV
chd-104	126	27	identified	identify	VERB
chd-104	126	28	(	(	PUNCT
chd-104	126	29	burstein	burstein	NOUN
chd-104	126	30	et	et	PROPN
chd-104	126	31	al	al	PROPN
chd-104	126	32	.	.	PROPN
chd-104	126	33	,	,	PUNCT
chd-104	126	34	2015	2015	NUM
chd-104	126	35	)	)	PUNCT
chd-104	126	36	that	that	PRON
chd-104	126	37	has	have	VERB
chd-104	126	38	the	the	DET
chd-104	126	39	worst	bad	ADJ
chd-104	126	40	disease	disease	NOUN
chd-104	126	41	-	-	PUNCT
chd-104	126	42	free	free	ADJ
chd-104	126	43	survival	survival	NOUN
chd-104	126	44	and	and	CCONJ
chd-104	126	45	bc	bc	ADJ
chd-104	126	46	-	-	ADJ
chd-104	126	47	specific	specific	ADJ
chd-104	126	48	survival	survival	NOUN
chd-104	126	49	among	among	ADP
chd-104	126	50	the	the	DET
chd-104	126	51	4	4	NUM
chd-104	126	52	prognostically	prognostically	ADV
chd-104	126	53	-	-	PUNCT
chd-104	126	54	distinct	distinct	ADJ
chd-104	126	55	tnbc	tnbc	NOUN
chd-104	126	56	molecular	molecular	ADJ
chd-104	126	57	subtypes	subtype	NOUN
chd-104	126	58	.	.	PUNCT
chd-104	127	1	our	our	PRON
chd-104	127	2	group	group	NOUN
chd-104	127	3	’s	’s	PART
chd-104	127	4	findings	finding	NOUN
chd-104	127	5	collectively	collectively	ADV
chd-104	127	6	suggest	suggest	VERB
chd-104	127	7	that	that	SCONJ
chd-104	127	8	the	the	DET
chd-104	127	9	notch	notch	NOUN
chd-104	127	10	signaling	signal	VERB
chd-104	127	11	pathway	pathway	NOUN
chd-104	127	12	may	may	AUX
chd-104	127	13	be	be	AUX
chd-104	127	14	upregulated	upregulate	VERB
chd-104	127	15	among	among	ADP
chd-104	127	16	tnbc	tnbc	ADJ
chd-104	127	17	patients	patient	NOUN
chd-104	127	18	of	of	ADP
chd-104	127	19	african	african	PROPN
chd-104	127	20	compared	compare	VERB
chd-104	127	21	to	to	ADP
chd-104	127	22	european	european	ADJ
chd-104	127	23	ancestry	ancestry	NOUN
chd-104	127	24	,	,	PUNCT
chd-104	127	25	and	and	CCONJ
chd-104	127	26	upregulated	upregulate	VERB
chd-104	127	27	notch	notch	NOUN
chd-104	127	28	signaling	signal	VERB
chd-104	127	29	may	may	AUX
chd-104	127	30	serve	serve	VERB
chd-104	127	31	as	as	ADP
chd-104	127	32	a	a	DET
chd-104	127	33	poor	poor	ADJ
chd-104	127	34	prognosis	prognosis	NOUN
chd-104	127	35	biomarker	biomarker	NOUN
chd-104	127	36	in	in	ADP
chd-104	127	37	tnbc	tnbc	NOUN
chd-104	127	38	.	.	PUNCT
chd-104	128	1	targeting	target	VERB
chd-104	128	2	notch	notch	NOUN
chd-104	128	3	signaling	signal	VERB
chd-104	128	4	may	may	AUX
chd-104	128	5	therefore	therefore	ADV
chd-104	128	6	be	be	AUX
chd-104	128	7	a	a	DET
chd-104	128	8	promising	promising	ADJ
chd-104	128	9	personalized	personalized	ADJ
chd-104	128	10	therapeutic	therapeutic	ADJ
chd-104	128	11	strategy	strategy	NOUN
chd-104	128	12	for	for	ADP
chd-104	128	13	tnbc	tnbc	ADJ
chd-104	128	14	patients	patient	NOUN
chd-104	128	15	of	of	ADP
chd-104	128	16	african	african	ADJ
chd-104	128	17	descent	descent	NOUN
chd-104	128	18	,	,	PUNCT
chd-104	128	19	including	include	VERB
chd-104	128	20	aas	aas	NOUN
chd-104	128	21	.	.	PUNCT
chd-104	129	1	taking	take	VERB
chd-104	129	2	it	it	PRON
chd-104	129	3	up	up	ADP
chd-104	129	4	a	a	DET
chd-104	129	5	notch	notch	NOUN
chd-104	129	6	:	:	PUNCT
chd-104	129	7	establishing	establish	VERB
chd-104	129	8	notch	notch	NOUN
chd-104	129	9	signaling	signal	VERB
chd-104	129	10	as	as	ADP
chd-104	129	11	therapeutic	therapeutic	ADJ
chd-104	129	12	target	target	NOUN
chd-104	129	13	of	of	ADP
chd-104	129	14	interest	interest	NOUN
chd-104	129	15	for	for	ADP
chd-104	129	16	triple	triple	ADJ
chd-104	129	17	negative	negative	ADJ
chd-104	129	18	breast	breast	NOUN
chd-104	129	19	cancer	cancer	NOUN
chd-104	129	20	patients	patient	NOUN
chd-104	129	21	of	of	ADP
chd-104	129	22	african	african	ADJ
chd-104	129	23	descent	descent	NOUN
chd-104	129	24	tnbc	tnbc	NOUN
chd-104	129	25	remains	remain	VERB
chd-104	129	26	the	the	DET
chd-104	129	27	primary	primary	ADJ
chd-104	129	28	culprit	culprit	NOUN
chd-104	129	29	for	for	ADP
chd-104	129	30	disproportionately	disproportionately	ADV
chd-104	129	31	lower	low	ADJ
chd-104	129	32	survival	survival	NOUN
chd-104	129	33	rates	rate	NOUN
chd-104	129	34	of	of	ADP
chd-104	129	35	aa	aa	NOUN
chd-104	129	36	compared	compare	VERB
chd-104	129	37	to	to	ADP
chd-104	129	38	ea	ea	PROPN
chd-104	129	39	bc	bc	PROPN
chd-104	129	40	patients	patient	NOUN
chd-104	129	41	.	.	PUNCT
chd-104	130	1	thus	thus	ADV
chd-104	130	2	,	,	PUNCT
chd-104	130	3	identifying	identify	VERB
chd-104	130	4	novel	novel	ADJ
chd-104	130	5	therapeutic	therapeutic	ADJ
chd-104	130	6	targets	target	NOUN
chd-104	130	7	and/or	and/or	CCONJ
chd-104	130	8	risk	risk	NOUN
chd-104	130	9	-	-	PUNCT
chd-104	130	10	predictive	predictive	NOUN
chd-104	130	11	biomarkers	biomarker	NOUN
chd-104	130	12	for	for	ADP
chd-104	130	13	tnbc	tnbc	ADJ
chd-104	130	14	patients	patient	NOUN
chd-104	130	15	of	of	ADP
chd-104	130	16	african	african	ADJ
chd-104	130	17	ancestry	ancestry	NOUN
chd-104	130	18	will	will	AUX
chd-104	130	19	be	be	AUX
chd-104	130	20	critical	critical	ADJ
chd-104	130	21	to	to	ADP
chd-104	130	22	alleviating	alleviate	VERB
chd-104	130	23	the	the	DET
chd-104	130	24	racially	racially	ADV
chd-104	130	25	disparate	disparate	ADJ
chd-104	130	26	burden	burden	NOUN
chd-104	130	27	in	in	ADP
chd-104	130	28	bc	bc	PROPN
chd-104	130	29	.	.	PUNCT
chd-104	131	1	emerging	emerge	VERB
chd-104	131	2	evidence	evidence	NOUN
chd-104	131	3	suggest	suggest	VERB
chd-104	131	4	that	that	SCONJ
chd-104	131	5	inherent	inherent	ADJ
chd-104	131	6	differences	difference	NOUN
chd-104	131	7	exist	exist	VERB
chd-104	131	8	in	in	ADP
chd-104	131	9	tumor	tumor	NOUN
chd-104	131	10	biology	biology	NOUN
chd-104	131	11	between	between	ADP
chd-104	131	12	aa	aa	PROPN
chd-104	131	13	and	and	CCONJ
chd-104	131	14	ea	ea	NOUN
chd-104	131	15	tnbc	tnbc	ADJ
chd-104	131	16	patients	patient	NOUN
chd-104	131	17	.	.	PUNCT
chd-104	132	1	getz	getz	PROPN
chd-104	132	2	et	et	PROPN
chd-104	132	3	al	al	PROPN
chd-104	132	4	.	.	PROPN
chd-104	132	5	discovered	discover	VERB
chd-104	132	6	that	that	SCONJ
chd-104	132	7	dysregulated	dysregulated	ADJ
chd-104	132	8	genes	gene	NOUN
chd-104	132	9	in	in	ADP
chd-104	132	10	the	the	DET
chd-104	132	11	wnt/catenin	wnt/catenin	ADJ
chd-104	132	12	pathway	pathway	NOUN
chd-104	132	13	were	be	AUX
chd-104	132	14	significantly	significantly	ADV
chd-104	132	15	more	more	ADV
chd-104	132	16	enriched	enriched	ADJ
chd-104	132	17	among	among	ADP
chd-104	132	18	tnbc	tnbc	ADJ
chd-104	132	19	patient	patient	ADJ
chd-104	132	20	samples	sample	NOUN
chd-104	132	21	of	of	ADP
chd-104	132	22	african	african	ADJ
chd-104	132	23	compared	compare	VERB
chd-104	132	24	to	to	ADP
chd-104	132	25	european	european	PROPN
chd-104	132	26	ancestry	ancestry	PROPN
chd-104	132	27	,	,	PUNCT
chd-104	132	28	which	which	PRON
chd-104	132	29	may	may	AUX
chd-104	132	30	rationalize	rationalize	VERB
chd-104	132	31	the	the	DET
chd-104	132	32	aggressive	aggressive	ADJ
chd-104	132	33	tnbc	tnbc	NOUN
chd-104	132	34	phenotypes	phenotype	NOUN
chd-104	132	35	observed	observe	VERB
chd-104	132	36	among	among	ADP
chd-104	132	37	patients	patient	NOUN
chd-104	132	38	of	of	ADP
chd-104	132	39	african	african	ADJ
chd-104	132	40	descent	descent	NOUN
chd-104	132	41	(	(	PUNCT
chd-104	132	42	dietze	dietze	PROPN
chd-104	132	43	et	et	PROPN
chd-104	132	44	al	al	PROPN
chd-104	132	45	.	.	PROPN
chd-104	132	46	,	,	PUNCT
chd-104	132	47	2015	2015	NUM
chd-104	132	48	)	)	PUNCT
chd-104	132	49	.	.	PUNCT
chd-104	133	1	however	however	ADV
chd-104	133	2	,	,	PUNCT
chd-104	133	3	more	more	ADJ
chd-104	133	4	work	work	NOUN
chd-104	133	5	is	be	AUX
chd-104	133	6	warranted	warrant	VERB
chd-104	133	7	to	to	PART
chd-104	133	8	examine	examine	VERB
chd-104	133	9	inherent	inherent	ADJ
chd-104	133	10	tumor	tumor	NOUN
chd-104	133	11	biological	biological	ADJ
chd-104	133	12	differences	difference	NOUN
chd-104	133	13	between	between	ADP
chd-104	133	14	racially	racially	ADV
chd-104	133	15	-	-	PUNCT
chd-104	133	16	distinct	distinct	ADJ
chd-104	133	17	tnbc	tnbc	NOUN
chd-104	133	18	patients	patient	NOUN
chd-104	133	19	.	.	PUNCT
chd-104	134	1	our	our	PRON
chd-104	134	2	group	group	NOUN
chd-104	134	3	sought	seek	VERB
chd-104	134	4	to	to	PART
chd-104	134	5	investigate	investigate	VERB
chd-104	134	6	differences	difference	NOUN
chd-104	134	7	in	in	ADP
chd-104	134	8	tumor	tumor	NOUN
chd-104	134	9	biology	biology	NOUN
chd-104	134	10	between	between	ADP
chd-104	134	11	aa	aa	PROPN
chd-104	134	12	and	and	CCONJ
chd-104	134	13	ea	ea	NOUN
chd-104	134	14	tnbc	tnbc	VERB
chd-104	134	15	patients	patient	NOUN
chd-104	134	16	through	through	ADP
chd-104	134	17	analyzing	analyze	VERB
chd-104	134	18	the	the	DET
chd-104	134	19	publicly	publicly	ADV
chd-104	134	20	-	-	PUNCT
chd-104	134	21	available	available	ADJ
chd-104	134	22	gene	gene	NOUN
chd-104	134	23	expression	expression	NOUN
chd-104	134	24	dataset	dataset	NOUN
chd-104	134	25	,	,	PUNCT
chd-104	134	26	tcga	tcga	PROPN
chd-104	134	27	.	.	PUNCT
chd-104	135	1	interestingly	interestingly	ADV
chd-104	135	2	,	,	PUNCT
chd-104	135	3	notch	notch	ADJ
chd-104	135	4	signaling	signaling	NOUN
chd-104	135	5	emerged	emerge	VERB
chd-104	135	6	as	as	ADP
chd-104	135	7	a	a	DET
chd-104	135	8	pathway	pathway	NOUN
chd-104	135	9	significantly	significantly	ADV
chd-104	135	10	upregulated	upregulate	VERB
chd-104	135	11	among	among	ADP
chd-104	135	12	aa	aa	NOUN
chd-104	135	13	compared	compare	VERB
chd-104	135	14	to	to	ADP
chd-104	135	15	ea	ea	NOUN
chd-104	135	16	tnbc	tnbc	VERB
chd-104	135	17	patients	patient	NOUN
chd-104	135	18	.	.	PUNCT
chd-104	136	1	we	we	PRON
chd-104	136	2	observed	observe	VERB
chd-104	136	3	upregulation	upregulation	NOUN
chd-104	136	4	of	of	ADP
chd-104	136	5	the	the	DET
chd-104	136	6	notch	notch	NOUN
chd-104	136	7	signaling	signal	VERB
chd-104	136	8	pathway	pathway	NOUN
chd-104	136	9	among	among	ADP
chd-104	136	10	aa	aa	NOUN
chd-104	136	11	compared	compare	VERB
chd-104	136	12	to	to	ADP
chd-104	136	13	ea	ea	NOUN
chd-104	136	14	tnbc	tnbc	VERB
chd-104	136	15	samples	sample	NOUN
chd-104	136	16	as	as	ADV
chd-104	136	17	well	well	ADV
chd-104	136	18	as	as	ADP
chd-104	136	19	significant	significant	ADJ
chd-104	136	20	upregulation	upregulation	NOUN
chd-104	136	21	of	of	ADP
chd-104	136	22	genes	gene	NOUN
chd-104	136	23	encoding	encode	VERB
chd-104	136	24	key	key	ADJ
chd-104	136	25	notch	notch	NOUN
chd-104	136	26	signaling	signal	VERB
chd-104	136	27	proteins	protein	NOUN
chd-104	136	28	in	in	ADP
chd-104	136	29	this	this	DET
chd-104	136	30	pathway	pathway	NOUN
chd-104	136	31	such	such	ADJ
chd-104	136	32	as	as	ADP
chd-104	136	33	nrarp	nrarp	ADJ
chd-104	136	34	,	,	PUNCT
chd-104	136	35	dner	dner	NOUN
chd-104	136	36	,	,	PUNCT
chd-104	136	37	jag1	jag1	NOUN
chd-104	136	38	,	,	PUNCT
chd-104	136	39	jag2	jag2	NOUN
chd-104	136	40	,	,	PUNCT
chd-104	136	41	hes4	hes4	NOUN
chd-104	136	42	,	,	PUNCT
chd-104	136	43	and	and	CCONJ
chd-104	136	44	mmp9	mmp9	PROPN
chd-104	136	45	.	.	PUNCT
chd-104	137	1	nrarp	nrarp	ADJ
chd-104	137	2	is	be	AUX
chd-104	137	3	a	a	DET
chd-104	137	4	downstream	downstream	ADJ
chd-104	137	5	effector	effector	NOUN
chd-104	137	6	in	in	ADP
chd-104	137	7	the	the	DET
chd-104	137	8	notch	notch	ADJ
chd-104	137	9	pathway	pathway	NOUN
chd-104	137	10	and	and	CCONJ
chd-104	137	11	its	its	PRON
chd-104	137	12	overexpression	overexpression	NOUN
chd-104	137	13	has	have	AUX
chd-104	137	14	been	be	AUX
chd-104	137	15	associated	associate	VERB
chd-104	137	16	with	with	ADP
chd-104	137	17	breast	breast	NOUN
chd-104	137	18	carcinogenesis	carcinogenesis	NOUN
chd-104	137	19	and	and	CCONJ
chd-104	137	20	bc	bc	PROPN
chd-104	137	21	cell	cell	NOUN
chd-104	137	22	proliferation	proliferation	NOUN
chd-104	137	23	(	(	PUNCT
chd-104	137	24	imaoka	imaoka	NOUN
chd-104	137	25	et	et	NOUN
chd-104	137	26	al	al	PROPN
chd-104	137	27	.	.	PROPN
chd-104	137	28	,	,	PUNCT
chd-104	137	29	2014	2014	NUM
chd-104	137	30	)	)	PUNCT
chd-104	137	31	.	.	PUNCT
chd-104	138	1	jag1	jag1	NOUN
chd-104	138	2	and	and	CCONJ
chd-104	138	3	jag2	jag2	PROPN
chd-104	138	4	encode	encode	VERB
chd-104	138	5	two	two	NUM
chd-104	138	6	major	major	ADJ
chd-104	138	7	ligands	ligand	NOUN
chd-104	138	8	in	in	ADP
chd-104	138	9	the	the	DET
chd-104	138	10	canonical	canonical	ADJ
chd-104	138	11	notch	notch	NOUN
chd-104	138	12	signaling	signal	VERB
chd-104	138	13	pathway	pathway	NOUN
chd-104	138	14	(	(	PUNCT
chd-104	138	15	wang	wang	PROPN
chd-104	138	16	et	et	PROPN
chd-104	138	17	al	al	PROPN
chd-104	138	18	.	.	PROPN
chd-104	138	19	,	,	PUNCT
chd-104	138	20	2010	2010	NUM
chd-104	138	21	)	)	PUNCT
chd-104	138	22	.	.	PUNCT
chd-104	139	1	the	the	DET
chd-104	139	2	he	he	PRON
chd-104	139	3	s	s	VERB
chd-104	139	4	family	family	NOUN
chd-104	139	5	of	of	ADP
chd-104	139	6	transcription	transcription	NOUN
chd-104	139	7	factors	factor	NOUN
chd-104	139	8	represent	represent	VERB
chd-104	139	9	a	a	DET
chd-104	139	10	major	major	ADJ
chd-104	139	11	family	family	NOUN
chd-104	139	12	of	of	ADP
chd-104	139	13	downstream	downstream	ADJ
chd-104	139	14	target	target	NOUN
chd-104	139	15	genes	gene	NOUN
chd-104	139	16	in	in	ADP
chd-104	139	17	the	the	DET
chd-104	139	18	notch	notch	NOUN
chd-104	139	19	signaling	signal	VERB
chd-104	139	20	pathway	pathway	NOUN
chd-104	139	21	(	(	PUNCT
chd-104	139	22	acar	acar	NOUN
chd-104	139	23	et	et	PROPN
chd-104	139	24	al	al	PROPN
chd-104	139	25	.	.	PROPN
chd-104	139	26	,	,	PUNCT
chd-104	139	27	2016	2016	NUM
chd-104	139	28	)	)	PUNCT
chd-104	139	29	.	.	PUNCT
chd-104	140	1	mmp9	mmp9	PROPN
chd-104	140	2	is	be	AUX
chd-104	140	3	implicated	implicate	VERB
chd-104	140	4	in	in	ADP
chd-104	140	5	the	the	DET
chd-104	140	6	breakdown	breakdown	NOUN
chd-104	140	7	of	of	ADP
chd-104	140	8	the	the	DET
chd-104	140	9	extracellular	extracellular	ADJ
chd-104	140	10	matrix	matrix	NOUN
chd-104	140	11	to	to	PART
chd-104	140	12	facilitate	facilitate	VERB
chd-104	140	13	invasion	invasion	NOUN
chd-104	140	14	and	and	CCONJ
chd-104	140	15	metastasis	metastasis	NOUN
chd-104	140	16	in	in	ADP
chd-104	140	17	tnbc	tnbc	PROPN
chd-104	140	18	(	(	PUNCT
chd-104	140	19	mehner	mehner	NOUN
chd-104	140	20	et	et	PROPN
chd-104	140	21	al	al	PROPN
chd-104	140	22	.	.	PROPN
chd-104	140	23	,	,	PUNCT
chd-104	140	24	2014	2014	NUM
chd-104	140	25	)	)	PUNCT
chd-104	140	26	.	.	PUNCT
chd-104	141	1	furthermore	furthermore	ADV
chd-104	141	2	,	,	PUNCT
chd-104	141	3	we	we	PRON
chd-104	141	4	observed	observe	VERB
chd-104	141	5	significant	significant	ADJ
chd-104	141	6	downregulation	downregulation	NOUN
chd-104	141	7	of	of	ADP
chd-104	141	8	biological	biological	ADJ
chd-104	141	9	pathways	pathway	NOUN
chd-104	141	10	and	and	CCONJ
chd-104	141	11	gene	gene	NOUN
chd-104	141	12	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-104	141	13	e19	e19	ADJ
chd-104	141	14	cancer	cancer	NOUN
chd-104	141	15	health	health	NOUN
chd-104	141	16	disparities	disparity	NOUN
chd-104	141	17	research	research	NOUN
chd-104	141	18	ontologies	ontology	NOUN
chd-104	141	19	reflecting	reflect	VERB
chd-104	141	20	loss	loss	NOUN
chd-104	141	21	of	of	ADP
chd-104	141	22	cell	cell	NOUN
chd-104	141	23	-	-	PUNCT
chd-104	141	24	cell	cell	NOUN
chd-104	141	25	contacts	contact	NOUN
chd-104	141	26	,	,	PUNCT
chd-104	141	27	focal	focal	ADJ
chd-104	141	28	adhesion	adhesion	NOUN
chd-104	141	29	,	,	PUNCT
chd-104	141	30	and	and	CCONJ
chd-104	141	31	ecm	ecm	NOUN
chd-104	141	32	-	-	PUNCT
chd-104	141	33	receptor	receptor	NOUN
chd-104	141	34	interaction	interaction	NOUN
chd-104	141	35	as	as	ADV
chd-104	141	36	well	well	ADV
chd-104	141	37	as	as	ADP
chd-104	141	38	reduced	reduce	VERB
chd-104	141	39	epithelial	epithelial	ADJ
chd-104	141	40	cell	cell	NOUN
chd-104	141	41	development	development	NOUN
chd-104	141	42	,	,	PUNCT
chd-104	141	43	reduced	reduce	VERB
chd-104	141	44	endothelial	endothelial	ADJ
chd-104	141	45	cell	cell	NOUN
chd-104	141	46	proliferation	proliferation	NOUN
chd-104	141	47	,	,	PUNCT
chd-104	141	48	and	and	CCONJ
chd-104	141	49	dna	dna	PROPN
chd-104	141	50	damage	damage	NOUN
chd-104	141	51	response	response	NOUN
chd-104	141	52	among	among	ADP
chd-104	141	53	aa	aa	NOUN
chd-104	141	54	compared	compare	VERB
chd-104	141	55	to	to	ADP
chd-104	141	56	ea	ea	NOUN
chd-104	141	57	patients	patient	NOUN
chd-104	141	58	.	.	PUNCT
chd-104	142	1	notch	notch	ADJ
chd-104	142	2	signaling	signal	VERB
chd-104	142	3	regulates	regulate	VERB
chd-104	142	4	proliferation	proliferation	NOUN
chd-104	142	5	,	,	PUNCT
chd-104	142	6	apoptosis	apoptosis	NOUN
chd-104	142	7	,	,	PUNCT
chd-104	142	8	angiogenesis	angiogenesis	NOUN
chd-104	142	9	,	,	PUNCT
chd-104	142	10	hypoxia	hypoxia	NOUN
chd-104	142	11	,	,	PUNCT
chd-104	142	12	emt	emt	NOUN
chd-104	142	13	,	,	PUNCT
chd-104	142	14	and	and	CCONJ
chd-104	142	15	metastasis	metastasis	NOUN
chd-104	142	16	(	(	PUNCT
chd-104	142	17	acar	acar	NOUN
chd-104	142	18	et	et	PROPN
chd-104	142	19	al	al	PROPN
chd-104	142	20	.	.	PROPN
chd-104	142	21	,	,	PUNCT
chd-104	142	22	2016	2016	NUM
chd-104	142	23	)	)	PUNCT
chd-104	142	24	.	.	PUNCT
chd-104	143	1	thus	thus	ADV
chd-104	143	2	,	,	PUNCT
chd-104	143	3	significant	significant	ADJ
chd-104	143	4	downregulation	downregulation	NOUN
chd-104	143	5	of	of	ADP
chd-104	143	6	these	these	DET
chd-104	143	7	processes	process	NOUN
chd-104	143	8	among	among	ADP
chd-104	143	9	aa	aa	NOUN
chd-104	143	10	compared	compare	VERB
chd-104	143	11	to	to	ADP
chd-104	143	12	ea	ea	NOUN
chd-104	143	13	samples	sample	NOUN
chd-104	143	14	may	may	AUX
chd-104	143	15	reflect	reflect	VERB
chd-104	143	16	increased	increase	VERB
chd-104	143	17	proliferation	proliferation	NOUN
chd-104	143	18	,	,	PUNCT
chd-104	143	19	angiogenesis	angiogenesis	NOUN
chd-104	143	20	,	,	PUNCT
chd-104	143	21	metastasis	metastasis	NOUN
chd-104	143	22	,	,	PUNCT
chd-104	143	23	and	and	CCONJ
chd-104	143	24	reduced	reduce	VERB
chd-104	143	25	cell	cell	NOUN
chd-104	143	26	death	death	NOUN
chd-104	143	27	among	among	ADP
chd-104	143	28	aa	aa	PROPN
chd-104	143	29	patients	patient	NOUN
chd-104	143	30	.	.	PUNCT
chd-104	144	1	we	we	PRON
chd-104	144	2	also	also	ADV
chd-104	144	3	observed	observe	VERB
chd-104	144	4	significant	significant	ADJ
chd-104	144	5	upregulation	upregulation	NOUN
chd-104	144	6	of	of	ADP
chd-104	144	7	gene	gene	NOUN
chd-104	144	8	ontologies	ontology	NOUN
chd-104	144	9	reflecting	reflect	VERB
chd-104	144	10	t	t	NOUN
chd-104	144	11	cellmediated	cellmediate	VERB
chd-104	144	12	immune	immune	ADJ
chd-104	144	13	response	response	NOUN
chd-104	144	14	,	,	PUNCT
chd-104	144	15	which	which	PRON
chd-104	144	16	is	be	AUX
chd-104	144	17	upregulated	upregulate	VERB
chd-104	144	18	by	by	ADP
chd-104	144	19	notch	notch	NOUN
chd-104	144	20	signaling	signal	VERB
chd-104	144	21	(	(	PUNCT
chd-104	144	22	uzhachenko	uzhachenko	NOUN
chd-104	144	23	and	and	CCONJ
chd-104	144	24	shanker	shanker	NOUN
chd-104	144	25	,	,	PUNCT
chd-104	144	26	2016	2016	NUM
chd-104	144	27	)	)	PUNCT
chd-104	144	28	.	.	PUNCT
chd-104	145	1	hence	hence	ADV
chd-104	145	2	,	,	PUNCT
chd-104	145	3	we	we	PRON
chd-104	145	4	have	have	AUX
chd-104	145	5	uncovered	uncover	VERB
chd-104	145	6	notch	notch	NOUN
chd-104	145	7	signaling	signal	VERB
chd-104	145	8	as	as	ADP
chd-104	145	9	a	a	DET
chd-104	145	10	key	key	ADJ
chd-104	145	11	biological	biological	ADJ
chd-104	145	12	pathway	pathway	NOUN
chd-104	145	13	that	that	PRON
chd-104	145	14	may	may	AUX
chd-104	145	15	contribute	contribute	VERB
chd-104	145	16	to	to	ADP
chd-104	145	17	the	the	DET
chd-104	145	18	racially	racially	ADV
chd-104	145	19	disparate	disparate	ADJ
chd-104	145	20	burden	burden	NOUN
chd-104	145	21	in	in	ADP
chd-104	145	22	tnbc	tnbc	NOUN
chd-104	145	23	and	and	CCONJ
chd-104	145	24	serve	serve	VERB
chd-104	145	25	as	as	ADP
chd-104	145	26	a	a	DET
chd-104	145	27	potential	potential	ADJ
chd-104	145	28	therapeutic	therapeutic	ADJ
chd-104	145	29	target	target	NOUN
chd-104	145	30	for	for	ADP
chd-104	145	31	aa	aa	NOUN
chd-104	145	32	patients	patient	NOUN
chd-104	145	33	.	.	PUNCT
chd-104	146	1	our	our	PRON
chd-104	146	2	findings	finding	NOUN
chd-104	146	3	thus	thus	ADV
chd-104	146	4	encourage	encourage	VERB
chd-104	146	5	a	a	DET
chd-104	146	6	closer	close	ADJ
chd-104	146	7	look	look	NOUN
chd-104	146	8	at	at	ADP
chd-104	146	9	this	this	DET
chd-104	146	10	biological	biological	ADJ
chd-104	146	11	pathway	pathway	NOUN
chd-104	146	12	as	as	ADP
chd-104	146	13	a	a	DET
chd-104	146	14	potential	potential	ADJ
chd-104	146	15	racial	racial	ADJ
chd-104	146	16	disparity	disparity	NOUN
chd-104	146	17	biomarker	biomarker	NOUN
chd-104	146	18	and	and	CCONJ
chd-104	146	19	therapeutic	therapeutic	ADJ
chd-104	146	20	target	target	NOUN
chd-104	146	21	for	for	ADP
chd-104	146	22	tnbc	tnbc	NOUN
chd-104	146	23	.	.	PUNCT
chd-104	147	1	however	however	ADV
chd-104	147	2	,	,	PUNCT
chd-104	147	3	validation	validation	NOUN
chd-104	147	4	of	of	ADP
chd-104	147	5	our	our	PRON
chd-104	147	6	results	result	NOUN
chd-104	147	7	in	in	ADP
chd-104	147	8	additional	additional	ADJ
chd-104	147	9	gene	gene	NOUN
chd-104	147	10	expression	expression	NOUN
chd-104	147	11	datasets	dataset	NOUN
chd-104	147	12	as	as	ADV
chd-104	147	13	well	well	ADV
chd-104	147	14	as	as	ADP
chd-104	147	15	at	at	ADP
chd-104	147	16	the	the	DET
chd-104	147	17	protein	protein	NOUN
chd-104	147	18	expression	expression	NOUN
chd-104	147	19	level	level	NOUN
chd-104	147	20	among	among	ADP
chd-104	147	21	patient	patient	ADJ
chd-104	147	22	samples	sample	NOUN
chd-104	147	23	of	of	ADP
chd-104	147	24	known	know	VERB
chd-104	147	25	tnbc	tnbc	NOUN
chd-104	147	26	molecular	molecular	ADJ
chd-104	147	27	subtypes	subtype	NOUN
chd-104	147	28	will	will	AUX
chd-104	147	29	be	be	AUX
chd-104	147	30	critical	critical	ADJ
chd-104	147	31	to	to	ADP
chd-104	147	32	achieving	achieve	VERB
chd-104	147	33	this	this	DET
chd-104	147	34	aim	aim	NOUN
chd-104	147	35	.	.	PUNCT
chd-104	148	1	furthermore	furthermore	ADV
chd-104	148	2	,	,	PUNCT
chd-104	148	3	investigating	investigate	VERB
chd-104	148	4	the	the	DET
chd-104	148	5	effects	effect	NOUN
chd-104	148	6	of	of	ADP
chd-104	148	7	manipulating	manipulate	VERB
chd-104	148	8	notch	notch	NOUN
chd-104	148	9	signaling	signal	VERB
chd-104	148	10	among	among	ADP
chd-104	148	11	racially	racially	ADV
chd-104	148	12	-	-	PUNCT
chd-104	148	13	distinct	distinct	ADJ
chd-104	148	14	tnbc	tnbc	NOUN
chd-104	148	15	patient	patient	NOUN
chd-104	148	16	-	-	PUNCT
chd-104	148	17	derived	derive	VERB
chd-104	148	18	cell	cell	NOUN
chd-104	148	19	lines	line	NOUN
chd-104	148	20	or	or	CCONJ
chd-104	148	21	in	in	ADP
chd-104	148	22	vivo	vivo	NOUN
chd-104	148	23	will	will	AUX
chd-104	148	24	be	be	AUX
chd-104	148	25	pertinent	pertinent	ADJ
chd-104	148	26	to	to	ADP
chd-104	148	27	effectively	effectively	ADV
chd-104	148	28	targeting	target	VERB
chd-104	148	29	this	this	DET
chd-104	148	30	pathway	pathway	NOUN
chd-104	148	31	in	in	ADP
chd-104	148	32	patients	patient	NOUN
chd-104	148	33	of	of	ADP
chd-104	148	34	african	african	ADJ
chd-104	148	35	ancestry	ancestry	NOUN
chd-104	148	36	.	.	PUNCT
chd-104	149	1	notch	notch	ADJ
chd-104	149	2	signaling	signal	VERB
chd-104	149	3	inhibitors	inhibitor	NOUN
chd-104	149	4	such	such	ADJ
chd-104	149	5	as	as	ADP
chd-104	149	6	gsi	gsi	PROPN
chd-104	149	7	and	and	CCONJ
chd-104	149	8	aspartyl	aspartyl	NOUN
chd-104	149	9	protease	protease	NOUN
chd-104	149	10	inhibitors	inhibitor	NOUN
chd-104	149	11	are	be	AUX
chd-104	149	12	currently	currently	ADV
chd-104	149	13	under	under	ADP
chd-104	149	14	clinical	clinical	ADJ
chd-104	149	15	development	development	NOUN
chd-104	149	16	and	and	CCONJ
chd-104	149	17	in	in	ADP
chd-104	149	18	clinical	clinical	ADJ
chd-104	149	19	trials	trial	NOUN
chd-104	149	20	as	as	ADP
chd-104	149	21	investigational	investigational	ADJ
chd-104	149	22	targeted	target	VERB
chd-104	149	23	therapies	therapy	NOUN
chd-104	149	24	for	for	ADP
chd-104	149	25	tnbc	tnbc	ADJ
chd-104	149	26	patients	patient	NOUN
chd-104	149	27	(	(	PUNCT
chd-104	149	28	jamdade	jamdade	VERB
chd-104	149	29	et	et	PROPN
chd-104	149	30	al	al	PROPN
chd-104	149	31	.	.	PROPN
chd-104	149	32	,	,	PUNCT
chd-104	149	33	2015	2015	NUM
chd-104	149	34	)	)	PUNCT
chd-104	149	35	.	.	PUNCT
chd-104	150	1	gsi	gsi	PROPN
chd-104	150	2	inhibitors	inhibitor	NOUN
chd-104	150	3	are	be	AUX
chd-104	150	4	associated	associate	VERB
chd-104	150	5	with	with	ADP
chd-104	150	6	side	side	NOUN
chd-104	150	7	effects	effect	NOUN
chd-104	150	8	including	include	VERB
chd-104	150	9	fatigue	fatigue	NOUN
chd-104	150	10	,	,	PUNCT
chd-104	150	11	myelosuppression	myelosuppression	NOUN
chd-104	150	12	,	,	PUNCT
chd-104	150	13	fever	fever	NOUN
chd-104	150	14	,	,	PUNCT
chd-104	150	15	rash	rash	ADJ
chd-104	150	16	,	,	PUNCT
chd-104	150	17	chills	chill	NOUN
chd-104	150	18	,	,	PUNCT
chd-104	150	19	anorexia	anorexia	ADJ
chd-104	150	20	,	,	PUNCT
chd-104	150	21	and	and	CCONJ
chd-104	150	22	hypophosphatemia	hypophosphatemia	NOUN
chd-104	150	23	.	.	PUNCT
chd-104	151	1	improving	improve	VERB
chd-104	151	2	the	the	DET
chd-104	151	3	toxicity	toxicity	NOUN
chd-104	151	4	profile	profile	NOUN
chd-104	151	5	and	and	CCONJ
chd-104	151	6	efficacies	efficacy	NOUN
chd-104	151	7	of	of	ADP
chd-104	151	8	gsis	gsis	NOUN
chd-104	151	9	,	,	PUNCT
chd-104	151	10	and	and	CCONJ
chd-104	151	11	development	development	NOUN
chd-104	151	12	of	of	ADP
chd-104	151	13	more	more	ADV
chd-104	151	14	effective	effective	ADJ
chd-104	151	15	inhibitors	inhibitor	NOUN
chd-104	151	16	of	of	ADP
chd-104	151	17	notch	notch	NOUN
chd-104	151	18	signaling	signal	VERB
chd-104	151	19	could	could	AUX
chd-104	151	20	be	be	AUX
chd-104	151	21	crucial	crucial	ADJ
chd-104	151	22	for	for	ADP
chd-104	151	23	improving	improve	VERB
chd-104	151	24	outcomes	outcome	NOUN
chd-104	151	25	among	among	ADP
chd-104	151	26	aa	aa	PROPN
chd-104	151	27	tnbc	tnbc	PROPN
chd-104	151	28	patients	patient	NOUN
chd-104	151	29	.	.	PUNCT
chd-104	152	1	acknowledgements	acknowledgement	NOUN
chd-104	152	2	we	we	PRON
chd-104	152	3	have	have	VERB
chd-104	152	4	no	no	DET
chd-104	152	5	individuals	individual	NOUN
chd-104	152	6	to	to	PART
chd-104	152	7	acknowledge	acknowledge	VERB
chd-104	152	8	.	.	PUNCT
chd-104	153	1	conflict	conflict	NOUN
chd-104	153	2	of	of	ADP
chd-104	153	3	interest	interest	NOUN
chd-104	153	4	the	the	DET
chd-104	153	5	authors	author	NOUN
chd-104	153	6	declare	declare	VERB
chd-104	153	7	that	that	SCONJ
chd-104	153	8	no	no	DET
chd-104	153	9	competing	compete	VERB
chd-104	153	10	or	or	CCONJ
chd-104	153	11	conflict	conflict	NOUN
chd-104	153	12	of	of	ADP
chd-104	153	13	interests	interest	NOUN
chd-104	153	14	exists	exist	VERB
chd-104	153	15	.	.	PUNCT
chd-104	154	1	the	the	DET
chd-104	154	2	funders	funder	NOUN
chd-104	154	3	had	have	VERB
chd-104	154	4	no	no	DET
chd-104	154	5	role	role	NOUN
chd-104	154	6	in	in	ADP
chd-104	154	7	study	study	NOUN
chd-104	154	8	design	design	NOUN
chd-104	154	9	,	,	PUNCT
chd-104	154	10	writing	writing	NOUN
chd-104	154	11	of	of	ADP
chd-104	154	12	the	the	DET
chd-104	154	13	manuscript	manuscript	NOUN
chd-104	154	14	,	,	PUNCT
chd-104	154	15	or	or	CCONJ
chd-104	154	16	decision	decision	NOUN
chd-104	154	17	to	to	PART
chd-104	154	18	publish	publish	VERB
chd-104	154	19	.	.	PUNCT
chd-104	155	1	authors	author	NOUN
chd-104	155	2	’	’	PART
chd-104	155	3	contributions	contribution	NOUN
chd-104	155	4	nikita	nikita	PROPN
chd-104	155	5	wright	wright	PROPN
chd-104	155	6	was	be	AUX
chd-104	155	7	involved	involve	VERB
chd-104	155	8	in	in	ADP
chd-104	155	9	the	the	DET
chd-104	155	10	data	datum	NOUN
chd-104	155	11	collection	collection	NOUN
chd-104	155	12	and	and	CCONJ
chd-104	155	13	drafting	drafting	NOUN
chd-104	155	14	of	of	ADP
chd-104	155	15	the	the	DET
chd-104	155	16	article	article	NOUN
chd-104	155	17	.	.	PUNCT
chd-104	156	1	shristi	shristi	PROPN
chd-104	156	2	bhattarai	bhattarai	PROPN
chd-104	156	3	was	be	AUX
chd-104	156	4	involved	involve	VERB
chd-104	156	5	in	in	ADP
chd-104	156	6	the	the	DET
chd-104	156	7	drafting	drafting	NOUN
chd-104	156	8	and	and	CCONJ
chd-104	156	9	editing	editing	NOUN
chd-104	156	10	of	of	ADP
chd-104	156	11	the	the	DET
chd-104	156	12	article	article	NOUN
chd-104	156	13	.	.	PUNCT
chd-104	157	1	bikram	bikram	PROPN
chd-104	157	2	sahoo	sahoo	PROPN
chd-104	157	3	and	and	CCONJ
chd-104	157	4	mishal	mishal	PROPN
chd-104	157	5	imaan	imaan	PROPN
chd-104	157	6	syed	syed	PROPN
chd-104	157	7	were	be	AUX
chd-104	157	8	involved	involve	VERB
chd-104	157	9	in	in	ADP
chd-104	157	10	data	data	NOUN
chd-104	157	11	collection	collection	NOUN
chd-104	157	12	/	/	SYM
chd-104	157	13	analysis	analysis	NOUN
chd-104	157	14	.	.	PUNCT
chd-104	158	1	dr	dr	PROPN
chd-104	158	2	.	.	PROPN
chd-104	158	3	padmashree	padmashree	PROPN
chd-104	158	4	rida	rida	PROPN
chd-104	158	5	was	be	AUX
chd-104	158	6	involved	involve	VERB
chd-104	158	7	in	in	ADP
chd-104	158	8	conceptualization	conceptualization	NOUN
chd-104	158	9	and	and	CCONJ
chd-104	158	10	editing	editing	NOUN
chd-104	158	11	of	of	ADP
chd-104	158	12	the	the	DET
chd-104	158	13	article	article	NOUN
chd-104	158	14	.	.	PUNCT
chd-104	159	1	dr	dr	PROPN
chd-104	159	2	.	.	PROPN
chd-104	159	3	ritu	ritu	PROPN
chd-104	159	4	aneja	aneja	PROPN
chd-104	159	5	was	be	AUX
chd-104	159	6	involved	involve	VERB
chd-104	159	7	in	in	ADP
chd-104	159	8	conceptualization	conceptualization	NOUN
chd-104	159	9	,	,	PUNCT
chd-104	159	10	editing	editing	NOUN
chd-104	159	11	,	,	PUNCT
chd-104	159	12	and	and	CCONJ
chd-104	159	13	oversight	oversight	NOUN
chd-104	159	14	of	of	ADP
chd-104	159	15	the	the	DET
chd-104	159	16	study	study	NOUN
chd-104	159	17	.	.	PUNCT
chd-104	160	1	references	reference	NOUN
chd-104	160	2	acar	acar	VERB
chd-104	160	3	,	,	PUNCT
chd-104	160	4	a.	a.	NOUN
chd-104	160	5	,	,	PUNCT
chd-104	160	6	simoes	simoe	NOUN
chd-104	160	7	,	,	PUNCT
chd-104	160	8	b.m	b.m	PROPN
chd-104	160	9	.	.	PROPN
chd-104	160	10	,	,	PUNCT
chd-104	160	11	clarke	clarke	PROPN
chd-104	160	12	,	,	PUNCT
chd-104	160	13	r.b	r.b	PROPN
chd-104	160	14	.	.	PROPN
chd-104	160	15	,	,	PUNCT
chd-104	160	16	and	and	CCONJ
chd-104	160	17	brennan	brennan	PROPN
chd-104	160	18	,	,	PUNCT
chd-104	160	19	k.	k.	PROPN
chd-104	160	20	(	(	PUNCT
chd-104	160	21	2016	2016	NUM
chd-104	160	22	)	)	PUNCT
chd-104	160	23	.	.	PUNCT
chd-104	161	1	a	a	DET
chd-104	161	2	role	role	NOUN
chd-104	161	3	for	for	ADP
chd-104	161	4	notch	notch	NOUN
chd-104	161	5	signalling	signal	VERB
chd-104	161	6	in	in	ADP
chd-104	161	7	breast	breast	NOUN
chd-104	161	8	cancer	cancer	NOUN
chd-104	161	9	and	and	CCONJ
chd-104	161	10	endocrine	endocrine	ADJ
chd-104	161	11	resistance	resistance	NOUN
chd-104	161	12	.	.	PUNCT
chd-104	162	1	stem	stem	NOUN
chd-104	162	2	cells	cell	NOUN
chd-104	162	3	int	int	VERB
chd-104	162	4	2016	2016	NUM
chd-104	162	5	,	,	PUNCT
chd-104	162	6	2498764	2498764	NUM
chd-104	162	7	.	.	PUNCT
chd-104	163	1	adrianto	adrianto	NOUN
chd-104	163	2	,	,	PUNCT
chd-104	163	3	i.	i.	PROPN
chd-104	163	4	,	,	PUNCT
chd-104	163	5	lin	lin	PROPN
chd-104	163	6	,	,	PUNCT
chd-104	163	7	c.p	c.p	PROPN
chd-104	163	8	.	.	PROPN
chd-104	163	9	,	,	PUNCT
chd-104	163	10	hale	hale	PROPN
chd-104	163	11	,	,	PUNCT
chd-104	163	12	j.j	j.j	PROPN
chd-104	163	13	.	.	PROPN
chd-104	163	14	,	,	PUNCT
chd-104	163	15	levin	levin	PROPN
chd-104	163	16	,	,	PUNCT
chd-104	163	17	a.m.	a.m.	ADV
chd-104	163	18	,	,	PUNCT
chd-104	163	19	datta	datta	PROPN
chd-104	163	20	,	,	PUNCT
chd-104	163	21	i.	i.	PROPN
chd-104	163	22	,	,	PUNCT
chd-104	163	23	parker	parker	PROPN
chd-104	163	24	,	,	PUNCT
chd-104	163	25	r.	r.	PROPN
chd-104	163	26	,	,	PUNCT
chd-104	163	27	adler	adler	PROPN
chd-104	163	28	,	,	PUNCT
chd-104	163	29	a.	a.	PROPN
chd-104	163	30	,	,	PUNCT
chd-104	163	31	kelly	kelly	PROPN
chd-104	163	32	,	,	PUNCT
chd-104	163	33	j.a	j.a	PROPN
chd-104	163	34	.	.	PROPN
chd-104	163	35	,	,	PUNCT
chd-104	163	36	kaufman	kaufman	PROPN
chd-104	163	37	,	,	PUNCT
chd-104	163	38	k.m	k.m	PROPN
chd-104	163	39	.	.	PROPN
chd-104	163	40	,	,	PUNCT
chd-104	163	41	lessard	lessard	PROPN
chd-104	163	42	,	,	PUNCT
chd-104	163	43	c.j	c.j	PROPN
chd-104	163	44	.	.	PROPN
chd-104	163	45	,	,	PUNCT
chd-104	163	46	et	et	PROPN
chd-104	163	47	al	al	PROPN
chd-104	163	48	.	.	PUNCT
chd-104	163	49	(	(	PUNCT
chd-104	163	50	2012	2012	NUM
chd-104	163	51	)	)	PUNCT
chd-104	163	52	.	.	PUNCT
chd-104	164	1	genome	genome	NOUN
chd-104	164	2	-	-	PUNCT
chd-104	164	3	wide	wide	ADJ
chd-104	164	4	association	association	NOUN
chd-104	164	5	study	study	NOUN
chd-104	164	6	of	of	ADP
chd-104	164	7	african	african	ADJ
chd-104	164	8	and	and	CCONJ
chd-104	164	9	european	european	ADJ
chd-104	164	10	americans	americans	PROPN
chd-104	164	11	implicates	implicate	VERB
chd-104	164	12	multiple	multiple	ADJ
chd-104	164	13	shared	share	VERB
chd-104	164	14	and	and	CCONJ
chd-104	164	15	ethnic	ethnic	ADJ
chd-104	164	16	specific	specific	ADJ
chd-104	164	17	loci	loci	NOUN
chd-104	164	18	in	in	ADP
chd-104	164	19	sarcoidosis	sarcoidosis	NOUN
chd-104	164	20	susceptibility	susceptibility	NOUN
chd-104	164	21	.	.	PUNCT
chd-104	165	1	plos	plos	PROPN
chd-104	165	2	one	one	NUM
chd-104	165	3	7	7	NUM
chd-104	165	4	,	,	PUNCT
chd-104	165	5	e43907	e43907	PROPN
chd-104	165	6	.	.	PUNCT
chd-104	166	1	agboola	agboola	PROPN
chd-104	166	2	,	,	PUNCT
chd-104	166	3	a.j	a.j	PROPN
chd-104	166	4	.	.	PROPN
chd-104	166	5	,	,	PUNCT
chd-104	166	6	musa	musa	PROPN
chd-104	166	7	,	,	PUNCT
chd-104	166	8	a.a	a.a	PROPN
chd-104	166	9	.	.	PROPN
chd-104	166	10	,	,	PUNCT
chd-104	166	11	wanangwa	wanangwa	PROPN
chd-104	166	12	,	,	PUNCT
chd-104	166	13	n.	n.	NOUN
chd-104	166	14	,	,	PUNCT
chd-104	166	15	abdel	abdel	PROPN
chd-104	166	16	-	-	PUNCT
chd-104	166	17	fatah	fatah	PROPN
chd-104	166	18	,	,	PUNCT
chd-104	166	19	t.	t.	PROPN
chd-104	166	20	,	,	PUNCT
chd-104	166	21	nolan	nolan	PROPN
chd-104	166	22	,	,	PUNCT
chd-104	166	23	c.c	c.c	PROPN
chd-104	166	24	.	.	PROPN
chd-104	166	25	,	,	PUNCT
chd-104	166	26	ayoade	ayoade	PROPN
chd-104	166	27	,	,	PUNCT
chd-104	166	28	b.a	b.a	PROPN
chd-104	166	29	.	.	PROPN
chd-104	166	30	,	,	PUNCT
chd-104	166	31	oyebadejo	oyebadejo	PROPN
chd-104	166	32	,	,	PUNCT
chd-104	166	33	t.y	t.y	PROPN
chd-104	166	34	.	.	PROPN
chd-104	166	35	,	,	PUNCT
chd-104	166	36	banjo	banjo	PROPN
chd-104	166	37	,	,	PUNCT
chd-104	166	38	a.a	a.a	PROPN
chd-104	166	39	.	.	PROPN
chd-104	166	40	,	,	PUNCT
chd-104	166	41	deji	deji	PROPN
chd-104	166	42	-	-	PUNCT
chd-104	166	43	agboola	agboola	PROPN
chd-104	166	44	,	,	PUNCT
chd-104	166	45	a.m.	a.m.	ADV
chd-104	166	46	,	,	PUNCT
chd-104	166	47	rakha	rakha	PROPN
chd-104	166	48	,	,	PUNCT
chd-104	166	49	e.a	e.a	PROPN
chd-104	166	50	.	.	PROPN
chd-104	166	51	,	,	PUNCT
chd-104	166	52	et	et	PROPN
chd-104	166	53	al	al	PROPN
chd-104	166	54	.	.	PUNCT
chd-104	166	55	(	(	PUNCT
chd-104	166	56	2012	2012	NUM
chd-104	166	57	)	)	PUNCT
chd-104	166	58	.	.	PUNCT
chd-104	167	1	molecular	molecular	ADJ
chd-104	167	2	characteristics	characteristic	NOUN
chd-104	167	3	and	and	CCONJ
chd-104	167	4	prognostic	prognostic	ADJ
chd-104	167	5	features	feature	NOUN
chd-104	167	6	of	of	ADP
chd-104	167	7	breast	breast	NOUN
chd-104	167	8	cancer	cancer	NOUN
chd-104	167	9	in	in	ADP
chd-104	167	10	nigerian	nigerian	PROPN
chd-104	167	11	compared	compare	VERB
chd-104	167	12	with	with	ADP
chd-104	167	13	uk	uk	PROPN
chd-104	167	14	women	woman	NOUN
chd-104	167	15	.	.	PUNCT
chd-104	168	1	breast	breast	NOUN
chd-104	168	2	cancer	cancer	NOUN
chd-104	168	3	research	research	NOUN
chd-104	168	4	and	and	CCONJ
chd-104	168	5	treatment	treatment	NOUN
chd-104	168	6	135	135	NUM
chd-104	168	7	,	,	PUNCT
chd-104	168	8	555	555	NUM
chd-104	168	9	-	-	SYM
chd-104	168	10	569	569	NUM
chd-104	168	11	.	.	PUNCT
chd-104	169	1	bianchini	bianchini	PROPN
chd-104	169	2	,	,	PUNCT
chd-104	169	3	g.	g.	PROPN
chd-104	169	4	,	,	PUNCT
chd-104	169	5	balko	balko	PROPN
chd-104	169	6	,	,	PUNCT
chd-104	169	7	j.m	j.m	PROPN
chd-104	169	8	.	.	PROPN
chd-104	169	9	,	,	PUNCT
chd-104	169	10	mayer	mayer	PROPN
chd-104	169	11	,	,	PUNCT
chd-104	169	12	i.a	i.a	PROPN
chd-104	169	13	.	.	PROPN
chd-104	169	14	,	,	PUNCT
chd-104	169	15	sanders	sanders	PROPN
chd-104	169	16	,	,	PUNCT
chd-104	169	17	m.e	m.e	PROPN
chd-104	169	18	.	.	PROPN
chd-104	169	19	,	,	PUNCT
chd-104	169	20	and	and	CCONJ
chd-104	169	21	gianni	gianni	PROPN
chd-104	169	22	,	,	PUNCT
chd-104	169	23	l.	l.	PROPN
chd-104	169	24	(	(	PUNCT
chd-104	169	25	2016a	2016a	NUM
chd-104	169	26	)	)	PUNCT
chd-104	169	27	.	.	PUNCT
chd-104	170	1	triple	triple	ADJ
chd-104	170	2	-	-	PUNCT
chd-104	170	3	negative	negative	ADJ
chd-104	170	4	breast	breast	NOUN
chd-104	170	5	cancer	cancer	NOUN
chd-104	170	6	:	:	PUNCT
chd-104	170	7	challenges	challenge	NOUN
chd-104	170	8	and	and	CCONJ
chd-104	170	9	opportunities	opportunity	NOUN
chd-104	170	10	of	of	ADP
chd-104	170	11	a	a	DET
chd-104	170	12	heterogeneous	heterogeneous	ADJ
chd-104	170	13	disease	disease	NOUN
chd-104	170	14	.	.	PUNCT
chd-104	171	1	nat	nat	PROPN
chd-104	171	2	rev	rev	VERB
chd-104	171	3	clin	clin	PROPN
chd-104	171	4	oncol	oncol	PROPN
chd-104	171	5	13	13	NUM
chd-104	171	6	,	,	PUNCT
chd-104	171	7	674	674	NUM
chd-104	171	8	-	-	SYM
chd-104	171	9	690	690	NUM
chd-104	171	10	.	.	PUNCT
chd-104	172	1	bianchini	bianchini	PROPN
chd-104	172	2	,	,	PUNCT
chd-104	172	3	g.	g.	PROPN
chd-104	172	4	,	,	PUNCT
chd-104	172	5	balko	balko	PROPN
chd-104	172	6	,	,	PUNCT
chd-104	172	7	j.m	j.m	PROPN
chd-104	172	8	.	.	PROPN
chd-104	172	9	,	,	PUNCT
chd-104	172	10	mayer	mayer	PROPN
chd-104	172	11	,	,	PUNCT
chd-104	172	12	i.a	i.a	PROPN
chd-104	172	13	.	.	PROPN
chd-104	172	14	,	,	PUNCT
chd-104	172	15	sanders	sanders	PROPN
chd-104	172	16	,	,	PUNCT
chd-104	172	17	m.e	m.e	PROPN
chd-104	172	18	.	.	PROPN
chd-104	172	19	,	,	PUNCT
chd-104	172	20	and	and	CCONJ
chd-104	172	21	gianni	gianni	PROPN
chd-104	172	22	,	,	PUNCT
chd-104	172	23	l.	l.	PROPN
chd-104	172	24	(	(	PUNCT
chd-104	172	25	2016b	2016b	NUM
chd-104	172	26	)	)	PUNCT
chd-104	172	27	.	.	PUNCT
chd-104	173	1	triple	triple	ADJ
chd-104	173	2	-	-	PUNCT
chd-104	173	3	negative	negative	ADJ
chd-104	173	4	breast	breast	NOUN
chd-104	173	5	cancer	cancer	NOUN
chd-104	173	6	:	:	PUNCT
chd-104	174	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-104	174	2	e20	e20	NOUN
chd-104	174	3	cancer	cancer	NOUN
chd-104	174	4	health	health	NOUN
chd-104	174	5	disparities	disparity	NOUN
chd-104	174	6	research	research	NOUN
chd-104	174	7	challenges	challenge	NOUN
chd-104	174	8	and	and	CCONJ
chd-104	174	9	opportunities	opportunity	NOUN
chd-104	174	10	of	of	ADP
chd-104	174	11	a	a	DET
chd-104	174	12	heterogeneous	heterogeneous	ADJ
chd-104	174	13	disease	disease	NOUN
chd-104	174	14	.	.	PUNCT
chd-104	175	1	nature	nature	NOUN
chd-104	175	2	reviews	review	VERB
chd-104	175	3	clinical	clinical	ADJ
chd-104	175	4	oncology	oncology	NOUN
chd-104	175	5	.	.	PUNCT
chd-104	176	1	borggrefe	borggrefe	ADJ
chd-104	176	2	,	,	PUNCT
chd-104	176	3	t.	t.	NOUN
chd-104	176	4	,	,	PUNCT
chd-104	176	5	and	and	CCONJ
chd-104	176	6	liefke	liefke	PROPN
chd-104	176	7	,	,	PUNCT
chd-104	176	8	r.	r.	PROPN
chd-104	176	9	(	(	PUNCT
chd-104	176	10	2012	2012	NUM
chd-104	176	11	)	)	PUNCT
chd-104	176	12	.	.	PUNCT
chd-104	177	1	fine	fine	ADJ
chd-104	177	2	-	-	PUNCT
chd-104	177	3	tuning	tuning	NOUN
chd-104	177	4	of	of	ADP
chd-104	177	5	the	the	DET
chd-104	177	6	intracellular	intracellular	ADJ
chd-104	177	7	canonical	canonical	ADJ
chd-104	177	8	notch	notch	NOUN
chd-104	177	9	signaling	signal	VERB
chd-104	177	10	pathway	pathway	NOUN
chd-104	177	11	.	.	PUNCT
chd-104	178	1	cell	cell	NOUN
chd-104	178	2	cycle	cycle	NOUN
chd-104	178	3	(	(	PUNCT
chd-104	178	4	georgetown	georgetown	PROPN
chd-104	178	5	,	,	PUNCT
chd-104	178	6	tex	tex	PROPN
chd-104	178	7	)	)	PUNCT
chd-104	178	8	11	11	NUM
chd-104	178	9	,	,	PUNCT
chd-104	178	10	264	264	NUM
chd-104	178	11	-	-	SYM
chd-104	178	12	276	276	NUM
chd-104	178	13	.	.	PUNCT
chd-104	179	1	bowen	bowen	PROPN
chd-104	179	2	,	,	PUNCT
chd-104	179	3	r.l	r.l	PROPN
chd-104	179	4	.	.	PROPN
chd-104	179	5	,	,	PUNCT
chd-104	179	6	duffy	duffy	PROPN
chd-104	179	7	,	,	PUNCT
chd-104	179	8	s.w	s.w	PROPN
chd-104	179	9	.	.	PROPN
chd-104	179	10	,	,	PUNCT
chd-104	179	11	ryan	ryan	PROPN
chd-104	179	12	,	,	PUNCT
chd-104	179	13	d.a	d.a	PROPN
chd-104	179	14	.	.	PROPN
chd-104	179	15	,	,	PUNCT
chd-104	179	16	hart	hart	PROPN
chd-104	179	17	,	,	PUNCT
chd-104	179	18	i.r	i.r	PROPN
chd-104	179	19	.	.	PROPN
chd-104	179	20	,	,	PUNCT
chd-104	179	21	and	and	CCONJ
chd-104	179	22	jones	jones	PROPN
chd-104	179	23	,	,	PUNCT
chd-104	179	24	j.l	j.l	PROPN
chd-104	179	25	.	.	PROPN
chd-104	179	26	(	(	PUNCT
chd-104	179	27	2008	2008	NUM
chd-104	179	28	)	)	PUNCT
chd-104	179	29	.	.	PUNCT
chd-104	180	1	early	early	ADJ
chd-104	180	2	onset	onset	NOUN
chd-104	180	3	of	of	ADP
chd-104	180	4	breast	breast	NOUN
chd-104	180	5	cancer	cancer	NOUN
chd-104	180	6	in	in	ADP
chd-104	180	7	a	a	DET
chd-104	180	8	group	group	NOUN
chd-104	180	9	of	of	ADP
chd-104	180	10	british	british	ADJ
chd-104	180	11	black	black	ADJ
chd-104	180	12	women	woman	NOUN
chd-104	180	13	.	.	PUNCT
chd-104	181	1	british	british	ADJ
chd-104	181	2	journal	journal	PROPN
chd-104	181	3	of	of	ADP
chd-104	181	4	cancer	cancer	NOUN
chd-104	181	5	98	98	NUM
chd-104	181	6	,	,	PUNCT
chd-104	181	7	277	277	NUM
chd-104	181	8	-	-	SYM
chd-104	181	9	281	281	NUM
chd-104	181	10	.	.	PUNCT
chd-104	182	1	bray	bray	PROPN
chd-104	182	2	,	,	PUNCT
chd-104	182	3	s.j	s.j	PROPN
chd-104	182	4	.	.	PROPN
chd-104	182	5	,	,	PUNCT
chd-104	182	6	takada	takada	PROPN
chd-104	182	7	,	,	PUNCT
chd-104	182	8	s.	s.	PROPN
chd-104	182	9	,	,	PUNCT
chd-104	182	10	harrison	harrison	PROPN
chd-104	182	11	,	,	PUNCT
chd-104	182	12	e.	e.	PROPN
chd-104	182	13	,	,	PUNCT
chd-104	182	14	shen	shen	PROPN
chd-104	182	15	,	,	PUNCT
chd-104	182	16	s.c	s.c	PROPN
chd-104	182	17	.	.	PROPN
chd-104	182	18	,	,	PUNCT
chd-104	182	19	and	and	CCONJ
chd-104	182	20	fergusonsmith	fergusonsmith	PROPN
chd-104	182	21	,	,	PUNCT
chd-104	182	22	a.c	a.c	PROPN
chd-104	182	23	.	.	PROPN
chd-104	182	24	(	(	PUNCT
chd-104	182	25	2008	2008	NUM
chd-104	182	26	)	)	PUNCT
chd-104	182	27	.	.	PUNCT
chd-104	183	1	the	the	DET
chd-104	183	2	atypical	atypical	ADJ
chd-104	183	3	mammalian	mammalian	ADJ
chd-104	183	4	ligand	ligand	NOUN
chd-104	183	5	deltalike	deltalike	NOUN
chd-104	183	6	homologue	homologue	NOUN
chd-104	183	7	1	1	NUM
chd-104	183	8	(	(	PUNCT
chd-104	183	9	dlk1	dlk1	PROPN
chd-104	183	10	)	)	PUNCT
chd-104	183	11	can	can	AUX
chd-104	183	12	regulate	regulate	VERB
chd-104	183	13	notch	notch	ADV
chd-104	183	14	signalling	signal	VERB
chd-104	183	15	in	in	ADP
chd-104	183	16	drosophila	drosophila	NOUN
chd-104	183	17	.	.	PUNCT
chd-104	184	1	bmc	bmc	ADJ
chd-104	184	2	developmental	developmental	ADJ
chd-104	184	3	biology	biology	NOUN
chd-104	184	4	8	8	NUM
chd-104	184	5	,	,	PUNCT
chd-104	184	6	11	11	NUM
chd-104	184	7	.	.	PUNCT
chd-104	185	1	brewster	brewster	NOUN
chd-104	185	2	,	,	PUNCT
chd-104	185	3	a.m.	a.m.	ADV
chd-104	185	4	,	,	PUNCT
chd-104	185	5	chavez	chavez	PROPN
chd-104	185	6	-	-	PUNCT
chd-104	185	7	macgregor	macgregor	PROPN
chd-104	185	8	,	,	PUNCT
chd-104	185	9	m.	m.	NOUN
chd-104	185	10	,	,	PUNCT
chd-104	185	11	and	and	CCONJ
chd-104	185	12	brown	brown	ADJ
chd-104	185	13	,	,	PUNCT
chd-104	185	14	p.	p.	NOUN
chd-104	185	15	(	(	PUNCT
chd-104	185	16	2014	2014	NUM
chd-104	185	17	)	)	PUNCT
chd-104	185	18	.	.	PUNCT
chd-104	186	1	epidemiology	epidemiology	NOUN
chd-104	186	2	,	,	PUNCT
chd-104	186	3	biology	biology	NOUN
chd-104	186	4	,	,	PUNCT
chd-104	186	5	and	and	CCONJ
chd-104	186	6	treatment	treatment	NOUN
chd-104	186	7	of	of	ADP
chd-104	186	8	triple	triple	ADJ
chd-104	186	9	-	-	PUNCT
chd-104	186	10	negative	negative	ADJ
chd-104	186	11	breast	breast	NOUN
chd-104	186	12	cancer	cancer	NOUN
chd-104	186	13	in	in	ADP
chd-104	186	14	women	woman	NOUN
chd-104	186	15	of	of	ADP
chd-104	186	16	african	african	ADJ
chd-104	186	17	ancestry	ancestry	NOUN
chd-104	186	18	.	.	PUNCT
chd-104	187	1	lancet	lancet	PROPN
chd-104	187	2	oncol	oncol	ADJ
chd-104	187	3	15	15	NUM
chd-104	187	4	,	,	PUNCT
chd-104	187	5	e625	e625	PROPN
chd-104	187	6	-	-	PUNCT
chd-104	187	7	634	634	NUM
chd-104	187	8	.	.	PUNCT
chd-104	188	1	brou	brou	PROPN
chd-104	188	2	,	,	PUNCT
chd-104	188	3	c.	c.	NOUN
chd-104	188	4	,	,	PUNCT
chd-104	188	5	logeat	logeat	NOUN
chd-104	188	6	,	,	PUNCT
chd-104	188	7	f.	f.	PROPN
chd-104	188	8	,	,	PUNCT
chd-104	188	9	gupta	gupta	PROPN
chd-104	188	10	,	,	PUNCT
chd-104	188	11	n.	n.	PROPN
chd-104	188	12	,	,	PUNCT
chd-104	188	13	bessia	bessia	PROPN
chd-104	188	14	,	,	PUNCT
chd-104	188	15	c.	c.	NOUN
chd-104	188	16	,	,	PUNCT
chd-104	188	17	lebail	lebail	NOUN
chd-104	188	18	,	,	PUNCT
chd-104	188	19	o.	o.	PROPN
chd-104	188	20	,	,	PUNCT
chd-104	188	21	doedens	doedens	PROPN
chd-104	188	22	,	,	PUNCT
chd-104	188	23	j.r	j.r	PROPN
chd-104	188	24	.	.	PROPN
chd-104	188	25	,	,	PUNCT
chd-104	188	26	cumano	cumano	PROPN
chd-104	188	27	,	,	PUNCT
chd-104	188	28	a.	a.	NOUN
chd-104	188	29	,	,	PUNCT
chd-104	188	30	roux	roux	NOUN
chd-104	188	31	,	,	PUNCT
chd-104	188	32	p.	p.	NOUN
chd-104	188	33	,	,	PUNCT
chd-104	188	34	black	black	ADJ
chd-104	188	35	,	,	PUNCT
chd-104	188	36	r.a	r.a	PROPN
chd-104	188	37	.	.	PROPN
chd-104	188	38	,	,	PUNCT
chd-104	188	39	and	and	CCONJ
chd-104	188	40	israel	israel	PROPN
chd-104	188	41	,	,	PUNCT
chd-104	188	42	a.	a.	NOUN
chd-104	188	43	(	(	PUNCT
chd-104	188	44	2000	2000	NUM
chd-104	188	45	)	)	PUNCT
chd-104	188	46	.	.	PUNCT
chd-104	189	1	a	a	DET
chd-104	189	2	novel	novel	ADJ
chd-104	189	3	proteolytic	proteolytic	ADJ
chd-104	189	4	cleavage	cleavage	NOUN
chd-104	189	5	involved	involve	VERB
chd-104	189	6	in	in	ADP
chd-104	189	7	notch	notch	ADJ
chd-104	189	8	signaling	signal	VERB
chd-104	189	9	:	:	PUNCT
chd-104	189	10	the	the	DET
chd-104	189	11	role	role	NOUN
chd-104	189	12	of	of	ADP
chd-104	189	13	the	the	DET
chd-104	189	14	disintegrin	disintegrin	NOUN
chd-104	189	15	-	-	PUNCT
chd-104	189	16	metalloprotease	metalloprotease	NOUN
chd-104	189	17	tace	tace	NOUN
chd-104	189	18	.	.	PUNCT
chd-104	190	1	molecular	molecular	ADJ
chd-104	190	2	cell	cell	NOUN
chd-104	190	3	5	5	NUM
chd-104	190	4	,	,	PUNCT
chd-104	190	5	207	207	NUM
chd-104	190	6	-	-	SYM
chd-104	190	7	216	216	NUM
chd-104	190	8	.	.	PUNCT
chd-104	191	1	burstein	burstein	PROPN
chd-104	191	2	,	,	PUNCT
chd-104	191	3	m.d	m.d	PROPN
chd-104	191	4	.	.	PROPN
chd-104	191	5	,	,	PUNCT
chd-104	191	6	tsimelzon	tsimelzon	PROPN
chd-104	191	7	,	,	PUNCT
chd-104	191	8	a.	a.	NOUN
chd-104	191	9	,	,	PUNCT
chd-104	191	10	poage	poage	NOUN
chd-104	191	11	,	,	PUNCT
chd-104	191	12	g.m	g.m	PROPN
chd-104	191	13	.	.	PROPN
chd-104	191	14	,	,	PUNCT
chd-104	191	15	covington	covington	PROPN
chd-104	191	16	,	,	PUNCT
chd-104	191	17	k.r	k.r	PROPN
chd-104	191	18	.	.	PROPN
chd-104	191	19	,	,	PUNCT
chd-104	191	20	contreras	contreras	PROPN
chd-104	191	21	,	,	PUNCT
chd-104	191	22	a.	a.	NOUN
chd-104	191	23	,	,	PUNCT
chd-104	191	24	fuqua	fuqua	PROPN
chd-104	191	25	,	,	PUNCT
chd-104	191	26	s.a	s.a	PROPN
chd-104	191	27	.	.	PROPN
chd-104	191	28	,	,	PUNCT
chd-104	191	29	savage	savage	NOUN
chd-104	191	30	,	,	PUNCT
chd-104	191	31	m.i	m.i	PROPN
chd-104	191	32	.	.	PROPN
chd-104	191	33	,	,	PUNCT
chd-104	191	34	osborne	osborne	PROPN
chd-104	191	35	,	,	PUNCT
chd-104	191	36	c.k	c.k	PROPN
chd-104	191	37	.	.	PROPN
chd-104	191	38	,	,	PUNCT
chd-104	191	39	hilsenbeck	hilsenbeck	PROPN
chd-104	191	40	,	,	PUNCT
chd-104	191	41	s.g	s.g	PROPN
chd-104	191	42	.	.	PROPN
chd-104	191	43	,	,	PUNCT
chd-104	191	44	chang	chang	PROPN
chd-104	191	45	,	,	PUNCT
chd-104	191	46	j.c	j.c	PROPN
chd-104	191	47	.	.	PROPN
chd-104	191	48	,	,	PUNCT
chd-104	191	49	et	et	PROPN
chd-104	191	50	al	al	PROPN
chd-104	191	51	.	.	PUNCT
chd-104	192	1	(	(	PUNCT
chd-104	192	2	2015	2015	NUM
chd-104	192	3	)	)	PUNCT
chd-104	192	4	.	.	PUNCT
chd-104	193	1	comprehensive	comprehensive	ADJ
chd-104	193	2	genomic	genomic	NOUN
chd-104	193	3	analysis	analysis	NOUN
chd-104	193	4	identifies	identify	VERB
chd-104	193	5	novel	novel	ADJ
chd-104	193	6	subtypes	subtype	NOUN
chd-104	193	7	and	and	CCONJ
chd-104	193	8	targets	target	NOUN
chd-104	193	9	of	of	ADP
chd-104	193	10	triple	triple	ADJ
chd-104	193	11	-	-	PUNCT
chd-104	193	12	negative	negative	ADJ
chd-104	193	13	breast	breast	NOUN
chd-104	193	14	cancer	cancer	NOUN
chd-104	193	15	.	.	PUNCT
chd-104	194	1	clinical	clinical	ADJ
chd-104	194	2	cancer	cancer	NOUN
chd-104	194	3	research	research	NOUN
chd-104	194	4	:	:	PUNCT
chd-104	194	5	an	an	DET
chd-104	194	6	official	official	ADJ
chd-104	194	7	journal	journal	NOUN
chd-104	194	8	of	of	ADP
chd-104	194	9	the	the	DET
chd-104	194	10	american	american	PROPN
chd-104	194	11	association	association	PROPN
chd-104	194	12	for	for	ADP
chd-104	194	13	cancer	cancer	NOUN
chd-104	194	14	research	research	NOUN
chd-104	194	15	21	21	NUM
chd-104	194	16	,	,	PUNCT
chd-104	194	17	1688	1688	NUM
chd-104	194	18	-	-	SYM
chd-104	194	19	1698	1698	NUM
chd-104	194	20	.	.	PUNCT
chd-104	195	1	carey	carey	PROPN
chd-104	195	2	,	,	PUNCT
chd-104	195	3	l.a	l.a	PROPN
chd-104	195	4	.	.	PROPN
chd-104	195	5	,	,	PUNCT
chd-104	195	6	perou	perou	NOUN
chd-104	195	7	,	,	PUNCT
chd-104	195	8	c.m	c.m	PROPN
chd-104	195	9	.	.	PROPN
chd-104	195	10	,	,	PUNCT
chd-104	195	11	livasy	livasy	PROPN
chd-104	195	12	,	,	PUNCT
chd-104	195	13	c.a	c.a	PROPN
chd-104	195	14	.	.	PROPN
chd-104	195	15	,	,	PUNCT
chd-104	195	16	dressler	dressler	PROPN
chd-104	195	17	,	,	PUNCT
chd-104	195	18	l.g	l.g	PROPN
chd-104	195	19	.	.	PROPN
chd-104	195	20	,	,	PUNCT
chd-104	195	21	cowan	cowan	PROPN
chd-104	195	22	,	,	PUNCT
chd-104	195	23	d.	d.	PROPN
chd-104	195	24	,	,	PUNCT
chd-104	195	25	conway	conway	PROPN
chd-104	195	26	,	,	PUNCT
chd-104	195	27	k.	k.	PROPN
chd-104	195	28	,	,	PUNCT
chd-104	195	29	karaca	karaca	PROPN
chd-104	195	30	,	,	PUNCT
chd-104	195	31	g.	g.	PROPN
chd-104	195	32	,	,	PUNCT
chd-104	195	33	troester	troester	PROPN
chd-104	195	34	,	,	PUNCT
chd-104	195	35	m.a	m.a	PROPN
chd-104	195	36	.	.	PROPN
chd-104	195	37	,	,	PUNCT
chd-104	195	38	tse	tse	PROPN
chd-104	195	39	,	,	PUNCT
chd-104	195	40	c.k	c.k	PROPN
chd-104	195	41	.	.	PROPN
chd-104	195	42	,	,	PUNCT
chd-104	195	43	edmiston	edmiston	PROPN
chd-104	195	44	,	,	PUNCT
chd-104	195	45	s.	s.	PROPN
chd-104	195	46	,	,	PUNCT
chd-104	195	47	et	et	PROPN
chd-104	195	48	al	al	PROPN
chd-104	195	49	.	.	PUNCT
chd-104	195	50	(	(	PUNCT
chd-104	195	51	2006	2006	NUM
chd-104	195	52	)	)	PUNCT
chd-104	195	53	.	.	PUNCT
chd-104	196	1	race	race	NOUN
chd-104	196	2	,	,	PUNCT
chd-104	196	3	breast	breast	NOUN
chd-104	196	4	cancer	cancer	NOUN
chd-104	196	5	subtypes	subtype	NOUN
chd-104	196	6	,	,	PUNCT
chd-104	196	7	and	and	CCONJ
chd-104	196	8	survival	survival	NOUN
chd-104	196	9	in	in	ADP
chd-104	196	10	the	the	DET
chd-104	196	11	carolina	carolina	PROPN
chd-104	196	12	breast	breast	PROPN
chd-104	196	13	cancer	cancer	NOUN
chd-104	196	14	study	study	NOUN
chd-104	196	15	.	.	PUNCT
chd-104	197	1	jama	jama	PROPN
chd-104	197	2	295	295	NUM
chd-104	197	3	,	,	PUNCT
chd-104	197	4	2492	2492	NUM
chd-104	197	5	-	-	SYM
chd-104	197	6	2502	2502	NUM
chd-104	197	7	.	.	PUNCT
chd-104	198	1	cohen	cohen	PROPN
chd-104	198	2	,	,	PUNCT
chd-104	198	3	m.	m.	NOUN
chd-104	198	4	,	,	PUNCT
chd-104	198	5	georgiou	georgiou	PROPN
chd-104	198	6	,	,	PUNCT
chd-104	198	7	m.	m.	NOUN
chd-104	198	8	,	,	PUNCT
chd-104	198	9	stevenson	stevenson	PROPN
chd-104	198	10	,	,	PUNCT
chd-104	198	11	n.l	n.l	PROPN
chd-104	198	12	.	.	PROPN
chd-104	198	13	,	,	PUNCT
chd-104	198	14	miodownik	miodownik	X
chd-104	198	15	,	,	PUNCT
chd-104	198	16	m.	m.	NOUN
chd-104	198	17	,	,	PUNCT
chd-104	198	18	and	and	CCONJ
chd-104	198	19	baum	baum	PROPN
chd-104	198	20	,	,	PUNCT
chd-104	198	21	b.	b.	PROPN
chd-104	198	22	(	(	PUNCT
chd-104	198	23	2010	2010	NUM
chd-104	198	24	)	)	PUNCT
chd-104	198	25	.	.	PUNCT
chd-104	199	1	dynamic	dynamic	ADJ
chd-104	199	2	filopodia	filopodia	NOUN
chd-104	199	3	transmit	transmit	NOUN
chd-104	199	4	intermittent	intermittent	ADJ
chd-104	199	5	delta	delta	NOUN
chd-104	199	6	-	-	PUNCT
chd-104	199	7	notch	notch	NOUN
chd-104	199	8	signaling	signal	VERB
chd-104	199	9	to	to	PART
chd-104	199	10	drive	drive	VERB
chd-104	199	11	pattern	pattern	NOUN
chd-104	199	12	refinement	refinement	NOUN
chd-104	199	13	during	during	ADP
chd-104	199	14	lateral	lateral	ADJ
chd-104	199	15	inhibition	inhibition	NOUN
chd-104	199	16	.	.	PUNCT
chd-104	200	1	developmental	developmental	ADJ
chd-104	200	2	cell	cell	NOUN
chd-104	200	3	19	19	NUM
chd-104	200	4	,	,	PUNCT
chd-104	200	5	78	78	NUM
chd-104	200	6	-	-	SYM
chd-104	200	7	89	89	NUM
chd-104	200	8	.	.	PUNCT
chd-104	201	1	cozier	cozy	ADJ
chd-104	201	2	,	,	PUNCT
chd-104	201	3	y.c	y.c	PROPN
chd-104	201	4	.	.	PROPN
chd-104	201	5	,	,	PUNCT
chd-104	201	6	berman	berman	PROPN
chd-104	201	7	,	,	PUNCT
chd-104	201	8	j.s	j.s	PROPN
chd-104	201	9	.	.	PROPN
chd-104	201	10	,	,	PUNCT
chd-104	201	11	palmer	palmer	PROPN
chd-104	201	12	,	,	PUNCT
chd-104	201	13	j.r	j.r	PROPN
chd-104	201	14	.	.	PROPN
chd-104	201	15	,	,	PUNCT
chd-104	201	16	boggs	boggs	PROPN
chd-104	201	17	,	,	PUNCT
chd-104	201	18	d.a	d.a	PROPN
chd-104	201	19	.	.	PROPN
chd-104	201	20	,	,	PUNCT
chd-104	201	21	serlin	serlin	PROPN
chd-104	201	22	,	,	PUNCT
chd-104	201	23	d.m	d.m	PROPN
chd-104	201	24	.	.	PROPN
chd-104	201	25	,	,	PUNCT
chd-104	201	26	and	and	CCONJ
chd-104	201	27	rosenberg	rosenberg	PROPN
chd-104	201	28	,	,	PUNCT
chd-104	201	29	l.	l.	PROPN
chd-104	201	30	(	(	PUNCT
chd-104	201	31	2011	2011	NUM
chd-104	201	32	)	)	PUNCT
chd-104	201	33	.	.	PUNCT
chd-104	202	1	sarcoidosis	sarcoidosis	NOUN
chd-104	202	2	in	in	ADP
chd-104	202	3	black	black	ADJ
chd-104	202	4	women	woman	NOUN
chd-104	202	5	in	in	ADP
chd-104	202	6	the	the	DET
chd-104	202	7	united	united	PROPN
chd-104	202	8	states	states	PROPN
chd-104	202	9	:	:	PUNCT
chd-104	202	10	data	datum	NOUN
chd-104	202	11	from	from	ADP
chd-104	202	12	the	the	DET
chd-104	202	13	black	black	ADJ
chd-104	202	14	women	woman	NOUN
chd-104	202	15	's	's	PART
chd-104	202	16	health	health	NOUN
chd-104	202	17	study	study	NOUN
chd-104	202	18	.	.	PUNCT
chd-104	203	1	chest	chest	NOUN
chd-104	203	2	139	139	NUM
chd-104	203	3	,	,	PUNCT
chd-104	203	4	144	144	NUM
chd-104	203	5	-	-	SYM
chd-104	203	6	150	150	NUM
chd-104	203	7	.	.	PUNCT
chd-104	204	1	criscitiello	criscitiello	PROPN
chd-104	204	2	,	,	PUNCT
chd-104	204	3	c.	c.	PROPN
chd-104	204	4	,	,	PUNCT
chd-104	204	5	azim	azim	PROPN
chd-104	204	6	,	,	PUNCT
chd-104	204	7	h.a	h.a	PROPN
chd-104	204	8	.	.	PROPN
chd-104	204	9	,	,	PUNCT
chd-104	204	10	jr	jr	PROPN
chd-104	204	11	.	.	PROPN
chd-104	204	12	,	,	PUNCT
chd-104	204	13	schouten	schouten	PROPN
chd-104	204	14	,	,	PUNCT
chd-104	204	15	p.c	p.c	PROPN
chd-104	204	16	.	.	PROPN
chd-104	204	17	,	,	PUNCT
chd-104	204	18	linn	linn	PROPN
chd-104	204	19	,	,	PUNCT
chd-104	204	20	s.c	s.c	PROPN
chd-104	204	21	.	.	PROPN
chd-104	204	22	,	,	PUNCT
chd-104	204	23	and	and	CCONJ
chd-104	204	24	sotiriou	sotiriou	PROPN
chd-104	204	25	,	,	PUNCT
chd-104	204	26	c.	c.	NOUN
chd-104	204	27	(	(	PUNCT
chd-104	204	28	2012	2012	NUM
chd-104	204	29	)	)	PUNCT
chd-104	204	30	.	.	PUNCT
chd-104	205	1	understanding	understand	VERB
chd-104	205	2	the	the	DET
chd-104	205	3	biology	biology	NOUN
chd-104	205	4	of	of	ADP
chd-104	205	5	triplenegative	triplenegative	ADJ
chd-104	205	6	breast	breast	NOUN
chd-104	205	7	cancer	cancer	NOUN
chd-104	205	8	.	.	PUNCT
chd-104	206	1	annals	annal	NOUN
chd-104	206	2	of	of	ADP
chd-104	206	3	oncology	oncology	NOUN
chd-104	206	4	:	:	PUNCT
chd-104	206	5	official	official	ADJ
chd-104	206	6	journal	journal	NOUN
chd-104	206	7	of	of	ADP
chd-104	206	8	the	the	DET
chd-104	206	9	european	european	PROPN
chd-104	206	10	society	society	PROPN
chd-104	206	11	for	for	ADP
chd-104	206	12	medical	medical	ADJ
chd-104	206	13	oncology	oncology	NOUN
chd-104	206	14	23	23	NUM
chd-104	206	15	suppl	suppl	ADJ
chd-104	206	16	6	6	NUM
chd-104	206	17	,	,	PUNCT
chd-104	206	18	vi13	vi13	PROPN
chd-104	206	19	-	-	PUNCT
chd-104	206	20	18	18	NUM
chd-104	206	21	.	.	PUNCT
chd-104	207	1	danforth	danforth	PROPN
chd-104	207	2	,	,	PUNCT
chd-104	207	3	d.n	d.n	PROPN
chd-104	207	4	.	.	PROPN
chd-104	207	5	,	,	PUNCT
chd-104	207	6	jr	jr	PROPN
chd-104	207	7	.	.	PROPN
chd-104	207	8	(	(	PUNCT
chd-104	207	9	2013	2013	NUM
chd-104	207	10	)	)	PUNCT
chd-104	207	11	.	.	PUNCT
chd-104	208	1	disparities	disparity	NOUN
chd-104	208	2	in	in	ADP
chd-104	208	3	breast	breast	NOUN
chd-104	208	4	cancer	cancer	NOUN
chd-104	208	5	outcomes	outcome	NOUN
chd-104	208	6	between	between	ADP
chd-104	208	7	caucasian	caucasian	ADJ
chd-104	208	8	and	and	CCONJ
chd-104	208	9	african	african	ADJ
chd-104	208	10	american	american	ADJ
chd-104	208	11	women	woman	NOUN
chd-104	208	12	:	:	PUNCT
chd-104	208	13	a	a	DET
chd-104	208	14	model	model	NOUN
chd-104	208	15	for	for	ADP
chd-104	208	16	describing	describe	VERB
chd-104	208	17	the	the	DET
chd-104	208	18	relationship	relationship	NOUN
chd-104	208	19	of	of	ADP
chd-104	208	20	biological	biological	ADJ
chd-104	208	21	and	and	CCONJ
chd-104	208	22	nonbiological	nonbiological	ADJ
chd-104	208	23	factors	factor	NOUN
chd-104	208	24	.	.	PUNCT
chd-104	209	1	breast	breast	NOUN
chd-104	209	2	cancer	cancer	NOUN
chd-104	209	3	research	research	NOUN
chd-104	209	4	:	:	PUNCT
chd-104	209	5	bcr	bcr	PROPN
chd-104	209	6	15	15	NUM
chd-104	209	7	,	,	PUNCT
chd-104	209	8	208	208	NUM
chd-104	209	9	.	.	PUNCT
chd-104	210	1	dickson	dickson	PROPN
chd-104	210	2	,	,	PUNCT
chd-104	210	3	b.c	b.c	PROPN
chd-104	210	4	.	.	PROPN
chd-104	210	5	,	,	PUNCT
chd-104	210	6	mulligan	mulligan	PROPN
chd-104	210	7	,	,	PUNCT
chd-104	210	8	a.m.	a.m.	ADV
chd-104	210	9	,	,	PUNCT
chd-104	210	10	zhang	zhang	PROPN
chd-104	210	11	,	,	PUNCT
chd-104	210	12	h.	h.	PROPN
chd-104	210	13	,	,	PUNCT
chd-104	210	14	lockwood	lockwood	PROPN
chd-104	210	15	,	,	PUNCT
chd-104	210	16	g.	g.	PROPN
chd-104	210	17	,	,	PUNCT
chd-104	210	18	o'malley	o'malley	PROPN
chd-104	210	19	,	,	PUNCT
chd-104	210	20	f.p	f.p	PROPN
chd-104	210	21	.	.	PROPN
chd-104	210	22	,	,	PUNCT
chd-104	210	23	egan	egan	PROPN
chd-104	210	24	,	,	PUNCT
chd-104	210	25	s.e	s.e	PROPN
chd-104	210	26	.	.	PROPN
chd-104	210	27	,	,	PUNCT
chd-104	210	28	and	and	CCONJ
chd-104	210	29	reedijk	reedijk	NOUN
chd-104	210	30	,	,	PUNCT
chd-104	210	31	m.	m.	NOUN
chd-104	210	32	(	(	PUNCT
chd-104	210	33	2007	2007	NUM
chd-104	210	34	)	)	PUNCT
chd-104	210	35	.	.	PUNCT
chd-104	211	1	highlevel	highlevel	ADJ
chd-104	211	2	jag1	jag1	NOUN
chd-104	211	3	mrna	mrna	PROPN
chd-104	211	4	and	and	CCONJ
chd-104	211	5	protein	protein	NOUN
chd-104	211	6	predict	predict	VERB
chd-104	211	7	poor	poor	ADJ
chd-104	211	8	outcome	outcome	NOUN
chd-104	211	9	in	in	ADP
chd-104	211	10	breast	breast	NOUN
chd-104	211	11	cancer	cancer	NOUN
chd-104	211	12	.	.	PUNCT
chd-104	212	1	modern	modern	ADJ
chd-104	212	2	pathology	pathology	NOUN
chd-104	212	3	:	:	PUNCT
chd-104	212	4	an	an	DET
chd-104	212	5	official	official	ADJ
chd-104	212	6	journal	journal	NOUN
chd-104	212	7	of	of	ADP
chd-104	212	8	the	the	DET
chd-104	212	9	united	united	PROPN
chd-104	212	10	states	states	PROPN
chd-104	212	11	and	and	CCONJ
chd-104	212	12	canadian	canadian	PROPN
chd-104	212	13	academy	academy	PROPN
chd-104	212	14	of	of	ADP
chd-104	212	15	pathology	pathology	PROPN
chd-104	212	16	,	,	PUNCT
chd-104	212	17	inc	inc	PROPN
chd-104	212	18	20	20	NUM
chd-104	212	19	,	,	PUNCT
chd-104	212	20	685	685	NUM
chd-104	212	21	-	-	SYM
chd-104	212	22	693	693	NUM
chd-104	212	23	.	.	PUNCT
chd-104	213	1	dietze	dietze	PROPN
chd-104	213	2	,	,	PUNCT
chd-104	213	3	e.c	e.c	PROPN
chd-104	213	4	.	.	PROPN
chd-104	213	5	,	,	PUNCT
chd-104	213	6	sistrunk	sistrunk	PROPN
chd-104	213	7	,	,	PUNCT
chd-104	213	8	c.	c.	PROPN
chd-104	213	9	,	,	PUNCT
chd-104	213	10	miranda	miranda	NOUN
chd-104	213	11	-	-	PUNCT
chd-104	213	12	carboni	carboni	PROPN
chd-104	213	13	,	,	PUNCT
chd-104	213	14	g.	g.	PROPN
chd-104	213	15	,	,	PUNCT
chd-104	213	16	o'regan	o'regan	PROPN
chd-104	213	17	,	,	PUNCT
chd-104	213	18	r.	r.	PROPN
chd-104	213	19	,	,	PUNCT
chd-104	213	20	and	and	CCONJ
chd-104	213	21	seewaldt	seewaldt	ADJ
chd-104	213	22	,	,	PUNCT
chd-104	213	23	v.l	v.l	PROPN
chd-104	213	24	.	.	PROPN
chd-104	214	1	(	(	PUNCT
chd-104	214	2	2015	2015	NUM
chd-104	214	3	)	)	PUNCT
chd-104	214	4	.	.	PUNCT
chd-104	215	1	triple	triple	ADJ
chd-104	215	2	-	-	PUNCT
chd-104	215	3	negative	negative	ADJ
chd-104	215	4	breast	breast	NOUN
chd-104	215	5	cancer	cancer	NOUN
chd-104	215	6	in	in	ADP
chd-104	215	7	african	african	ADJ
chd-104	215	8	-	-	PUNCT
chd-104	215	9	american	american	ADJ
chd-104	215	10	women	woman	NOUN
chd-104	215	11	:	:	PUNCT
chd-104	216	1	disparities	disparity	NOUN
chd-104	216	2	versus	versus	ADP
chd-104	216	3	biology	biology	NOUN
chd-104	216	4	.	.	PUNCT
chd-104	217	1	nat	nat	PROPN
chd-104	217	2	rev	rev	VERB
chd-104	217	3	cancer	cancer	NOUN
chd-104	217	4	15	15	NUM
chd-104	217	5	,	,	PUNCT
chd-104	217	6	248	248	NUM
chd-104	217	7	-	-	SYM
chd-104	217	8	254	254	NUM
chd-104	217	9	.	.	PUNCT
chd-104	218	1	dontu	dontu	PROPN
chd-104	218	2	,	,	PUNCT
chd-104	218	3	g.	g.	PROPN
chd-104	218	4	,	,	PUNCT
chd-104	218	5	jackson	jackson	PROPN
chd-104	218	6	,	,	PUNCT
chd-104	218	7	k.w	k.w	PROPN
chd-104	218	8	.	.	PROPN
chd-104	218	9	,	,	PUNCT
chd-104	218	10	mcnicholas	mcnicholas	PROPN
chd-104	218	11	,	,	PUNCT
chd-104	218	12	e.	e.	PROPN
chd-104	218	13	,	,	PUNCT
chd-104	218	14	kawamura	kawamura	PROPN
chd-104	218	15	,	,	PUNCT
chd-104	218	16	m.j	m.j	PROPN
chd-104	218	17	.	.	PROPN
chd-104	218	18	,	,	PUNCT
chd-104	218	19	abdallah	abdallah	PROPN
chd-104	218	20	,	,	PUNCT
chd-104	218	21	w.m	w.m	PROPN
chd-104	218	22	.	.	PROPN
chd-104	218	23	,	,	PUNCT
chd-104	218	24	and	and	CCONJ
chd-104	218	25	wicha	wicha	PROPN
chd-104	218	26	,	,	PUNCT
chd-104	218	27	m.s	m.s	PROPN
chd-104	218	28	.	.	PROPN
chd-104	218	29	(	(	PUNCT
chd-104	218	30	2004	2004	NUM
chd-104	218	31	)	)	PUNCT
chd-104	218	32	.	.	PUNCT
chd-104	219	1	role	role	NOUN
chd-104	219	2	of	of	ADP
chd-104	219	3	notch	notch	NOUN
chd-104	219	4	signaling	signal	VERB
chd-104	219	5	in	in	ADP
chd-104	219	6	cell	cell	NOUN
chd-104	219	7	-	-	PUNCT
chd-104	219	8	fate	fate	NOUN
chd-104	219	9	determination	determination	NOUN
chd-104	219	10	of	of	ADP
chd-104	219	11	human	human	ADJ
chd-104	219	12	mammary	mammary	ADJ
chd-104	219	13	stem	stem	NOUN
chd-104	219	14	/	/	SYM
chd-104	219	15	progenitor	progenitor	NOUN
chd-104	219	16	cells	cell	NOUN
chd-104	219	17	.	.	PUNCT
chd-104	220	1	breast	breast	NOUN
chd-104	220	2	cancer	cancer	NOUN
chd-104	220	3	research	research	NOUN
chd-104	220	4	:	:	PUNCT
chd-104	220	5	bcr	bcr	PROPN
chd-104	220	6	6	6	NUM
chd-104	220	7	,	,	PUNCT
chd-104	220	8	r605	r605	PROPN
chd-104	220	9	-	-	PUNCT
chd-104	220	10	615	615	NUM
chd-104	220	11	.	.	PUNCT
chd-104	221	1	fiuza	fiuza	NOUN
chd-104	221	2	,	,	PUNCT
chd-104	221	3	u.m	u.m	PROPN
chd-104	221	4	.	.	PROPN
chd-104	221	5	,	,	PUNCT
chd-104	221	6	and	and	CCONJ
chd-104	221	7	arias	aria	NOUN
chd-104	221	8	,	,	PUNCT
chd-104	221	9	a.m.	a.m.	PROPN
chd-104	221	10	(	(	PUNCT
chd-104	221	11	2007	2007	NUM
chd-104	221	12	)	)	PUNCT
chd-104	221	13	.	.	PUNCT
chd-104	222	1	cell	cell	NOUN
chd-104	222	2	and	and	CCONJ
chd-104	222	3	molecular	molecular	ADJ
chd-104	222	4	biology	biology	NOUN
chd-104	222	5	of	of	ADP
chd-104	222	6	notch	notch	NOUN
chd-104	222	7	.	.	PUNCT
chd-104	223	1	the	the	DET
chd-104	223	2	journal	journal	NOUN
chd-104	223	3	of	of	ADP
chd-104	223	4	endocrinology	endocrinology	NOUN
chd-104	223	5	194	194	NUM
chd-104	223	6	,	,	PUNCT
chd-104	223	7	459	459	NUM
chd-104	223	8	-	-	SYM
chd-104	223	9	474	474	NUM
chd-104	223	10	.	.	PUNCT
chd-104	224	1	harrison	harrison	PROPN
chd-104	224	2	,	,	PUNCT
chd-104	224	3	h.	h.	PROPN
chd-104	224	4	,	,	PUNCT
chd-104	224	5	farnie	farnie	PROPN
chd-104	224	6	,	,	PUNCT
chd-104	224	7	g.	g.	PROPN
chd-104	224	8	,	,	PUNCT
chd-104	224	9	howell	howell	PROPN
chd-104	224	10	,	,	PUNCT
chd-104	224	11	s.j	s.j	PROPN
chd-104	224	12	.	.	PROPN
chd-104	224	13	,	,	PUNCT
chd-104	224	14	rock	rock	PROPN
chd-104	224	15	,	,	PUNCT
chd-104	224	16	r.e	r.e	PROPN
chd-104	224	17	.	.	PROPN
chd-104	224	18	,	,	PUNCT
chd-104	224	19	stylianou	stylianou	PROPN
chd-104	224	20	,	,	PUNCT
chd-104	224	21	s.	s.	PROPN
chd-104	224	22	,	,	PUNCT
chd-104	224	23	brennan	brennan	PROPN
chd-104	224	24	,	,	PUNCT
chd-104	224	25	k.r	k.r	PROPN
chd-104	224	26	.	.	PROPN
chd-104	224	27	,	,	PUNCT
chd-104	224	28	bundred	bundre	VERB
chd-104	224	29	,	,	PUNCT
chd-104	224	30	n.j	n.j	PROPN
chd-104	224	31	.	.	PROPN
chd-104	224	32	,	,	PUNCT
chd-104	224	33	and	and	CCONJ
chd-104	224	34	clarke	clarke	PROPN
chd-104	224	35	,	,	PUNCT
chd-104	224	36	r.b	r.b	PROPN
chd-104	224	37	.	.	PROPN
chd-104	224	38	(	(	PUNCT
chd-104	224	39	2010	2010	NUM
chd-104	224	40	)	)	PUNCT
chd-104	224	41	.	.	PUNCT
chd-104	225	1	regulation	regulation	NOUN
chd-104	225	2	of	of	ADP
chd-104	225	3	breast	breast	NOUN
chd-104	225	4	cancer	cancer	NOUN
chd-104	225	5	stem	stem	NOUN
chd-104	225	6	cell	cell	NOUN
chd-104	225	7	activity	activity	NOUN
chd-104	225	8	by	by	ADP
chd-104	225	9	signaling	signal	VERB
chd-104	225	10	through	through	ADP
chd-104	225	11	the	the	DET
chd-104	225	12	notch4	notch4	NOUN
chd-104	225	13	receptor	receptor	NOUN
chd-104	225	14	.	.	PUNCT
chd-104	226	1	cancer	cancer	NOUN
chd-104	226	2	research	research	NOUN
chd-104	226	3	70	70	NUM
chd-104	226	4	,	,	PUNCT
chd-104	226	5	709718	709718	NUM
chd-104	226	6	.	.	PUNCT
chd-104	227	1	howlader	howlader	PROPN
chd-104	227	2	n	n	CCONJ
chd-104	227	3	,	,	PUNCT
chd-104	227	4	n.a	n.a	PROPN
chd-104	227	5	.	.	PROPN
chd-104	227	6	,	,	PUNCT
chd-104	227	7	krapcho	krapcho	PROPN
chd-104	227	8	m	m	PROPN
chd-104	227	9	,	,	PUNCT
chd-104	227	10	garshell	garshell	PROPN
chd-104	227	11	j	j	PROPN
chd-104	227	12	,	,	PUNCT
chd-104	227	13	miller	miller	PROPN
chd-104	227	14	d	d	PROPN
chd-104	227	15	,	,	PUNCT
chd-104	227	16	altekruse	altekruse	VERB
chd-104	227	17	sf	sf	PROPN
chd-104	227	18	,	,	PUNCT
chd-104	227	19	kosary	kosary	NOUN
chd-104	227	20	cl	cl	PROPN
chd-104	227	21	,	,	PUNCT
chd-104	227	22	yu	yu	PROPN
chd-104	227	23	m	m	PROPN
chd-104	227	24	,	,	PUNCT
chd-104	227	25	ruhl	ruhl	PROPN
chd-104	227	26	j	j	PROPN
chd-104	227	27	,	,	PUNCT
chd-104	227	28	tatalovich	tatalovich	PROPN
chd-104	227	29	z	z	PROPN
chd-104	227	30	,	,	PUNCT
chd-104	227	31	mariotto	mariotto	NOUN
chd-104	227	32	a	a	NOUN
chd-104	227	33	,	,	PUNCT
chd-104	227	34	lewis	lewis	PROPN
chd-104	227	35	dr	dr	PROPN
chd-104	227	36	,	,	PUNCT
chd-104	227	37	chen	chen	PROPN
chd-104	227	38	hs	hs	PROPN
chd-104	227	39	,	,	PUNCT
chd-104	227	40	feuer	feuer	PROPN
chd-104	227	41	ej	ej	PROPN
chd-104	227	42	,	,	PUNCT
chd-104	227	43	cronin	cronin	PROPN
chd-104	227	44	ka	ka	PROPN
chd-104	227	45	(	(	PUNCT
chd-104	227	46	eds	eds	PROPN
chd-104	227	47	)	)	PUNCT
chd-104	227	48	(	(	PUNCT
chd-104	227	49	2014	2014	NUM
chd-104	227	50	)	)	PUNCT
chd-104	227	51	.	.	PUNCT
chd-104	228	1	seer	seer	PROPN
chd-104	228	2	cancer	cancer	PROPN
chd-104	228	3	statistics	statistics	PROPN
chd-104	228	4	review	review	PROPN
chd-104	228	5	,	,	PUNCT
chd-104	228	6	1975	1975	NUM
chd-104	228	7	-	-	SYM
chd-104	228	8	2011	2011	NUM
chd-104	228	9	,	,	PUNCT
chd-104	228	10	national	national	PROPN
chd-104	228	11	cancer	cancer	PROPN
chd-104	228	12	institute	institute	PROPN
chd-104	228	13	.	.	PUNCT
chd-104	229	1	bethesda	bethesda	PROPN
chd-104	229	2	,	,	PUNCT
chd-104	229	3	md	md	PROPN
chd-104	229	4	.	.	PROPN
chd-104	230	1	in	in	ADP
chd-104	230	2	http://seercancergov	http://seercancergov	NOUN
chd-104	230	3	/	/	SYM
chd-104	230	4	csr/1975_2011/	csr/1975_2011/	NOUN
chd-104	230	5	(	(	PUNCT
chd-104	230	6	seer	seer	PROPN
chd-104	230	7	web	web	NOUN
chd-104	230	8	site	site	NOUN
chd-104	230	9	:	:	PUNCT
chd-104	230	10	seer	seer	NOUN
chd-104	230	11	)	)	PUNCT
chd-104	230	12	.	.	PUNCT
chd-104	231	1	imaoka	imaoka	NOUN
chd-104	231	2	,	,	PUNCT
chd-104	231	3	t.	t.	PROPN
chd-104	231	4	,	,	PUNCT
chd-104	231	5	okutani	okutani	NOUN
chd-104	231	6	,	,	PUNCT
chd-104	231	7	t.	t.	PROPN
chd-104	231	8	,	,	PUNCT
chd-104	231	9	daino	daino	PROPN
chd-104	231	10	,	,	PUNCT
chd-104	231	11	k.	k.	PROPN
chd-104	231	12	,	,	PUNCT
chd-104	231	13	iizuka	iizuka	PROPN
chd-104	231	14	,	,	PUNCT
chd-104	231	15	d.	d.	PROPN
chd-104	231	16	,	,	PUNCT
chd-104	231	17	nishimura	nishimura	PROPN
chd-104	231	18	,	,	PUNCT
chd-104	231	19	m.	m.	NOUN
chd-104	231	20	,	,	PUNCT
chd-104	231	21	and	and	CCONJ
chd-104	231	22	shimada	shimada	PROPN
chd-104	231	23	,	,	PUNCT
chd-104	231	24	y.	y.	PROPN
chd-104	231	25	(	(	PUNCT
chd-104	231	26	2014	2014	NUM
chd-104	231	27	)	)	PUNCT
chd-104	231	28	.	.	PUNCT
chd-104	232	1	overexpression	overexpression	NOUN
chd-104	232	2	of	of	ADP
chd-104	232	3	notchregulated	notchregulated	ADJ
chd-104	232	4	ankyrin	ankyrin	ADJ
chd-104	232	5	repeat	repeat	NOUN
chd-104	232	6	protein	protein	NOUN
chd-104	232	7	is	be	AUX
chd-104	232	8	associated	associate	VERB
chd-104	232	9	with	with	ADP
chd-104	232	10	breast	breast	NOUN
chd-104	232	11	cancer	cancer	NOUN
chd-104	232	12	cell	cell	NOUN
chd-104	232	13	proliferation	proliferation	NOUN
chd-104	232	14	.	.	PUNCT
chd-104	233	1	anticancer	anticancer	NOUN
chd-104	233	2	res	re	NOUN
chd-104	233	3	34	34	NUM
chd-104	233	4	,	,	PUNCT
chd-104	233	5	2165	2165	NUM
chd-104	233	6	-	-	SYM
chd-104	233	7	2171	2171	NUM
chd-104	233	8	.	.	PUNCT
chd-104	234	1	jamdade	jamdade	VERB
chd-104	234	2	,	,	PUNCT
chd-104	234	3	v.s.	v.s.	ADJ
chd-104	234	4	,	,	PUNCT
chd-104	234	5	sethi	sethi	PROPN
chd-104	234	6	,	,	PUNCT
chd-104	234	7	n.	n.	NOUN
chd-104	234	8	,	,	PUNCT
chd-104	234	9	mundhe	mundhe	NOUN
chd-104	234	10	,	,	PUNCT
chd-104	234	11	n.a	n.a	PROPN
chd-104	234	12	.	.	PROPN
chd-104	234	13	,	,	PUNCT
chd-104	234	14	kumar	kumar	PROPN
chd-104	234	15	,	,	PUNCT
chd-104	234	16	p.	p.	PROPN
chd-104	234	17	,	,	PUNCT
chd-104	234	18	lahkar	lahkar	NOUN
chd-104	234	19	,	,	PUNCT
chd-104	234	20	m.	m.	NOUN
chd-104	234	21	,	,	PUNCT
chd-104	234	22	and	and	CCONJ
chd-104	234	23	sinha	sinha	NOUN
chd-104	234	24	,	,	PUNCT
chd-104	234	25	n.	n.	NOUN
chd-104	234	26	(	(	PUNCT
chd-104	234	27	2015	2015	NUM
chd-104	234	28	)	)	PUNCT
chd-104	234	29	.	.	PUNCT
chd-104	235	1	therapeutic	therapeutic	ADJ
chd-104	235	2	targets	target	NOUN
chd-104	235	3	of	of	ADP
chd-104	235	4	triplenegative	triplenegative	ADJ
chd-104	235	5	breast	breast	NOUN
chd-104	235	6	cancer	cancer	NOUN
chd-104	235	7	:	:	PUNCT
chd-104	235	8	a	a	DET
chd-104	235	9	review	review	NOUN
chd-104	235	10	.	.	PUNCT
chd-104	236	1	br	br	PROPN
chd-104	237	1	j	j	PROPN
chd-104	237	2	pharmacol	pharmacol	PROPN
chd-104	237	3	172	172	NUM
chd-104	237	4	,	,	PUNCT
chd-104	237	5	4228	4228	NUM
chd-104	237	6	-	-	SYM
chd-104	237	7	4237	4237	NUM
chd-104	237	8	.	.	PUNCT
chd-104	238	1	james	james	PROPN
chd-104	238	2	,	,	PUNCT
chd-104	238	3	d.g	d.g	PROPN
chd-104	238	4	.	.	PROPN
chd-104	238	5	,	,	PUNCT
chd-104	238	6	and	and	CCONJ
chd-104	238	7	sherlock	sherlock	NOUN
chd-104	238	8	,	,	PUNCT
chd-104	238	9	s.	s.	PROPN
chd-104	238	10	(	(	PUNCT
chd-104	238	11	1994	1994	NUM
chd-104	238	12	)	)	PUNCT
chd-104	238	13	.	.	PUNCT
chd-104	239	1	sarcoidosis	sarcoidosis	NOUN
chd-104	239	2	of	of	ADP
chd-104	239	3	the	the	DET
chd-104	239	4	liver	liver	NOUN
chd-104	239	5	.	.	PUNCT
chd-104	240	1	sarcoidosis	sarcoidosis	NOUN
chd-104	240	2	11	11	NUM
chd-104	240	3	,	,	PUNCT
chd-104	240	4	2	2	NUM
chd-104	240	5	-	-	SYM
chd-104	240	6	6	6	NUM
chd-104	240	7	.	.	PUNCT
chd-104	240	8	jiagge	jiagge	PROPN
chd-104	240	9	,	,	PUNCT
chd-104	240	10	e.	e.	PROPN
chd-104	240	11	,	,	PUNCT
chd-104	240	12	chitale	chitale	PROPN
chd-104	240	13	,	,	PUNCT
chd-104	240	14	d.	d.	PROPN
chd-104	240	15	,	,	PUNCT
chd-104	240	16	and	and	CCONJ
chd-104	240	17	newman	newman	PROPN
chd-104	240	18	,	,	PUNCT
chd-104	240	19	l.a	l.a	PROPN
chd-104	240	20	.	.	PROPN
chd-104	240	21	(	(	PUNCT
chd-104	240	22	2018	2018	NUM
chd-104	240	23	)	)	PUNCT
chd-104	240	24	.	.	PUNCT
chd-104	241	1	triplenegative	triplenegative	VERB
chd-104	241	2	breast	breast	NOUN
chd-104	241	3	cancer	cancer	NOUN
chd-104	241	4	,	,	PUNCT
chd-104	241	5	stem	stem	NOUN
chd-104	241	6	cells	cell	NOUN
chd-104	241	7	,	,	PUNCT
chd-104	241	8	and	and	CCONJ
chd-104	241	9	african	african	ADJ
chd-104	241	10	ancestry	ancestry	NOUN
chd-104	241	11	.	.	PUNCT
chd-104	242	1	the	the	DET
chd-104	242	2	american	american	PROPN
chd-104	242	3	journal	journal	PROPN
chd-104	242	4	of	of	ADP
chd-104	242	5	pathology	pathology	PROPN
chd-104	242	6	188	188	NUM
chd-104	242	7	,	,	PUNCT
chd-104	242	8	271	271	NUM
chd-104	242	9	-	-	SYM
chd-104	242	10	279	279	NUM
chd-104	242	11	.	.	PUNCT
chd-104	243	1	kassam	kassam	PROPN
chd-104	243	2	,	,	PUNCT
chd-104	243	3	f.	f.	PROPN
chd-104	243	4	,	,	PUNCT
chd-104	243	5	enright	enright	PROPN
chd-104	243	6	,	,	PUNCT
chd-104	243	7	k.	k.	PROPN
chd-104	243	8	,	,	PUNCT
chd-104	243	9	dent	dent	PROPN
chd-104	243	10	,	,	PUNCT
chd-104	243	11	r.	r.	PROPN
chd-104	243	12	,	,	PUNCT
chd-104	243	13	dranitsaris	dranitsaris	PROPN
chd-104	243	14	,	,	PUNCT
chd-104	243	15	g.	g.	PROPN
chd-104	243	16	,	,	PUNCT
chd-104	243	17	myers	myers	PROPN
chd-104	243	18	,	,	PUNCT
chd-104	243	19	j.	j.	PROPN
chd-104	243	20	,	,	PUNCT
chd-104	243	21	flynn	flynn	PROPN
chd-104	243	22	,	,	PUNCT
chd-104	243	23	c.	c.	PROPN
chd-104	243	24	,	,	PUNCT
chd-104	243	25	fralick	fralick	PROPN
chd-104	243	26	,	,	PUNCT
chd-104	243	27	m.	m.	NOUN
chd-104	243	28	,	,	PUNCT
chd-104	243	29	kumar	kumar	PROPN
chd-104	243	30	,	,	PUNCT
chd-104	243	31	r.	r.	PROPN
chd-104	243	32	,	,	PUNCT
chd-104	243	33	and	and	CCONJ
chd-104	243	34	clemons	clemon	NOUN
chd-104	243	35	,	,	PUNCT
chd-104	243	36	m.	m.	NOUN
chd-104	243	37	(	(	PUNCT
chd-104	243	38	2009	2009	NUM
chd-104	243	39	)	)	PUNCT
chd-104	243	40	.	.	PUNCT
chd-104	244	1	survival	survival	NOUN
chd-104	244	2	outcomes	outcome	NOUN
chd-104	244	3	for	for	ADP
chd-104	244	4	patients	patient	NOUN
chd-104	244	5	with	with	ADP
chd-104	244	6	metastatic	metastatic	ADJ
chd-104	244	7	triplenegative	triplenegative	ADJ
chd-104	244	8	breast	breast	NOUN
chd-104	244	9	cancer	cancer	NOUN
chd-104	244	10	:	:	PUNCT
chd-104	244	11	implications	implication	NOUN
chd-104	244	12	for	for	ADP
chd-104	244	13	clinical	clinical	ADJ
chd-104	244	14	practice	practice	NOUN
chd-104	244	15	and	and	CCONJ
chd-104	244	16	trial	trial	NOUN
chd-104	244	17	design	design	NOUN
chd-104	244	18	.	.	PUNCT
chd-104	245	1	clin	clin	PROPN
chd-104	245	2	breast	breast	PROPN
chd-104	245	3	cancer	cancer	NOUN
chd-104	245	4	9	9	NUM
chd-104	245	5	,	,	PUNCT
chd-104	245	6	29	29	NUM
chd-104	245	7	-	-	SYM
chd-104	245	8	33	33	NUM
chd-104	245	9	.	.	PUNCT
chd-104	246	1	keenan	keenan	PROPN
chd-104	246	2	,	,	PUNCT
chd-104	246	3	t.	t.	PROPN
chd-104	246	4	,	,	PUNCT
chd-104	246	5	moy	moy	PROPN
chd-104	246	6	,	,	PUNCT
chd-104	246	7	b.	b.	PROPN
chd-104	246	8	,	,	PUNCT
chd-104	246	9	mroz	mroz	PROPN
chd-104	246	10	,	,	PUNCT
chd-104	246	11	e.a	e.a	PROPN
chd-104	246	12	.	.	PROPN
chd-104	246	13	,	,	PUNCT
chd-104	246	14	ross	ross	PROPN
chd-104	246	15	,	,	PUNCT
chd-104	246	16	k.	k.	PROPN
chd-104	246	17	,	,	PUNCT
chd-104	246	18	niemierko	niemierko	PROPN
chd-104	246	19	,	,	PUNCT
chd-104	246	20	a.	a.	NOUN
chd-104	246	21	,	,	PUNCT
chd-104	246	22	rocco	rocco	NOUN
chd-104	246	23	,	,	PUNCT
chd-104	246	24	j.w	j.w	PROPN
chd-104	246	25	.	.	PROPN
chd-104	246	26	,	,	PUNCT
chd-104	246	27	isakoff	isakoff	PROPN
chd-104	246	28	,	,	PUNCT
chd-104	246	29	s.	s.	PROPN
chd-104	246	30	,	,	PUNCT
chd-104	246	31	ellisen	ellisen	PROPN
chd-104	246	32	,	,	PUNCT
chd-104	246	33	l.w	l.w	PROPN
chd-104	246	34	.	.	PROPN
chd-104	246	35	,	,	PUNCT
chd-104	246	36	and	and	CCONJ
chd-104	246	37	bardia	bardia	PROPN
chd-104	246	38	,	,	PUNCT
chd-104	246	39	a.	a.	NOUN
chd-104	246	40	(	(	PUNCT
chd-104	246	41	2015	2015	NUM
chd-104	246	42	)	)	PUNCT
chd-104	246	43	.	.	PUNCT
chd-104	247	1	comparison	comparison	NOUN
chd-104	247	2	of	of	ADP
chd-104	247	3	the	the	DET
chd-104	247	4	genomic	genomic	ADJ
chd-104	247	5	landscape	landscape	NOUN
chd-104	247	6	between	between	ADP
chd-104	247	7	primary	primary	ADJ
chd-104	247	8	breast	breast	NOUN
chd-104	247	9	cancer	cancer	NOUN
chd-104	247	10	in	in	ADP
chd-104	247	11	african	african	ADJ
chd-104	247	12	american	american	PROPN
chd-104	247	13	versus	versus	ADP
chd-104	247	14	white	white	ADJ
chd-104	247	15	women	woman	NOUN
chd-104	247	16	and	and	CCONJ
chd-104	247	17	the	the	DET
chd-104	247	18	association	association	NOUN
chd-104	247	19	of	of	ADP
chd-104	247	20	racial	racial	ADJ
chd-104	247	21	differences	difference	NOUN
chd-104	247	22	with	with	ADP
chd-104	247	23	tumor	tumor	NOUN
chd-104	247	24	recurrence	recurrence	NOUN
chd-104	247	25	.	.	PUNCT
chd-104	248	1	journal	journal	NOUN
chd-104	248	2	of	of	ADP
chd-104	248	3	clinical	clinical	ADJ
chd-104	248	4	oncology	oncology	NOUN
chd-104	248	5	:	:	PUNCT
chd-104	248	6	official	official	ADJ
chd-104	248	7	journal	journal	NOUN
chd-104	248	8	of	of	ADP
chd-104	248	9	the	the	DET
chd-104	248	10	american	american	ADJ
chd-104	248	11	society	society	NOUN
chd-104	248	12	of	of	ADP
chd-104	248	13	clinical	clinical	ADJ
chd-104	248	14	oncology	oncology	NOUN
chd-104	248	15	33	33	NUM
chd-104	248	16	,	,	PUNCT
chd-104	248	17	36213627	36213627	NUM
chd-104	248	18	.	.	PUNCT
chd-104	249	1	lehmann	lehmann	PROPN
chd-104	249	2	,	,	PUNCT
chd-104	249	3	b.d	b.d	PROPN
chd-104	249	4	.	.	PROPN
chd-104	249	5	,	,	PUNCT
chd-104	249	6	bauer	bauer	PROPN
chd-104	249	7	,	,	PUNCT
chd-104	249	8	j.a	j.a	PROPN
chd-104	249	9	.	.	PROPN
chd-104	249	10	,	,	PUNCT
chd-104	249	11	chen	chen	PROPN
chd-104	249	12	,	,	PUNCT
chd-104	249	13	x.	x.	PROPN
chd-104	249	14	,	,	PUNCT
chd-104	249	15	sanders	sanders	PROPN
chd-104	249	16	,	,	PUNCT
chd-104	249	17	m.e	m.e	PROPN
chd-104	249	18	.	.	PROPN
chd-104	249	19	,	,	PUNCT
chd-104	249	20	chakravarthy	chakravarthy	ADJ
chd-104	249	21	,	,	PUNCT
chd-104	249	22	a.b	a.b	PROPN
chd-104	249	23	.	.	PROPN
chd-104	249	24	,	,	PUNCT
chd-104	249	25	shyr	shyr	PROPN
chd-104	249	26	,	,	PUNCT
chd-104	249	27	y.	y.	NOUN
chd-104	249	28	,	,	PUNCT
chd-104	249	29	and	and	CCONJ
chd-104	249	30	pietenpol	pietenpol	NOUN
chd-104	249	31	,	,	PUNCT
chd-104	249	32	j.a	j.a	PROPN
chd-104	249	33	.	.	PROPN
chd-104	249	34	(	(	PUNCT
chd-104	249	35	2011	2011	NUM
chd-104	249	36	)	)	PUNCT
chd-104	249	37	.	.	PUNCT
chd-104	250	1	identification	identification	NOUN
chd-104	250	2	of	of	ADP
chd-104	250	3	human	human	ADJ
chd-104	250	4	triple	triple	ADJ
chd-104	250	5	-	-	PUNCT
chd-104	250	6	negative	negative	ADJ
chd-104	250	7	breast	breast	NOUN
chd-104	250	8	cancer	cancer	NOUN
chd-104	250	9	http://seercancergov	http://seercancergov	NOUN
chd-104	250	10	/	/	SYM
chd-104	250	11	csr/1975_2011/	csr/1975_2011/	NOUN
chd-104	250	12	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-104	250	13	e21	e21	ADJ
chd-104	250	14	cancer	cancer	NOUN
chd-104	250	15	health	health	NOUN
chd-104	250	16	disparities	disparity	NOUN
chd-104	250	17	research	research	VERB
chd-104	250	18	subtypes	subtype	NOUN
chd-104	250	19	and	and	CCONJ
chd-104	250	20	preclinical	preclinical	ADJ
chd-104	250	21	models	model	NOUN
chd-104	250	22	for	for	ADP
chd-104	250	23	selection	selection	NOUN
chd-104	250	24	of	of	ADP
chd-104	250	25	targeted	target	VERB
chd-104	250	26	therapies	therapy	NOUN
chd-104	250	27	.	.	PUNCT
chd-104	251	1	j	j	PROPN
chd-104	251	2	clin	clin	PROPN
chd-104	251	3	invest	invest	VERB
chd-104	251	4	121	121	NUM
chd-104	251	5	,	,	PUNCT
chd-104	251	6	2750	2750	NUM
chd-104	251	7	-	-	SYM
chd-104	251	8	2767	2767	NUM
chd-104	251	9	.	.	PUNCT
chd-104	252	1	lehmann	lehmann	PROPN
chd-104	252	2	,	,	PUNCT
chd-104	252	3	b.d	b.d	PROPN
chd-104	252	4	.	.	PROPN
chd-104	252	5	,	,	PUNCT
chd-104	252	6	jovanovic	jovanovic	PROPN
chd-104	252	7	,	,	PUNCT
chd-104	252	8	b.	b.	PROPN
chd-104	252	9	,	,	PUNCT
chd-104	252	10	chen	chen	PROPN
chd-104	252	11	,	,	PUNCT
chd-104	252	12	x.	x.	PROPN
chd-104	252	13	,	,	PUNCT
chd-104	252	14	estrada	estrada	PROPN
chd-104	252	15	,	,	PUNCT
chd-104	252	16	m.v	m.v	PROPN
chd-104	252	17	.	.	PROPN
chd-104	252	18	,	,	PUNCT
chd-104	252	19	johnson	johnson	PROPN
chd-104	252	20	,	,	PUNCT
chd-104	252	21	k.n	k.n	PROPN
chd-104	252	22	.	.	PROPN
chd-104	252	23	,	,	PUNCT
chd-104	252	24	shyr	shyr	PROPN
chd-104	252	25	,	,	PUNCT
chd-104	252	26	y.	y.	PROPN
chd-104	252	27	,	,	PUNCT
chd-104	252	28	moses	moses	PROPN
chd-104	252	29	,	,	PUNCT
chd-104	252	30	h.l	h.l	PROPN
chd-104	252	31	.	.	PROPN
chd-104	252	32	,	,	PUNCT
chd-104	252	33	sanders	sanders	PROPN
chd-104	252	34	,	,	PUNCT
chd-104	252	35	m.e	m.e	PROPN
chd-104	252	36	.	.	PROPN
chd-104	252	37	,	,	PUNCT
chd-104	252	38	and	and	CCONJ
chd-104	252	39	pietenpol	pietenpol	NOUN
chd-104	252	40	,	,	PUNCT
chd-104	252	41	j.a	j.a	PROPN
chd-104	252	42	.	.	PROPN
chd-104	252	43	(	(	PUNCT
chd-104	252	44	2016	2016	NUM
chd-104	252	45	)	)	PUNCT
chd-104	252	46	.	.	PUNCT
chd-104	253	1	refinement	refinement	NOUN
chd-104	253	2	of	of	ADP
chd-104	253	3	triple	triple	ADJ
chd-104	253	4	-	-	PUNCT
chd-104	253	5	negative	negative	ADJ
chd-104	253	6	breast	breast	NOUN
chd-104	253	7	cancer	cancer	NOUN
chd-104	253	8	molecular	molecular	ADJ
chd-104	253	9	subtypes	subtype	NOUN
chd-104	253	10	:	:	PUNCT
chd-104	253	11	implications	implication	NOUN
chd-104	253	12	for	for	ADP
chd-104	253	13	neoadjuvant	neoadjuvant	ADJ
chd-104	253	14	chemotherapy	chemotherapy	NOUN
chd-104	253	15	selection	selection	NOUN
chd-104	253	16	.	.	PUNCT
chd-104	254	1	plos	plos	PROPN
chd-104	254	2	one	one	NUM
chd-104	254	3	11	11	NUM
chd-104	254	4	,	,	PUNCT
chd-104	254	5	e0157368	e0157368	PROPN
chd-104	254	6	.	.	PROPN
chd-104	254	7	lindner	lindner	PROPN
chd-104	254	8	,	,	PUNCT
chd-104	254	9	r.	r.	PROPN
chd-104	254	10	,	,	PUNCT
chd-104	254	11	sullivan	sullivan	PROPN
chd-104	254	12	,	,	PUNCT
chd-104	254	13	c.	c.	PROPN
chd-104	254	14	,	,	PUNCT
chd-104	254	15	offor	offor	PROPN
chd-104	254	16	,	,	PUNCT
chd-104	254	17	o.	o.	PROPN
chd-104	254	18	,	,	PUNCT
chd-104	254	19	lezon	lezon	PROPN
chd-104	254	20	-	-	PUNCT
chd-104	254	21	geyda	geyda	PROPN
chd-104	254	22	,	,	PUNCT
chd-104	254	23	k.	k.	PROPN
chd-104	254	24	,	,	PUNCT
chd-104	254	25	halligan	halligan	PROPN
chd-104	254	26	,	,	PUNCT
chd-104	254	27	k.	k.	PROPN
chd-104	254	28	,	,	PUNCT
chd-104	254	29	fischbach	fischbach	ADV
chd-104	254	30	,	,	PUNCT
chd-104	254	31	n.	n.	NOUN
chd-104	254	32	,	,	PUNCT
chd-104	254	33	shah	shah	NOUN
chd-104	254	34	,	,	PUNCT
chd-104	254	35	m.	m.	NOUN
chd-104	254	36	,	,	PUNCT
chd-104	254	37	bossuyt	bossuyt	NOUN
chd-104	254	38	,	,	PUNCT
chd-104	254	39	v.	v.	PROPN
chd-104	254	40	,	,	PUNCT
chd-104	254	41	schulz	schulz	PROPN
chd-104	254	42	,	,	PUNCT
chd-104	254	43	v.	v.	PROPN
chd-104	254	44	,	,	PUNCT
chd-104	254	45	tuck	tuck	NOUN
chd-104	254	46	,	,	PUNCT
chd-104	254	47	d.p	d.p	PROPN
chd-104	254	48	.	.	PROPN
chd-104	254	49	,	,	PUNCT
chd-104	254	50	et	et	PROPN
chd-104	254	51	al	al	PROPN
chd-104	254	52	.	.	PROPN
chd-104	255	1	(	(	PUNCT
chd-104	255	2	2013	2013	NUM
chd-104	255	3	)	)	PUNCT
chd-104	255	4	.	.	PUNCT
chd-104	256	1	molecular	molecular	ADJ
chd-104	256	2	phenotypes	phenotype	NOUN
chd-104	256	3	in	in	ADP
chd-104	256	4	triple	triple	ADJ
chd-104	256	5	negative	negative	ADJ
chd-104	256	6	breast	breast	NOUN
chd-104	256	7	cancer	cancer	NOUN
chd-104	256	8	from	from	ADP
chd-104	256	9	african	african	ADJ
chd-104	256	10	american	american	ADJ
chd-104	256	11	patients	patient	NOUN
chd-104	256	12	suggest	suggest	VERB
chd-104	256	13	targets	target	NOUN
chd-104	256	14	for	for	ADP
chd-104	256	15	therapy	therapy	NOUN
chd-104	256	16	.	.	PUNCT
chd-104	257	1	plos	plos	PROPN
chd-104	257	2	one	one	NUM
chd-104	257	3	8	8	NUM
chd-104	257	4	,	,	PUNCT
chd-104	257	5	e71915	e71915	NOUN
chd-104	257	6	.	.	NOUN
chd-104	257	7	locatelli	locatelli	NOUN
chd-104	257	8	,	,	PUNCT
chd-104	257	9	m.	m.	NOUN
chd-104	257	10	,	,	PUNCT
chd-104	257	11	and	and	CCONJ
chd-104	257	12	curigliano	curigliano	PROPN
chd-104	257	13	,	,	PUNCT
chd-104	257	14	g.	g.	PROPN
chd-104	257	15	(	(	PUNCT
chd-104	257	16	2017	2017	NUM
chd-104	257	17	)	)	PUNCT
chd-104	257	18	.	.	PUNCT
chd-104	258	1	notch	notch	ADJ
chd-104	258	2	inhibitors	inhibitor	NOUN
chd-104	258	3	and	and	CCONJ
chd-104	258	4	their	their	PRON
chd-104	258	5	role	role	NOUN
chd-104	258	6	in	in	ADP
chd-104	258	7	the	the	DET
chd-104	258	8	treatment	treatment	NOUN
chd-104	258	9	of	of	ADP
chd-104	258	10	triple	triple	ADJ
chd-104	258	11	negative	negative	ADJ
chd-104	258	12	breast	breast	NOUN
chd-104	258	13	cancer	cancer	NOUN
chd-104	258	14	:	:	PUNCT
chd-104	258	15	promises	promise	NOUN
chd-104	258	16	and	and	CCONJ
chd-104	258	17	failures	failure	NOUN
chd-104	258	18	.	.	PUNCT
chd-104	259	1	current	current	ADJ
chd-104	259	2	opinion	opinion	NOUN
chd-104	259	3	in	in	ADP
chd-104	259	4	oncology	oncology	NOUN
chd-104	259	5	29	29	NUM
chd-104	259	6	,	,	PUNCT
chd-104	259	7	411	411	NUM
chd-104	259	8	-	-	SYM
chd-104	259	9	427	427	NUM
chd-104	259	10	.	.	PUNCT
chd-104	260	1	lund	lund	PROPN
chd-104	260	2	,	,	PUNCT
chd-104	260	3	m.j	m.j	PROPN
chd-104	260	4	.	.	PROPN
chd-104	260	5	,	,	PUNCT
chd-104	260	6	trivers	triver	NOUN
chd-104	260	7	,	,	PUNCT
chd-104	260	8	k.f	k.f	PROPN
chd-104	260	9	.	.	PROPN
chd-104	260	10	,	,	PUNCT
chd-104	260	11	porter	porter	PROPN
chd-104	260	12	,	,	PUNCT
chd-104	260	13	p.l	p.l	PROPN
chd-104	260	14	.	.	PROPN
chd-104	260	15	,	,	PUNCT
chd-104	260	16	coates	coates	PROPN
chd-104	260	17	,	,	PUNCT
chd-104	260	18	r.j	r.j	PROPN
chd-104	260	19	.	.	PROPN
chd-104	260	20	,	,	PUNCT
chd-104	260	21	leylandjones	leylandjones	PROPN
chd-104	260	22	,	,	PUNCT
chd-104	260	23	b.	b.	PROPN
chd-104	260	24	,	,	PUNCT
chd-104	260	25	brawley	brawley	PROPN
chd-104	260	26	,	,	PUNCT
chd-104	260	27	o.w	o.w	PROPN
chd-104	260	28	.	.	PROPN
chd-104	260	29	,	,	PUNCT
chd-104	260	30	flagg	flagg	PROPN
chd-104	260	31	,	,	PUNCT
chd-104	260	32	e.w	e.w	PROPN
chd-104	260	33	.	.	PROPN
chd-104	260	34	,	,	PUNCT
chd-104	260	35	o'regan	o'regan	PROPN
chd-104	260	36	,	,	PUNCT
chd-104	260	37	r.m	r.m	PROPN
chd-104	260	38	.	.	PROPN
chd-104	260	39	,	,	PUNCT
chd-104	260	40	gabram	gabram	PROPN
chd-104	260	41	,	,	PUNCT
chd-104	260	42	s.g	s.g	PROPN
chd-104	260	43	.	.	PROPN
chd-104	260	44	,	,	PUNCT
chd-104	260	45	and	and	CCONJ
chd-104	260	46	eley	eley	PROPN
chd-104	260	47	,	,	PUNCT
chd-104	260	48	j.w	j.w	PROPN
chd-104	260	49	.	.	PROPN
chd-104	260	50	(	(	PUNCT
chd-104	260	51	2009	2009	NUM
chd-104	260	52	)	)	PUNCT
chd-104	260	53	.	.	PUNCT
chd-104	261	1	race	race	NOUN
chd-104	261	2	and	and	CCONJ
chd-104	261	3	triple	triple	ADJ
chd-104	261	4	negative	negative	ADJ
chd-104	261	5	threats	threat	NOUN
chd-104	261	6	to	to	ADP
chd-104	261	7	breast	breast	NOUN
chd-104	261	8	cancer	cancer	NOUN
chd-104	261	9	survival	survival	NOUN
chd-104	261	10	:	:	PUNCT
chd-104	261	11	a	a	DET
chd-104	261	12	populationbased	populationbase	VERB
chd-104	261	13	study	study	NOUN
chd-104	261	14	in	in	ADP
chd-104	261	15	atlanta	atlanta	PROPN
chd-104	261	16	,	,	PUNCT
chd-104	261	17	ga	ga	PROPN
chd-104	261	18	.	.	PROPN
chd-104	261	19	breast	breast	NOUN
chd-104	261	20	cancer	cancer	NOUN
chd-104	261	21	res	re	NOUN
chd-104	261	22	treat	treat	VERB
chd-104	261	23	113	113	NUM
chd-104	261	24	,	,	PUNCT
chd-104	261	25	357	357	NUM
chd-104	261	26	-	-	SYM
chd-104	261	27	370	370	NUM
chd-104	261	28	.	.	PUNCT
chd-104	262	1	ly	ly	PROPN
chd-104	262	2	,	,	PUNCT
chd-104	262	3	m.	m.	NOUN
chd-104	262	4	,	,	PUNCT
chd-104	262	5	antoine	antoine	PROPN
chd-104	262	6	,	,	PUNCT
chd-104	262	7	m.	m.	NOUN
chd-104	262	8	,	,	PUNCT
chd-104	262	9	dembele	dembele	PROPN
chd-104	262	10	,	,	PUNCT
chd-104	262	11	a.k	a.k	PROPN
chd-104	262	12	.	.	PROPN
chd-104	262	13	,	,	PUNCT
chd-104	262	14	levy	levy	NOUN
chd-104	262	15	,	,	PUNCT
chd-104	262	16	p.	p.	NOUN
chd-104	262	17	,	,	PUNCT
chd-104	262	18	rodenas	rodena	NOUN
chd-104	262	19	,	,	PUNCT
chd-104	262	20	a.	a.	NOUN
chd-104	262	21	,	,	PUNCT
chd-104	262	22	toure	toure	NOUN
chd-104	262	23	,	,	PUNCT
chd-104	262	24	b.a	b.a	PROPN
chd-104	262	25	.	.	PROPN
chd-104	262	26	,	,	PUNCT
chd-104	262	27	badiaga	badiaga	NOUN
chd-104	262	28	,	,	PUNCT
chd-104	262	29	y.	y.	NOUN
chd-104	262	30	,	,	PUNCT
chd-104	262	31	dembele	dembele	PROPN
chd-104	262	32	,	,	PUNCT
chd-104	262	33	b.k	b.k	PROPN
chd-104	262	34	.	.	PROPN
chd-104	262	35	,	,	PUNCT
chd-104	262	36	bagayogo	bagayogo	PROPN
chd-104	262	37	,	,	PUNCT
chd-104	262	38	d.c	d.c	PROPN
chd-104	262	39	.	.	PROPN
chd-104	262	40	,	,	PUNCT
chd-104	262	41	diallo	diallo	PROPN
chd-104	262	42	,	,	PUNCT
chd-104	262	43	y.l	y.l	PROPN
chd-104	262	44	.	.	PROPN
chd-104	262	45	,	,	PUNCT
chd-104	262	46	et	et	PROPN
chd-104	262	47	al	al	PROPN
chd-104	262	48	.	.	PUNCT
chd-104	262	49	(	(	PUNCT
chd-104	262	50	2012	2012	NUM
chd-104	262	51	)	)	PUNCT
chd-104	262	52	.	.	PUNCT
chd-104	263	1	high	high	ADJ
chd-104	263	2	incidence	incidence	NOUN
chd-104	263	3	of	of	ADP
chd-104	263	4	triple	triple	ADJ
chd-104	263	5	-	-	PUNCT
chd-104	263	6	negative	negative	ADJ
chd-104	263	7	tumors	tumor	NOUN
chd-104	263	8	in	in	ADP
chd-104	263	9	sub	sub	ADJ
chd-104	263	10	-	-	ADJ
chd-104	263	11	saharan	saharan	ADJ
chd-104	263	12	africa	africa	PROPN
chd-104	263	13	:	:	PUNCT
chd-104	263	14	a	a	DET
chd-104	263	15	prospective	prospective	ADJ
chd-104	263	16	study	study	NOUN
chd-104	263	17	of	of	ADP
chd-104	263	18	breast	breast	NOUN
chd-104	263	19	cancer	cancer	NOUN
chd-104	263	20	characteristics	characteristic	NOUN
chd-104	263	21	and	and	CCONJ
chd-104	263	22	risk	risk	NOUN
chd-104	263	23	factors	factor	NOUN
chd-104	263	24	in	in	ADP
chd-104	263	25	malian	malian	ADJ
chd-104	263	26	women	woman	NOUN
chd-104	263	27	seen	see	VERB
chd-104	263	28	in	in	ADP
chd-104	263	29	a	a	DET
chd-104	263	30	bamako	bamako	PROPN
chd-104	263	31	university	university	PROPN
chd-104	263	32	hospital	hospital	NOUN
chd-104	263	33	.	.	PUNCT
chd-104	264	1	oncology	oncology	NOUN
chd-104	264	2	83	83	NUM
chd-104	264	3	,	,	PUNCT
chd-104	264	4	257	257	NUM
chd-104	264	5	-	-	SYM
chd-104	264	6	263	263	NUM
chd-104	264	7	.	.	PUNCT
chd-104	265	1	mehner	mehner	PROPN
chd-104	265	2	,	,	PUNCT
chd-104	265	3	c.	c.	PROPN
chd-104	265	4	,	,	PUNCT
chd-104	265	5	hockla	hockla	PROPN
chd-104	265	6	,	,	PUNCT
chd-104	265	7	a.	a.	PROPN
chd-104	265	8	,	,	PUNCT
chd-104	265	9	miller	miller	PROPN
chd-104	265	10	,	,	PUNCT
chd-104	265	11	e.	e.	PROPN
chd-104	265	12	,	,	PUNCT
chd-104	265	13	ran	run	VERB
chd-104	265	14	,	,	PUNCT
chd-104	265	15	s.	s.	PROPN
chd-104	265	16	,	,	PUNCT
chd-104	265	17	radisky	radisky	PROPN
chd-104	265	18	,	,	PUNCT
chd-104	265	19	d.c	d.c	PROPN
chd-104	265	20	.	.	PROPN
chd-104	265	21	,	,	PUNCT
chd-104	265	22	and	and	CCONJ
chd-104	265	23	radisky	radisky	NOUN
chd-104	265	24	,	,	PUNCT
chd-104	265	25	e.s	e.s	PROPN
chd-104	265	26	.	.	PROPN
chd-104	265	27	(	(	PUNCT
chd-104	265	28	2014	2014	NUM
chd-104	265	29	)	)	PUNCT
chd-104	265	30	.	.	PUNCT
chd-104	266	1	tumor	tumor	NOUN
chd-104	266	2	cell	cell	NOUN
chd-104	266	3	-	-	PUNCT
chd-104	266	4	produced	produce	VERB
chd-104	266	5	matrix	matrix	NOUN
chd-104	266	6	metalloproteinase	metalloproteinase	NOUN
chd-104	266	7	9	9	NUM
chd-104	266	8	(	(	PUNCT
chd-104	266	9	mmp-9	mmp-9	X
chd-104	266	10	)	)	PUNCT
chd-104	266	11	drives	drive	VERB
chd-104	266	12	malignant	malignant	ADJ
chd-104	266	13	progression	progression	NOUN
chd-104	266	14	and	and	CCONJ
chd-104	266	15	metastasis	metastasis	NOUN
chd-104	266	16	of	of	ADP
chd-104	266	17	basal	basal	NOUN
chd-104	266	18	-	-	PUNCT
chd-104	266	19	like	like	ADJ
chd-104	266	20	triple	triple	ADJ
chd-104	266	21	negative	negative	ADJ
chd-104	266	22	breast	breast	NOUN
chd-104	266	23	cancer	cancer	NOUN
chd-104	266	24	.	.	PUNCT
chd-104	267	1	oncotarget	oncotarget	NOUN
chd-104	267	2	5	5	NUM
chd-104	267	3	,	,	PUNCT
chd-104	267	4	2736	2736	NUM
chd-104	267	5	-	-	SYM
chd-104	267	6	2749	2749	NUM
chd-104	267	7	.	.	PUNCT
chd-104	268	1	mittal	mittal	PROPN
chd-104	268	2	,	,	PUNCT
chd-104	268	3	s.	s.	PROPN
chd-104	268	4	,	,	PUNCT
chd-104	268	5	subramanyam	subramanyam	NOUN
chd-104	268	6	,	,	PUNCT
chd-104	268	7	d.	d.	PROPN
chd-104	268	8	,	,	PUNCT
chd-104	268	9	dey	dey	PROPN
chd-104	268	10	,	,	PUNCT
chd-104	268	11	d.	d.	PROPN
chd-104	268	12	,	,	PUNCT
chd-104	268	13	kumar	kumar	PROPN
chd-104	268	14	,	,	PUNCT
chd-104	268	15	r.v	r.v	PROPN
chd-104	268	16	.	.	PROPN
chd-104	268	17	,	,	PUNCT
chd-104	268	18	and	and	CCONJ
chd-104	268	19	rangarajan	rangarajan	NOUN
chd-104	268	20	,	,	PUNCT
chd-104	268	21	a.	a.	NOUN
chd-104	268	22	(	(	PUNCT
chd-104	268	23	2009	2009	NUM
chd-104	268	24	)	)	PUNCT
chd-104	268	25	.	.	PUNCT
chd-104	269	1	cooperation	cooperation	NOUN
chd-104	269	2	of	of	ADP
chd-104	269	3	notch	notch	NOUN
chd-104	269	4	and	and	CCONJ
chd-104	269	5	ras	ras	ADJ
chd-104	269	6	/	/	SYM
chd-104	269	7	mapk	mapk	NOUN
chd-104	269	8	signaling	signal	VERB
chd-104	269	9	pathways	pathway	NOUN
chd-104	269	10	in	in	ADP
chd-104	269	11	human	human	ADJ
chd-104	269	12	breast	breast	NOUN
chd-104	269	13	carcinogenesis	carcinogenesis	NOUN
chd-104	269	14	.	.	PUNCT
chd-104	270	1	molecular	molecular	ADJ
chd-104	270	2	cancer	cancer	NOUN
chd-104	270	3	8	8	NUM
chd-104	270	4	,	,	PUNCT
chd-104	270	5	128	128	NUM
chd-104	270	6	.	.	PUNCT
chd-104	271	1	nam	nam	PROPN
chd-104	271	2	,	,	PUNCT
chd-104	271	3	y.	y.	NOUN
chd-104	271	4	,	,	PUNCT
chd-104	271	5	sliz	sliz	NOUN
chd-104	271	6	,	,	PUNCT
chd-104	271	7	p.	p.	NOUN
chd-104	271	8	,	,	PUNCT
chd-104	271	9	song	song	PROPN
chd-104	271	10	,	,	PUNCT
chd-104	271	11	l.	l.	PROPN
chd-104	271	12	,	,	PUNCT
chd-104	271	13	aster	aster	NOUN
chd-104	271	14	,	,	PUNCT
chd-104	271	15	j.c	j.c	PROPN
chd-104	271	16	.	.	PROPN
chd-104	271	17	,	,	PUNCT
chd-104	271	18	and	and	CCONJ
chd-104	271	19	blacklow	blacklow	NOUN
chd-104	271	20	,	,	PUNCT
chd-104	271	21	s.c	s.c	PROPN
chd-104	271	22	.	.	PROPN
chd-104	271	23	(	(	PUNCT
chd-104	271	24	2006	2006	NUM
chd-104	271	25	)	)	PUNCT
chd-104	271	26	.	.	PUNCT
chd-104	272	1	structural	structural	ADJ
chd-104	272	2	basis	basis	NOUN
chd-104	272	3	for	for	ADP
chd-104	272	4	cooperativity	cooperativity	NOUN
chd-104	272	5	in	in	ADP
chd-104	272	6	recruitment	recruitment	NOUN
chd-104	272	7	of	of	ADP
chd-104	272	8	maml	maml	ADJ
chd-104	272	9	coactivators	coactivator	NOUN
chd-104	272	10	to	to	PART
chd-104	272	11	notch	notch	VERB
chd-104	272	12	transcription	transcription	NOUN
chd-104	272	13	complexes	complex	NOUN
chd-104	272	14	.	.	PUNCT
chd-104	273	1	cell	cell	NOUN
chd-104	273	2	124	124	NUM
chd-104	273	3	,	,	PUNCT
chd-104	273	4	973	973	NUM
chd-104	273	5	-	-	SYM
chd-104	273	6	983	983	NUM
chd-104	273	7	.	.	PUNCT
chd-104	274	1	newman	newman	PROPN
chd-104	274	2	,	,	PUNCT
chd-104	274	3	l.a	l.a	PROPN
chd-104	274	4	.	.	PROPN
chd-104	274	5	,	,	PUNCT
chd-104	274	6	griffith	griffith	PROPN
chd-104	274	7	,	,	PUNCT
chd-104	274	8	k.a	k.a	PROPN
chd-104	274	9	.	.	PROPN
chd-104	274	10	,	,	PUNCT
chd-104	274	11	jatoi	jatoi	PROPN
chd-104	274	12	,	,	PUNCT
chd-104	274	13	i.	i.	PROPN
chd-104	274	14	,	,	PUNCT
chd-104	274	15	simon	simon	PROPN
chd-104	274	16	,	,	PUNCT
chd-104	274	17	m.s	m.s	PROPN
chd-104	274	18	.	.	PROPN
chd-104	274	19	,	,	PUNCT
chd-104	274	20	crowe	crowe	PROPN
chd-104	274	21	,	,	PUNCT
chd-104	274	22	j.p	j.p	PROPN
chd-104	274	23	.	.	PROPN
chd-104	274	24	,	,	PUNCT
chd-104	274	25	and	and	CCONJ
chd-104	274	26	colditz	colditz	PROPN
chd-104	274	27	,	,	PUNCT
chd-104	274	28	g.a	g.a	PROPN
chd-104	274	29	.	.	PROPN
chd-104	274	30	(	(	PUNCT
chd-104	274	31	2006	2006	NUM
chd-104	274	32	)	)	PUNCT
chd-104	274	33	.	.	PUNCT
chd-104	275	1	meta	meta	ADJ
chd-104	275	2	-	-	PUNCT
chd-104	275	3	analysis	analysis	NOUN
chd-104	275	4	of	of	ADP
chd-104	275	5	survival	survival	NOUN
chd-104	275	6	in	in	ADP
chd-104	275	7	african	african	ADJ
chd-104	275	8	american	american	ADJ
chd-104	275	9	and	and	CCONJ
chd-104	275	10	white	white	ADJ
chd-104	275	11	american	american	ADJ
chd-104	275	12	patients	patient	NOUN
chd-104	275	13	with	with	ADP
chd-104	275	14	breast	breast	NOUN
chd-104	275	15	cancer	cancer	NOUN
chd-104	275	16	:	:	PUNCT
chd-104	275	17	ethnicity	ethnicity	NOUN
chd-104	275	18	compared	compare	VERB
chd-104	275	19	with	with	ADP
chd-104	275	20	socioeconomic	socioeconomic	ADJ
chd-104	275	21	status	status	NOUN
chd-104	275	22	.	.	PUNCT
chd-104	276	1	journal	journal	NOUN
chd-104	276	2	of	of	ADP
chd-104	276	3	clinical	clinical	ADJ
chd-104	276	4	oncology	oncology	NOUN
chd-104	276	5	:	:	PUNCT
chd-104	276	6	official	official	ADJ
chd-104	276	7	journal	journal	NOUN
chd-104	276	8	of	of	ADP
chd-104	276	9	the	the	DET
chd-104	276	10	american	american	ADJ
chd-104	276	11	society	society	NOUN
chd-104	276	12	of	of	ADP
chd-104	276	13	clinical	clinical	ADJ
chd-104	276	14	oncology	oncology	NOUN
chd-104	276	15	24	24	NUM
chd-104	276	16	,	,	PUNCT
chd-104	276	17	1342	1342	NUM
chd-104	276	18	-	-	SYM
chd-104	276	19	1349	1349	NUM
chd-104	276	20	.	.	PUNCT
chd-104	277	1	newman	newman	PROPN
chd-104	277	2	,	,	PUNCT
chd-104	277	3	l.a	l.a	PROPN
chd-104	277	4	.	.	PROPN
chd-104	277	5	,	,	PUNCT
chd-104	277	6	and	and	CCONJ
chd-104	277	7	kaljee	kaljee	NOUN
chd-104	277	8	,	,	PUNCT
chd-104	277	9	l.m	l.m	PROPN
chd-104	277	10	.	.	PROPN
chd-104	277	11	(	(	PUNCT
chd-104	277	12	2017	2017	NUM
chd-104	277	13	)	)	PUNCT
chd-104	277	14	.	.	PUNCT
chd-104	278	1	health	health	NOUN
chd-104	278	2	disparities	disparity	NOUN
chd-104	278	3	and	and	CCONJ
chd-104	278	4	triple	triple	ADJ
chd-104	278	5	-	-	PUNCT
chd-104	278	6	negative	negative	ADJ
chd-104	278	7	breast	breast	NOUN
chd-104	278	8	cancer	cancer	NOUN
chd-104	278	9	in	in	ADP
chd-104	278	10	african	african	ADJ
chd-104	278	11	american	american	ADJ
chd-104	278	12	women	woman	NOUN
chd-104	278	13	:	:	PUNCT
chd-104	278	14	a	a	DET
chd-104	278	15	review	review	NOUN
chd-104	278	16	.	.	PUNCT
chd-104	279	1	jama	jama	PROPN
chd-104	279	2	surgery	surgery	NOUN
chd-104	279	3	152	152	NUM
chd-104	279	4	,	,	PUNCT
chd-104	279	5	485	485	NUM
chd-104	279	6	-	-	SYM
chd-104	279	7	493	493	NUM
chd-104	279	8	.	.	PUNCT
chd-104	280	1	olsauskas	olsauskas	NOUN
chd-104	280	2	-	-	PUNCT
chd-104	280	3	kuprys	kuprys	PROPN
chd-104	280	4	,	,	PUNCT
chd-104	280	5	r.	r.	PROPN
chd-104	280	6	,	,	PUNCT
chd-104	280	7	zlobin	zlobin	PROPN
chd-104	280	8	,	,	PUNCT
chd-104	280	9	a.	a.	NOUN
chd-104	280	10	,	,	PUNCT
chd-104	280	11	and	and	CCONJ
chd-104	280	12	osipo	osipo	ADJ
chd-104	280	13	,	,	PUNCT
chd-104	280	14	c.	c.	PROPN
chd-104	280	15	(	(	PUNCT
chd-104	280	16	2013	2013	NUM
chd-104	280	17	)	)	PUNCT
chd-104	280	18	.	.	PUNCT
chd-104	281	1	gamma	gamma	PROPN
chd-104	281	2	secretase	secretase	NOUN
chd-104	281	3	inhibitors	inhibitor	NOUN
chd-104	281	4	of	of	ADP
chd-104	281	5	notch	notch	ADJ
chd-104	281	6	signaling	signal	VERB
chd-104	281	7	.	.	PUNCT
chd-104	282	1	oncotargets	oncotarget	NOUN
chd-104	282	2	and	and	CCONJ
chd-104	282	3	therapy	therapy	NOUN
chd-104	282	4	6	6	NUM
chd-104	282	5	,	,	PUNCT
chd-104	282	6	943	943	NUM
chd-104	282	7	-	-	SYM
chd-104	282	8	955	955	NUM
chd-104	282	9	.	.	PUNCT
chd-104	283	1	parr	parr	PROPN
chd-104	283	2	,	,	PUNCT
chd-104	283	3	c.	c.	PROPN
chd-104	283	4	,	,	PUNCT
chd-104	283	5	watkins	watkins	PROPN
chd-104	283	6	,	,	PUNCT
chd-104	283	7	g.	g.	PROPN
chd-104	283	8	,	,	PUNCT
chd-104	283	9	and	and	CCONJ
chd-104	283	10	jiang	jiang	PROPN
chd-104	283	11	,	,	PUNCT
chd-104	283	12	w.g	w.g	PROPN
chd-104	283	13	.	.	PROPN
chd-104	283	14	(	(	PUNCT
chd-104	283	15	2004	2004	NUM
chd-104	283	16	)	)	PUNCT
chd-104	283	17	.	.	PUNCT
chd-104	284	1	the	the	DET
chd-104	284	2	possible	possible	ADJ
chd-104	284	3	correlation	correlation	NOUN
chd-104	284	4	of	of	ADP
chd-104	284	5	notch-1	notch-1	NUM
chd-104	284	6	and	and	CCONJ
chd-104	284	7	notch-2	notch-2	NUM
chd-104	284	8	with	with	ADP
chd-104	284	9	clinical	clinical	ADJ
chd-104	284	10	outcome	outcome	NOUN
chd-104	284	11	and	and	CCONJ
chd-104	284	12	tumour	tumour	ADJ
chd-104	284	13	clinicopathological	clinicopathological	ADJ
chd-104	284	14	parameters	parameter	NOUN
chd-104	284	15	in	in	ADP
chd-104	284	16	human	human	ADJ
chd-104	284	17	breast	breast	NOUN
chd-104	284	18	cancer	cancer	NOUN
chd-104	284	19	.	.	PUNCT
chd-104	285	1	international	international	ADJ
chd-104	285	2	journal	journal	NOUN
chd-104	285	3	of	of	ADP
chd-104	285	4	molecular	molecular	ADJ
chd-104	285	5	medicine	medicine	NOUN
chd-104	285	6	14	14	NUM
chd-104	285	7	,	,	PUNCT
chd-104	285	8	779	779	NUM
chd-104	285	9	-	-	SYM
chd-104	285	10	786	786	NUM
chd-104	285	11	.	.	PUNCT
chd-104	286	1	raab	raab	PROPN
chd-104	286	2	,	,	PUNCT
chd-104	286	3	m.s	m.s	PROPN
chd-104	286	4	.	.	PROPN
chd-104	286	5	,	,	PUNCT
chd-104	286	6	breitkreutz	breitkreutz	VERB
chd-104	286	7	,	,	PUNCT
chd-104	286	8	i.	i.	NOUN
chd-104	286	9	,	,	PUNCT
chd-104	286	10	anderhub	anderhub	PROPN
chd-104	286	11	,	,	PUNCT
chd-104	286	12	s.	s.	PROPN
chd-104	286	13	,	,	PUNCT
chd-104	286	14	ronnest	ronnest	NOUN
chd-104	286	15	,	,	PUNCT
chd-104	286	16	m.h	m.h	PROPN
chd-104	286	17	.	.	PROPN
chd-104	286	18	,	,	PUNCT
chd-104	286	19	leber	leber	PROPN
chd-104	286	20	,	,	PUNCT
chd-104	286	21	b.	b.	PROPN
chd-104	286	22	,	,	PUNCT
chd-104	286	23	larsen	larsen	PROPN
chd-104	286	24	,	,	PUNCT
chd-104	286	25	t.o	t.o	PROPN
chd-104	286	26	.	.	PROPN
chd-104	286	27	,	,	PUNCT
chd-104	286	28	weiz	weiz	PROPN
chd-104	286	29	,	,	PUNCT
chd-104	286	30	l.	l.	PROPN
chd-104	286	31	,	,	PUNCT
chd-104	286	32	konotop	konotop	PROPN
chd-104	286	33	,	,	PUNCT
chd-104	286	34	g.	g.	PROPN
chd-104	286	35	,	,	PUNCT
chd-104	286	36	hayden	hayden	PROPN
chd-104	286	37	,	,	PUNCT
chd-104	286	38	p.j	p.j	PROPN
chd-104	286	39	.	.	PROPN
chd-104	286	40	,	,	PUNCT
chd-104	286	41	podar	podar	NOUN
chd-104	286	42	,	,	PUNCT
chd-104	286	43	k.	k.	PROPN
chd-104	286	44	,	,	PUNCT
chd-104	286	45	et	et	PROPN
chd-104	286	46	al	al	PROPN
chd-104	286	47	.	.	PUNCT
chd-104	286	48	(	(	PUNCT
chd-104	286	49	2012	2012	NUM
chd-104	286	50	)	)	PUNCT
chd-104	286	51	.	.	PUNCT
chd-104	287	1	gf-15	gf-15	NOUN
chd-104	287	2	,	,	PUNCT
chd-104	287	3	a	a	DET
chd-104	287	4	novel	novel	ADJ
chd-104	287	5	inhibitor	inhibitor	NOUN
chd-104	287	6	of	of	ADP
chd-104	287	7	centrosomal	centrosomal	ADJ
chd-104	287	8	clustering	clustering	NOUN
chd-104	287	9	,	,	PUNCT
chd-104	287	10	suppresses	suppress	VERB
chd-104	287	11	tumor	tumor	NOUN
chd-104	287	12	cell	cell	NOUN
chd-104	287	13	growth	growth	NOUN
chd-104	287	14	in	in	ADP
chd-104	287	15	vitro	vitro	X
chd-104	287	16	and	and	CCONJ
chd-104	287	17	in	in	ADP
chd-104	287	18	vivo	vivo	NOUN
chd-104	287	19	.	.	PUNCT
chd-104	288	1	cancer	cancer	NOUN
chd-104	288	2	res	re	NOUN
chd-104	288	3	72	72	NUM
chd-104	288	4	,	,	PUNCT
chd-104	288	5	5374	5374	NUM
chd-104	288	6	-	-	SYM
chd-104	288	7	5385	5385	NUM
chd-104	288	8	.	.	PUNCT
chd-104	289	1	ranganathan	ranganathan	PROPN
chd-104	289	2	,	,	PUNCT
chd-104	289	3	p.	p.	PROPN
chd-104	289	4	,	,	PUNCT
chd-104	289	5	weaver	weaver	PROPN
chd-104	289	6	,	,	PUNCT
chd-104	289	7	k.l	k.l	PROPN
chd-104	289	8	.	.	PROPN
chd-104	289	9	,	,	PUNCT
chd-104	289	10	and	and	CCONJ
chd-104	289	11	capobianco	capobianco	NOUN
chd-104	289	12	,	,	PUNCT
chd-104	289	13	a.j	a.j	PROPN
chd-104	289	14	.	.	PROPN
chd-104	289	15	(	(	PUNCT
chd-104	289	16	2011	2011	NUM
chd-104	289	17	)	)	PUNCT
chd-104	289	18	.	.	PUNCT
chd-104	290	1	notch	notch	NOUN
chd-104	290	2	signalling	signal	VERB
chd-104	290	3	in	in	ADP
chd-104	290	4	solid	solid	ADJ
chd-104	290	5	tumours	tumour	NOUN
chd-104	290	6	:	:	PUNCT
chd-104	290	7	a	a	DET
chd-104	290	8	little	little	ADJ
chd-104	290	9	bit	bit	NOUN
chd-104	290	10	of	of	ADP
chd-104	290	11	everything	everything	PRON
chd-104	290	12	but	but	SCONJ
chd-104	290	13	not	not	PART
chd-104	290	14	all	all	DET
chd-104	290	15	the	the	DET
chd-104	290	16	time	time	NOUN
chd-104	290	17	.	.	PUNCT
chd-104	291	1	nature	nature	NOUN
chd-104	291	2	reviews	review	VERB
chd-104	291	3	cancer	cancer	NOUN
chd-104	291	4	11	11	NUM
chd-104	291	5	,	,	PUNCT
chd-104	291	6	338	338	NUM
chd-104	291	7	-	-	SYM
chd-104	291	8	351	351	NUM
chd-104	291	9	.	.	PUNCT
chd-104	292	1	rizzo	rizzo	PROPN
chd-104	292	2	,	,	PUNCT
chd-104	292	3	p.	p.	NOUN
chd-104	292	4	,	,	PUNCT
chd-104	292	5	miao	miao	PROPN
chd-104	292	6	,	,	PUNCT
chd-104	292	7	h.	h.	PROPN
chd-104	292	8	,	,	PUNCT
chd-104	292	9	d'souza	d'souza	PROPN
chd-104	292	10	,	,	PUNCT
chd-104	292	11	g.	g.	PROPN
chd-104	292	12	,	,	PUNCT
chd-104	292	13	osipo	osipo	PROPN
chd-104	292	14	,	,	PUNCT
chd-104	292	15	c.	c.	NOUN
chd-104	292	16	,	,	PUNCT
chd-104	292	17	song	song	NOUN
chd-104	292	18	,	,	PUNCT
chd-104	292	19	l.l	l.l	PROPN
chd-104	292	20	.	.	PROPN
chd-104	292	21	,	,	PUNCT
chd-104	292	22	yun	yun	PROPN
chd-104	292	23	,	,	PUNCT
chd-104	292	24	j.	j.	PROPN
chd-104	292	25	,	,	PUNCT
chd-104	292	26	zhao	zhao	PROPN
chd-104	292	27	,	,	PUNCT
chd-104	292	28	h.	h.	PROPN
chd-104	292	29	,	,	PUNCT
chd-104	292	30	mascarenhas	mascarenhas	PROPN
chd-104	292	31	,	,	PUNCT
chd-104	292	32	j.	j.	PROPN
chd-104	292	33	,	,	PUNCT
chd-104	292	34	wyatt	wyatt	PROPN
chd-104	292	35	,	,	PUNCT
chd-104	292	36	d.	d.	PROPN
chd-104	292	37	,	,	PUNCT
chd-104	292	38	antico	antico	PROPN
chd-104	292	39	,	,	PUNCT
chd-104	292	40	g.	g.	PROPN
chd-104	292	41	,	,	PUNCT
chd-104	292	42	et	et	PROPN
chd-104	292	43	al	al	PROPN
chd-104	292	44	.	.	PUNCT
chd-104	292	45	(	(	PUNCT
chd-104	292	46	2008	2008	NUM
chd-104	292	47	)	)	PUNCT
chd-104	292	48	.	.	PUNCT
chd-104	293	1	cross	cross	ADJ
chd-104	293	2	-	-	NOUN
chd-104	293	3	talk	talk	NOUN
chd-104	293	4	between	between	ADP
chd-104	293	5	notch	notch	NOUN
chd-104	293	6	and	and	CCONJ
chd-104	293	7	the	the	DET
chd-104	293	8	estrogen	estrogen	NOUN
chd-104	293	9	receptor	receptor	NOUN
chd-104	293	10	in	in	ADP
chd-104	293	11	breast	breast	NOUN
chd-104	293	12	cancer	cancer	NOUN
chd-104	293	13	suggests	suggest	VERB
chd-104	293	14	novel	novel	ADJ
chd-104	293	15	therapeutic	therapeutic	ADJ
chd-104	293	16	approaches	approach	NOUN
chd-104	293	17	.	.	PUNCT
chd-104	294	1	cancer	cancer	NOUN
chd-104	294	2	research	research	NOUN
chd-104	294	3	68	68	NUM
chd-104	294	4	,	,	PUNCT
chd-104	294	5	5226	5226	NUM
chd-104	294	6	-	-	SYM
chd-104	294	7	5235	5235	NUM
chd-104	294	8	.	.	PUNCT
chd-104	295	1	robinson	robinson	PROPN
chd-104	295	2	,	,	PUNCT
chd-104	295	3	d.r	d.r	PROPN
chd-104	295	4	.	.	PROPN
chd-104	295	5	,	,	PUNCT
chd-104	295	6	kalyana	kalyana	PROPN
chd-104	295	7	-	-	PUNCT
chd-104	295	8	sundaram	sundaram	PROPN
chd-104	295	9	,	,	PUNCT
chd-104	295	10	s.	s.	PROPN
chd-104	295	11	,	,	PUNCT
chd-104	295	12	wu	wu	PROPN
chd-104	295	13	,	,	PUNCT
chd-104	295	14	y.m	y.m	PROPN
chd-104	295	15	.	.	PROPN
chd-104	295	16	,	,	PUNCT
chd-104	295	17	shankar	shankar	PROPN
chd-104	295	18	,	,	PUNCT
chd-104	295	19	s.	s.	PROPN
chd-104	295	20	,	,	PUNCT
chd-104	295	21	cao	cao	PROPN
chd-104	295	22	,	,	PUNCT
chd-104	295	23	x.	x.	NOUN
chd-104	295	24	,	,	PUNCT
chd-104	295	25	ateeq	ateeq	ADV
chd-104	295	26	,	,	PUNCT
chd-104	295	27	b.	b.	PROPN
chd-104	295	28	,	,	PUNCT
chd-104	295	29	asangani	asangani	PROPN
chd-104	295	30	,	,	PUNCT
chd-104	295	31	i.a	i.a	PROPN
chd-104	295	32	.	.	PROPN
chd-104	295	33	,	,	PUNCT
chd-104	295	34	iyer	iyer	PROPN
chd-104	295	35	,	,	PUNCT
chd-104	295	36	m.	m.	NOUN
chd-104	295	37	,	,	PUNCT
chd-104	295	38	maher	maher	PROPN
chd-104	295	39	,	,	PUNCT
chd-104	295	40	c.a	c.a	PROPN
chd-104	295	41	.	.	PROPN
chd-104	295	42	,	,	PUNCT
chd-104	295	43	grasso	grasso	PROPN
chd-104	295	44	,	,	PUNCT
chd-104	295	45	c.s	c.s	PROPN
chd-104	295	46	.	.	PROPN
chd-104	295	47	,	,	PUNCT
chd-104	295	48	et	et	PROPN
chd-104	295	49	al	al	PROPN
chd-104	295	50	.	.	PUNCT
chd-104	295	51	(	(	PUNCT
chd-104	295	52	2011	2011	NUM
chd-104	295	53	)	)	PUNCT
chd-104	295	54	.	.	PUNCT
chd-104	296	1	functionally	functionally	ADV
chd-104	296	2	recurrent	recurrent	ADJ
chd-104	296	3	rearrangements	rearrangement	NOUN
chd-104	296	4	of	of	ADP
chd-104	296	5	the	the	DET
chd-104	296	6	mast	mast	NOUN
chd-104	296	7	kinase	kinase	NOUN
chd-104	296	8	and	and	CCONJ
chd-104	296	9	notch	notch	ADJ
chd-104	296	10	gene	gene	NOUN
chd-104	296	11	families	family	NOUN
chd-104	296	12	in	in	ADP
chd-104	296	13	breast	breast	NOUN
chd-104	296	14	cancer	cancer	NOUN
chd-104	296	15	.	.	PUNCT
chd-104	297	1	nature	nature	NOUN
chd-104	297	2	medicine	medicine	PROPN
chd-104	297	3	17	17	NUM
chd-104	297	4	,	,	PUNCT
chd-104	297	5	1646	1646	NUM
chd-104	297	6	-	-	SYM
chd-104	297	7	1651	1651	NUM
chd-104	297	8	.	.	PUNCT
chd-104	298	1	ronchini	ronchini	PROPN
chd-104	298	2	,	,	PUNCT
chd-104	298	3	c.	c.	NOUN
chd-104	298	4	,	,	PUNCT
chd-104	298	5	and	and	CCONJ
chd-104	298	6	capobianco	capobianco	NOUN
chd-104	298	7	,	,	PUNCT
chd-104	298	8	a.j	a.j	PROPN
chd-104	298	9	.	.	PROPN
chd-104	298	10	(	(	PUNCT
chd-104	298	11	2001	2001	NUM
chd-104	298	12	)	)	PUNCT
chd-104	298	13	.	.	PUNCT
chd-104	299	1	induction	induction	NOUN
chd-104	299	2	of	of	ADP
chd-104	299	3	cyclin	cyclin	NOUN
chd-104	299	4	d1	d1	PROPN
chd-104	299	5	transcription	transcription	NOUN
chd-104	299	6	and	and	CCONJ
chd-104	299	7	cdk2	cdk2	NOUN
chd-104	299	8	activity	activity	NOUN
chd-104	299	9	by	by	ADP
chd-104	299	10	notch(ic	notch(ic	NOUN
chd-104	299	11	):	):	PUNCT
chd-104	299	12	implication	implication	NOUN
chd-104	299	13	for	for	ADP
chd-104	299	14	cell	cell	NOUN
chd-104	299	15	cycle	cycle	NOUN
chd-104	299	16	disruption	disruption	NOUN
chd-104	299	17	in	in	ADP
chd-104	299	18	transformation	transformation	NOUN
chd-104	299	19	by	by	ADP
chd-104	299	20	notch(ic	notch(ic	NOUN
chd-104	299	21	)	)	PUNCT
chd-104	299	22	.	.	PUNCT
chd-104	300	1	molecular	molecular	ADJ
chd-104	300	2	and	and	CCONJ
chd-104	300	3	cellular	cellular	ADJ
chd-104	300	4	biology	biology	NOUN
chd-104	300	5	21	21	NUM
chd-104	300	6	,	,	PUNCT
chd-104	300	7	5925	5925	NUM
chd-104	300	8	-	-	SYM
chd-104	300	9	5934	5934	NUM
chd-104	300	10	.	.	PUNCT
chd-104	301	1	sansone	sansone	NOUN
chd-104	301	2	,	,	PUNCT
chd-104	301	3	p.	p.	PROPN
chd-104	301	4	,	,	PUNCT
chd-104	301	5	storci	storci	VERB
chd-104	301	6	,	,	PUNCT
chd-104	301	7	g.	g.	PROPN
chd-104	301	8	,	,	PUNCT
chd-104	301	9	giovannini	giovannini	PROPN
chd-104	301	10	,	,	PUNCT
chd-104	301	11	c.	c.	NOUN
chd-104	301	12	,	,	PUNCT
chd-104	301	13	pandolfi	pandolfi	NOUN
chd-104	301	14	,	,	PUNCT
chd-104	301	15	s.	s.	PROPN
chd-104	301	16	,	,	PUNCT
chd-104	301	17	pianetti	pianetti	PROPN
chd-104	301	18	,	,	PUNCT
chd-104	301	19	s.	s.	PROPN
chd-104	301	20	,	,	PUNCT
chd-104	301	21	taffurelli	taffurelli	PROPN
chd-104	301	22	,	,	PUNCT
chd-104	301	23	m.	m.	NOUN
chd-104	301	24	,	,	PUNCT
chd-104	301	25	santini	santini	PROPN
chd-104	301	26	,	,	PUNCT
chd-104	301	27	d.	d.	PROPN
chd-104	301	28	,	,	PUNCT
chd-104	301	29	ceccarelli	ceccarelli	PROPN
chd-104	301	30	,	,	PUNCT
chd-104	301	31	c.	c.	PROPN
chd-104	301	32	,	,	PUNCT
chd-104	301	33	chieco	chieco	PROPN
chd-104	301	34	,	,	PUNCT
chd-104	301	35	p.	p.	NOUN
chd-104	301	36	,	,	PUNCT
chd-104	301	37	and	and	CCONJ
chd-104	301	38	bonafe	bonafe	NOUN
chd-104	301	39	,	,	PUNCT
chd-104	301	40	m.	m.	NOUN
chd-104	301	41	(	(	PUNCT
chd-104	301	42	2007	2007	NUM
chd-104	301	43	)	)	PUNCT
chd-104	301	44	.	.	PUNCT
chd-104	302	1	p66shc	p66shc	NOUN
chd-104	302	2	/	/	SYM
chd-104	302	3	notch-3	notch-3	PROPN
chd-104	302	4	interplay	interplay	NOUN
chd-104	302	5	controls	control	VERB
chd-104	302	6	self	self	NOUN
chd-104	302	7	-	-	PUNCT
chd-104	302	8	renewal	renewal	NOUN
chd-104	302	9	and	and	CCONJ
chd-104	302	10	hypoxia	hypoxia	NOUN
chd-104	302	11	survival	survival	NOUN
chd-104	302	12	in	in	ADP
chd-104	302	13	human	human	ADJ
chd-104	302	14	stem	stem	NOUN
chd-104	302	15	/	/	SYM
chd-104	302	16	progenitor	progenitor	NOUN
chd-104	302	17	cells	cell	NOUN
chd-104	302	18	of	of	ADP
chd-104	302	19	the	the	DET
chd-104	302	20	mammary	mammary	ADJ
chd-104	302	21	gland	gland	NOUN
chd-104	302	22	expanded	expand	VERB
chd-104	302	23	in	in	ADP
chd-104	302	24	vitro	vitro	X
chd-104	302	25	as	as	ADP
chd-104	302	26	mammospheres	mammosphere	NOUN
chd-104	302	27	.	.	PUNCT
chd-104	303	1	stem	stem	NOUN
chd-104	303	2	cells	cell	NOUN
chd-104	303	3	(	(	PUNCT
chd-104	303	4	dayton	dayton	PROPN
chd-104	303	5	,	,	PUNCT
chd-104	303	6	ohio	ohio	PROPN
chd-104	303	7	)	)	PUNCT
chd-104	303	8	25	25	NUM
chd-104	303	9	,	,	PUNCT
chd-104	303	10	807	807	NUM
chd-104	303	11	-	-	SYM
chd-104	303	12	815	815	NUM
chd-104	303	13	.	.	PUNCT
chd-104	304	1	schroeter	schroeter	PROPN
chd-104	304	2	,	,	PUNCT
chd-104	304	3	e.h	e.h	PROPN
chd-104	304	4	.	.	PROPN
chd-104	304	5	,	,	PUNCT
chd-104	304	6	kisslinger	kisslinger	PROPN
chd-104	304	7	,	,	PUNCT
chd-104	304	8	j.a	j.a	PROPN
chd-104	304	9	.	.	PROPN
chd-104	304	10	,	,	PUNCT
chd-104	304	11	and	and	CCONJ
chd-104	304	12	kopan	kopan	PROPN
chd-104	304	13	,	,	PUNCT
chd-104	304	14	r.	r.	PROPN
chd-104	304	15	(	(	PUNCT
chd-104	304	16	1998	1998	NUM
chd-104	304	17	)	)	PUNCT
chd-104	304	18	.	.	PUNCT
chd-104	305	1	notch-1	notch-1	NUM
chd-104	305	2	signalling	signal	VERB
chd-104	305	3	requires	require	VERB
chd-104	305	4	ligand	ligand	NOUN
chd-104	305	5	-	-	PUNCT
chd-104	305	6	induced	induce	VERB
chd-104	305	7	proteolytic	proteolytic	ADJ
chd-104	305	8	release	release	NOUN
chd-104	305	9	of	of	ADP
chd-104	305	10	intracellular	intracellular	ADJ
chd-104	305	11	domain	domain	NOUN
chd-104	305	12	.	.	PUNCT
chd-104	306	1	nature	nature	NOUN
chd-104	306	2	393	393	NUM
chd-104	306	3	,	,	PUNCT
chd-104	306	4	382	382	NUM
chd-104	306	5	-	-	SYM
chd-104	306	6	386	386	NUM
chd-104	306	7	.	.	PUNCT
chd-104	307	1	shah	shah	PROPN
chd-104	307	2	,	,	PUNCT
chd-104	307	3	s.p	s.p	PROPN
chd-104	307	4	.	.	PROPN
chd-104	307	5	,	,	PUNCT
chd-104	307	6	roth	roth	PROPN
chd-104	307	7	,	,	PUNCT
chd-104	307	8	a.	a.	PROPN
chd-104	307	9	,	,	PUNCT
chd-104	307	10	goya	goya	PROPN
chd-104	307	11	,	,	PUNCT
chd-104	307	12	r.	r.	PROPN
chd-104	307	13	,	,	PUNCT
chd-104	307	14	oloumi	oloumi	PROPN
chd-104	307	15	,	,	PUNCT
chd-104	307	16	a.	a.	NOUN
chd-104	307	17	,	,	PUNCT
chd-104	307	18	ha	ha	INTJ
chd-104	307	19	,	,	PUNCT
chd-104	307	20	g.	g.	PROPN
chd-104	307	21	,	,	PUNCT
chd-104	307	22	zhao	zhao	PROPN
chd-104	307	23	,	,	PUNCT
chd-104	307	24	y.	y.	PROPN
chd-104	307	25	,	,	PUNCT
chd-104	307	26	turashvili	turashvili	NOUN
chd-104	307	27	,	,	PUNCT
chd-104	307	28	g.	g.	PROPN
chd-104	307	29	,	,	PUNCT
chd-104	307	30	ding	ding	NOUN
chd-104	307	31	,	,	PUNCT
chd-104	307	32	j.	j.	PROPN
chd-104	307	33	,	,	PUNCT
chd-104	307	34	tse	tse	PROPN
chd-104	307	35	,	,	PUNCT
chd-104	307	36	k.	k.	PROPN
chd-104	307	37	,	,	PUNCT
chd-104	307	38	haffari	haffari	PROPN
chd-104	307	39	,	,	PUNCT
chd-104	307	40	g.	g.	PROPN
chd-104	307	41	,	,	PUNCT
chd-104	307	42	et	et	PROPN
chd-104	307	43	al	al	PROPN
chd-104	307	44	.	.	PUNCT
chd-104	307	45	(	(	PUNCT
chd-104	307	46	2012	2012	NUM
chd-104	307	47	)	)	PUNCT
chd-104	307	48	.	.	PUNCT
chd-104	308	1	the	the	DET
chd-104	308	2	clonal	clonal	ADJ
chd-104	308	3	and	and	CCONJ
chd-104	308	4	mutational	mutational	ADJ
chd-104	308	5	evolution	evolution	NOUN
chd-104	308	6	spectrum	spectrum	NOUN
chd-104	308	7	of	of	ADP
chd-104	308	8	primary	primary	ADJ
chd-104	308	9	triple	triple	ADJ
chd-104	308	10	-	-	PUNCT
chd-104	308	11	negative	negative	ADJ
chd-104	308	12	breast	breast	NOUN
chd-104	308	13	cancers	cancer	NOUN
chd-104	308	14	.	.	PUNCT
chd-104	309	1	nature	nature	NOUN
chd-104	309	2	486	486	NUM
chd-104	309	3	,	,	PUNCT
chd-104	309	4	395	395	NUM
chd-104	309	5	-	-	SYM
chd-104	309	6	399	399	NUM
chd-104	309	7	.	.	PUNCT
chd-104	310	1	sharma	sharma	PROPN
chd-104	310	2	,	,	PUNCT
chd-104	310	3	v.m	v.m	PROPN
chd-104	310	4	.	.	PROPN
chd-104	310	5	,	,	PUNCT
chd-104	310	6	calvo	calvo	PROPN
chd-104	310	7	,	,	PUNCT
chd-104	310	8	j.a	j.a	PROPN
chd-104	310	9	.	.	PROPN
chd-104	310	10	,	,	PUNCT
chd-104	310	11	draheim	draheim	PROPN
chd-104	310	12	,	,	PUNCT
chd-104	310	13	k.m	k.m	PROPN
chd-104	310	14	.	.	PROPN
chd-104	310	15	,	,	PUNCT
chd-104	310	16	cunningham	cunningham	PROPN
chd-104	310	17	,	,	PUNCT
chd-104	310	18	l.a	l.a	PROPN
chd-104	310	19	.	.	PROPN
chd-104	310	20	,	,	PUNCT
chd-104	310	21	hermance	hermance	NOUN
chd-104	310	22	,	,	PUNCT
chd-104	310	23	n.	n.	NOUN
chd-104	310	24	,	,	PUNCT
chd-104	310	25	beverly	beverly	PROPN
chd-104	310	26	,	,	PUNCT
chd-104	310	27	l.	l.	PROPN
chd-104	310	28	,	,	PUNCT
chd-104	310	29	krishnamoorthy	krishnamoorthy	ADJ
chd-104	310	30	,	,	PUNCT
chd-104	310	31	v.	v.	PROPN
chd-104	310	32	,	,	PUNCT
chd-104	310	33	bhasin	bhasin	NOUN
chd-104	310	34	,	,	PUNCT
chd-104	310	35	m.	m.	NOUN
chd-104	310	36	,	,	PUNCT
chd-104	310	37	capobianco	capobianco	NOUN
chd-104	310	38	,	,	PUNCT
chd-104	310	39	a.j	a.j	PROPN
chd-104	310	40	.	.	PROPN
chd-104	310	41	,	,	PUNCT
chd-104	310	42	and	and	CCONJ
chd-104	310	43	kelliher	kelliher	PROPN
chd-104	310	44	,	,	PUNCT
chd-104	310	45	m.a	m.a	PROPN
chd-104	310	46	.	.	PROPN
chd-104	310	47	(	(	PUNCT
chd-104	310	48	2006	2006	NUM
chd-104	310	49	)	)	PUNCT
chd-104	310	50	.	.	PUNCT
chd-104	311	1	notch1	notch1	PROPN
chd-104	311	2	contributes	contribute	VERB
chd-104	311	3	to	to	AUX
chd-104	311	4	mouse	mouse	PROPN
chd-104	311	5	t	t	PROPN
chd-104	311	6	-	-	PUNCT
chd-104	311	7	cell	cell	NOUN
chd-104	311	8	leukemia	leukemia	NOUN
chd-104	311	9	by	by	ADP
chd-104	311	10	directly	directly	ADV
chd-104	311	11	inducing	induce	VERB
chd-104	311	12	the	the	DET
chd-104	311	13	expression	expression	NOUN
chd-104	311	14	of	of	ADP
chd-104	311	15	c	c	NOUN
chd-104	311	16	-	-	PUNCT
chd-104	311	17	myc	myc	NOUN
chd-104	311	18	.	.	PUNCT
chd-104	312	1	mol	mol	ADP
chd-104	312	2	cell	cell	NOUN
chd-104	312	3	biol	biol	NOUN
chd-104	312	4	26	26	NUM
chd-104	312	5	,	,	PUNCT
chd-104	312	6	8022	8022	NUM
chd-104	312	7	-	-	SYM
chd-104	312	8	8031	8031	NUM
chd-104	312	9	.	.	PUNCT
chd-104	313	1	shih	shih	PROPN
chd-104	313	2	ie	ie	PROPN
chd-104	313	3	,	,	PUNCT
chd-104	313	4	m.	m.	NOUN
chd-104	313	5	,	,	PUNCT
chd-104	313	6	and	and	CCONJ
chd-104	313	7	wang	wang	PROPN
chd-104	313	8	,	,	PUNCT
chd-104	313	9	t.l	t.l	PROPN
chd-104	313	10	.	.	PUNCT
chd-104	313	11	(	(	PUNCT
chd-104	313	12	2007	2007	NUM
chd-104	313	13	)	)	PUNCT
chd-104	313	14	.	.	PUNCT
chd-104	314	1	notch	notch	ADJ
chd-104	314	2	signaling	signal	VERB
chd-104	314	3	,	,	PUNCT
chd-104	314	4	gammasecretase	gammasecretase	VERB
chd-104	314	5	inhibitors	inhibitor	NOUN
chd-104	314	6	,	,	PUNCT
chd-104	314	7	and	and	CCONJ
chd-104	314	8	cancer	cancer	NOUN
chd-104	314	9	therapy	therapy	NOUN
chd-104	314	10	.	.	PUNCT
chd-104	315	1	cancer	cancer	NOUN
chd-104	315	2	research	research	PROPN
chd-104	315	3	67	67	NUM
chd-104	315	4	,	,	PUNCT
chd-104	315	5	1879	1879	NUM
chd-104	315	6	-	-	SYM
chd-104	315	7	1882	1882	NUM
chd-104	315	8	.	.	PUNCT
chd-104	316	1	speiser	speiser	PROPN
chd-104	316	2	,	,	PUNCT
chd-104	316	3	j.	j.	PROPN
chd-104	316	4	,	,	PUNCT
chd-104	316	5	foreman	foreman	NOUN
chd-104	316	6	,	,	PUNCT
chd-104	316	7	k.	k.	PROPN
chd-104	316	8	,	,	PUNCT
chd-104	316	9	drinka	drinka	PROPN
chd-104	316	10	,	,	PUNCT
chd-104	316	11	e.	e.	PROPN
chd-104	316	12	,	,	PUNCT
chd-104	316	13	godellas	godellas	PROPN
chd-104	316	14	,	,	PUNCT
chd-104	316	15	c.	c.	PROPN
chd-104	316	16	,	,	PUNCT
chd-104	316	17	perez	perez	PROPN
chd-104	316	18	,	,	PUNCT
chd-104	316	19	c.	c.	PROPN
chd-104	316	20	,	,	PUNCT
chd-104	316	21	salhadar	salhadar	PROPN
chd-104	316	22	,	,	PUNCT
chd-104	316	23	a.	a.	PROPN
chd-104	316	24	,	,	PUNCT
chd-104	316	25	ersahin	ersahin	PROPN
chd-104	316	26	,	,	PUNCT
chd-104	316	27	c.	c.	NOUN
chd-104	316	28	,	,	PUNCT
chd-104	316	29	and	and	CCONJ
chd-104	316	30	rajan	rajan	PROPN
chd-104	316	31	,	,	PUNCT
chd-104	316	32	p.	p.	NOUN
chd-104	316	33	(	(	PUNCT
chd-104	316	34	2012	2012	NUM
chd-104	316	35	)	)	PUNCT
chd-104	316	36	.	.	PUNCT
chd-104	317	1	notch-1	notch-1	NUM
chd-104	317	2	and	and	CCONJ
chd-104	317	3	notch-4	notch-4	PRON
chd-104	317	4	biomarker	biomarker	NOUN
chd-104	317	5	expression	expression	NOUN
chd-104	317	6	in	in	ADP
chd-104	317	7	triple	triple	ADJ
chd-104	317	8	-	-	PUNCT
chd-104	317	9	negative	negative	ADJ
chd-104	317	10	breast	breast	NOUN
chd-104	317	11	cancer	cancer	NOUN
chd-104	317	12	.	.	PUNCT
chd-104	318	1	international	international	ADJ
chd-104	318	2	journal	journal	NOUN
chd-104	318	3	of	of	ADP
chd-104	318	4	surgical	surgical	ADJ
chd-104	318	5	pathology	pathology	NOUN
chd-104	318	6	20	20	NUM
chd-104	318	7	,	,	PUNCT
chd-104	318	8	139	139	NUM
chd-104	318	9	-	-	SYM
chd-104	318	10	145	145	NUM
chd-104	318	11	.	.	PUNCT
chd-104	319	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-104	319	2	e22	e22	PROPN
chd-104	319	3	cancer	cancer	NOUN
chd-104	319	4	health	health	NOUN
chd-104	319	5	disparities	disparity	NOUN
chd-104	319	6	research	research	PROPN
chd-104	319	7	stark	stark	PROPN
chd-104	319	8	,	,	PUNCT
chd-104	319	9	a.	a.	PROPN
chd-104	319	10	,	,	PUNCT
chd-104	319	11	kleer	kleer	PROPN
chd-104	319	12	,	,	PUNCT
chd-104	319	13	c.g	c.g	PROPN
chd-104	319	14	.	.	PROPN
chd-104	319	15	,	,	PUNCT
chd-104	319	16	martin	martin	PROPN
chd-104	319	17	,	,	PUNCT
chd-104	319	18	i.	i.	PROPN
chd-104	319	19	,	,	PUNCT
chd-104	319	20	awuah	awuah	PROPN
chd-104	319	21	,	,	PUNCT
chd-104	319	22	b.	b.	PROPN
chd-104	319	23	,	,	PUNCT
chd-104	319	24	nsiah	nsiah	PROPN
chd-104	319	25	-	-	PUNCT
chd-104	319	26	asare	asare	PROPN
chd-104	319	27	,	,	PUNCT
chd-104	319	28	a.	a.	NOUN
chd-104	319	29	,	,	PUNCT
chd-104	319	30	takyi	takyi	NOUN
chd-104	319	31	,	,	PUNCT
chd-104	319	32	v.	v.	PROPN
chd-104	319	33	,	,	PUNCT
chd-104	319	34	braman	braman	PROPN
chd-104	319	35	,	,	PUNCT
chd-104	319	36	m.	m.	NOUN
chd-104	319	37	,	,	PUNCT
chd-104	319	38	quayson	quayson	NOUN
chd-104	319	39	,	,	PUNCT
chd-104	319	40	s.e	s.e	PROPN
chd-104	319	41	.	.	PROPN
chd-104	319	42	,	,	PUNCT
chd-104	319	43	zarbo	zarbo	PROPN
chd-104	319	44	,	,	PUNCT
chd-104	319	45	r.	r.	PROPN
chd-104	319	46	,	,	PUNCT
chd-104	319	47	wicha	wicha	ADV
chd-104	319	48	,	,	PUNCT
chd-104	319	49	m.	m.	NOUN
chd-104	319	50	,	,	PUNCT
chd-104	319	51	et	et	PROPN
chd-104	319	52	al	al	PROPN
chd-104	319	53	.	.	PROPN
chd-104	320	1	(	(	PUNCT
chd-104	320	2	2010a	2010a	NUM
chd-104	320	3	)	)	PUNCT
chd-104	320	4	.	.	PUNCT
chd-104	321	1	african	african	ADJ
chd-104	321	2	ancestry	ancestry	NOUN
chd-104	321	3	and	and	CCONJ
chd-104	321	4	higher	high	ADJ
chd-104	321	5	prevalence	prevalence	NOUN
chd-104	321	6	of	of	ADP
chd-104	321	7	triple	triple	ADJ
chd-104	321	8	-	-	PUNCT
chd-104	321	9	negative	negative	ADJ
chd-104	321	10	breast	breast	NOUN
chd-104	321	11	cancer	cancer	NOUN
chd-104	321	12	:	:	PUNCT
chd-104	321	13	findings	finding	NOUN
chd-104	321	14	from	from	ADP
chd-104	321	15	an	an	DET
chd-104	321	16	international	international	ADJ
chd-104	321	17	study	study	NOUN
chd-104	321	18	.	.	PUNCT
chd-104	322	1	cancer	cancer	NOUN
chd-104	322	2	116	116	NUM
chd-104	322	3	,	,	PUNCT
chd-104	322	4	4926	4926	NUM
chd-104	322	5	-	-	SYM
chd-104	322	6	4932	4932	NUM
chd-104	322	7	.	.	PUNCT
chd-104	323	1	stark	stark	PROPN
chd-104	323	2	,	,	PUNCT
chd-104	323	3	a.	a.	PROPN
chd-104	323	4	,	,	PUNCT
chd-104	323	5	kleer	kleer	PROPN
chd-104	323	6	,	,	PUNCT
chd-104	323	7	c.g	c.g	PROPN
chd-104	323	8	.	.	PROPN
chd-104	323	9	,	,	PUNCT
chd-104	323	10	martin	martin	PROPN
chd-104	323	11	,	,	PUNCT
chd-104	323	12	i.	i.	PROPN
chd-104	323	13	,	,	PUNCT
chd-104	323	14	awuah	awuah	PROPN
chd-104	323	15	,	,	PUNCT
chd-104	323	16	b.	b.	PROPN
chd-104	323	17	,	,	PUNCT
chd-104	323	18	nsiah	nsiah	PROPN
chd-104	323	19	-	-	PUNCT
chd-104	323	20	asare	asare	PROPN
chd-104	323	21	,	,	PUNCT
chd-104	323	22	a.	a.	NOUN
chd-104	323	23	,	,	PUNCT
chd-104	323	24	takyi	takyi	NOUN
chd-104	323	25	,	,	PUNCT
chd-104	323	26	v.	v.	PROPN
chd-104	323	27	,	,	PUNCT
chd-104	323	28	braman	braman	PROPN
chd-104	323	29	,	,	PUNCT
chd-104	323	30	m.	m.	NOUN
chd-104	323	31	,	,	PUNCT
chd-104	323	32	quayson	quayson	NOUN
chd-104	323	33	,	,	PUNCT
chd-104	323	34	s.e	s.e	PROPN
chd-104	323	35	.	.	PROPN
chd-104	323	36	,	,	PUNCT
chd-104	323	37	zarbo	zarbo	PROPN
chd-104	323	38	,	,	PUNCT
chd-104	323	39	r.	r.	PROPN
chd-104	323	40	,	,	PUNCT
chd-104	323	41	wicha	wicha	ADV
chd-104	323	42	,	,	PUNCT
chd-104	323	43	m.	m.	NOUN
chd-104	323	44	,	,	PUNCT
chd-104	323	45	et	et	PROPN
chd-104	323	46	al	al	PROPN
chd-104	323	47	.	.	PROPN
chd-104	323	48	(	(	PUNCT
chd-104	323	49	2010b	2010b	NUM
chd-104	323	50	)	)	PUNCT
chd-104	323	51	.	.	PUNCT
chd-104	324	1	african	african	ADJ
chd-104	324	2	ancestry	ancestry	NOUN
chd-104	324	3	and	and	CCONJ
chd-104	324	4	higher	high	ADJ
chd-104	324	5	prevalence	prevalence	NOUN
chd-104	324	6	of	of	ADP
chd-104	324	7	triple	triple	ADJ
chd-104	324	8	-	-	PUNCT
chd-104	324	9	negative	negative	ADJ
chd-104	324	10	breast	breast	NOUN
chd-104	324	11	cancer	cancer	NOUN
chd-104	324	12	:	:	PUNCT
chd-104	324	13	findings	finding	NOUN
chd-104	324	14	from	from	ADP
chd-104	324	15	an	an	DET
chd-104	324	16	international	international	ADJ
chd-104	324	17	study	study	NOUN
chd-104	324	18	.	.	PUNCT
chd-104	325	1	cancer	cancer	NOUN
chd-104	325	2	116	116	NUM
chd-104	325	3	,	,	PUNCT
chd-104	325	4	4926	4926	NUM
chd-104	325	5	-	-	SYM
chd-104	325	6	4932	4932	NUM
chd-104	325	7	.	.	PUNCT
chd-104	326	1	stewart	stewart	PROPN
chd-104	326	2	,	,	PUNCT
chd-104	326	3	p.a	p.a	PROPN
chd-104	326	4	.	.	PROPN
chd-104	326	5	,	,	PUNCT
chd-104	326	6	luks	luks	PROPN
chd-104	326	7	,	,	PUNCT
chd-104	326	8	j.	j.	PROPN
chd-104	326	9	,	,	PUNCT
chd-104	326	10	roycik	roycik	PROPN
chd-104	326	11	,	,	PUNCT
chd-104	326	12	m.d	m.d	PROPN
chd-104	326	13	.	.	PROPN
chd-104	326	14	,	,	PUNCT
chd-104	326	15	sang	sing	VERB
chd-104	326	16	,	,	PUNCT
chd-104	326	17	q.x	q.x	PROPN
chd-104	326	18	.	.	PROPN
chd-104	326	19	,	,	PUNCT
chd-104	326	20	and	and	CCONJ
chd-104	326	21	zhang	zhang	PROPN
chd-104	326	22	,	,	PUNCT
chd-104	326	23	j.	j.	PROPN
chd-104	326	24	(	(	PUNCT
chd-104	326	25	2013	2013	NUM
chd-104	326	26	)	)	PUNCT
chd-104	326	27	.	.	PUNCT
chd-104	327	1	differentially	differentially	ADV
chd-104	327	2	expressed	express	VERB
chd-104	327	3	transcripts	transcript	NOUN
chd-104	327	4	and	and	CCONJ
chd-104	327	5	dysregulated	dysregulated	ADJ
chd-104	327	6	signaling	signal	VERB
chd-104	327	7	pathways	pathway	NOUN
chd-104	327	8	and	and	CCONJ
chd-104	327	9	networks	network	NOUN
chd-104	327	10	in	in	ADP
chd-104	327	11	african	african	ADJ
chd-104	327	12	american	american	ADJ
chd-104	327	13	breast	breast	NOUN
chd-104	327	14	cancer	cancer	NOUN
chd-104	327	15	.	.	PUNCT
chd-104	328	1	plos	plos	PROPN
chd-104	328	2	one	one	NUM
chd-104	328	3	8	8	NUM
chd-104	328	4	,	,	PUNCT
chd-104	328	5	e82460	e82460	PROPN
chd-104	328	6	.	.	PUNCT
chd-104	329	1	sullivan	sullivan	PROPN
chd-104	329	2	,	,	PUNCT
chd-104	329	3	h.c	h.c	PROPN
chd-104	329	4	.	.	PROPN
chd-104	329	5	,	,	PUNCT
chd-104	329	6	oprea	oprea	NOUN
chd-104	329	7	-	-	PUNCT
chd-104	329	8	ilies	ilie	NOUN
chd-104	329	9	,	,	PUNCT
chd-104	329	10	g.	g.	PROPN
chd-104	329	11	,	,	PUNCT
chd-104	329	12	adams	adams	PROPN
chd-104	329	13	,	,	PUNCT
chd-104	329	14	a.l	a.l	PROPN
chd-104	329	15	.	.	PROPN
chd-104	329	16	,	,	PUNCT
chd-104	329	17	page	page	NOUN
chd-104	329	18	,	,	PUNCT
chd-104	329	19	a.j	a.j	PROPN
chd-104	329	20	.	.	PROPN
chd-104	329	21	,	,	PUNCT
chd-104	329	22	kim	kim	PROPN
chd-104	329	23	,	,	PUNCT
chd-104	329	24	s.	s.	PROPN
chd-104	329	25	,	,	PUNCT
chd-104	329	26	wang	wang	PROPN
chd-104	329	27	,	,	PUNCT
chd-104	329	28	j.	j.	PROPN
chd-104	329	29	,	,	PUNCT
chd-104	329	30	and	and	CCONJ
chd-104	329	31	cohen	cohen	PROPN
chd-104	329	32	,	,	PUNCT
chd-104	329	33	c.	c.	PROPN
chd-104	329	34	(	(	PUNCT
chd-104	329	35	2014	2014	NUM
chd-104	329	36	)	)	PUNCT
chd-104	329	37	.	.	PUNCT
chd-104	330	1	triple	triple	ADJ
chd-104	330	2	-	-	PUNCT
chd-104	330	3	negative	negative	ADJ
chd-104	330	4	breast	breast	NOUN
chd-104	330	5	carcinoma	carcinoma	NOUN
chd-104	330	6	in	in	ADP
chd-104	330	7	african	african	ADJ
chd-104	330	8	american	american	ADJ
chd-104	330	9	and	and	CCONJ
chd-104	330	10	caucasian	caucasian	ADJ
chd-104	330	11	women	woman	NOUN
chd-104	330	12	:	:	PUNCT
chd-104	330	13	clinicopathology	clinicopathology	NOUN
chd-104	330	14	,	,	PUNCT
chd-104	330	15	immunomarkers	immunomarker	NOUN
chd-104	330	16	,	,	PUNCT
chd-104	330	17	and	and	CCONJ
chd-104	330	18	outcome	outcome	NOUN
chd-104	330	19	.	.	PUNCT
chd-104	331	1	appl	appl	PROPN
chd-104	331	2	immunohistochem	immunohistochem	PROPN
chd-104	331	3	mol	mol	ADP
chd-104	331	4	morphol	morphol	NOUN
chd-104	331	5	22	22	NUM
chd-104	331	6	,	,	PUNCT
chd-104	331	7	17	17	NUM
chd-104	331	8	-	-	SYM
chd-104	331	9	23	23	NUM
chd-104	331	10	.	.	PUNCT
chd-104	332	1	touplikioti	touplikioti	PROPN
chd-104	332	2	,	,	PUNCT
chd-104	332	3	p.	p.	NOUN
chd-104	332	4	(	(	PUNCT
chd-104	332	5	2012	2012	NUM
chd-104	332	6	)	)	PUNCT
chd-104	332	7	.	.	PUNCT
chd-104	333	1	expression	expression	NOUN
chd-104	333	2	of	of	ADP
chd-104	333	3	notch	notch	ADJ
chd-104	333	4	receptors	receptor	NOUN
chd-104	333	5	in	in	ADP
chd-104	333	6	primary	primary	ADJ
chd-104	333	7	breast	breast	NOUN
chd-104	333	8	cancer	cancer	NOUN
chd-104	333	9	and	and	CCONJ
chd-104	333	10	correlation	correlation	NOUN
chd-104	333	11	with	with	ADP
chd-104	333	12	pathological	pathological	ADJ
chd-104	333	13	features	feature	NOUN
chd-104	333	14	,	,	PUNCT
chd-104	333	15	vol	vol	NOUN
chd-104	333	16	02	02	NUM
chd-104	333	17	.	.	PUNCT
chd-104	334	1	uzhachenko	uzhachenko	PROPN
chd-104	334	2	,	,	PUNCT
chd-104	334	3	r.	r.	PROPN
chd-104	334	4	,	,	PUNCT
chd-104	334	5	and	and	CCONJ
chd-104	334	6	shanker	shanker	NOUN
chd-104	334	7	,	,	PUNCT
chd-104	334	8	a.	a.	NOUN
chd-104	334	9	(	(	PUNCT
chd-104	334	10	2016	2016	NUM
chd-104	334	11	)	)	PUNCT
chd-104	334	12	.	.	PUNCT
chd-104	335	1	notching	notch	VERB
chd-104	335	2	tumor	tumor	NOUN
chd-104	335	3	:	:	PUNCT
chd-104	335	4	signaling	signal	VERB
chd-104	335	5	through	through	ADP
chd-104	335	6	notch	notch	ADJ
chd-104	335	7	receptors	receptor	NOUN
chd-104	335	8	improves	improve	VERB
chd-104	335	9	antitumor	antitumor	PROPN
chd-104	335	10	t	t	PROPN
chd-104	335	11	cell	cell	NOUN
chd-104	335	12	immunity	immunity	NOUN
chd-104	335	13	.	.	PUNCT
chd-104	336	1	oncoimmunology	oncoimmunology	NOUN
chd-104	336	2	5	5	NUM
chd-104	336	3	,	,	PUNCT
chd-104	336	4	e1122864	e1122864	PROPN
chd-104	336	5	.	.	PUNCT
chd-104	337	1	van	van	PROPN
chd-104	337	2	tetering	tetering	PROPN
chd-104	337	3	,	,	PUNCT
chd-104	337	4	g.	g.	PROPN
chd-104	337	5	,	,	PUNCT
chd-104	337	6	van	van	PROPN
chd-104	337	7	diest	diest	NOUN
chd-104	337	8	,	,	PUNCT
chd-104	337	9	p.	p.	PROPN
chd-104	337	10	,	,	PUNCT
chd-104	337	11	verlaan	verlaan	PROPN
chd-104	337	12	,	,	PUNCT
chd-104	337	13	i.	i.	PROPN
chd-104	337	14	,	,	PUNCT
chd-104	337	15	van	van	PROPN
chd-104	337	16	der	der	PROPN
chd-104	337	17	wall	wall	PROPN
chd-104	337	18	,	,	PUNCT
chd-104	337	19	e.	e.	PROPN
chd-104	337	20	,	,	PUNCT
chd-104	337	21	kopan	kopan	PROPN
chd-104	337	22	,	,	PUNCT
chd-104	337	23	r.	r.	PROPN
chd-104	337	24	,	,	PUNCT
chd-104	337	25	and	and	CCONJ
chd-104	337	26	vooijs	vooijs	PROPN
chd-104	337	27	,	,	PUNCT
chd-104	337	28	m.	m.	NOUN
chd-104	337	29	(	(	PUNCT
chd-104	337	30	2009	2009	NUM
chd-104	337	31	)	)	PUNCT
chd-104	337	32	.	.	PUNCT
chd-104	338	1	metalloprotease	metalloprotease	PROPN
chd-104	338	2	adam10	adam10	PROPN
chd-104	338	3	is	be	AUX
chd-104	338	4	required	require	VERB
chd-104	338	5	for	for	ADP
chd-104	338	6	notch1	notch1	NOUN
chd-104	338	7	site	site	NOUN
chd-104	338	8	2	2	NUM
chd-104	338	9	cleavage	cleavage	NOUN
chd-104	338	10	.	.	PUNCT
chd-104	339	1	the	the	DET
chd-104	339	2	journal	journal	NOUN
chd-104	339	3	of	of	ADP
chd-104	339	4	biological	biological	ADJ
chd-104	339	5	chemistry	chemistry	NOUN
chd-104	339	6	284	284	NUM
chd-104	339	7	,	,	PUNCT
chd-104	339	8	31018	31018	NUM
chd-104	339	9	-	-	SYM
chd-104	339	10	31027	31027	NUM
chd-104	339	11	.	.	PUNCT
chd-104	340	1	wang	wang	PROPN
chd-104	340	2	,	,	PUNCT
chd-104	340	3	z.	z.	PROPN
chd-104	340	4	,	,	PUNCT
chd-104	340	5	li	li	PROPN
chd-104	340	6	,	,	PUNCT
chd-104	340	7	y.	y.	PROPN
chd-104	340	8	,	,	PUNCT
chd-104	340	9	and	and	CCONJ
chd-104	340	10	sarkar	sarkar	PROPN
chd-104	340	11	,	,	PUNCT
chd-104	340	12	f.h	f.h	PROPN
chd-104	340	13	.	.	PROPN
chd-104	340	14	(	(	PUNCT
chd-104	340	15	2010	2010	NUM
chd-104	340	16	)	)	PUNCT
chd-104	340	17	.	.	PUNCT
chd-104	341	1	notch	notch	ADJ
chd-104	341	2	signaling	signal	VERB
chd-104	341	3	proteins	protein	NOUN
chd-104	341	4	:	:	PUNCT
chd-104	341	5	legitimate	legitimate	ADJ
chd-104	341	6	targets	target	NOUN
chd-104	341	7	for	for	ADP
chd-104	341	8	cancer	cancer	NOUN
chd-104	341	9	therapy	therapy	NOUN
chd-104	341	10	.	.	PUNCT
chd-104	342	1	curr	curr	PROPN
chd-104	342	2	protein	protein	NOUN
chd-104	342	3	pept	pept	VERB
chd-104	342	4	sci	sci	PROPN
chd-104	342	5	11	11	NUM
chd-104	342	6	,	,	PUNCT
chd-104	342	7	398	398	NUM
chd-104	342	8	-	-	SYM
chd-104	342	9	408	408	NUM
chd-104	342	10	.	.	PUNCT
chd-104	343	1	weijzen	weijzen	PROPN
chd-104	343	2	,	,	PUNCT
chd-104	343	3	s.	s.	PROPN
chd-104	343	4	,	,	PUNCT
chd-104	343	5	rizzo	rizzo	PROPN
chd-104	343	6	,	,	PUNCT
chd-104	343	7	p.	p.	PROPN
chd-104	343	8	,	,	PUNCT
chd-104	343	9	braid	braid	PROPN
chd-104	343	10	,	,	PUNCT
chd-104	343	11	m.	m.	NOUN
chd-104	343	12	,	,	PUNCT
chd-104	343	13	vaishnav	vaishnav	PROPN
chd-104	343	14	,	,	PUNCT
chd-104	343	15	r.	r.	PROPN
chd-104	343	16	,	,	PUNCT
chd-104	343	17	jonkheer	jonkheer	PROPN
chd-104	343	18	,	,	PUNCT
chd-104	343	19	s.m	s.m	PROPN
chd-104	343	20	.	.	PROPN
chd-104	343	21	,	,	PUNCT
chd-104	343	22	zlobin	zlobin	PROPN
chd-104	343	23	,	,	PUNCT
chd-104	343	24	a.	a.	PROPN
chd-104	343	25	,	,	PUNCT
chd-104	343	26	osborne	osborne	PROPN
chd-104	343	27	,	,	PUNCT
chd-104	343	28	b.a	b.a	PROPN
chd-104	343	29	.	.	PROPN
chd-104	343	30	,	,	PUNCT
chd-104	343	31	gottipati	gottipati	PROPN
chd-104	343	32	,	,	PUNCT
chd-104	343	33	s.	s.	PROPN
chd-104	343	34	,	,	PUNCT
chd-104	343	35	aster	aster	NOUN
chd-104	343	36	,	,	PUNCT
chd-104	343	37	j.c	j.c	PROPN
chd-104	343	38	.	.	PROPN
chd-104	343	39	,	,	PUNCT
chd-104	343	40	hahn	hahn	PROPN
chd-104	343	41	,	,	PUNCT
chd-104	343	42	w.c	w.c	PROPN
chd-104	343	43	.	.	PROPN
chd-104	343	44	,	,	PUNCT
chd-104	343	45	et	et	PROPN
chd-104	343	46	al	al	PROPN
chd-104	343	47	.	.	PUNCT
chd-104	343	48	(	(	PUNCT
chd-104	343	49	2002	2002	NUM
chd-104	343	50	)	)	PUNCT
chd-104	343	51	.	.	PUNCT
chd-104	344	1	activation	activation	NOUN
chd-104	344	2	of	of	ADP
chd-104	344	3	notch-1	notch-1	NUM
chd-104	344	4	signaling	signal	VERB
chd-104	344	5	maintains	maintain	VERB
chd-104	344	6	the	the	DET
chd-104	344	7	neoplastic	neoplastic	ADJ
chd-104	344	8	phenotype	phenotype	NOUN
chd-104	344	9	in	in	ADP
chd-104	344	10	human	human	ADJ
chd-104	344	11	rastransformed	rastransformed	NOUN
chd-104	344	12	cells	cell	NOUN
chd-104	344	13	.	.	PUNCT
chd-104	345	1	nature	nature	NOUN
chd-104	345	2	medicine	medicine	PROPN
chd-104	345	3	8	8	NUM
chd-104	345	4	,	,	PUNCT
chd-104	345	5	979	979	NUM
chd-104	345	6	-	-	SYM
chd-104	345	7	986	986	NUM
chd-104	345	8	.	.	PUNCT
chd-104	346	1	weng	weng	PROPN
chd-104	346	2	,	,	PUNCT
chd-104	346	3	a.p	a.p	PROPN
chd-104	346	4	.	.	PROPN
chd-104	346	5	,	,	PUNCT
chd-104	346	6	millholland	millholland	PROPN
chd-104	346	7	,	,	PUNCT
chd-104	346	8	j.m	j.m	PROPN
chd-104	346	9	.	.	PROPN
chd-104	346	10	,	,	PUNCT
chd-104	346	11	yashiro	yashiro	NOUN
chd-104	346	12	-	-	PUNCT
chd-104	346	13	ohtani	ohtani	NOUN
chd-104	346	14	,	,	PUNCT
chd-104	346	15	y.	y.	PROPN
chd-104	346	16	,	,	PUNCT
chd-104	346	17	arcangeli	arcangeli	NOUN
chd-104	346	18	,	,	PUNCT
chd-104	346	19	m.l	m.l	PROPN
chd-104	346	20	.	.	PROPN
chd-104	346	21	,	,	PUNCT
chd-104	346	22	lau	lau	PROPN
chd-104	346	23	,	,	PUNCT
chd-104	346	24	a.	a.	PROPN
chd-104	346	25	,	,	PUNCT
chd-104	346	26	wai	wai	PROPN
chd-104	346	27	,	,	PUNCT
chd-104	346	28	c.	c.	PROPN
chd-104	346	29	,	,	PUNCT
chd-104	346	30	del	del	PROPN
chd-104	346	31	bianco	bianco	PROPN
chd-104	346	32	,	,	PUNCT
chd-104	346	33	c.	c.	PROPN
chd-104	346	34	,	,	PUNCT
chd-104	346	35	rodriguez	rodriguez	PROPN
chd-104	346	36	,	,	PUNCT
chd-104	346	37	c.g	c.g	PROPN
chd-104	346	38	.	.	PROPN
chd-104	346	39	,	,	PUNCT
chd-104	346	40	sai	sai	PROPN
chd-104	346	41	,	,	PUNCT
chd-104	346	42	h.	h.	PROPN
chd-104	346	43	,	,	PUNCT
chd-104	346	44	tobias	tobias	PROPN
chd-104	346	45	,	,	PUNCT
chd-104	346	46	j.	j.	PROPN
chd-104	346	47	,	,	PUNCT
chd-104	346	48	et	et	PROPN
chd-104	346	49	al	al	PROPN
chd-104	346	50	.	.	PUNCT
chd-104	347	1	(	(	PUNCT
chd-104	347	2	2006	2006	NUM
chd-104	347	3	)	)	PUNCT
chd-104	347	4	.	.	PUNCT
chd-104	348	1	c	c	X
chd-104	348	2	-	-	PUNCT
chd-104	348	3	myc	myc	PROPN
chd-104	348	4	is	be	AUX
chd-104	348	5	an	an	DET
chd-104	348	6	important	important	ADJ
chd-104	348	7	direct	direct	ADJ
chd-104	348	8	target	target	NOUN
chd-104	348	9	of	of	ADP
chd-104	348	10	notch1	notch1	NOUN
chd-104	348	11	in	in	ADP
chd-104	348	12	t	t	NOUN
chd-104	348	13	-	-	PUNCT
chd-104	348	14	cell	cell	NOUN
chd-104	348	15	acute	acute	ADJ
chd-104	348	16	lymphoblastic	lymphoblastic	ADJ
chd-104	348	17	leukemia	leukemia	NOUN
chd-104	348	18	/	/	SYM
chd-104	348	19	lymphoma	lymphoma	NOUN
chd-104	348	20	.	.	PUNCT
chd-104	349	1	genes	gene	NOUN
chd-104	349	2	&	&	CCONJ
chd-104	349	3	development	development	NOUN
chd-104	349	4	20	20	NUM
chd-104	349	5	,	,	PUNCT
chd-104	349	6	20962109	20962109	NUM
chd-104	349	7	.	.	PUNCT
chd-104	350	1	wilson	wilson	PROPN
chd-104	350	2	,	,	PUNCT
chd-104	350	3	j.j	j.j	PROPN
chd-104	350	4	.	.	PROPN
chd-104	350	5	,	,	PUNCT
chd-104	350	6	and	and	CCONJ
chd-104	350	7	kovall	kovall	PROPN
chd-104	350	8	,	,	PUNCT
chd-104	350	9	r.a	r.a	PROPN
chd-104	350	10	.	.	PROPN
chd-104	350	11	(	(	PUNCT
chd-104	350	12	2006	2006	NUM
chd-104	350	13	)	)	PUNCT
chd-104	350	14	.	.	PUNCT
chd-104	351	1	crystal	crystal	NOUN
chd-104	351	2	structure	structure	NOUN
chd-104	351	3	of	of	ADP
chd-104	351	4	the	the	DET
chd-104	351	5	csl	csl	NOUN
chd-104	351	6	-	-	PUNCT
chd-104	351	7	notch	notch	NOUN
chd-104	351	8	-	-	PUNCT
chd-104	351	9	mastermind	mastermind	NOUN
chd-104	351	10	ternary	ternary	ADJ
chd-104	351	11	complex	complex	NOUN
chd-104	351	12	bound	bind	VERB
chd-104	351	13	to	to	ADP
chd-104	351	14	dna	dna	PROPN
chd-104	351	15	.	.	PUNCT
chd-104	352	1	cell	cell	NOUN
chd-104	352	2	124	124	NUM
chd-104	352	3	,	,	PUNCT
chd-104	352	4	985	985	NUM
chd-104	352	5	-	-	SYM
chd-104	352	6	996	996	NUM
chd-104	352	7	.	.	PUNCT
chd-104	353	1	wu	wu	PROPN
chd-104	353	2	,	,	PUNCT
chd-104	353	3	x.	x.	NOUN
chd-104	353	4	,	,	PUNCT
chd-104	353	5	ye	ye	PRON
chd-104	353	6	,	,	PUNCT
chd-104	353	7	y.	y.	NOUN
chd-104	353	8	,	,	PUNCT
chd-104	353	9	barcenas	barcenas	PROPN
chd-104	353	10	,	,	PUNCT
chd-104	353	11	c.h	c.h	PROPN
chd-104	353	12	.	.	PROPN
chd-104	353	13	,	,	PUNCT
chd-104	353	14	chow	chow	PROPN
chd-104	353	15	,	,	PUNCT
chd-104	353	16	w.h	w.h	PROPN
chd-104	353	17	.	.	PROPN
chd-104	353	18	,	,	PUNCT
chd-104	353	19	meng	meng	PROPN
chd-104	353	20	,	,	PUNCT
chd-104	353	21	q.h	q.h	PROPN
chd-104	353	22	.	.	PROPN
chd-104	353	23	,	,	PUNCT
chd-104	353	24	chavez	chavez	PROPN
chd-104	353	25	-	-	PUNCT
chd-104	353	26	macgregor	macgregor	PROPN
chd-104	353	27	,	,	PUNCT
chd-104	353	28	m.	m.	NOUN
chd-104	353	29	,	,	PUNCT
chd-104	353	30	hildebrandt	hildebrandt	PROPN
chd-104	353	31	,	,	PUNCT
chd-104	353	32	m.a	m.a	PROPN
chd-104	353	33	.	.	PROPN
chd-104	353	34	,	,	PUNCT
chd-104	353	35	zhao	zhao	PROPN
chd-104	353	36	,	,	PUNCT
chd-104	353	37	h.	h.	PROPN
chd-104	353	38	,	,	PUNCT
chd-104	353	39	gu	gu	PROPN
chd-104	353	40	,	,	PUNCT
chd-104	353	41	x.	x.	PROPN
chd-104	353	42	,	,	PUNCT
chd-104	353	43	deng	deng	PROPN
chd-104	353	44	,	,	PUNCT
chd-104	353	45	y.	y.	PROPN
chd-104	353	46	,	,	PUNCT
chd-104	353	47	et	et	PROPN
chd-104	353	48	al	al	PROPN
chd-104	353	49	.	.	PUNCT
chd-104	353	50	(	(	PUNCT
chd-104	353	51	2017	2017	NUM
chd-104	353	52	)	)	PUNCT
chd-104	353	53	.	.	PUNCT
chd-104	354	1	personalized	personalize	VERB
chd-104	354	2	prognostic	prognostic	ADJ
chd-104	354	3	prediction	prediction	NOUN
chd-104	354	4	models	model	NOUN
chd-104	354	5	for	for	ADP
chd-104	354	6	breast	breast	NOUN
chd-104	354	7	cancer	cancer	NOUN
chd-104	354	8	recurrence	recurrence	NOUN
chd-104	354	9	and	and	CCONJ
chd-104	354	10	survival	survival	NOUN
chd-104	354	11	incorporating	incorporate	VERB
chd-104	354	12	multidimensional	multidimensional	ADJ
chd-104	354	13	data	datum	NOUN
chd-104	354	14	.	.	PUNCT
chd-104	355	1	journal	journal	NOUN
chd-104	355	2	of	of	ADP
chd-104	355	3	the	the	DET
chd-104	355	4	national	national	PROPN
chd-104	355	5	cancer	cancer	PROPN
chd-104	355	6	institute	institute	PROPN
chd-104	355	7	109	109	NUM
chd-104	355	8	.	.	PUNCT
chd-104	356	1	yao	yao	PROPN
chd-104	356	2	,	,	PUNCT
chd-104	356	3	k.	k.	PROPN
chd-104	356	4	,	,	PUNCT
chd-104	356	5	rizzo	rizzo	PROPN
chd-104	356	6	,	,	PUNCT
chd-104	356	7	p.	p.	PROPN
chd-104	356	8	,	,	PUNCT
chd-104	356	9	rajan	rajan	PROPN
chd-104	356	10	,	,	PUNCT
chd-104	356	11	p.	p.	PROPN
chd-104	356	12	,	,	PUNCT
chd-104	356	13	albain	albain	PROPN
chd-104	356	14	,	,	PUNCT
chd-104	356	15	k.	k.	PROPN
chd-104	356	16	,	,	PUNCT
chd-104	356	17	rychlik	rychlik	PROPN
chd-104	356	18	,	,	PUNCT
chd-104	356	19	k.	k.	PROPN
chd-104	356	20	,	,	PUNCT
chd-104	356	21	shah	shah	PROPN
chd-104	356	22	,	,	PUNCT
chd-104	356	23	s.	s.	PROPN
chd-104	356	24	,	,	PUNCT
chd-104	356	25	and	and	CCONJ
chd-104	356	26	miele	miele	PROPN
chd-104	356	27	,	,	PUNCT
chd-104	356	28	l.	l.	PROPN
chd-104	356	29	(	(	PUNCT
chd-104	356	30	2011	2011	NUM
chd-104	356	31	)	)	PUNCT
chd-104	356	32	.	.	PUNCT
chd-104	357	1	notch-1	notch-1	NUM
chd-104	357	2	and	and	CCONJ
chd-104	357	3	notch-4	notch-4	NUM
chd-104	357	4	receptors	receptor	NOUN
chd-104	357	5	as	as	ADP
chd-104	357	6	prognostic	prognostic	ADJ
chd-104	357	7	markers	marker	NOUN
chd-104	357	8	in	in	ADP
chd-104	357	9	breast	breast	NOUN
chd-104	357	10	cancer	cancer	NOUN
chd-104	357	11	.	.	PUNCT
chd-104	358	1	international	international	ADJ
chd-104	358	2	journal	journal	NOUN
chd-104	358	3	of	of	ADP
chd-104	358	4	surgical	surgical	ADJ
chd-104	358	5	pathology	pathology	NOUN
chd-104	358	6	19	19	NUM
chd-104	358	7	,	,	PUNCT
chd-104	358	8	607	607	NUM
chd-104	358	9	-	-	SYM
chd-104	358	10	613	613	NUM
chd-104	358	11	.	.	PUNCT
chd-104	359	1	zardawi	zardawi	PROPN
chd-104	359	2	,	,	PUNCT
chd-104	359	3	s.j	s.j	PROPN
chd-104	359	4	.	.	PROPN
chd-104	359	5	,	,	PUNCT
chd-104	359	6	zardawi	zardawi	PROPN
chd-104	359	7	,	,	PUNCT
chd-104	359	8	i.	i.	PROPN
chd-104	359	9	,	,	PUNCT
chd-104	359	10	mcneil	mcneil	PROPN
chd-104	359	11	,	,	PUNCT
chd-104	359	12	c.m	c.m	PROPN
chd-104	359	13	.	.	PROPN
chd-104	359	14	,	,	PUNCT
chd-104	359	15	millar	millar	PROPN
chd-104	359	16	,	,	PUNCT
chd-104	359	17	e.k	e.k	PROPN
chd-104	359	18	.	.	PROPN
chd-104	359	19	,	,	PUNCT
chd-104	359	20	mcleod	mcleod	PROPN
chd-104	359	21	,	,	PUNCT
chd-104	359	22	d.	d.	PROPN
chd-104	359	23	,	,	PUNCT
chd-104	359	24	morey	morey	PROPN
chd-104	359	25	,	,	PUNCT
chd-104	359	26	a.l	a.l	PROPN
chd-104	359	27	.	.	PROPN
chd-104	359	28	,	,	PUNCT
chd-104	359	29	crea	crea	PROPN
chd-104	359	30	,	,	PUNCT
chd-104	359	31	p.	p.	PROPN
chd-104	359	32	,	,	PUNCT
chd-104	359	33	murphy	murphy	PROPN
chd-104	359	34	,	,	PUNCT
chd-104	359	35	n.c	n.c	PROPN
chd-104	359	36	.	.	PROPN
chd-104	359	37	,	,	PUNCT
chd-104	359	38	pinese	pinese	PROPN
chd-104	359	39	,	,	PUNCT
chd-104	359	40	m.	m.	NOUN
chd-104	359	41	,	,	PUNCT
chd-104	359	42	lopezknowles	lopezknowle	NOUN
chd-104	359	43	,	,	PUNCT
chd-104	359	44	e.	e.	PROPN
chd-104	359	45	,	,	PUNCT
chd-104	359	46	et	et	PROPN
chd-104	359	47	al	al	PROPN
chd-104	359	48	.	.	PUNCT
chd-104	359	49	(	(	PUNCT
chd-104	359	50	2010	2010	NUM
chd-104	359	51	)	)	PUNCT
chd-104	359	52	.	.	PUNCT
chd-104	360	1	high	high	ADJ
chd-104	360	2	notch1	notch1	NOUN
chd-104	360	3	protein	protein	NOUN
chd-104	360	4	expression	expression	NOUN
chd-104	360	5	is	be	AUX
chd-104	360	6	an	an	DET
chd-104	360	7	early	early	ADJ
chd-104	360	8	event	event	NOUN
chd-104	360	9	in	in	ADP
chd-104	360	10	breast	breast	NOUN
chd-104	360	11	cancer	cancer	NOUN
chd-104	360	12	development	development	NOUN
chd-104	360	13	and	and	CCONJ
chd-104	360	14	is	be	AUX
chd-104	360	15	associated	associate	VERB
chd-104	360	16	with	with	ADP
chd-104	360	17	the	the	DET
chd-104	360	18	her-2	her-2	NUM
chd-104	360	19	molecular	molecular	ADJ
chd-104	360	20	subtype	subtype	NOUN
chd-104	360	21	.	.	PUNCT
chd-104	361	1	histopathology	histopathology	NOUN
chd-104	361	2	56	56	NUM
chd-104	361	3	,	,	PUNCT
chd-104	361	4	286	286	NUM
chd-104	361	5	-	-	SYM
chd-104	361	6	296	296	NUM
chd-104	361	7	.	.	PUNCT